,CUI1,CUI2,label
0,Schwannian Stroma More than 50 Percent of the Tumor Volume,Urinary Bladder Inflammatory Myofibroblastic Tumor,0
1,Recurrent Malignant Neoplasm,Childhood Malignant Solid Neoplasm,0
2,White blood cell count increased (lab result),"Transitional cell papilloma, inverted",0
3,Fenestrated Pattern,Pancreatic Endocrine Carcinoma,0
4,Schwannian Stroma More than 50 Percent of the Tumor Volume,Inflammatory Myofibroblastic Tumor,0
5,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Breast Cancer, Familial",0
6,Small Aggregates of Tumor Cells Present,Thymic Small Cell Carcinoma,0
7,Fenestrated Pattern,"Polyposis, Gastric",0
8,Rubbery Skin Lesion,Skin Cavernous Hemangioma,0
9,Fenestrated Pattern,Stage IIIA Thymoma AJCC v8,0
10,Solar Radiation Toxicity,Stage II Laryngeal Cancer AJCC v8,0
11,Absence of Malignant Features,Secondary malignant neoplasm of vagina,0
12,Absence of Malignant Features,benign fibrous histiocytoma of bone,0
13,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Bladder Cancer AJCC v7,0
14,Aggressive Clinical Course,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
15,Increased megakaryocytes (bone marrow),"Thymoma, type B3",0
16,Spindle Cell Metaplasia of Malignant Cells Present,"Adenocarcinoma of lung, stage II",0
17,Fenestrated Pattern,Kaposi's sarcoma classical type,0
18,Fenestrated Pattern,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8,0
19,Increased megakaryocytes (bone marrow),Mastocytosis,0
20,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lymphoplasmacytoid lymphoma/immunocytoma refractory,0
21,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Parotid Gland Carcinoma,0
22,Solar Radiation Toxicity,Kaposi's sarcoma classical type,0
23,Perivascular Lymphocytic Infiltrate,Adult Acute Lymphocytic Leukemia,0
24,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraductal Cribriform Breast Adenocarcinoma,0
25,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Borderline Ovarian Endometrioid Cystadenofibroma,0
26,Lesion Less than 5mm in Diameter,Reactive Cutaneous Fibrous Lesion,0
27,Spindle Cell Metaplasia of Malignant Cells Present,Malignant melanoma of iris,0
28,Squamous Differentiation,"Squamous cell carcinoma, small cell, nonkeratinizing",0
29,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Minor Salivary Gland Carcinoma,0
30,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,BCLC Stage D Hepatocellular Carcinoma,0
31,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,adenosquamous carcinoma of salivary gland,0
32,Fenestrated Pattern,Stage 0 Pharynx Carcinoma,0
33,Mixed Neoplastic Glandular and Squamous Cell Population,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
34,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinomatosis of peritoneal cavity,0
35,Vacuolated Plasma Cells in the Bone Marrow,Uveal Melanoma Metastatic in the Liver,0
36,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Utricle-Associated Mucosal Gland Hyperplasia,0
37,Spindle Cell Metaplasia of Malignant Cells Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,0
38,Multihormonal Immunoreactivity Present in a Single Cell Type,Spindle Cell Type B Uveal Melanoma,0
39,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Monoclonal Gammopathy of Undetermined Significance,0
40,Histiocytosis,Pulmonary Histiocytosis X,0
41,Absence of Malignant Features,PNET of bone localized,0
42,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Virus-Related Carcinoma,0
43,Increased megakaryocytes (bone marrow),Stage IV Non-Hodgkin Lymphoma,0
44,Fenestrated Pattern,Bladder adenocarcinoma stage IV,0
45,Mixed Neoplastic Glandular and Squamous Cell Population,Minor Salivary Gland Squamous Cell Carcinoma,0
46,Recurrent Genetic Abnormalities Present,Recurrent Childhood Optic Nerve Glioma,0
47,Fenestrated Pattern,Colonic Polyps,0
48,Fenestrated Pattern,Protoplasmic astrocytoma,0
49,Malignant Primitive Cellular Infiltrate,Malignant Ovarian Transitional Cell Tumor,0
50,Increased megakaryocytes (bone marrow),Struma Ovarii,0
51,High Grade Lesion,Grade 2 Rectal Adenocarcinoma,0
52,Malignant Primitive Cellular Infiltrate,Malignant Lung PEComa,0
53,Large Spaces Filled with Blood Present,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,0
54,Increased megakaryocytes (bone marrow),Lymphadenitis,0
55,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenocarcinoma of rete ovarii,0
56,Increased megakaryocytes (bone marrow),Embryonal Carcinoma,0
57,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mediastinal Neurofibroma,0
58,Villous Projections of the Neoplastic Epithelium Present,Paget Disease of the Scrotum,0
59,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Retiform hemangioendothelioma,0
60,Increased megakaryocytes (bone marrow),Vulvar Blue Nevus,0
61,Endometrial Type Glands and Stroma Present,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7,0
62,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Meckel Diverticulum Neuroendocrine Tumor G1,0
63,Acute inflammation,Adult Acute Megakaryoblastic Leukemia,0
64,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Cerebellar Neuronal and Mixed Neuronal-Glial Tumor,0
65,Fenestrated Pattern,Colorectal Hodgkin Lymphoma,0
66,Increased megakaryocytes (bone marrow),Stage II Oropharyngeal Carcinoma,0
67,Neoplastic Growth or Spread,Growth Hormone-Secreting Pituitary Adenoma,0
68,Spindle Cell Metaplasia of Malignant Cells Present,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",0
69,Metastatic/Recurrent Disease,Maternally Derived Graft Versus Host Disease,0
70,Solar Radiation Toxicity,Pilocytic Astrocytoma,0
71,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Focal nodular hyperplasia of liver,0
72,Recurrent Genetic Abnormalities Present,Recurrent Adult Spinal Cord Neoplasm,0
73,Fenestrated Pattern,Intracortical osteosarcoma,0
74,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Functioning Pituitary Gland Macroadenoma,0
75,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
76,Solitary Skin Tumor,Breast Phyllodes Tumor,0
77,Immature Myeloid Cells Increased in Bone Marrow,Childhood Central Nervous System Immature Teratoma,0
78,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Undifferentiated carcinoma of ovary,0
79,Fenestrated Pattern,Vestibular Micropapillomatosis,0
80,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cervical Esophagus Adenocarcinoma,0
81,Absence of Malignant Features,Benign neoplasm of uterus,0
82,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of lacrimal gland,0
83,Absence of Malignant Features,Leiomyosarcoma of cervix uteri,0
84,Primary Site Unspecified,Primary mediastinal large B-cell lymphoma recurrent,0
85,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ovarian Carcinoid Tumor,0
86,Fried-Egg Appearance of the Bone Marrow,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
87,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Cell Adrenal Cortical Adenoma,0
88,Endometrial Type Glands and Stroma Present,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
89,Solar Radiation Toxicity,Stage IIC Rectal Cancer AJCC v8,0
90,Spindle Cell Metaplasia of Malignant Cells Present,Stage 0 Merkel Cell Carcinoma AJCC v7,0
91,Fenestrated Pattern,Paraganglioma,0
92,Spindle Cell Metaplasia of Malignant Cells Present,Laryngeal Acantholytic Squamous Cell Carcinoma,0
93,Marked Thickening of the Bladder Urothelium Present,Bladder Non-Invasive Papillary Urothelial Neoplasm,0
94,Retiform Structures Comprise 90% or More of the Tumor,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
95,Solar Radiation Toxicity,Fallopian Tube Papilloma,0
96,Venous Type Vascular Channel Formation,Type B Lymphomatoid Papulosis,0
97,Intraepithelial Neoplasia,High Grade Penile Intraepithelial Neoplasia,0
98,Increased megakaryocytes (bone marrow),AIDS-Related Idiopathic Thrombocytopenic Purpura,0
99,Absence of Malignant Features,Secondary malignant neoplasm of retina,0
100,Mixed Cellular Population,Choroid Mixed Cell Melanoma,0
101,Marked Thickening of the Bladder Urothelium Present,Bladder transitional cell carcinoma stage IV,0
102,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of thymus,0
103,Small Lesion,Stage I Small Intestinal Adenocarcinoma AJCC v8,0
104,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage II Appendix Neuroendocrine Tumor AJCC v7,0
105,Solar Radiation Toxicity,Stage II Uterine Corpus Cancer AJCC v6,0
106,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Vulvar Sweat Gland Neoplasm,0
107,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign lipomatous tumor,0
108,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenoid cystic carcinoma of the oral cavity stage III,0
109,Fenestrated Pattern,Stage IV Laryngeal Carcinoma,0
110,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Ovarian Serous Tumor,0
111,Spindle Cell Metaplasia of Malignant Cells Present,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,0
112,Neoplastic Plasma Cells Present in Bone Marrow,Stage I Bone Sarcoma AJCC v7,0
113,Spindle Cell Metaplasia of Malignant Cells Present,Malignant teratoma of testis,0
114,Solitary Skin Tumor,Testicular Carcinoid Tumor,0
115,Cystic Lesion,Congenital Cystic Hygroma,0
116,Increased megakaryocytes (bone marrow),Transplant-Related Carcinoma,0
117,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Superficial spreading malignant melanoma of skin,0
118,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,0
119,Fenestrated Pattern,Leiomyosarcoma recurrent,0
120,Solar Radiation Toxicity,Female Reproductive System Adenofibroma,0
121,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Stromal tumor of ovary,0
122,Solar Radiation Toxicity,Chest Wall Fibromatosis,0
123,Fenestrated Pattern,Childhood Seminoma,0
124,High Grade Lesion,Grade 1 Teratoma,0
125,Spindle Cell Metaplasia of Malignant Cells Present,Stage I Merkel Cell Carcinoma AJCC v7,0
126,Intersecting Sharply Marginated Clusters of Spindle Cells Present,benign neoplasm of floor of mouth,0
127,Follicular Structures Present,Ann Arbor Stage II Follicular Lymphoma,0
128,Increased megakaryocytes (bone marrow),Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,0
129,Mixed Cellular Population,Bladder Mixed Adenocarcinoma,0
130,Schwannian Stroma More than 50 Percent of the Tumor Volume,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,0
131,Nodular and Diffuse Pattern,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",0
132,Epithelial hyperplasia of skin,Pulmonary nodular lymphoid hyperplasia,0
133,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Leukoplakia, Hairy",0
134,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Leiomyosarcoma,0
135,Immature Myeloid Cells Increased in Bone Marrow,Stage IVA Bone Sarcoma AJCC v7,0
136,Angiocentric Pattern,Angiocentric lymphoma stage I,0
137,Intersecting Sharply Marginated Clusters of Spindle Cells Present,mucoepidermoid carcinoma of floor of mouth,0
138,Increased megakaryocytes (bone marrow),Trabecular adenocarcinoma,0
139,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Thymic Carcinoid Tumor,0
140,Spindle Cell Metaplasia of Malignant Cells Present,Transitional Cell Intraepithelial Neoplasia,0
141,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Uterine Corpus Cancer AJCC v8,0
142,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vaginal intraepithelial neoplasia,0
143,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,0
144,Fenestrated Pattern,Stage IA2 Lung Cancer AJCC v8,0
145,Multihormonal Immunoreactivity Present in a Single Cell Type,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,0
146,Small Aggregates of Tumor Cells Present,Stage IV Lung Small Cell Carcinoma AJCC v7,0
147,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ovarian Dermoid Cyst with Adenocarcinoma,0
148,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",0
149,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
150,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postcricoid cancer,0
151,Schwannian Stroma More than 50 Percent of the Tumor Volume,Adenoid cystic carcinoma of the oral cavity stage I,0
152,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Cervical Adenomyoma, Endocervical Type",0
153,Proliferation of Small Ducts Present,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8,0
154,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Degeneration of uterine fibroid,0
155,Spindle Cell Osteo-Fibrous Component Present,Stage I Renal Cell Carcinoma,0
156,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Mixed Tumor,0
157,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,basaloid carcinoma of anus,0
158,Intersecting Sharply Marginated Clusters of Spindle Cells Present,rhabdomyosarcoma of extrahepatic bile duct,0
159,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Epithelioid Hemangioendothelioma,0
160,Spindle Cell Metaplasia of Malignant Cells Present,Stage IA Lung Non-Small Cell Carcinoma AJCC v7,0
161,Large Spaces Filled with Blood Present,Acute myeloid leukemia with multilineage dysplasia,0
162,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of gum,0
163,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Fallopian Tube Cancer by AJCC v8 Stage,0
164,Fenestrated Pattern,Appendix Mucinous Cystadenoma,0
165,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Rhabdomyosarcoma,0
166,Recurrent Malignant Neoplasm,High Grade Malignant Neoplasm,0
167,Fenestrated Pattern,Cholangiocarcinoma non-resectable,0
168,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extracavitary Primary Effusion Lymphoma,0
169,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Vulvar Cancer AJCC v8,0
170,Generalized Hydropic Villous Change,"Adenoma, Villous",0
171,Exophytic Papillary Lesion,Nasopharyngeal Papillary Adenocarcinoma,0
172,Absence of Malignant Features,benign granular cell tumor of gallbladder,0
173,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IIA Gastric Cancer AJCC v8,0
174,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Neuroendocrine Tumors,0
175,Large Spaces Filled with Blood Present,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",0
176,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Choroid Plexus Neoplasm,0
177,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Fibrolipoma,0
178,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Ph-Like Acute Lymphoblastic Leukemia,0
179,Plasma cell inflammation,Cystic basal cell carcinoma,0
180,Metaplasia of Malignant Cells Present,Malignant tumor of pleura,0
181,Solitary Skin Tumor,Metachronous Wilms Tumor,0
182,Confluent Sheets of Anaplastic T-Lymphocytes Present,Anaplastic Oligoastrocytoma,0
183,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Radial scar,0
184,Tumor Mass,Hemosiderotic Fibrolipomatous Tumor,0
185,Fenestrated Pattern,Refractory B-Cell Prolymphocytic Leukemia,0
186,Increased megakaryocytes (bone marrow),EBV-Related Post-Transplant Lymphoproliferative Disorder,0
187,Solar Radiation Toxicity,Radiation-Related Osteosarcoma,0
188,Spindle Cell Metaplasia of Malignant Cells Present,Ovarian Granulosa Cell Tumor,0
189,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant nipple neoplasm,0
190,Absence of Malignant Features,carcinosarcoma of fallopian tube,0
191,Absence of Malignant Features,small cell carcinoma of salivary gland,0
192,Solitary Skin Tumor,Benign Notochordal Cell Tumor,0
193,Mixture of Germ Cell Neoplastic Components Present,"Langerhans Cell Histiocytosis, Disseminated",0
194,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of renal pelvis,0
195,Increased megakaryocytes (bone marrow),"Adenoma, Microcystic",0
196,Large Spaces Filled with Blood Present,Endometrial Large Cell Neuroendocrine Carcinoma,0
197,Increased megakaryocytes (bone marrow),Stage IA Hepatocellular Carcinoma AJCC v8,0
198,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Head and Neck Carcinoma,0
199,Tumor Mass,Stage IIB Gestational Trophoblastic Tumor AJCC v7,0
200,Large Spaces Filled with Blood Present,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,0
201,Solar Radiation Toxicity,Stage IVB Osteosarcoma AJCC v7,0
202,Mixed Neoplastic Glandular and Squamous Cell Population,Testicular Mixed Yolk Sac Tumor and Teratoma,0
203,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lung Adenocarcinoma by AJCC v7 Stage,0
204,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hepatoblastoma recurrent,0
205,Mammary Gland Type Features Present,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,0
206,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Lip and Oral Cavity Cancer AJCC v8,0
207,Fenestrated Pattern,Colon adenoma,0
208,Fenestrated Pattern,Choriocarcinoma,0
209,Absence of Malignant Features,Malignant neoplasm of brain,0
210,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Intestinal T-Cell Lymphoma,0
211,Fenestrated Pattern,Non-Hematologic Malignancy,0
212,Neoplastic Plasma Cells Present in Bone Marrow,Adenocarcinoma in situ in tubulovillous adenoma,0
213,Solar Radiation Toxicity,Radiation-Induced Dermatitis,0
214,Mammary Gland Type Features Present,Acidophil Stem Cell Pituitary Gland Adenoma,0
215,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of neck,0
216,Multihormonal Immunoreactivity Present in a Single Cell Type,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,0
217,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Lung Adenosquamous Carcinoma,0
218,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7,0
219,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of gum,0
220,Multihormonal Immunoreactivity Present in a Single Cell Type,Nasopharyngeal Basaloid Squamous Cell Carcinoma,0
221,Spindle Cell Metaplasia of Malignant Cells Present,Metastatic Bladder Small Cell Carcinoma,0
222,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostate cancer stage B,0
223,Solar Radiation Toxicity,Precursor T-lymphoblastic lymphoma/leukemia stage I,0
224,Skin Erosion,"Skin Diseases, Bacterial",0
225,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Colorectal Cancer,0
226,Fenestrated Pattern,Iatrogenic Kaposi Sarcoma,0
227,Nests of Nevus Cells Resembling Nerve Bundles Present,Recurrent Nevus,0
228,Diffuse Lesion,Diffuse Large B-Cell Lymphoma,0
229,Solar Radiation Toxicity,Stage I Burkitt Lymphoma,0
230,Absence of Malignant Features,Malignant Neoplasm by Grade,0
231,Nodular and Diffuse Pattern,Stage IA Cervical Cancer AJCC v6 and v7,0
232,Recurrent Malignant Neoplasm,Papillary Breast Neoplasm,0
233,Fenestrated Pattern,Bladder adenocarcinoma recurrent,0
234,Mammary Gland Type Features Present,Refractory Adrenal Gland Pheochromocytoma,0
235,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epidermolysis Bullosa,0
236,Well Differentiated Lesion,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,0
237,Solar Radiation Toxicity,Ocular Cicatricial Pemphigoid,0
238,Absence of Malignant Features,adenoid cystic carcinoma of pharynx,0
239,Mature Schwannian Stroma Present,Mature Testicular Teratoma,0
240,Increased megakaryocytes (bone marrow),"Kaposi's sarcoma, metastatic",0
241,Spindle Cell Metaplasia of Malignant Cells Present,Malignant melanoma in precancerous melanosis,0
242,Cutaneous plaque,Grade 1 Cutaneous Follicular Lymphoma,0
243,Diffuse Cellular Infiltrate,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
244,Fenestrated Pattern,Nasopharyngeal Angiofibroma,0
245,Increased megakaryocytes (bone marrow),Gastric Hepatoid Adenocarcinoma,0
246,Multihormonal Immunoreactivity Present in a Single Cell Type,Refractory Oral Cavity Squamous Cell Carcinoma,0
247,Spindle Cell Metaplasia of Malignant Cells Present,cystadenocarcinoma of intrahepatic bile duct,0
248,Large Mass,Large cell acanthoma,0
249,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,0
250,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Gallbladder Cancer AJCC v6,0
251,Follicular Differentiation,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,0
252,Fenestrated Pattern,Stage IVC Colorectal Cancer AJCC v8,0
253,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",0
254,Mammary Gland Type Features Present,Vulvar Adenocarcinoma of Sweat Gland Type,0
255,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Squamous cell carcinoma of conjunctiva,0
256,Fenestrated Pattern,Immunodeficiency-Associated Lymphoproliferative Disorder,0
257,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Urachal Urothelial Carcinoma,0
258,Glandular cell atypia,"Spindle cell melanoma, type A",0
259,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Testicular Seminoma, Pseudoglandular Variant",0
260,Endometrial Type Glands and Stroma Present,Renal Pelvis and Ureter Cancer by AJCC v8 Stage,0
261,Peau d'orange surface of breast,atypical medullary carcinoma of breast,0
262,Villous Projections of the Neoplastic Epithelium Present,Adenoid cystic carcinoma of the oral cavity stage IV,0
263,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Central Nervous System Embryonal Neoplasm,0
264,Glandular Differentiation,Superficial Epithelioma with Sebaceous Differentiation,0
265,Schwannian Stroma More than 50 Percent of the Tumor Volume,Meckel Diverticulum Neuroendocrine Tumor G1,0
266,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,BRCA-Mutated Ovarian Carcinoma,0
267,Marked Thickening of the Bladder Urothelium Present,Bladder transitional cell carcinoma stage III,0
268,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Esophageal Adenocarcinoma by AJCC v8 Stage,0
269,Tubular Pattern,"Testicular Yolk Sac Tumor, Myxomatous Pattern",0
270,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epidermolysis Bullosa,0
271,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Kidney Angiomyolipoma,0
272,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of penis,0
273,Hyperplastic Tissue Present,Locally Advanced Soft Tissue Sarcoma,0
274,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIB Cutaneous Melanoma AJCC v8,0
275,Fenestrated Pattern,Colon Juvenile Polyp,0
276,Spindle Cell Metaplasia of Malignant Cells Present,non-Hodgkin's lymphoma of accessory sinus,0
277,Glandular cell atypia,Benign germ cell neoplasm,0
278,Increased megakaryocytes (bone marrow),Adamantinous Craniopharyngioma,0
279,Spindle Cell Osteo-Fibrous Component Present,Soft Palate Squamous Cell Carcinoma,0
280,Solar Radiation Toxicity,Stage 0a Urethral Cancer AJCC v7,0
281,Mammary Gland Type Features Present,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,0
282,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoid tumor,0
283,Fenestrated Pattern,Advanced Carcinoma,0
284,Increased megakaryocytes (bone marrow),Lung Biphasic Synovial Sarcoma,0
285,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myelodysplastic-Myeloproliferative Diseases,0
286,Increased megakaryocytes (bone marrow),Stage IVA Uterine Sarcoma AJCC v7,0
287,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Platinum-Resistant Ovarian Carcinoma,0
288,Solitary Skin Tumor,Adenomatoid Tumor,0
289,Increased megakaryocytes (bone marrow),EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,0
290,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Carcinoma in situ of vagina,0
291,Fenestrated Pattern,Childhood Gemistocytic Astrocytoma,0
292,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sellar Embryonal Carcinoma,0
293,Fenestrated Pattern,Stage IVC Major Salivary Gland Cancer AJCC v8,0
294,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Carcinoma,0
295,Fenestrated Pattern,Microcystic adnexal carcinoma,0
296,Increased megakaryocytes (bone marrow),"Mixed Tumor, Mullerian",0
297,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Calcifying Fibrous Pseudotumor,0
298,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unfavorable Non-Hodgkin Lymphoma,0
299,Follicular Differentiation,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,0
300,Squamous Metaplasia of Malignant Cells Present,"Squamous cell carcinoma, microinvasive",0
301,Fenestrated Pattern,Stage IV Appendix Carcinoma AJCC v8,0
302,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of anal canal,0
303,Fenestrated Pattern,Hemophagocytic Syndrome,0
304,Solitary Skin Tumor,Malignant Solitary Fibrous Tumor,0
305,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Central Nervous System Embryonal Carcinoma,0
306,Increased megakaryocytes (bone marrow),Refractory Hepatoblastoma,0
307,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric T-Cell Non-Hodgkin Lymphoma,0
308,Solar Radiation Toxicity,Stage II Colon Cancer,0
309,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hemangioma of choroid,0
310,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0a Ureter Cancer AJCC v7,0
311,Increased megakaryocytes (bone marrow),Refractory Mediastinal Lymphoma,0
312,Increased megakaryocytes (bone marrow),Centroblastic lymphoma stage I,0
313,Mammary Gland Type Features Present,Follicular Variant Thyroid Gland Papillary Carcinoma,0
314,Spindle Cell Metaplasia of Malignant Cells Present,Resectable Malignant Mesothelioma,0
315,Fenestrated Pattern,Cardiac Paraganglioma,0
316,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Pineoblastoma,0
317,Schwannian Stroma More than 50 Percent of the Tumor Volume,Temporal Lobe Ependymal Tumor,0
318,Solar Radiation Toxicity,Naevus spider acquired,0
319,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Choroid Spindle Cell Melanoma,0
320,Increased megakaryocytes (bone marrow),Cervical Adenofibroma,0
321,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Ectopic Fibroadenoma,0
322,Prominent Elastic Tissue Cores Present,Stage IIA Adult Soft Tissue Sarcoma AJCC v7,0
323,Nodular and Diffuse Pattern,Mixed epithelioid and spindle cell melanoma,0
324,Dilated Terminal Duct Lobular Units Present,Stage IA Intrahepatic Bile Duct Cancer AJCC v8,0
325,Solar Radiation Toxicity,Central Nervous System Paraganglioma,0
326,Spindle Cell Metaplasia of Malignant Cells Present,Hepatocellular Small Cell Change,0
327,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Vaginal Tubular Adenoma,0
328,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenosquamous carcinoma of ovary,0
329,Increased megakaryocytes (bone marrow),"Gemistocytic Astrocytoma, IDH-Mutant",0
330,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of muscle,0
331,Increased megakaryocytes (bone marrow),Pleural Carcinomatosis,0
332,Schwannian Stroma More than 50 Percent of the Tumor Volume,Anaplastic Kidney Wilms Tumor,0
333,Basal Cells with Pale Cytoplasm Present,Basal Cell Neoplasm,0
334,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastrointestinal polyps,0
335,Fenestrated Pattern,Cranial nerve palsies,0
336,Monoclonal Myeloid or Lymphoid Cells Present,Intracranial Myeloid Sarcoma,0
337,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Esophageal Squamous Cell Carcinoma AJCC v7,0
338,Endometrial Type Glands and Stroma Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,0
339,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma of sublingual gland,0
340,Absence of Malignant Features,undifferentiated carcinoma of anal canal,0
341,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lynch Syndrome,0
342,Fenestrated Pattern,Secondary Prostate Urothelial Carcinoma,0
343,High Grade Non Cartilaginous Sarcomatous Stroma Present,Ann Arbor Stage IV Grade 1 Follicular Lymphoma,0
344,Multihormonal Immunoreactivity Present in a Single Cell Type,Lung Squamous Cell Carcinoma by AJCC v7 Stage,0
345,Solar Radiation Toxicity,Stage IV Prostate Cancer AJCC v7,0
346,Nuclear Atypia,Endometrial Hyperplasia without Atypia,0
347,Solar Radiation Toxicity,Stage IVB Gallbladder Cancer AJCC v8,0
348,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ascending Colon Neuroendocrine Tumor G1,0
349,Increased megakaryocytes (bone marrow),Advanced Synovial Sarcoma,0
350,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Condyloma acuminata of vulva,0
351,Fenestrated Pattern,Borderline Ovarian Mucinous Adenofibroma,0
352,Intersecting Sharply Marginated Clusters of Spindle Cells Present,malignant lymphoma of pancreatic lymph nodes,0
353,Increased megakaryocytes (bone marrow),Noninfiltrating intraductal papillary adenocarcinoma,0
354,Large Spaces Filled with Blood Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0
355,Fenestrated Pattern,Burkitt Leukemia,0
356,Aggressive Clinical Course,Clinical Stage IB Cutaneous Melanoma AJCC v8,0
357,Increased megakaryocytes (bone marrow),Stage IVA Primary Peritoneal Cancer AJCC v8,0
358,Fenestrated Pattern,Stage III Rectal Cancer AJCC v8,0
359,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Prostatic Duct Urothelial Carcinoma,0
360,Large Mass,Occult Lung Large Cell Carcinoma,0
361,Abundance of Small Lymphocytes,Stage IV Small Intestinal Adenocarcinoma AJCC v8,0
362,Solar Radiation Toxicity,Angioimmunoblastic T-cell lymphoma stage IV,0
363,Melanoma Cells Present,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,0
364,Solitary Skin Tumor,Stage IV Gastric Neuroendocrine Tumor AJCC v8,0
365,Diffuse Cellular Infiltrate,Adult Cardiac Cellular Rhabdomyoma,0
366,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Mucinous cystadenoma of ovary,0
367,Increased megakaryocytes (bone marrow),Uterine Corpus Bizarre Leiomyoma,0
368,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastrointestinal polyps,0
369,Multihormonal Immunoreactivity Present in a Single Cell Type,Rectal Small Cell Neuroendocrine Carcinoma,0
370,Lesion with Diameter of 2cm or Less,adenocarcinoma of gallbladder with squamous metaplasia,0
371,Plasma cell inflammation,"Intraocular melanoma, spindle cell",0
372,Solar Radiation Toxicity,Vaginal Endometrioid Adenocarcinoma,0
373,Myofibroblastic Differentiation,Cardiac Inflammatory Myofibroblastic Tumor,0
374,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",0
375,Fenestrated Pattern,"Carcinoma, Cribriform",0
376,Large Spaces Filled with Blood Present,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0
377,Increased megakaryocytes (bone marrow),Juvenile cataract,0
378,Recurrent Malignant Neoplasm,Recurrent Childhood Malignant Germ Cell Tumor,0
379,Multihormonal Immunoreactivity Present in a Single Cell Type,Pancreatic Small Cell Neuroendocrine Carcinoma,0
380,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Urachal Adenocarcinoma,0
381,Plasma cell inflammation,Non-small cell carcinoma,0
382,Well Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Carcinoma,0
383,Neoplastic Plasma Cells Present in Bone Marrow,Polyp in nasopharynx,0
384,Glandular cell atypia,Gallbladder squamous cell carcinoma,0
385,No Evidence of Metastatic Disease,Metastatic Cervical Carcinoma,0
386,Increased megakaryocytes (bone marrow),Desmoplastic infantile ganglioglioma,0
387,Absence of Malignant Features,Malignant Gastric Gastrointestinal Stromal Tumor,0
388,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Childhood Atypical Teratoid/Rhabdoid Tumor,0
389,Increased megakaryocytes (bone marrow),Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
390,Nerve palsy,Recurrent Childhood Optic Nerve Astrocytoma,0
391,Increased megakaryocytes (bone marrow),BCLC Stage B Hepatocellular Carcinoma,0
392,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ovarian Dermoid Cyst with Adenocarcinoma,0
393,Spindle Cell Metaplasia of Malignant Cells Present,benign mature teratoma of pancreas,0
394,Solar Radiation Toxicity,Solar lentigo,0
395,Increased megakaryocytes (bone marrow),Pulmonary lymphangioleiomyomatosis,0
396,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of ciliary body,0
397,Increased megakaryocytes (bone marrow),FIGO Stage IIIA1 Ovarian Cancer,0
398,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Cancer by AJCC v6 Stage,0
399,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Ovarian Cancer AJCC v8,0
400,Nodular and Diffuse Pattern,BN2 Diffuse Large B-Cell Lymphoma,0
401,Fenestrated Pattern,Thyroid Angiosarcoma,0
402,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma of soft palate,0
403,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Gastric Cancer AJCC v7,0
404,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Contact dermatitis due to arnica,0
405,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hyperplasia,0
406,Solar Radiation Toxicity,Adamantinous Craniopharyngioma,0
407,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Adult Hodgkin Lymphoma by Ann Arbor Stage,0
408,Nodular and Diffuse Pattern,Stage I Testicular Cancer AJCC v6 and v7,0
409,Clear Perinuclear Halo Present,Clear Cell Adrenal Cortical Adenoma,0
410,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Hindgut Carcinoid Tumor,0
411,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Chordoma,0
412,Spindle Cell Osteo-Fibrous Component Present,ISS Stage II Plasma Cell Myeloma,0
413,Increased megakaryocytes (bone marrow),Seborrheic keratosis,0
414,Absence of Malignant Features,mucoepidermoid carcinoma of accessory sinus,0
415,Photosensitivity of skin,Acantholytic squamous cell carcinoma of skin,0
416,Photosensitivity of skin,Compound nevus of skin,0
417,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of esophagus,0
418,Endometrial Type Glands and Stroma Present,Multiple Endocrine Neoplasia Type 1,0
419,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anaplastic Pleomorphic Xanthoastrocytoma,0
420,Fenestrated Pattern,Cervix carcinoma recurrent,0
421,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Primary Peritoneal Cancer AJCC v8,0
422,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,undifferentiated carcinoma of cervix,0
423,Solar Radiation Toxicity,Adult Brain Stem Astrocytoma,0
424,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Primary Peritoneal Cancer AJCC v8,0
425,Stable Disease,Paget Disease Extramammary,0
426,Nodular and Diffuse Pattern,Stage IVC Lip Cancer AJCC v6 and v7,0
427,Fenestrated Pattern,Urticaria Pigmentosa,0
428,Mammary Gland Type Features Present,Stage IVC Major Salivary Gland Cancer AJCC v8,0
429,Intermediate Grade Neuroendocrine Lesion,High Grade Ovarian Serous Adenocarcinoma,0
430,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Rhabdomyosarcoma,0
431,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Juvenile rheumatoid arthritis,0
432,Neoplastic Plasma Cells Present in Bone Marrow,Bone Cancer by AJCC v8 Stage,0
433,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Ovarian Luteinized Thecoma,0
434,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Meningeal melanoma,0
435,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Ann Arbor Stage III Mature T- and NK-Cell Lymphoma,0
436,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,0
437,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Supraglottic Verrucous Carcinoma,0
438,Absence of Malignant Features,Stage I Ampulla of Vater Cancer AJCC v8,0
439,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,AIDS-Related Pneumocystis Pneumonia,0
440,Endometrial Type Glands and Stroma Present,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
441,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Ameloblastoma,0
442,Epithelial hyperplasia of skin,Strawberry nevus of skin,0
443,Endometrial Type Glands and Stroma Present,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
444,Solar Radiation Toxicity,"Cystadenoma, Mucinous",0
445,Absence of Malignant Features,Malignant tumor of ethmoid sinus,0
446,Spindle Cell Metaplasia of Malignant Cells Present,Intermediate Cell Type Uveal Melanoma,0
447,Solar Radiation Toxicity,Brain Glioblastoma,0
448,Spindle Cell Metaplasia of Malignant Cells Present,basal cell adenocarcinoma of salivary gland,0
449,Well Differentiated Neuroendocrine Lesion,Refractory Abdominal Neuroendocrine Neoplasm,0
450,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,0
451,Spindle Cell Metaplasia of Malignant Cells Present,Fallopian Tube Transitional Cell Carcinoma,0
452,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Keratoacanthoma,0
453,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Uterine Corpus Sarcoma by AJCC v8 Stage,0
454,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Acrokeratosis Verruciformis of Hopf,0
455,Absence of Malignant Features,Malignant neoplasm of gastrointestinal tract,0
456,Solitary Skin Tumor,Stage II Gastric Neuroendocrine Tumor AJCC v8,0
457,Fenestrated Pattern,Seborrheic keratosis,0
458,Increased megakaryocytes (bone marrow),T-Cell Lymphoma,0
459,Lesion with Diameter of 2cm or Less,Adult Acute Promyelocytic Leukemia with PML-RARA,0
460,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Childhood Rectal Carcinoma,0
461,Absence of Malignant Features,Malignant Mesothelioma of Peritoneum,0
462,Malignant Primitive Cellular Infiltrate,Locally Advanced Unresectable Malignant Neoplasm,0
463,Tissue Differentiation Uncertain,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
464,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Frontal Sinus Inverted Papilloma,0
465,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Early Favorable Hodgkin Lymphoma,0
466,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Penile Cancer by AJCC v6 Stage,0
467,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Urinary System Neoplasm,0
468,Recurrent Malignant Neoplasm,Refractory Neoplasm,0
469,Solar Radiation Toxicity,Androgen-Producing Adrenal Cortex Adenoma,0
470,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Macrofollicular adenoma,0
471,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Non-hodgkin lymphoma of colon,0
472,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mature B-Cell Non-Hodgkin Lymphoma,0
473,Increased megakaryocytes (bone marrow),Stage I Childhood Lymphoblastic Lymphoma,0
474,Increased megakaryocytes (bone marrow),Laryngeal Leiomyosarcoma,0
475,Spindle Cell Metaplasia of Malignant Cells Present,"Cranial Nerve Neoplasms, Malignant",0
476,Diffuse Lesion,Stage I Diffuse Large B-Cell Lymphoma,0
477,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Adenocarcinoma with cartilaginous and osseous metaplasia,0
478,Increased megakaryocytes (bone marrow),Infiltrating Bladder Urothelial Carcinoma,0
479,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Post-transplant lymphoproliferative disorder, polymorphic",0
480,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Abscess of skin AND/OR subcutaneous tissue,0
481,Tumor Mass,Stage I Gestational Trophoblastic Tumor AJCC v7,0
482,Fenestrated Pattern,Stage II Colon Cancer,0
483,Recurrent Malignant Neoplasm,Grade 3a Malignant Neoplasm,0
484,Basal Cells with Pale Cytoplasm Present,Basal cell carcinoma - adamantinoid,0
485,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Gallbladder Neuroendocrine Tumor G2,0
486,Increased megakaryocytes (bone marrow),"Phyllodes tumor, borderline",0
487,Plasma cell inflammation,Bladder transitional cell carcinoma stage I,0
488,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Congenital Vena Cava Abnormality,0
489,Intraepithelial Neoplasia,Cervical Squamous Intraepithelial Neoplasia,0
490,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,sarcoma of accessory sinus,0
491,Absence of Malignant Features,Multiple self-healing epithelioma of Ferguson-Smith,0
492,Mixed Neoplastic Glandular and Squamous Cell Population,Ciliary Body Mixed Cell Melanoma,0
493,Increased megakaryocytes (bone marrow),Stage IVA Vulvar Cancer AJCC v8,0
494,Hyperplastic Tissue Present,Soft Tissue Sarcoma by AJCC v8 Stage,0
495,Fenestrated Pattern,Stage IIIA Testicular Cancer AJCC v8,0
496,Multihormonal Immunoreactivity Present in a Single Cell Type,Islet Cell Tumor,0
497,Solar Radiation Toxicity,Intra-Abdominal Paraganglioma,0
498,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Invasive Ductal Breast Carcinoma,0
499,Metaplasia of Malignant Cells Present,Malignant carcinoid tumor of lung,0
500,Fenestrated Pattern,Stage I Hypopharyngeal Carcinoma AJCC v8,0
501,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,0
502,Increased megakaryocytes (bone marrow),Cervical Mullerian Papilloma,0
503,Fenestrated Pattern,Stage I Prostate Cancer AJCC v8,0
504,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,small cell carcinoma of gallbladder,0
505,Spindle Cell Metaplasia of Malignant Cells Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0
506,Marked Thickening of the Bladder Urothelium Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",0
507,Increased megakaryocytes (bone marrow),Adult Angiosarcoma,0
508,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Colorectal Cancer AJCC v7,0
509,Absence of Malignant Features,Secondary malignant neoplasm of bone,0
510,Spindle Cell Metaplasia of Malignant Cells Present,"T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant",0
511,High Grade Non Cartilaginous Sarcomatous Stroma Present,Low Grade Prostatic Intraepithelial Neoplasia,0
512,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Uterine Corpus PEComa,0
513,Fenestrated Pattern,Nasopharyngeal carcinoma,0
514,Solar Radiation Toxicity,Stage IIIA Hilar Cholangiocarcinoma AJCC v8,0
515,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of retina,0
516,Fenestrated Pattern,Carotid Body Paraganglioma,0
517,Absence of Malignant Features,Carcinoma ex pleomorphic adenoma of parotid gland,0
518,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyosarcoma of mediastinum,0
519,Fenestrated Pattern,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,0
520,Solar Radiation Toxicity,Cardiac rhabdomyoma,0
521,Lesion with Diameter of 2cm or Less,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
522,Fenestrated Pattern,Lung Mucinous Cystadenoma,0
523,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Castration-Naive Prostate Carcinoma,0
524,Recurrent Malignant Neoplasm,Recurrent Childhood Pleomorphic Xanthoastrocytoma,0
525,Solar Radiation Toxicity,lymphangiosarcoma,0
526,Mixed Neoplastic Glandular and Squamous Cell Population,"Lung Squamous Cell Carcinoma, Small Cell Variant",0
527,Mammary Gland Type Features Present,Anterior Pituitary Gland Endocrine Neoplasm,0
528,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gallbladder adenocarcinoma,0
529,Nodular and Diffuse Pattern,Nodular amyloidosis,0
530,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Uveal Melanoma AJCC v7,0
531,Solar Radiation Toxicity,Adult Meningioma,0
532,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Choroid Necrotic Melanoma,0
533,Local disease,Hodgkin's disease nodular sclerosis stage I,0
534,Gastric dysplasia,Gastric Large Cell Neuroendocrine Carcinoma,0
535,Intersecting Sharply Marginated Clusters of Spindle Cells Present,leiomyosarcoma of anus,0
536,High Grade Non Cartilaginous Sarcomatous Stroma Present,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,0
537,Increased megakaryocytes (bone marrow),Chondrosarcoma recurrent,0
538,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0a Urethral Cancer AJCC v7,0
539,Recurrent Malignant Neoplasm,Recurrent Dedifferentiated Liposarcoma,0
540,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign epithelial neoplasm of skin,0
541,Increased megakaryocytes (bone marrow),Stage IIIB Cutaneous Melanoma AJCC v7,0
542,Absence of Malignant Features,Malignant Breast Eccrine Spiradenoma,0
543,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor,0
544,Tumor Mass,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,0
545,Basal Cells with Pale Cytoplasm Present,Basal cell carcinoma - adamantinoid,0
546,Malignant Primitive Cellular Infiltrate,Unresectable Malignant Mesothelioma,0
547,Increased megakaryocytes (bone marrow),Stage IVA Hepatocellular Carcinoma AJCC v7,0
548,Fenestrated Pattern,Gallbladder Sarcoma,0
549,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Cervical Cancer by AJCC v7 Stage,0
550,Fenestrated Pattern,Neonatal leukemia,0
551,Diffuse Lesion,Diffuse hyperplasia,0
552,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Ingestion dermatitis due to food,0
553,Proliferation of Follicular Dendritic Cells Present,Thyroid Gland Follicular Adenoma,0
554,Humoral hypercalcemia of malignancy (disorder),Treatment related secondary malignancy,0
555,Spindle Cell Metaplasia of Malignant Cells Present,Adenoid cystic carcinoma of parotid gland,0
556,Solar Radiation Toxicity,Adult T-cell lymphoma/leukemia stage I,0
557,Lesion with Diameter of 2cm or Less,B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),0
558,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,0
559,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Acute Myeloid Leukemia (AML-M2),0
560,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IIIA Gestational Trophoblastic Tumor AJCC v7,0
561,Increased megakaryocytes (bone marrow),Stage III Childhood Burkitt Lymphoma,0
562,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Central Nervous System Embryonal Carcinoma,0
563,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anaplastic Hemispheric Astrocytoma,0
564,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Dermatophytosis of groin and perianal area,0
565,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Ependymoma,0
566,Absence of Malignant Features,Malignant neoplasm of floor of mouth,0
567,Villous Projections of the Neoplastic Epithelium Present,Lipoma of the tongue,0
568,Fenestrated Pattern,Alveolar Soft Part Sarcoma,0
569,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Ductal and Lobular Carcinoma,0
570,Fenestrated Pattern,Stage IB Uterine Corpus Cancer AJCC v8,0
571,Fenestrated Pattern,Cutaneous schistosomiasis,0
572,Breast Implant-Related Lesion,Childhood Breast Carcinoma,0
573,Increased megakaryocytes (bone marrow),Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8,0
574,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Clear Cell Intrahepatic Cholangiocarcinoma,0
575,Small Aggregates of Tumor Cells Present,Small Lymphocytic Lymphoma,0
576,Intermediate Grade Neuroendocrine Lesion,Intermediate Osteogenic Neoplasm,0
577,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Optic Nerve Glioma, Childhood",0
578,Nodular and Diffuse Pattern,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6,0
579,Spindle Cell Osteo-Fibrous Component Present,Childhood Renal Cell Carcinoma,0
580,Recurrent Malignant Neoplasm,Low Grade Malignant Neoplasm,0
581,Multihormonal Immunoreactivity Present in a Single Cell Type,Locally Advanced Unresectable Renal Cell Carcinoma,0
582,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Radiation-induced disorder,0
583,Solar Radiation Toxicity,Stage IIIA Prostate Cancer AJCC v8,0
584,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,FIGO Stage IIIA1 Ovarian Cancer,0
585,Tumor Mass,Infratentorial Ependymal Tumor,0
586,Increased megakaryocytes (bone marrow),Xeroderma,0
587,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7,0
588,Intersecting Sharply Marginated Clusters of Spindle Cells Present,malignant tumor of male genital organ,0
589,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermal Duct Tumor,0
590,Increased megakaryocytes (bone marrow),Stage IIIC Ovarian Cancer,0
591,Solitary Skin Tumor,Pancreatic Neuroendocrine Tumor G1,0
592,Spindle Cell Metaplasia of Malignant Cells Present,Adenoma of middle ear,0
593,Epithelioid Differentiation,Childhood Epithelioid Sarcoma,0
594,Malignant Primitive Cellular Infiltrate,Penile Urethral Malignant Neoplasm,0
595,Schwannian Stroma More than 50 Percent of the Tumor Volume,Squamous cell carcinoma of the paranasal sinus,0
596,Fenestrated Pattern,Benign vascular neoplasm,0
597,Intersecting Sharply Marginated Clusters of Spindle Cells Present,sarcoma of penis,0
598,Fenestrated Pattern,Ganglioneuroma,0
599,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Fibromatosis, Aggressive",0
600,Increased megakaryocytes (bone marrow),Stage I Nasopharyngeal Carcinoma,0
601,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of postcricoid region,0
602,Absence of Malignant Features,Malignant Meningioma,0
603,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenocarcinoma of renal pelvis,0
604,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Appendix Carcinoma AJCC v8,0
605,Intermediate Grade Neuroendocrine Lesion,Adult Grade II Meningioma,0
606,Spindle Cell Metaplasia of Malignant Cells Present,Glioblastoma multiforme of spinal cord,0
607,Increased megakaryocytes (bone marrow),Adult Angiosarcoma,0
608,Absence of Malignant Features,Malignant Ovarian Transitional Cell Tumor,0
609,Recurrent Genetic Abnormalities Present,Recurrent Childhood Gemistocytic Astrocytoma,0
610,Questionable Invasive Lesion,Early Invasive Cervical Adenocarcinoma,0
611,Increased megakaryocytes (bone marrow),Stage IV Childhood Hodgkin Lymphoma,0
612,Cutaneous plaque,Cutaneous Melanoma by AJCC v6 Stage,0
613,NRBC - Nucleated red blood cell present result,Morpheic basal cell carcinoma,0
614,Solar Radiation Toxicity,Gallbladder Leiomyosarcoma,0
615,Squamous metaplasia of bladder,Squamous cell carcinoma of floor of mouth,0
616,Immature Myeloid Cells Increased in Bone Marrow,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,0
617,Non-Encapsulated Neoplasm,Refractory Plasma Cell Neoplasm,0
618,Spindle Cell Osteo-Fibrous Component Present,Inverted Squamous Cell Papilloma,0
619,Increased megakaryocytes (bone marrow),Perineal Ectopic Fibroadenoma,0
620,Increased megakaryocytes (bone marrow),PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,0
621,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sparsely Granulated Somatotroph Adenoma,0
622,Cervical lymphadenopathy,Human Papillomavirus-Related Cervical Carcinoma,0
623,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Undifferentiated Pleomorphic Sarcoma,0
624,Increased megakaryocytes (bone marrow),Stage IIIA Fallopian Tube Cancer AJCC v7,0
625,Increased megakaryocytes (bone marrow),Stage I Intrahepatic Cholangiocarcinoma AJCC v8,0
626,Photosensitivity of skin,Dermoid cyst of skin,0
627,Melanoma Cells Present,Stage I Cutaneous Melanoma AJCC v6,0
628,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Nasopharyngeal Carcinoma,0
629,Increased megakaryocytes (bone marrow),Oral Cavity Pleomorphic Adenoma,0
630,Fenestrated Pattern,Hypereosinophilic syndrome,0
631,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gonadoblastoma,0
632,No Evidence of Metastatic Disease,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
633,Unfavorable Clinical Outcome,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,0
634,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Peutz-Jeghers Polyp of the Stomach,0
635,Nodular and Diffuse Pattern,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,0
636,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Ligament Endometrioid Adenocarcinoma,0
637,Cervical lymphadenopathy,Stage IIA Cervical Cancer AJCC v7,0
638,Schwannian Stroma More than 50 Percent of the Tumor Volume,squamous cell carcinoma of the thyroid gland,0
639,Mammary Gland Type Features Present,Major Salivary Gland Carcinoma,0
640,Low Grade Neuroendocrine Lesion,Neuroendocrine cervical carcinoma,0
641,Increased megakaryocytes (bone marrow),Stage III Childhood Hepatocellular Carcinoma AJCC v7,0
642,Numerous Stromal Mast Cells Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",0
643,Nodular and Diffuse Pattern,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
644,Low Grade Neuroendocrine Lesion,"Carcinoma, Neuroendocrine",0
645,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Localized Unresectable Adult Hepatocellular Carcinoma,0
646,Fenestrated Pattern,Basophilic Adenocarcinoma,0
647,Solar Radiation Toxicity,Synovial sarcoma non-metastatic,0
648,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
649,Low Mitotic Activity,Low grade cervical glandular intraepithelial neoplasia,0
650,Rubbery Skin Lesion,"Skin Diseases, Bacterial",0
651,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Uterine Corpus Carcinosarcoma,0
652,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Angioimmunoblastic Lymphadenopathy,0
653,Osseous Metaplasia of Malignant Cells Present,Malignant tumor of renal pelvis,0
654,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Cervical Cancer AJCC v8,0
655,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Inflammatory Leiomyosarcoma,0
656,Increased megakaryocytes (bone marrow),Sclerosing Epithelioid Fibrosarcoma,0
657,Fenestrated Pattern,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,0
658,Fenestrated Pattern,Stage IVC Laryngeal Cancer AJCC v7,0
659,Absence of Malignant Features,Benign neoplasm of frontal sinus,0
660,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Castration-Naive Prostate Carcinoma,0
661,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of small intestine,0
662,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Eyelid Carcinoma by AJCC v7 Stage,0
663,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Nasal Cavity Carcinoma,0
664,Neoplastic Plasma Cells Present in Bone Marrow,"Castleman Disease, Plasma Cell Type",0
665,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Non-Hodgkin Lymphoma,0
666,Malignant Primitive Cellular Infiltrate,Malignant Esophageal Neoplasm by Anatomic Region,0
667,Hypertensive disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
668,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
669,Bone Marrow Involvement,Stage III Bone Sarcoma AJCC v7,0
670,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Cervical Cancer AJCC v8,0
671,Fenestrated Pattern,Lymphomatoid Papulosis,0
672,Large Spaces Filled with Blood Present,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0
673,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Breast Carcinoma,0
674,Solitary Skin Tumor,"Skin Diseases, Infectious",0
675,Solar Radiation Toxicity,Stage I Adult Hodgkin Lymphoma,0
676,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ossifying Renal Tumor of Infancy,0
677,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,0
678,Spindle Cell Metaplasia of Malignant Cells Present,tubulopapillary adenoma of gallbladder,0
679,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,AIDS-Related Human Papillomavirus Infection,0
680,Metastatic/Recurrent Disease,Multi-centric Castleman's Disease,0
681,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Non-Hodgkin Breast Lymphoma,0
682,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Brenner Tumor,0
683,Glandular Differentiation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
684,Glandular Differentiation,Burkitt Lymphoma with Plasmacytoid Differentiation,0
685,Fenestrated Pattern,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,0
686,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7,0
687,Mixture of Germ Cell Neoplastic Components Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,0
688,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,BRCA1 Syndrome,0
689,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Immunoblastic Lymphoma,0
690,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,0
691,Solar Radiation Toxicity,Cardiac Intramuscular Hemangioma,0
692,Retiform Structures Comprise 90% or More of the Tumor,Malignant Mixed Tumor of the Minor Salivary Gland,0
693,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of thalamus,0
694,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Desmoid-Type Fibromatosis,0
695,Neoplastic Plasma Cells Present in Bone Marrow,Bone Marrow Transplantation Nephropathy,0
696,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,clear cell adenocarcinoma of urethra,0
697,Spindle Cell Metaplasia of Malignant Cells Present,Sarcoma of liver,0
698,Glandular cell atypia,HPV positive oropharyngeal squamous cell carcinoma,0
699,Solar Radiation Toxicity,Gallbladder adenoma,0
700,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,alveolar rhabdomyosarcoma of orbit,0
701,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
702,Tumor Mass,Stage III Ileal Neuroendocrine Tumor AJCC v8,0
703,Increased megakaryocytes (bone marrow),Stage I Ureter Cancer AJCC v7,0
704,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sclerosing Breast Papilloma,0
705,Absence of Malignant Features,basal cell carcinoma of penis,0
706,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Testicular Mixed Germ Cell Tumor,0
707,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tuberous Sclerosis,0
708,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gallbladder Kaposi's Sarcoma,0
709,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
710,Large Mass,Refractory Intravascular Large B-Cell Lymphoma,0
711,Mixture of Germ Cell Neoplastic Components Present,Childhood Subependymal Giant Cell Astrocytoma,0
712,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Tubular adenoma of breast,0
713,Increased megakaryocytes (bone marrow),Sex Hormone-Producing Adrenal Cortex Adenoma,0
714,Increased megakaryocytes (bone marrow),Stage IV Ovarian Cancer AJCC v8,0
715,Fenestrated Pattern,Childhood Oligoastrocytoma,0
716,Mammary Gland Type Features Present,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
717,Well Differentiated Neuroendocrine Lesion,Rectal Neuroendocrine Neoplasm,0
718,Increased megakaryocytes (bone marrow),ENSAT Stage IV Adrenal Cortex Carcinoma,0
719,Marked Thickening of the Bladder Urothelium Present,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,0
720,Plasma cell inflammation,"Leydig cell tumor, malignant",0
721,Photosensitivity of skin,Verruciform xanthoma of skin,0
722,Increased megakaryocytes (bone marrow),Stage IVA Oropharyngeal Carcinoma AJCC v7,0
723,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
724,Broad Fibrous Bands Formation,High Grade Broad Ligament Serous Adenocarcinoma,0
725,Hydropic Villous Change,Colorectal Villous Adenoma,0
726,Aberrant Thyroid Tissue Present,Soft Tissue Angiosarcoma,0
727,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adult Intracranial Germ Cell Tumor,0
728,Non-Encapsulated Neoplasm,Adult Choroid Plexus Neoplasm,0
729,Spindle Cell Metaplasia of Malignant Cells Present,"Sarcoma, Spindle Cell",0
730,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Childhood Anaplastic Large Cell Lymphoma,0
731,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,non-Hodgkin's lymphoma of nasal cavity,0
732,Fried-Egg Appearance of the Bone Marrow,Carcinoid tumor of the liver,0
733,Epithelial hyperplasia of skin,Compound nevus of skin,0
734,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and 7,0
735,Multihormonal Immunoreactivity Present in a Single Cell Type,Childhood Brain Germ Cell Tumor,0
736,Absence of Malignant Features,Polyp of large intestine,0
737,Fenestrated Pattern,Vulvar Fibrolipoma,0
738,Fenestrated Pattern,Urethral Urothelial Papilloma,0
739,Fenestrated Pattern,"Sarcoma, metastatic",0
740,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Contact dermatitis due to solar radiation,0
741,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Rectal Cancer AJCC v8,0
742,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,malignant epithelioid hemangioendothelioma of liver,0
743,Odontogenic Cysts,Peripheral Odontogenic Fibroma,0
744,Glandular cell atypia,Papillary transitional cell carcinoma,0
745,Solar Radiation Toxicity,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8,0
746,Spindle Cell Metaplasia of Malignant Cells Present,squamous cell carcinoma of ureter,0
747,Spindle Cell Metaplasia of Malignant Cells Present,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",0
748,Solitary Skin Tumor,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,0
749,Well Differentiated Neuroendocrine Lesion,Neuroendocrine cervical carcinoma,0
750,Recurrent Malignant Neoplasm,Urothelial Neoplasm,0
751,Recurrent Genetic Abnormalities Present,Recurrent HIV-Associated Lymphoproliferative Disorder,0
752,Dilated Terminal Duct Lobular Units Present,Stage IV Distal Bile Duct Cancer AJCC v8,0
753,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IV Fallopian Tube Cancer AJCC v6 and v7,0
754,Increased megakaryocytes (bone marrow),Borderline cystadenoma,0
755,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Papilloma,0
756,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
757,Schwannian Stroma More than 50 Percent of the Tumor Volume,Squamous cell carcinoma of the oral cavity stage I,0
758,Fenestrated Pattern,Early T Acute Lymphoblastic Leukemia,0
759,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hypopharyngeal Carcinoma,0
760,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,"Carcinoma, Ovarian Epithelial",0
761,Solar Radiation Toxicity,Testicular choriocarcinoma stage I,0
762,Solar Radiation Toxicity,Adult Ganglioglioma,0
763,Increased megakaryocytes (bone marrow),Gastric Hamartoma,0
764,Squamous Differentiation,"Squamous cell carcinoma, small cell, nonkeratinizing",0
765,Squamous metaplasia of bladder,hepatoid adenocarcinoma of bladder,0
766,Cellular Stratification,Vulvar Cellular Angiofibroma,0
767,Mixture of Germ Cell Neoplastic Components Present,Ampulla of Vater Squamous Cell Carcinoma,0
768,Chronic Clinical Course,Chronic lymphocytic leukemia stage 1,0
769,Increased megakaryocytes (bone marrow),Pleural Schwannoma,0
770,Acute inflammation,Acute cellular allograft nephropathy,0
771,Fenestrated Pattern,Secondary Prostate Urothelial Carcinoma,0
772,Fenestrated Pattern,Melanotic medulloblastoma,0
773,Mixed Neoplastic Glandular and Squamous Cell Population,Frontal Sinus Squamous Cell Carcinoma,0
774,Increased megakaryocytes (bone marrow),Refractory Ovarian Endometrioid Adenocarcinoma,0
775,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,T-cell lymphoma stage III,0
776,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endobronchial Leiomyoma,0
777,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Minor Salivary Gland Undifferentiated Carcinoma,0
778,Increased megakaryocytes (bone marrow),PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,0
779,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Oral Cavity Benign Granular Cell Tumor,0
780,Solar Radiation Toxicity,Anal polyp,0
781,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Advanced Head and Neck Carcinoma,0
782,Recurrent Malignant Neoplasm,Recurrent Dedifferentiated Liposarcoma,0
783,Spindle Cell Metaplasia of Malignant Cells Present,fibroma of testis,0
784,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
785,Recurrent Genetic Abnormalities Present,Recurrent Spinal Cord Neoplasm,0
786,Melanoma Cells Present,Refractory Melanoma,0
787,Fenestrated Pattern,Stage III Nasopharyngeal Carcinoma,0
788,Increased megakaryocytes (bone marrow),Ocular Sebaceous Carcinoma,0
789,Spindle Cell Metaplasia of Malignant Cells Present,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,0
790,Spindle Cell Metaplasia of Malignant Cells Present,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,0
791,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Head and Neck Neoplasm,0
792,Peau d'orange surface of breast,Giant fibroadenoma of breast,0
793,Solar Radiation Toxicity,Stage 0 Ureter Cancer AJCC v7,0
794,Fenestrated Pattern,Cecum Carcinoma,0
795,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Hodgkin Lymphoma,0
796,Fenestrated Pattern,Breast cancer recurrent,0
797,Absence of Malignant Features,Secondary malignant neoplasm of ovary,0
798,Recurrent Genetic Abnormalities Present,Recurrent Gastroesophageal Junction Adenocarcinoma,0
799,Well Differentiated Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
800,Fenestrated Pattern,Stage III Colon Cancer,0
801,Fenestrated Pattern,"Melanoma, Amelanotic",0
802,Windblown Appearance of Atypical Keratinocytes,Prostatic Atypical Adenomatous Hyperplasia,0
803,Increased megakaryocytes (bone marrow),Virus-Related Lymphoma,0
804,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,malignant epithelioid hemangioendothelioma of liver,0
805,No Evidence of Metastatic Disease,Metastatic Adrenal Gland Pheochromocytoma,0
806,Metaplasia of Malignant Cells Present,Malignant melanoma of rectum,0
807,Multihormonal Immunoreactivity Present in a Single Cell Type,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
808,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hemangioendothelioma of skin,0
809,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
810,Endometrial Type Glands and Stroma Present,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
811,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Luminal B Prostate Carcinoma,0
812,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Neuroblastic tumors,0
813,Increased megakaryocytes (bone marrow),Metastatic angiosarcoma,0
814,Absence of Malignant Features,Recurrent Subsequent Malignant Neoplasm,0
815,Increased megakaryocytes (bone marrow),Thyroid Gland Hemangioma,0
816,Mammary Gland Type Features Present,Sebaceous Gland Neoplasms,0
817,Endometrial Type Glands and Stroma Present,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
818,Solar Radiation Toxicity,Stage IB Lung Adenocarcinoma AJCC v7,0
819,Mammary Gland Type Features Present,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
820,Fenestrated Pattern,Hobnail Hemangioma,0
821,Recurrent Genetic Abnormalities Present,Recurrent Indolent Adult Non-Hodgkin Lymphoma,0
822,Follicular Cell Differentiation,Cutaneous Follicular Lymphoma,0
823,Increased megakaryocytes (bone marrow),Stage IIIA Eyelid Carcinoma AJCC v7,0
824,Fenestrated Pattern,Unresectable Paraganglioma,0
825,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA Vulvar Carcinoma AJCC v6,0
826,Fenestrated Pattern,External Auditory Canal Ceruminous Adenoma,0
827,Solar Radiation Toxicity,Vaginal Endometrioid Adenocarcinoma,0
828,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Peripheral T-Cell Lymphoma,0
829,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Esophagus Carcinoma,0
830,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,BCLC Stage 0 Hepatocellular Carcinoma,0
831,Intermediate Grade Neuroendocrine Lesion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
832,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of exocrine pancreas,0
833,Solitary Skin Tumor,Digestive System Neuroendocrine Tumor G2,0
834,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Retinoblastoma unilateral,0
835,Fenestrated Pattern,Stage III Prostate Cancer AJCC v7,0
836,Solar Radiation Toxicity,Glioblastoma,0
837,Glandular cell atypia,Large cell lung cancer stage II,0
838,Fenestrated Pattern,Testicular cancer metastatic,0
839,Increased megakaryocytes (bone marrow),Pilar-Associated Mesenchyme Neoplasm,0
840,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Neuroendocrine carcinoma of appendix,0
841,Mammary Gland Type Features Present,Parotid Gland Lipoma,0
842,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Hard Palate Neoplasm,0
843,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Lung Cancer AJCC v8,0
844,Mixed Neoplastic Glandular and Squamous Cell Population,Mediastinal Mixed Germ Cell Tumor,0
845,Increased megakaryocytes (bone marrow),Pemphigus Vulgaris,0
846,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pharyngeal Carcinoma by AJCC v7 Stage,0
847,Fenestrated Pattern,FIGO Stage IIIA1 Ovarian Cancer,0
848,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,0
849,Metaplasia of Malignant Cells Present,Malignant tumor of iris,0
850,Antoni B Pattern,Adult B Lymphoblastic Lymphoma,0
851,Recurrent Genetic Abnormalities Present,Recurrent Parathyroid Gland Carcinoma,0
852,Plasma cell inflammation,Large cell lung cancer stage III,0
853,Increased megakaryocytes (bone marrow),Intramuscular lipoma,0
854,Increased megakaryocytes (bone marrow),Advanced Melanoma,0
855,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Breast Carcinoma Metastatic in the Central Nervous System,0
856,Mature Neutrophils Present,Central Nervous System Mature Teratoma,0
857,Absence of Malignant Features,Adenocarcinoma of rete ovarii,0
858,Malignant Primitive Cellular Infiltrate,Malignant Paraganglionic Neoplasm,0
859,Epithelial Differentiation,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,0
860,Increased megakaryocytes (bone marrow),Anaplastic Diencephalic Astrocytoma,0
861,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Advanced Stage Hodgkin Lymphoma AJCC v8,0
862,Fenestrated Pattern,Alveolar rhabdomyosarcoma,0
863,Glandular cell atypia,Nasopharyngeal squamous cell carcinoma stage I,0
864,Endometrial Type Glands and Stroma Present,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",0
865,Fenestrated Pattern,Fusion-Positive Alveolar Rhabdomyosarcoma,0
866,Increased megakaryocytes (bone marrow),Thyroid Hyalinizing Trabecular Adenoma,0
867,Increased megakaryocytes (bone marrow),Refractory Burkitt Leukemia,0
868,Peau d'orange surface of breast,follicular malignant lymphoma of breast,0
869,Fenestrated Pattern,Rectal Juvenile Polyp,0
870,Increased megakaryocytes (bone marrow),Stage 0 Urethral Cancer AJCC v7,0
871,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Basaloid Carcinoma,0
872,Increased megakaryocytes (bone marrow),Biliary papillomatosis,0
873,Increased megakaryocytes (bone marrow),Composite hemangioendothelioma,0
874,Fenestrated Pattern,Lepidic Predominant Adenocarcinoma,0
875,Fenestrated Pattern,Colonic tubulovillous adenoma,0
876,Fenestrated Pattern,Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8,0
877,Increased megakaryocytes (bone marrow),Angioimmunoblastic T-cell lymphoma recurrent,0
878,Solitary Skin Tumor,Vulvar Yolk Sac Tumor,0
879,Fenestrated Pattern,"Hodgkin lymphoma, lymphocyte depletion",0
880,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Ventricular and Brain Stem Ependymal Tumor,0
881,Glandular cell atypia,Lip basal cell carcinoma,0
882,No Evidence of Metastatic Disease,Metastatic thymic carcinoma,0
883,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Carcinoma Unspecified Site,0
884,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Triple-Negative Breast Carcinoma,0
885,Nodular lesions,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
886,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign pheochromocytoma of adrenal gland,0
887,Bone Marrow Involvement,Stage IVA Bone Cancer AJCC v7,0
888,Solar Radiation Toxicity,Stage I Uterine Corpus Cancer AJCC v8,0
889,Malignant Primitive Cellular Infiltrate,Malignant Head and Neck Neoplasm,0
890,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Carcinoma,0
891,Islands of Odontogenic Epithelium Present,Germinative Follicular Epithelium Neoplasm,0
892,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Villous adenoma of duodenum,0
893,Increased megakaryocytes (bone marrow),Gastric Intestinal-Type Adenocarcinoma,0
894,Spindle Cell Metaplasia of Malignant Cells Present,large cell neuroendocrine carcinoma of lung,0
895,Spindle Cell Metaplasia of Malignant Cells Present,Glucagon Cell Hyperplasia and Neoplasia,0
896,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Thyroid Gland Medullary Carcinoma,0
897,Recurrent Genetic Abnormalities Present,Recurrent Meningioma,0
898,Spindle Cell Osteo-Fibrous Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,0
899,Aggressive Clinical Course,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma,0
900,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Urethral Carcinoma,0
901,Solar Radiation Toxicity,Unna-Thost Syndrome,0
902,Spindle Cell Metaplasia of Malignant Cells Present,Leiomyosarcoma of cervix uteri,0
903,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Ameloblastoma,0
904,Endometrial Type Glands and Stroma Present,Stage II Immature Testicular Teratoma AJCC v6 and v7,0
905,Solar Radiation Toxicity,Stage I Childhood Lymphoblastic Lymphoma,0
906,Nodular and Diffuse Pattern,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
907,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Prostate Carcinoma,0
908,Absence of Malignant Features,Stage IB Pleural Malignant Mesothelioma AJCC v7,0
909,Schwannian Stroma More than 50 Percent of the Tumor Volume,Angiosarcoma of the breast,0
910,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus Epithelioid Leiomyosarcoma,0
911,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of the prostate stage I,0
912,Large Spaces Filled with Blood Present,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1,0
913,Solar Radiation Toxicity,Rhabdoid meningioma,0
914,Solitary mass,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",0
915,Solar Radiation Toxicity,Rhabdomyosarcoma,0
916,Cervical lymphadenopathy,Cervical Rhabdomyoma,0
917,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Paraganglionic Neoplasm,0
918,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ovarian Embryonal Carcinoma,0
919,Abundance of Small Lymphocytes,Small Intestinal Diffuse Large B-Cell Lymphoma,0
920,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
921,Intersecting Sharply Marginated Clusters of Spindle Cells Present,sarcoma of vagina,0
922,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bartholin Gland Adenoma,0
923,Spindle Cell Metaplasia of Malignant Cells Present,Locally Advanced Unresectable Malignant Neoplasm,0
924,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,"Adenocarcinoma, Tubular",0
925,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,0
926,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ovarian Sex Cord Tumor with Annular Tubules,0
927,Increased megakaryocytes (bone marrow),Stage IIIC Appendix Carcinoma AJCC v7,0
928,Nodular and Diffuse Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma,0
929,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Clear cell squamous cell carcinoma of skin,0
930,Mixture of Germ Cell Neoplastic Components Present,Classic Variant of Chromophobe Renal Cell Carcinoma,0
931,Large Spaces Filled with Blood Present,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta,0
932,Recurrent Malignant Neoplasm,Malignant Neoplasm by Grade,0
933,Solar Radiation Toxicity,Stage IIIa Penile Cancer AJCC v7,0
934,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Adult Immunoblastic Lymphoma,0
935,Breast Implant-Related Lesion,Prognostic Stage IIIC Breast Cancer AJCC v8,0
936,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Glioblastoma by Gene Expression Profile,0
937,High Grade Lesion,Recurrent Grade 2 Follicular Lymphoma,0
938,Metaplasia of Malignant Cells Present,Malignant melanoma of vulva,0
939,Diffuse Cellular Infiltrate,Adult Diffuse Large B-Cell Lymphoma,0
940,Multihormonal Immunoreactivity Present in a Single Cell Type,Refractory Langerhans Cell Histiocytosis,0
941,Fenestrated Pattern,Epithelioid neurofibroma,0
942,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of subglottis,0
943,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucoepidermoid carcinoma of the oral cavity,0
944,Nodular and Diffuse Pattern,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",0
945,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Gastric Carcinoma,0
946,Increased megakaryocytes (bone marrow),Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
947,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Masaoka-Koga Stage III,0
948,Solitary Skin Tumor,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor,0
949,Multihormonal Immunoreactivity Present in a Single Cell Type,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
950,Aberrant Thyroid Tissue Present,Thyroid Nodule,0
951,Glandular cell atypia,Hereditary clear cell renal cell carcinoma,0
952,Tumor Mass,Intestinal Neuroendocrine Tumor,0
953,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyosarcoma of retroperitoneum,0
954,Spindle Cell Metaplasia of Malignant Cells Present,Large Cell Dysplasia,0
955,Absence of Malignant Features,Secondary malignant neoplasm of chest wall,0
956,Recurrent Malignant Neoplasm,Recurrent Childhood Gliosarcoma,0
957,Numerous Stromal Mast Cells Present,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
958,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,0
959,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Low-grade fibromyxoid sarcoma,0
960,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Gastrinoma, malignant",0
961,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Acute vascular insufficiency of intestine (disorder),0
962,Endometrial Type Glands and Stroma Present,Porokeratotic eccrine ostial and dermal duct nevus,0
963,Solitary Skin Tumor,Hindgut Carcinoid Tumor,0
964,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Benign Mixed Tumor of the Vulva,0
965,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Fallopian Tube Cancer by AJCC v7 Stage,0
966,Spindle Cell Metaplasia of Malignant Cells Present,Papillary transitional cell neoplasm of low malignant potential,0
967,Increased megakaryocytes (bone marrow),Stage IIA Pancreatic Cancer AJCC v8,0
968,Solar Radiation Toxicity,Pseudolymphoma,0
969,Fenestrated Pattern,Pseudoporphyria,0
970,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Carcinoma,0
971,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVC Major Salivary Gland Cancer AJCC v7,0
972,Nodular and Diffuse Pattern,Stage II Ovarian Dysgerminoma AJCC v6 and v7,0
973,Pleural effusion disorder,Pleural Biphasic Synovial Sarcoma,0
974,Increased megakaryocytes (bone marrow),Paraganglioma,0
975,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,0
976,Fenestrated Pattern,Childhood Immunoblastic Lymphoma,0
977,Fenestrated Pattern,Alkylating Agent-Related Myelodysplastic Syndrome,0
978,Solitary Skin Tumor,Pericardial Solitary Fibrous Tumor,0
979,Osseous Metaplasia of Malignant Cells Present,Malignant blue nevus of skin,0
980,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Traditional Serrated Adenoma,0
981,White blood cell count increased (lab result),"Transitional cell papilloma, benign",0
982,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,0
983,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of trachea,0
984,Solar Radiation Toxicity,Angioimmunoblastic T-cell lymphoma stage IV,0
985,Absence of Malignant Features,Ampulla of Vater Adenosquamous Carcinoma,0
986,Increased megakaryocytes (bone marrow),Tonsillar Lymphoma,0
987,Microinvasive tumor,Benign squamous cell tumor,0
988,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Vaginal Cancer AJCC v8,0
989,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Renal Pelvis Urothelial Carcinoma,0
990,Spindle Cell Metaplasia of Malignant Cells Present,Non-Small Cell Adenocarcinoma,0
991,Increased megakaryocytes (bone marrow),Diencephalic Glioblastoma,0
992,Recurrent Genetic Abnormalities Present,Recurrent Childhood Pilomyxoid Astrocytoma,0
993,Solar Radiation Toxicity,Stage II Urethral Cancer AJCC v7,0
994,Large Spaces Filled with Blood Present,Recurrent Childhood Anaplastic Large Cell Lymphoma,0
995,Small Aggregates of Tumor Cells Present,Adult Desmoplastic Small Round Cell Tumor,0
996,Fenestrated Pattern,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,0
997,Increased megakaryocytes (bone marrow),Refractory Melanoma,0
998,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Testicular Embryonal Carcinoma,0
999,Increased megakaryocytes (bone marrow),Stage IIIB Eyelid Carcinoma AJCC v8,0
1000,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of extrahepatic bile duct,0
1001,Tubular Pattern,"Testicular Yolk Sac Tumor, Myxomatous Pattern",0
1002,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Nasopharyngeal Carcinoma AJCC v8,0
1003,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Congenital Nonbullous Ichthyosiform Erythroderma,0
1004,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Granulomatous dermatitis,0
1005,Bone Marrow Involvement,Stage II Bone Sarcoma AJCC v7,0
1006,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Medulloblastoma, SHH-Activated",0
1007,Cervical Glandular Dysplasia,Ectopic Cervical Thymoma,0
1008,Solar Radiation Toxicity,Adult Medulloblastoma,0
1009,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Angiolipoma,0
1010,Increased megakaryocytes (bone marrow),Stage IVB Colon Cancer AJCC v7,0
1011,Photosensitivity of skin,Tufted angioma of skin,0
1012,Increased megakaryocytes (bone marrow),Duodenal-type follicular lymphoma,0
1013,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Reproductive Endocrine Neoplasm,0
1014,Stable Disease,Erdheim-Chester Disease,0
1015,Fenestrated Pattern,Stage IA Lung Adenosquamous Carcinoma AJCC v7,0
1016,Mammary Gland Type Features Present,Lung Mucous Gland Adenoma,0
1017,Solar Radiation Toxicity,Pancreatoblastoma,0
1018,Fenestrated Pattern,Cerebellopontine Angle Schwannoma,0
1019,Increased megakaryocytes (bone marrow),"Retinoblastoma, differentiated",0
1020,Hypertensive disease,Hodgkin's disease lymphocyte depletion type refractory,0
1021,Nodular and Diffuse Pattern,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
1022,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
1023,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Ureter Urothelial Carcinoma,0
1024,Unfavorable Clinical Outcome,Clinical Stage II Gastric Cancer AJCC v8,0
1025,Increased megakaryocytes (bone marrow),Neurodermatitis,0
1026,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2",0
1027,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anogenital papillomaviral intraepithelial neoplasia,0
1028,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Acinic Cell Breast Carcinoma,0
1029,High Grade Non Cartilaginous Sarcomatous Stroma Present,Ann Arbor Stage III Grade 2 Follicular Lymphoma,0
1030,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Esophageal Schwannoma,0
1031,Fenestrated Pattern,Rectosigmoid Adenocarcinoma,0
1032,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Posterior Pharyngeal Wall Carcinoma,0
1033,Mixture of Embryonal and Alveolar Features Present,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7,0
1034,Fenestrated Pattern,Corneal intraepithelial neoplasia,0
1035,Large Spaces Filled with Blood Present,Diffuse Large B-Cell Lymphoma,0
1036,Diffuse Cellular Infiltrate,Cellular Blue Nevus,0
1037,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Carcinoma of Unknown Primary,0
1038,Loss of INI 1 Protein Expression,"Seminoma of testis, stage 1",0
1039,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Placental Choriocarcinoma,0
1040,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hereditary Male Breast Carcinoma,0
1041,IDH Gene Family Mutation Status Unknown,MiT Family Translocation-Associated Renal Cell Carcinoma,0
1042,Fenestrated Pattern,Marginal zone lymphoma stage IV,0
1043,Solar Radiation Toxicity,Seminal Vesicle Cystadenoma,0
1044,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Lymphoma by Ann Arbor Stage,0
1045,Intersecting Sharply Marginated Clusters of Spindle Cells Present,clear cell adenocarcinofibroma of ovary,0
1046,Absence of Malignant Features,Childhood Recurrent Malignant Solid Neoplasm,0
1047,Fenestrated Pattern,Stage 0a Penile Cancer AJCC v8,0
1048,Fenestrated Pattern,Uterine Corpus Carcinofibroma,0
1049,Spindle Cell Metaplasia of Malignant Cells Present,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
1050,Fenestrated Pattern,Childhood Kidney Angiomyolipoma,0
1051,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Glioma,0
1052,Increased megakaryocytes (bone marrow),Esophageal Adenocarcinoma by AJCC v7 Stage,0
1053,Mixture of Germ Cell Neoplastic Components Present,Squamous Cell Carcinoma of Unknown Primary,0
1054,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Thymoma, type A, malignant",0
1055,Metaplasia of Malignant Cells Present,Malignant tumor of ethmoid sinus,0
1056,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Colon Cancer AJCC v7,0
1057,Increased megakaryocytes (bone marrow),Carcinoma duodenum resectable,0
1058,Blasts Expressing CD56 and Immature T-Cell Markers Present,Chronic Adult T-Cell Leukemia/Lymphoma,0
1059,Increased megakaryocytes (bone marrow),Stage II Childhood Burkitt Lymphoma,0
1060,Increased megakaryocytes (bone marrow),Parapsoriasis,0
1061,Intersecting Sharply Marginated Clusters of Spindle Cells Present,carcinoma of eye,0
1062,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anal Lymphoma,0
1063,Nests of Nevus Cells Resembling Nerve Bundles Present,Acral Skin Nevus,0
1064,Fenestrated Pattern,Stage IIIC Rectal Cancer AJCC v7,0
1065,Endometrial Type Glands and Stroma Present,Infiltrating duct and lobular carcinoma,0
1066,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Small Congenital Melanocytic Nevus,0
1067,Endometrial Type Glands and Stroma Present,Epithelioid and spindle cell nevus,0
1068,Increased megakaryocytes (bone marrow),Stage IV Ovarian Cancer AJCC v8,0
1069,Photosensitivity of skin,Malignant fibrous histiocytoma of skin,0
1070,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hereditary Kidney Oncocytoma,0
1071,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Cell Carcinoma,0
1072,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IIIB Gestational Trophoblastic Tumor AJCC v7,0
1073,Skin Erosion,Skin Pigmentation Disorder,0
1074,Low Grade Cartilaginous Component Present,Low Grade Adenosquamous Breast Carcinoma,0
1075,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,AIDS-Related Human Papillomavirus Infection,0
1076,Recurrent Genetic Abnormalities Present,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,0
1077,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Eyelid Carcinoma AJCC v7,0
1078,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Carcinoma of lower gum,0
1079,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Risk Myelodysplastic Syndrome,0
1080,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Lymphoblastic Lymphoma,0
1081,Follicular Differentiation,Methotrexate-Associated Follicular Lymphoma,0
1082,Solar Radiation Toxicity,Lipoblastomatosis,0
1083,Fenestrated Pattern,Tendon Sheath Lipoma,0
1084,Non-Encapsulated Neoplasm,Childhood Spinal Cord Neoplasm,0
1085,Small Aggregates of Tumor Cells Present,Small cell carcinoma of prostate,0
1086,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Xeroderma pigmentosum, group G",0
1087,Increased megakaryocytes (bone marrow),Adult Gliosarcoma,0
1088,Increased megakaryocytes (bone marrow),Hidroacanthoma simplex,0
1089,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Choroidal and Ciliary Body Melanoma AJCC v8,0
1090,Less than 2 Mitoses per 10HPF,ROSE Cluster 2,0
1091,Fenestrated Pattern,Necrobiosis Lipoidica,0
1092,Spindle Cell Metaplasia of Malignant Cells Present,Refractory Malignant Solid Neoplasm,0
1093,Aggressive Clinical Course,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,0
1094,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Major Salivary Gland Cancer AJCC v8,0
1095,NRBC - Nucleated red blood cell present result,Nasopharyngeal squamous cell carcinoma recurrent,0
1096,Lesion with Diameter of 2cm or Less,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
1097,Glandular Differentiation,"Glandular intraepithelial neoplasia, low grade",0
1098,Neoplastic Plasma Cells Present in Bone Marrow,Stage IVA Bone Cancer AJCC v7,0
1099,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus Cancer by AJCC v8 Stage,0
1100,Canalicular Pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",0
1101,Multihormonal Immunoreactivity Present in a Single Cell Type,Ovarian Transitional Cell Tumor,0
1102,Solar Radiation Toxicity,Desmoplastic infantile ganglioglioma,0
1103,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Digestive System Adenocarcinoma,0
1104,Tumor Mass,Breast Phyllodes Tumor,0
1105,Recurrent Malignant Neoplasm,Precursor Lymphoid Neoplasm,0
1106,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,mucinous adenocarcinoma of cervix,0
1107,Endometrial Type Glands and Stroma Present,"Cervical Mucinous Adenocarcinoma, Gastric Type",0
1108,Increased megakaryocytes (bone marrow),Ovarian Serous Adenocarcinoma,0
1109,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ependymoma of brain stem,0
1110,Multihormonal Immunoreactivity Present in a Single Cell Type,Occult Lung Small Cell Carcinoma,0
1111,Fenestrated Pattern,Stage IIB Colorectal Cancer AJCC v8,0
1112,Multihormonal Immunoreactivity Present in a Single Cell Type,Pancreatic Acinar Cell Neoplasm,0
1113,Multihormonal Immunoreactivity Present in a Single Cell Type,Transitional Cell Intraepithelial Neoplasia,0
1114,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,0
1115,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Dermatophytosis of groin and perianal area,0
1116,Increased megakaryocytes (bone marrow),Stage IIIC Eyelid Carcinoma AJCC v7,0
1117,Solar Radiation Toxicity,Stage III Osteosarcoma AJCC v7,0
1118,Chromogranin A Positive Neoplastic Cells Present,Luminal A Breast Carcinoma,0
1119,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIB Cervical Cancer AJCC v6 and v7,0
1120,High Grade Non Cartilaginous Sarcomatous Stroma Present,Sarcoma NCI Grade 3,0
1121,Lesion with Diameter of 10mm or Less,Ovarian Dermoid Cyst with Secondary Melanocytic Lesion,0
1122,Small Aggregates of Tumor Cells Present,Small Intestinal Undifferentiated Carcinoma,0
1123,Multihormonal Immunoreactivity Present in a Single Cell Type,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),0
1124,Mixed Cellular Population,Mixed Liposarcoma,0
1125,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lung Adenocarcinoma by AJCC v7 Stage,0
1126,Solar Radiation Toxicity,Densely Granulated Non-Functioning Corticotroph Adenoma,0
1127,Increased megakaryocytes (bone marrow),Monodermal Testicular Teratoma,0
1128,Aberrant Thyroid Tissue Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,0
1129,Increased megakaryocytes (bone marrow),"Paget's Disease, Mammary",0
1130,Solar Radiation Toxicity,Inner Ear Lipoma,0
1131,Fenestrated Pattern,Hepatosplenic T-cell lymphoma,0
1132,Mixed Neoplastic Glandular and Squamous Cell Population,Pituitary Gland Mixed Gangliocytoma-Adenoma,0
1133,Increased megakaryocytes (bone marrow),Gestational Trophoblastic Neoplasms,0
1134,Spindle Cell Metaplasia of Malignant Cells Present,Ampulla of Vater Tubulovillous Adenoma,0
1135,Endometrial Type Glands and Stroma Present,Endometrial cystic hyperplasia,0
1136,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,0
1137,Small Aggregates of Tumor Cells Present,Ampulla of Vater Neuroendocrine Tumor,0
1138,Schwannian Stroma More than 50 Percent of the Tumor Volume,Thymus Solitary Fibrous Tumor,0
1139,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IA Eyelid Carcinoma AJCC v7,0
1140,Metaplasia of Malignant Cells Present,Malignant neoplasm of large intestine,0
1141,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Capillary Hemangioma,0
1142,Increased megakaryocytes (bone marrow),Anaplastic Brain Stem Astrocytoma,0
1143,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",0
1144,Solitary Skin Tumor,Thymus Solitary Fibrous Tumor,0
1145,Fenestrated Pattern,Stage I Thymoma AJCC v8,0
1146,Absence of Muscle Invasion,Benign Smooth Muscle Neoplasm,0
1147,Increased megakaryocytes (bone marrow),Stage IVA Osteosarcoma AJCC v7,0
1148,Recurrent Genetic Abnormalities Present,Recurrent T Acute Lymphoblastic Leukemia,0
1149,Absence of Malignant Features,Recurrent Malignant Neoplasm of Salivary Gland,0
1150,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Ureter Urothelial Carcinoma,0
1151,Increased megakaryocytes (bone marrow),Mediastinal Thymoma,0
1152,Mixed Neoplastic Glandular and Squamous Cell Population,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,0
1153,Spindle Cell Osteo-Fibrous Component Present,Plasma Cell Myeloma by RISS Stage,0
1154,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Juxta-Articular Myxoma,0
1155,Absence of Malignant Features,Stage III Ampulla of Vater Cancer AJCC v7,0
1156,Papillary Pattern,Papillary Meningioma,0
1157,Solar Radiation Toxicity,Sellar Neurocytoma,0
1158,Increased megakaryocytes (bone marrow),Nasal Cavity Lymphoma,0
1159,Solar Radiation Toxicity,Mucinous neoplasm,0
1160,Increased megakaryocytes (bone marrow),Central Nervous System Choriocarcinoma,0
1161,Metastatic/Recurrent Disease,Paget Disease Extramammary,0
1162,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Clear cell cystadenofibroma,0
1163,Mammary Gland Type Features Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral",0
1164,Less than 2 Mitoses per 10HPF,Grade 2 Colorectal Adenocarcinoma,0
1165,Large Spaces Filled with Blood Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,0
1166,Fenestrated Pattern,Stage IIIB Vulvar Cancer AJCC v7,0
1167,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1168,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Brain Neoplasm,0
1169,Fenestrated Pattern,Core binding factor acute myeloid leukemia,0
1170,Increased megakaryocytes (bone marrow),Lymphoma stage III,0
1171,Lesion with Diameter of 2cm or Less,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0
1172,Mammary Gland Type Features Present,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
1173,Intersecting Sharply Marginated Clusters of Spindle Cells Present,benign mature teratoma of pancreas,0
1174,Aberrant Thyroid Tissue Present,Soft Tissue Angiosarcoma,0
1175,Endometrial Type Glands and Stroma Present,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",0
1176,High Grade Lesion,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1",0
1177,Fenestrated Pattern,Stage III Renal Pelvis Cancer AJCC v7,0
1178,Spindle Cell Metaplasia of Malignant Cells Present,Adult Pineal Parenchymal Cell Neoplasm,0
1179,Neoplastic Cells with TFH Cell Phenotype Present,Ovarian Sertoli Cell Tumor with Lipid Storage,0
1180,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Differentiating Neuroblastoma,0
1181,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Stage III Pleural Malignant Mesothelioma AJCC v7,0
1182,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Gastroesophageal Junction Adenocarcinoma,0
1183,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Neuroblastic tumors,0
1184,Fenestrated Pattern,Disseminated neuroblastoma,0
1185,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Uterine Corpus Cancer AJCC v8,0
1186,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Cutaneous Melanoma by AJCC v8 Stage,0
1187,Large Spaces Filled with Blood Present,Myeloid Neoplasms with Germline GATA2 Mutation,0
1188,Villous Projections of the Neoplastic Epithelium Present,Mucoepidermoid carcinoma of the oral cavity stage III,0
1189,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Synovial sarcoma recurrent,0
1190,Increased megakaryocytes (bone marrow),Pleomorphic Hepatocellular Carcinoma,0
1191,Fenestrated Pattern,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,0
1192,Fenestrated Pattern,"Thymoma, type A",0
1193,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hairy leukoplakia of tongue,0
1194,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Cowden-Associated Polyp,0
1195,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIA Pancreatic Cancer AJCC v8,0
1196,Fenestrated Pattern,Sclerosing Epithelioid Fibrosarcoma,0
1197,Skin Erosion,Skin Clear Cell Basal Cell Carcinoma,0
1198,Increased megakaryocytes (bone marrow),Gallbladder Rhabdomyosarcoma,0
1199,Well Differentiated Lesion,Poorly Differentiated Hepatocellular Carcinoma,0
1200,Well Differentiated Lesion,Poorly Differentiated Neuroblastoma,0
1201,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Unresectable Gastric Adenocarcinoma,0
1202,Recurrent Malignant Neoplasm,Recurrent Appendix Mucinous Adenocarcinoma,0
1203,Stromal Invasion,Stromal sarcoma,0
1204,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ovarian Cystic Teratoma,0
1205,Spindle Cell Metaplasia of Malignant Cells Present,Secondary malignant neoplasm of sternum,0
1206,Fenestrated Pattern,Lymphatic Vessel Tumors,0
1207,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Neuroendocrine neoplasm of gallbladder,0
1208,Spindle Cell Metaplasia of Malignant Cells Present,Hurthle Cell Tumor,0
1209,Increased megakaryocytes (bone marrow),Stage III Gallbladder Cancer AJCC v7,0
1210,Solar Radiation Toxicity,Post polycythaemia vera myelofibrosis,0
1211,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical Adenomatous Lung Hyperplasia,0
1212,Gastric dysplasia,Gastric Choriocarcinoma,0
1213,Nests of Nevus Cells Resembling Nerve Bundles Present,Atypical Spitz Nevus,0
1214,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Acute Megakaryoblastic Leukemia with NUP98-KDM5A,0
1215,Mammary Gland Type Features Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,0
1216,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Prostate Cancer AJCC v8,0
1217,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Acute Myeloid Leukemia with Variant MLL Translocations,0
1218,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Gastric Carcinoma,0
1219,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Kidney Mixed Epithelial and Stromal Tumor Family,0
1220,Small Aggregates of Tumor Cells Present,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",0
1221,Solitary Skin Tumor,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
1222,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraductal papillomatosis,0
1223,Fenestrated Pattern,Juvenile astrocytoma,0
1224,Lesion with Diameter of 2cm or Less,cystic mucinous tumor of pancreas with moderate dysplasia,0
1225,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Malignant Liver Neoplasm,0
1226,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Lymphoepithelioma-Like Hepatocellular Carcinoma,0
1227,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Breast Cancer by AJCC v8 Stage,0
1228,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Prostate Urothelial Carcinoma,0
1229,Increased megakaryocytes (bone marrow),Uterine Corpus Choriocarcinoma,0
1230,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Laryngeal Carcinoma,0
1231,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Occult Breast Carcinoma,0
1232,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cardiac Synovial Sarcoma,0
1233,Solar Radiation Toxicity,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,0
1234,Fenestrated Pattern,Benign Infratentorial Neoplasms,0
1235,Absence of Malignant Features,mixed acinar-endocrine carcinoma of pancreas,0
1236,Vacuolated Plasma Cells in the Bone Marrow,Colon Carcinoma Metastatic in the Lung,0
1237,Congenital Abnormality,Congenital Nonbullous Ichthyosiform Erythroderma,0
1238,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Inflammatory carcinoma of breast stage III,0
1239,Solar Radiation Toxicity,Seborrheic dermatitis,0
1240,Tissue Differentiation Uncertain,Colon Mucosa-Associated Lymphoid Tissue Lymphoma,0
1241,Increased megakaryocytes (bone marrow),Stage IIIC Testicular Cancer AJCC v8,0
1242,Fenestrated Pattern,Pancreatic Intraepithelial Neoplasia-1A,0
1243,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
1244,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IB Pancreatic Cancer AJCC v6 and v7,0
1245,Mammary Gland Type Features Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,0
1246,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,0
1247,Increased megakaryocytes (bone marrow),Encephalocraniocutaneous lipomatosis,0
1248,Absence of Malignant Features,Malignant Testicular Sex Cord-Stromal Tumor,0
1249,Low Grade Cartilaginous Component Present,Colorectal Low Grade Intraepithelial Neoplasia,0
1250,Primary Site Unspecified,Refractory Primary Peritoneal Carcinoma,0
1251,Nodular and Diffuse Pattern,"Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome",0
1252,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Placental Choriocarcinoma,0
1253,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Uterine Corpus Leiomyosarcoma AJCC v8,0
1254,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8,0
1255,Solitary Skin Tumor,Dentinogenic Ghost Cell Tumor,0
1256,Atypical Lymphocytes Present in Peripheral Blood,Blood Vessel Tumors,0
1257,Solar Radiation Toxicity,Familial Neuroblastoma,0
1258,Marked Thickening of the Bladder Urothelium Present,Bladder Cancer by AJCC v7 Stage,0
1259,Skin Erosion,"Skin Diseases, Vascular",0
1260,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Breast Cancer by AJCC v8 Stage,0
1261,Absence of Malignant Features,fibrosarcoma of kidney,0
1262,Fenestrated Pattern,Stage IV Prostate Cancer AJCC v8,0
1263,Spindle Cell Metaplasia of Malignant Cells Present,Fallopian Tube Transitional Cell Carcinoma,0
1264,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Chordoma,0
1265,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Precancerous skin lesion,0
1266,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Appendix Mucinous Adenocarcinoma,0
1267,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign tumor of exocrine pancreas,0
1268,Solitary Skin Tumor,Rectal Neuroendocrine Tumor,0
1269,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Stage IIB Ampulla of Vater Cancer AJCC v8,0
1270,Intermediate Grade Neuroendocrine Lesion,Childhood Grade III Meningioma,0
1271,Solar Radiation Toxicity,Vaginal Rhabdomyosarcoma,0
1272,Local disease,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,0
1273,Schwannian Stroma More than 50 Percent of the Tumor Volume,Childhood Ependymal Tumor,0
1274,Recurrent Malignant Neoplasm,Recurrent Vulvar Carcinoma,0
1275,Fenestrated Pattern,Aflatoxins-Related Hepatocellular Carcinoma,0
1276,Fenestrated Pattern,Refractory Kaposi Sarcoma,0
1277,Large Spaces Filled with Blood Present,Acute Myeloid Leukemia with t(17;17)(q21;q21),0
1278,Increased megakaryocytes (bone marrow),"lymphomatoid papulosis, type A",0
1279,Solitary Skin Tumor,Adult Yolk Sac Tumor,0
1280,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Metastases to abdominal cavity,0
1281,Prominent In Situ Component Present,Intermediate Grade Ductal Breast Carcinoma In Situ,0
1282,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
1283,Locally Aggressive Lesion,Locally Advanced Unresectable Carcinoma,0
1284,Fenestrated Pattern,Indolent Non-Hodgkin Lymphoma,0
1285,Spindle Cell Osteo-Fibrous Component Present,ISS Stage III Plasma Cell Myeloma,0
1286,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Acute Leukemia of Ambiguous Lineage,0
1287,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Carcinoid tumor of ileum,0
1288,Increased megakaryocytes (bone marrow),Fibrous Meningioma,0
1289,Nodular and Diffuse Pattern,Porokeratotic eccrine ostial and dermal duct nevus,0
1290,Spindle Cell Metaplasia of Malignant Cells Present,leiomyoma of extrahepatic bile duct,0
1291,Solitary Skin Tumor,Glioneuronal Tumor with Neuropil-Like Islands,0
1292,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Erythema toxicum neonatorum,0
1293,Increased megakaryocytes (bone marrow),Vaginal Mucinous Adenocarcinoma,0
1294,Increased megakaryocytes (bone marrow),Anaplastic Oligoastrocytoma,0
1295,Non-Encapsulated Neoplasm,Childhood Mediastinal Neurogenic Neoplasm,0
1296,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,0
1297,Recurrent Malignant Neoplasm,Recurrent Hematologic Malignancy,0
1298,Spindle Cell Metaplasia of Malignant Cells Present,benign mature teratoma of pancreas,0
1299,Increased megakaryocytes (bone marrow),Cementoma,0
1300,Solar Radiation Toxicity,Larynx carcinoma recurrent,0
1301,Apocrine metaplasia,Apocrine breast carcinoma,0
1302,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Obesity Related Glomerulopathy,0
1303,Atypical Lymphocytes Present in Peripheral Blood,Cervical Atypical Polypoid Adenomyoma,0
1304,Recurrent disease,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,0
1305,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Erythema Multiforme Major,0
1306,Disease regression,Maternally Derived Graft Versus Host Disease,0
1307,Aberrant Thyroid Tissue Present,Thyroid stimulating hormone-producing pituitary tumor,0
1308,Intersecting Sharply Marginated Clusters of Spindle Cells Present,yolk sac tumor of mediastinum,0
1309,Increased megakaryocytes (bone marrow),Stage IC Eyelid Carcinoma AJCC v7,0
1310,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0
1311,NRBC - Nucleated red blood cell present result,Bladder squamous cell carcinoma stage II,0
1312,Fenestrated Pattern,Ann Arbor Stage IIIB Hodgkin Lymphoma,0
1313,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Immature Teratoma,0
1314,Mixed Neoplastic Glandular and Squamous Cell Population,Squamous Lung Dysplasia,0
1315,Locally Aggressive Lesion,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma,0
1316,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of mesothelial tissue of peritoneum,0
1317,Fenestrated Pattern,AIDS related complication,0
1318,Recurrent Genetic Abnormalities Present,Recurrent Childhood Visual Pathway Glioma,0
1319,Diffuse Cellular Infiltrate,N1 Diffuse Large B-Cell Lymphoma,0
1320,Increased megakaryocytes (bone marrow),Refractory T Lymphoblastic Lymphoma,0
1321,Neoplastic Plasma Cells Present in Bone Marrow,Osteosarcoma Arising in Paget Disease of Bone,0
1322,Fenestrated Pattern,Ann Arbor Stage IV AIDS-Related Lymphoma,0
1323,Spindle Cell Osteo-Fibrous Component Present,Blastoid Variant Mantle Cell Lymphoma,0
1324,Spindle Cell Osteo-Fibrous Component Present,Ciliary Body Spindle Cell Melanoma,0
1325,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Plexiform fibrohistiocytic tumor,0
1326,Increased megakaryocytes (bone marrow),Verrucous epidermal nevus,0
1327,Immature Myeloid Cells Increased in Bone Marrow,Carcinoma in a polyp,0
1328,Schwannian Stroma More than 50 Percent of the Tumor Volume,Blastema Predominant Kidney Wilms Tumor,0
1329,Spindle Cell Metaplasia of Malignant Cells Present,Spindle Cell/Pleomorphic Lipoma,0
1330,Exophytic Papillary Lesion,Thymic Papillary Adenocarcinoma,0
1331,Solar Radiation Toxicity,Stage IIIA Colon Cancer AJCC v7,0
1332,Nodular and Diffuse Pattern,Advanced Head and Neck Squamous Cell Carcinoma,0
1333,Schwannian Stroma More than 50 Percent of the Tumor Volume,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
1334,Tubular Structures Present,"Testicular Seminoma, Tubular Variant",0
1335,High Grade Lesion,Childhood Grade III Meningioma,0
1336,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Cervical Adenosquamous Carcinoma,0
1337,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Major Salivary Gland Cancer AJCC v8,0
1338,Nodular and Diffuse Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,0
1339,Pleural effusion disorder,Pleural Biphasic Synovial Sarcoma,0
1340,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of respiratory system,0
1341,Increased megakaryocytes (bone marrow),Sweat gland carcinoma,0
1342,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IC Fallopian Tube Cancer AJCC v8,0
1343,Fenestrated Pattern,Pancreatic Intraepithelial Neoplasia-1,0
1344,Increased megakaryocytes (bone marrow),Trichilemmocarcinoma,0
1345,Increased megakaryocytes (bone marrow),Angiosarcoma non-metastatic,0
1346,Fried-Egg Appearance of the Bone Marrow,Sarcomatoid carcinoma of the lung,0
1347,High Grade Lesion,Grade 1 Invasive Breast Carcinoma,0
1348,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extranodal marginal zone B-cell lymphoma (MALT type) refractory,0
1349,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pineal parenchymal tumor of intermediate differentiation,0
1350,Recurrent Genetic Abnormalities Present,Recurrent Retinoblastoma,0
1351,Large Spaces Filled with Blood Present,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement,0
1352,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
1353,Absence of Malignant Features,Stage III Ampulla of Vater Cancer AJCC v7,0
1354,Melanoma Cells Present,Stage I Acral Lentiginous Melanoma AJCC v7,0
1355,High Grade Non Cartilaginous Sarcomatous Stroma Present,AJCC Grade 4 Sarcoma,0
1356,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
1357,Solar Radiation Toxicity,Peritoneal mesothelioma malignant advanced,0
1358,Increased megakaryocytes (bone marrow),Stage IIIB Appendix Carcinoma AJCC v7,0
1359,Spindle Cell Metaplasia of Malignant Cells Present,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,0
1360,Recurrent Malignant Neoplasm,Recurrent Olfactory Neuroblastoma,0
1361,Fenestrated Pattern,Lipofibromatosis,0
1362,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
1363,Mammary Gland Type Features Present,Recurrent Parotid Gland Adenoid Cystic Carcinoma,0
1364,Intersecting Sharply Marginated Clusters of Spindle Cells Present,carcinoma of lacrimal gland,0
1365,Large Spaces Filled with Blood Present,Stage IB Lung Large Cell Carcinoma AJCC v7,0
1366,Cellular Stratification,Cellular leiomyoma,0
1367,Rapidly Enlarging Mass,Rapidly progressive glomerulonephritis,0
1368,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of cerebellum,0
1369,Fenestrated Pattern,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",0
1370,Increased megakaryocytes (bone marrow),Serous Neoplasm,0
1371,Arborising Network of Cords of Basaloid Cells Present,Basaloid carcinoma,0
1372,Myofibroblastic Differentiation,Lung Inflammatory Myofibroblastic Tumor,0
1373,Squamous metaplasia of bladder,Squamous cell carcinoma of vulva,0
1374,Hypertensive disease,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,0
1375,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Basaloid Carcinoma,0
1376,Solar Radiation Toxicity,Placental infarct,0
1377,Chronic Inflammatory Infiltrate,Juvenile Chronic Polyarthritis,0
1378,Intermediate Grade Neuroendocrine Lesion,Intermediate Grade Malignant Neoplasm,0
1379,Breast Implant-Related Lesion,Breast cancer recurrent,0
1380,Malignant Primitive Cellular Infiltrate,Malignant Pulmonary Vein Neoplasm,0
1381,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
1382,Increased megakaryocytes (bone marrow),Beckwith-Wiedemann Syndrome,0
1383,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Ampulla of Vater Cancer AJCC v8,0
1384,Fenestrated Pattern,Stage I Adult Non-Hodgkin Lymphoma,0
1385,Multihormonal Immunoreactivity Present in a Single Cell Type,Advanced Gastric Large Cell Neuroendocrine Carcinoma,0
1386,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Intrahepatic Bile Duct Cancer AJCC v8,0
1387,Fenestrated Pattern,Stage 0 Hilar Cholangiocarcinoma AJCC v8,0
1388,Recurrent Genetic Abnormalities Present,Recurrent Childhood Gemistocytic Astrocytoma,0
1389,Increased megakaryocytes (bone marrow),Stage IIIC Uveal Melanoma AJCC v7,0
1390,Fenestrated Pattern,Adult Brain Glioblastoma,0
1391,Fenestrated Pattern,Stage I Fallopian Tube Cancer AJCC v8,0
1392,Increased megakaryocytes (bone marrow),Stage IB Breast Cancer AJCC v7,0
1393,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,0
1394,Increased megakaryocytes (bone marrow),Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8,0
1395,White blood cell count increased (lab result),Bile duct signet-ring cell carcinoma,0
1396,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Oropharyngeal Poorly Differentiated Carcinoma,0
1397,Fenestrated Pattern,Strumal carcinoid,0
1398,Malignant Primitive Cellular Infiltrate,Stage IV Malignant Mediastinal Germ Cell Tumor,0
1399,Fenestrated Pattern,Prognostic Stage IV Breast Cancer AJCC v8,0
1400,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myxosarcoma,0
1401,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,T-Cell Prolymphocytic Leukemia,0
1402,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Merkel Cell Carcinoma AJCC v7,0
1403,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of kidney,0
1404,Absence of Malignant Features,Locally Advanced Malignant Solid Neoplasm,0
1405,Increased megakaryocytes (bone marrow),"Leukemia, Radiation-Induced",0
1406,Increased megakaryocytes (bone marrow),"Dermatitis, Allergic Contact",0
1407,Indolent Clinical Course,Hodgkin Lymphoma by Clinical Course,0
1408,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Gastric Carcinoma,0
1409,Solar Radiation Toxicity,"Adenocarcinoma, Scirrhous",0
1410,Multihormonal Immunoreactivity Present in a Single Cell Type,"Uterine Carcinosarcoma, Homologous Type",0
1411,Absence of Malignant Features,Benign neoplasm of breast,0
1412,Blasts Expressing CD56 and Immature T-Cell Markers Present,Central Nervous System Immature Teratoma,0
1413,Squamous metaplasia of bladder,Nephrogenic metaplasia,0
1414,Squamous Differentiation,Squamous non-small cell lung cancer,0
1415,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of tongue,0
1416,Malignant Primitive Cellular Infiltrate,Refractory Malignant Peripheral Nerve Sheath Tumor,0
1417,Spindle Cell Metaplasia of Malignant Cells Present,keratinizing squamous cell carcinoma of lung,0
1418,Increased megakaryocytes (bone marrow),Non-Hodgkin Lymphoma During Pregnancy,0
1419,Solar Radiation Toxicity,Adult Pineocytoma,0
1420,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Squamous cell carcinoma with horn formation,0
1421,Multihormonal Immunoreactivity Present in a Single Cell Type,acute biphenotypic leukemia in relapse,0
1422,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Uterine Sarcoma AJCC v7,0
1423,Venous Type Vascular Channel Formation,"Breast Fibrocystic Change, Proliferative Type",0
1424,Spindle Cell Metaplasia of Malignant Cells Present,Locally Advanced Malignant Neoplasm,0
1425,Fenestrated Pattern,Brain sarcoma,0
1426,Mixed Neoplastic Glandular and Squamous Cell Population,High-Grade Squamous Intraepithelial Lesions,0
1427,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Rectal Adenosquamous Carcinoma,0
1428,IDH Gene Family Mutation Status Unknown,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
1429,Nodular and Diffuse Pattern,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
1430,Absence of Malignant Features,Malignant Granulosa Cell Tumor,0
1431,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse neurofibroma,0
1432,Non-Encapsulated Neoplasm,Bladder Non-Invasive Papillary Urothelial Neoplasm,0
1433,Venous Type Vascular Channel Formation,Refractory Neurofibromatosis Type 1,0
1434,Fenestrated Pattern,B-cell lymphoma stage I,0
1435,Increased megakaryocytes (bone marrow),Keratoderma,0
1436,Solar Radiation Toxicity,Lymphoma,0
1437,Solar Radiation Toxicity,Adult Non-Hodgkin Lymphoma,0
1438,Nodular and Diffuse Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
1439,Papillary Pattern,Cerebellar Papillary Meningioma,0
1440,Spindle Cell Metaplasia of Malignant Cells Present,Non-Resectable Malignant Liver Neoplasm,0
1441,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Female Reproductive System Neoplasm,0
1442,Chondromyxoid Stroma Formation,Sternal Chondromyxoid Fibroma,0
1443,Increased megakaryocytes (bone marrow),Childhood Pleomorphic Rhabdomyosarcoma,0
1444,Tubular Structures Present,Colorectal Tubular Adenoma,0
1445,Solar Radiation Toxicity,Childhood Lymphoma,0
1446,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of stomach,0
1447,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Esophageal Cancer AJCC v7,0
1448,Fenestrated Pattern,Testicular Dermoid Cyst,0
1449,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Gastric Intraepithelial Neoplasia,0
1450,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Renal Pelvis Cancer AJCC v7,0
1451,Increased megakaryocytes (bone marrow),Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma,0
1452,Cervical lymphadenopathy,Locally Advanced Cervical Adenocarcinoma,0
1453,Squamous Differentiation,Squamous Lung Dysplasia,0
1454,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Epithelioid Hemangioendothelioma,0
1455,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Neuroendocrine neoplasm of appendix,0
1456,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cutis Laxa,0
1457,Local disease,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,0
1458,Tissue Differentiation Uncertain,Stage IIA Adult Soft Tissue Sarcoma AJCC v7,0
1459,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenocarcinoma of ureter,0
1460,Solitary Skin Tumor,"Carcinoma, Skin Appendage",0
1461,Increased megakaryocytes (bone marrow),Vaginal Cancer by AJCC v7 Stage,0
1462,Increased megakaryocytes (bone marrow),Sweat Gland Neoplasms,0
1463,Increased megakaryocytes (bone marrow),Stage III Adrenal Cortex Carcinoma AJCC v8,0
1464,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Superficial Spreading Melanoma AJCC v6 and v7,0
1465,Increased megakaryocytes (bone marrow),Locally Advanced Carcinoma,0
1466,Increased megakaryocytes (bone marrow),Refractory Endometrial Endometrioid Adenocarcinoma,0
1467,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Non-Destructive Post-Transplant Lymphoproliferative Disorder,0
1468,Increased megakaryocytes (bone marrow),Extracavitary Primary Effusion Lymphoma,0
1469,Solar Radiation Toxicity,Stage IIB Penile Cancer AJCC v8,0
1470,Human Papillomavirus Negative,Human Papillomavirus-Related Verrucous Carcinoma,0
1471,Increased megakaryocytes (bone marrow),"Thecoma, luteinized",0
1472,Cellular Stratification,Cellular Neurofibroma,0
1473,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of parathyroid gland,0
1474,Monomorphic Cellular Infiltrate,Monomorphic Post-Transplant Lymphoproliferative Disorder,0
1475,Fenestrated Pattern,Vaginal Endometrioid Adenocarcinoma,0
1476,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Breast Carcinoma,0
1477,Multihormonal Immunoreactivity Present in a Single Cell Type,Vulvar Non-Keratinizing Squamous Cell Carcinoma,0
1478,Eccrine Differentiation,Benign Breast Eccrine Spiradenoma,0
1479,NRBC - Nucleated red blood cell present result,Oropharyngeal squamous cell carcinoma stage III,0
1480,Villous Projections of the Neoplastic Epithelium Present,Warty Carcinoma of the Penis,0
1481,Solitary Skin Tumor,Recurrent Rhabdoid Tumor,0
1482,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hemangioma of retina,0
1483,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Synovial sarcoma, biphasic",0
1484,Large Spaces Filled with Blood Present,Myeloid Neoplasms with Germline Predisposition,0
1485,Small Aggregates of Tumor Cells Present,Small cell carcinoma of lung,0
1486,Immature Granulocytes in Peripheral Blood Increased,Peripheral Breast Papilloma,0
1487,Multihormonal Immunoreactivity Present in a Single Cell Type,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,0
1488,Squamous metaplasia of bladder,Squamous cell carcinoma of tonsil,0
1489,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1490,Mammary Gland Type Features Present,Parathyroid Gland Oncocytic Adenoma,0
1491,Well Differentiated Lesion,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,0
1492,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ovarian Mucinous Adenocarcinoma,0
1493,Congenital Abnormality,Mixed Congenital Mesoblastic Nephroma,0
1494,Multihormonal Immunoreactivity Present in a Single Cell Type,Adenocarcinoma in tubular adenoma,0
1495,Spindle Cell Metaplasia of Malignant Cells Present,Stage I Renal Cell Cancer AJCC v8,0
1496,Solar Radiation Toxicity,Childhood Astrocytoma,0
1497,Canalicular Pattern,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
1498,Absence of Malignant Features,Carcinoma of anal canal,0
1499,Absence of Malignant Features,liposarcoma of kidney,0
1500,Eosinophilic inflammation,Childhood Acute Eosinophilic Leukemia,0
1501,Exophytic Papillary Lesion,Papillary Thyroid Microcarcinoma,0
1502,Fenestrated Pattern,Stage II Laryngeal Cancer AJCC v8,0
1503,Solar Radiation Toxicity,Stage IV Lung Cancer AJCC v7,0
1504,Fenestrated Pattern,Vulvar Dysplastic Melanocytic Nevus,0
1505,Increased megakaryocytes (bone marrow),Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8,0
1506,Increased megakaryocytes (bone marrow),Splenic diffuse red pulp small B-cell lymphoma,0
1507,Non-Encapsulated Neoplasm,Adult Cerebellar Neoplasm,0
1508,Increased megakaryocytes (bone marrow),Leukemia recurrent,0
1509,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell papilloma of eyelid,0
1510,Increased megakaryocytes (bone marrow),Intraductal Breast Myoepitheliosis,0
1511,Spindle Cell Metaplasia of Malignant Cells Present,Stage IVB Basal Cell Lip Carcinoma,0
1512,Diffuse Lesion,AIDS-Related Diffuse Large B-cell Lymphoma,0
1513,NRBC - Nucleated red blood cell present result,Lung squamous cell carcinoma recurrent,0
1514,Follicular Differentiation,Recurrent Follicular Lymphoma,0
1515,Recurrent Malignant Neoplasm,Recurrent Malignant Pharyngeal Neoplasm,0
1516,Spindle Cell Metaplasia of Malignant Cells Present,mesenchymal chondrosarcoma of bone,0
1517,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Pure Erythroid Leukemia,0
1518,Fenestrated Pattern,Testicular Dermoid Cyst,0
1519,Fenestrated Pattern,Hemolymphangioma,0
1520,Spindle Cell Metaplasia of Malignant Cells Present,Transitional cell carcinoma of ureter,0
1521,Recurrent Genetic Abnormalities Present,Recurrent Paraganglioma,0
1522,Malignant Primitive Cellular Infiltrate,Grade 3a Malignant Neoplasm,0
1523,Solar Radiation Toxicity,Childhood Central Nervous System Ganglioneuroblastoma,0
1524,Large Spaces Filled with Blood Present,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,0
1525,Glandular cell atypia,"Papillary transitional cell carcinoma, non-invasive",0
1526,Increased megakaryocytes (bone marrow),"Trophoblastic tumor, epithelioid",0
1527,No Evidence of Metastatic Disease,Metastatic Prostate Carcinoma,0
1528,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bullous pemphigoid,0
1529,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pleural Desmoplastic Mesothelioma,0
1530,Increased megakaryocytes (bone marrow),calcifying aponeurotic fibroma,0
1531,Rubbery Skin Lesion,Skin appendage adenoma,0
1532,Fenestrated Pattern,Anal Extramucosal (Perianal) Adenocarcinoma,0
1533,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Splenic Manifestation of Chronic Lymphocytic Leukemia,0
1534,Increased megakaryocytes (bone marrow),Eccrine porocarcinoma,0
1535,Nodular and Diffuse Pattern,Diffuse Astrocytoma,0
1536,Solar Radiation Toxicity,Stage IC Uterine Corpus Adenosarcoma AJCC v8,0
1537,Absence of Malignant Features,Malignant Leptomeningeal Neoplasm,0
1538,Solar Radiation Toxicity,"Carcinoma, Endometrioid",0
1539,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fallopian Tube Mucinous Adenocarcinoma,0
1540,Mammary Gland Type Features Present,Recurrent Anterior Pituitary Gland Neoplasm,0
1541,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Liver Cancer,0
1542,Spindle Cell Metaplasia of Malignant Cells Present,"Adenocarcinoma of lung, stage II",0
1543,Recurrent Malignant Neoplasm,Childhood Central Nervous System Embryonal Neoplasm,0
1544,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Myofibroblastoma,0
1545,Recurrent Genetic Abnormalities Present,Recurrent Inverted Schneiderian Papilloma,0
1546,Increased megakaryocytes (bone marrow),Anal Extramucosal (Perianal) Adenocarcinoma,0
1547,Increased megakaryocytes (bone marrow),Paraganglioma,0
1548,Glandular cell atypia,Multifocal superficial basal cell carcinoma,0
1549,Absence of Stromal Invasion,Stromal Predominant Kidney Wilms Tumor,0
1550,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of thymus,0
1551,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of choroid,0
1552,No Evidence of Metastatic Disease,Metastatic basal cell carcinoma,0
1553,Fried-Egg Appearance of the Bone Marrow,Stage II Bone Sarcoma AJCC v7,0
1554,Absence of Malignant Features,Malignant Giant Cell Tumor of Bone,0
1555,Malignant Primitive Cellular Infiltrate,AIDS-Related Malignant Neoplasm,0
1556,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pericanalicular fibroadenoma,0
1557,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Anal Cancer AJCC v8,0
1558,Absence of Malignant Features,benign lipoma of gallbladder,0
1559,Intersecting Sharply Marginated Clusters of Spindle Cells Present,cystadenocarcinoma of salivary gland,0
1560,Recurrent Malignant Neoplasm,Benign Adult Brain Neoplasm,0
1561,Solar Radiation Toxicity,Childhood Cerebral Astrocytoma,0
1562,Increased megakaryocytes (bone marrow),Bladder cancer recurrent,0
1563,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Uveal Melanoma Metastatic in the Liver,0
1564,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Angiomyofibroblastoma,0
1565,Fenestrated Pattern,Refractory Uterine Corpus Carcinosarcoma,0
1566,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,adenocarcinoma of breast with squamous metaplasia,0
1567,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Cancer by AJCC v6 Stage,0
1568,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Leuteoma of Pregnancy,0
1569,Proliferation of Small Ducts Present,Stage IIA Small Intestinal Cancer AJCC v7,0
1570,Venous Type Vascular Channel Formation,Thymoma Type B,0
1571,Large Spaces Filled with Blood Present,Testicular Spermatocytic Seminoma with Sarcoma,0
1572,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Verrucous carcinoma,0
1573,No Evidence of Metastatic Disease,Metastatic malignant neoplasm to brain,0
1574,Fenestrated Pattern,Childhood Teratoma,0
1575,Fenestrated Pattern,Stage IV Uterine Corpus Adenosarcoma AJCC v8,0
1576,Increased megakaryocytes (bone marrow),Laryngeal Mucoepidermoid Carcinoma,0
1577,Fenestrated Pattern,Stage 2B Neuroblastoma,0
1578,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder adenocarcinoma stage III,0
1579,Florid Follicular Hyperplasia,Simple Endometrial Hyperplasia without Atypia,0
1580,Acute inflammation,Adult Acute Monoblastic Leukemia,0
1581,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epithelioid hemangioma of skin,0
1582,Nodular and Diffuse Pattern,Thyroid Diffuse Large B-Cell Lymphoma,0
1583,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Capillary hemangioma of retina,0
1584,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Extrarenal Rhabdoid Tumor of the Liver,0
1585,High Grade Lesion,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,0
1586,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Myofibroblastoma,0
1587,Absence of Malignant Features,Carcinoma of lung,0
1588,Increased megakaryocytes (bone marrow),Angioimmunoblastic T-cell lymphoma stage II,0
1589,Blasts Expressing CD56 and Immature T-Cell Markers Present,Immature Ovarian Teratoma,0
1590,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Hamartoma,0
1591,Cervical lymphadenopathy,Stage IVA Cervical Cancer AJCC v8,0
1592,Schwannian Stroma More than 50 Percent of the Tumor Volume,Crohn's disease of the ileum,0
1593,Intersecting Sharply Marginated Clusters of Spindle Cells Present,sarcoma of mediastinum,0
1594,Solar Radiation Toxicity,Stage IA Uterine Corpus Cancer AJCC v8,0
1595,NRBC - Nucleated red blood cell present result,"Transitional cell carcinoma, micropapillary",0
1596,Fenestrated Pattern,Hemangioma,0
1597,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Adrenal Cortex Carcinoma AJCC v7,0
1598,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hyperplasia,0
1599,Solar Radiation Toxicity,Lung Adenofibroma,0
1600,Fenestrated Pattern,Stage IVA Bladder Cancer AJCC v8,0
1601,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
1602,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVB Hypopharyngeal Carcinoma AJCC v8,0
1603,Intermediate Grade Neuroendocrine Lesion,Sarcoma NCI Grade 1,0
1604,Increased megakaryocytes (bone marrow),Stage IIIB Lung Cancer AJCC v7,0
1605,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Thymoma by Masaoka-Koga Stage,0
1606,Metaplasia of Malignant Cells Present,Malignant neoplasm of choroid,0
1607,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1608,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hodgkin's lymphoma of mediastinum,0
1609,Diffuse Immunoblastic Proliferation,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,0
1610,Solar Radiation Toxicity,Vaginal intraepithelial neoplasia,0
1611,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,non-Hodgkin's lymphoma of nasal cavity,0
1612,Solitary Skin Tumor,Refractory Peripheral Primitive Neuroectodermal Tumor,0
1613,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of esophagus,0
1614,Glandular Differentiation,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,0
1615,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Ovarian Serous Adenocarcinoma,0
1616,Small Lesion,Small cell lung cancer recurrent,0
1617,Increased megakaryocytes (bone marrow),Schwannomatosis,0
1618,Squamous Metaplasia of Malignant Cells Present,Squamous cell carcinoma of tongue,0
1619,Increased megakaryocytes (bone marrow),Anaplastic astrocytoma,0
1620,Increased megakaryocytes (bone marrow),Refractory Indolent Adult Non-Hodgkin Lymphoma,0
1621,Increased megakaryocytes (bone marrow),Centroblastic lymphoma stage III,0
1622,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Mesothelioma, biphasic, malignant",0
1623,Fenestrated Pattern,Colon Juvenile Polyp,0
1624,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of cervix,0
1625,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,lipoma of extrahepatic bile duct,0
1626,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Gastric Carcinoma,0
1627,Mixed Neoplastic Glandular and Squamous Cell Population,Gastric Squamous Cell Carcinoma,0
1628,Tumor Mass,Borderline Breast Phyllodes Tumor,0
1629,Spindle Cell Osteo-Fibrous Component Present,Renal Cell Cancer by AJCC v6 Stage,0
1630,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Adult Cerebellar Neoplasm,0
1631,Spindle Cell Metaplasia of Malignant Cells Present,Colon Small Cell Neuroendocrine Carcinoma,0
1632,Multihormonal Immunoreactivity Present in a Single Cell Type,Bladder Papillary Clear Cell Adenocarcinoma,0
1633,Endometrial Type Glands and Stroma Present,Stage III Ovarian Polyembryoma AJCC v6 and v7,0
1634,Increased megakaryocytes (bone marrow),Stage 0a Ureter Cancer AJCC v7,0
1635,Increased megakaryocytes (bone marrow),Undifferentiated Epithelioid Sarcoma,0
1636,Nodular and Diffuse Pattern,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1637,Solar Radiation Toxicity,GIANT PIGMENTED HAIRY NEVUS,0
1638,Increased megakaryocytes (bone marrow),Stage IV Fallopian Tube Cancer AJCC v8,0
1639,Fenestrated Pattern,Stage 0is Urethral Cancer AJCC v8,0
1640,Recurrent Genetic Abnormalities Present,Recurrent Breast Angiosarcoma,0
1641,Low Grade Neuroendocrine Lesion,Grade 2 Colorectal Adenocarcinoma,0
1642,Confluent Sheets of Anaplastic T-Lymphocytes Present,Recurrent Childhood Anaplastic Astrocytoma,0
1643,Radial Growth Phase,"Leukemia, Myeloid, Accelerated Phase",0
1644,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,High Grade Mucoepidermoid Breast Carcinoma,0
1645,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0
1646,Nodular and Diffuse Pattern,"Cervical, Thoracic, and Lumbosacral Spinal Cord Ependymal Tumor",0
1647,Monoclonal Myeloid or Lymphoid Cells Present,Cardiac Myeloid Sarcoma,0
1648,Fenestrated Pattern,Vaginal Rhabdomyoma,0
1649,Photosensitivity of skin,Glomus tumor of skin,0
1650,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
1651,Well Differentiated Hyaline Cartilage Present,Pleural Well Differentiated Papillary Mesothelioma,0
1652,Mixed Neoplastic Glandular and Squamous Cell Population,Unresectable Head and Neck Squamous Cell Carcinoma,0
1653,Solar Radiation Toxicity,Trichodiscoma,0
1654,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenoma of extrahepatic bile duct,0
1655,Increased megakaryocytes (bone marrow),Stage IIIB Anal Cancer AJCC v8,0
1656,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Medulloblastoma with extensive nodularity,0
1657,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,0
1658,Fenestrated Pattern,Advanced Urothelial Carcinoma,0
1659,Increased megakaryocytes (bone marrow),Stage IV Gestational Trophoblastic Neoplasm AJCC v8,0
1660,Fenestrated Pattern,Adult T-cell lymphoma/leukemia refractory,0
1661,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Oral Cavity Carcinoma,0
1662,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Astrocytic Tumor,0
1663,Increased megakaryocytes (bone marrow),Appendix Kaposi Sarcoma,0
1664,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Leukemia, Myeloid, Accelerated Phase",0
1665,Basal Cells with Pale Cytoplasm Present,Skin Basal Cell Carcinoma with Sebaceous Differentiation,0
1666,Large Spaces Filled with Blood Present,Burkitt Lymphoma with Plasmacytoid Differentiation,0
1667,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Metastatic Malignant Neoplasm in the Thoracic Cavity,0
1668,Spindle Cell Metaplasia of Malignant Cells Present,Lipoma of spermatic cord,0
1669,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Urethral Cancer by AJCC v7 Stage,0
1670,Absence of Malignant Features,Malignant Cervical Soft Tissue Neoplasm,0
1671,Blasts Expressing T-Lymphoid and Myeloid Markers Present,"Sarcoma, Myeloid",0
1672,Abundance of Small Lymphocytes,Small Lymphocytic Lymphoma,0
1673,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Spindle Cell Sarcoma,0
1674,Increased megakaryocytes (bone marrow),Gastric carcinoma stage IV,0
1675,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Vascular insufficiency of intestine,0
1676,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Recurrent Malignant Solid Neoplasm,0
1677,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Oligodendroglioma-Astrocytoma,0
1678,Tubular Pattern,"Testicular Yolk Sac Tumor, Myxomatous Pattern",0
1679,Absence of Malignant Features,Rare Childhood Malignant Neoplasm,0
1680,Multihormonal Immunoreactivity Present in a Single Cell Type,Benign Extragonadal Germ Cell Tumor,0
1681,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Angiosarcoma Associated with Lymphedema,0
1682,Mammary Gland Type Features Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1683,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,0
1684,Fenestrated Pattern,Hereditary pyropoikilocytosis,0
1685,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Paget Disease of the Anal Canal,0
1686,Dilated Terminal Duct Lobular Units Present,Locally Advanced Bile Duct Carcinoma,0
1687,Increased megakaryocytes (bone marrow),Adult Central Nervous System Neoplasm,0
1688,Fenestrated Pattern,Stage IA Lung Cancer AJCC v7,0
1689,Increased megakaryocytes (bone marrow),Parathyroid Gland Oncocytic Adenoma,0
1690,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Medulloblastoma with extensive nodularity,0
1691,Nodular and Diffuse Pattern,Lip and Oral Cavity Squamous Cell Carcinoma,0
1692,Endobronchial Lesion,Endobronchial Leiomyoma,0
1693,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hemangioendothelioma,0
1694,Glandular cell atypia,Non-small cell lung cancer stage IIIB,0
1695,Increased megakaryocytes (bone marrow),Post-kala-azar dermal leishmaniasis,0
1696,Absence of Malignant Features,Secondary malignant neoplasm of kidney,0
1697,Recurrent Genetic Abnormalities Present,Recurrent Parotid Gland Undifferentiated Carcinoma,0
1698,Intersecting Sharply Marginated Clusters of Spindle Cells Present,sarcoma of oral cavity,0
1699,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,0
1700,Solar Radiation Toxicity,AIDS-Related Retinopathy,0
1701,Cutaneous plaque,Pathologic Stage IIC Cutaneous Melanoma AJCC v8,0
1702,Unfavorable Clinical Outcome,Early Unfavorable Hodgkin Lymphoma,0
1703,Nodular and Diffuse Pattern,Cervical Mesonephric Remnants and Hyperplasia,0
1704,Tumor Mass,Localized Digestive System Neuroendocrine Tumor G1,0
1705,Increased megakaryocytes (bone marrow),Stage II Adrenal Cortex Carcinoma AJCC v8,0
1706,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Histiocytosis, Langerhans-Cell",0
1707,Fenestrated Pattern,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8,0
1708,Solar Radiation Toxicity,Spinal Cord Neurofibroma,0
1709,Mixed Neoplastic Glandular and Squamous Cell Population,Nasopharyngeal Basaloid Squamous Cell Carcinoma,0
1710,Recurrent Malignant Neoplasm,Recurrent Extraskeletal Myxoid Chondrosarcoma,0
1711,Spindle Cell Metaplasia of Malignant Cells Present,lipoma of bone,0
1712,Solar Radiation Toxicity,Cerebellopontine Angle Schwannoma,0
1713,Serrated Glandular Architecture,Colon Serrated Polyposis,0
1714,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sellar Ependymoma,0
1715,Malignant Primitive Cellular Infiltrate,Stage IV Pleural Malignant Mesothelioma AJCC v8,0
1716,Solar Radiation Toxicity,Stage IVB Laryngeal Cancer AJCC v7,0
1717,Cervical lymphadenopathy,Cervical Melanoma,0
1718,Recurrent Genetic Abnormalities Present,Recurrent Childhood Central Nervous System Embryonal Neoplasm,0
1719,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIA Breast Carcinoma,0
1720,White blood cell count increased (lab result),Transitional cell carcinoma urethra,0
1721,Absence of Malignant Features,Undifferentiated carcinoma of ovary,0
1722,Solar Radiation Toxicity,Anal Rhabdomyosarcoma,0
1723,Endometrial Type Glands and Stroma Present,"Breast Fibrocystic Change, Proliferative Type without Atypia",0
1724,Proliferation of Small Ducts Present,Small Intestinal Cancer by AJCC v7 Stage,0
1725,Increased megakaryocytes (bone marrow),Stage IVA Colon Cancer AJCC v8,0
1726,Fenestrated Pattern,FIGO Stage IIIC Ovarian Cancer,0
1727,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA Ovarian Cancer AJCC v8,0
1728,Fenestrated Pattern,Stage III Uterine Corpus Cancer AJCC v6,0
1729,Fenestrated Pattern,Stage I Ureter Cancer AJCC v8,0
1730,Fenestrated Pattern,MGMT-Methylated Glioblastoma,0
1731,Increased megakaryocytes (bone marrow),Precursor T-cell lymphoblastic lymphoma,0
1732,NRBC - Nucleated red blood cell present result,"Basal cell carcinoma, micronodular",0
1733,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Eccrine mixed tumor of skin,0
1734,Squamous Metaplasia of Malignant Cells Present,Squamous cell carcinoma of tonsil,0
1735,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mediastinal Leiomyoma,0
1736,Increased megakaryocytes (bone marrow),Esophageal Cancer by AJCC v7 Stage,0
1737,Multihormonal Immunoreactivity Present in a Single Cell Type,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,0
1738,Fenestrated Pattern,Astroblastoma,0
1739,Fenestrated Pattern,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,0
1740,Solar Radiation Toxicity,"Nevus, Intradermal",0
1741,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IA Lung Adenosquamous Carcinoma AJCC v7,0
1742,Absence of Malignant Features,Metaplastic carcinoma of breast,0
1743,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermal Duct Tumor,0
1744,Spindle Cell Metaplasia of Malignant Cells Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,0
1745,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma in situ of small intestine,0
1746,Loss of INI 1 Protein Expression,ROSE Cluster 1,0
1747,Spindle Cell Metaplasia of Malignant Cells Present,Multiple hamartoma of lung,0
1748,Multihormonal Immunoreactivity Present in a Single Cell Type,Refractory Neurofibromatosis Type 1,0
1749,Mesenchymal Differentiation,Mesenchymal Glioblastoma,0
1750,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Carcinoma,0
1751,Increased megakaryocytes (bone marrow),Metastatic Jugulotympanic Paraganglioma,0
1752,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cystadenoma of pancreas,0
1753,Increased megakaryocytes (bone marrow),Colorectal cancer recurrent,0
1754,Increased megakaryocytes (bone marrow),Locally Advanced Carcinoma,0
1755,Solar Radiation Toxicity,Extraskeletal osteosarcoma metastatic,0
1756,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,0
1757,Spindle Cell Metaplasia of Malignant Cells Present,Adenosarcoma of cervix uteri,0
1758,Large Mass,Adult Anaplastic Large Cell Lymphoma,0
1759,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Adult Liver Cancer AJCC v7,0
1760,Recurrent Genetic Abnormalities Present,Recurrent Female Reproductive System Carcinoma,0
1761,Increased megakaryocytes (bone marrow),Brain Glioblastoma,0
1762,Nodular and Diffuse Pattern,Advanced Head and Neck Squamous Cell Carcinoma,0
1763,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Refractory Bile Duct Carcinoma,0
1764,Low Grade Neuroendocrine Lesion,Grade 1 Colorectal Adenocarcinoma,0
1765,Villous Projections of the Neoplastic Epithelium Present,Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
1766,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 2 Clear Cell Renal Cell Carcinoma,0
1767,Chronic Inflammatory Infiltrate,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,0
1768,Fenestrated Pattern,Stage I Childhood Lymphoblastic Lymphoma,0
1769,Neutral Epithelial Mucin Present,Epithelial Predominant Kidney Wilms Tumor,0
1770,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1771,Fenestrated Pattern,Anatomic Stage IIIC Breast Cancer AJCC v8,0
1772,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Von Hippel-Lindau Syndrome,0
1773,Solar Radiation Toxicity,Adult Erythroleukemia,0
1774,Intersecting Sharply Marginated Clusters of Spindle Cells Present,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0
1775,Schwannian Stroma More than 50 Percent of the Tumor Volume,Proliferating Brenner Tumor,0
1776,Multihormonal Immunoreactivity Present in a Single Cell Type,Acute Myeloid Leukemia with a Variant RARA Translocation,0
1777,Endometrial Type Glands and Stroma Present,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor",0
1778,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Acute Myeloid Leukemia with t(5;17)(q35;q21),0
1779,Fenestrated Pattern,Laryngeal Lymphoepithelial Carcinoma,0
1780,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Appendix Carcinoma AJCC v7,0
1781,Increased megakaryocytes (bone marrow),Epidermodysplasia Verruciformis,0
1782,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,ROSE Cluster 1,0
1783,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hemangioma of spleen,0
1784,Increased megakaryocytes (bone marrow),Prostate Cancer by AJCC v8 Stage,0
1785,Aberrant Thyroid Tissue Present,Thyroid Gland Mucinous Follicular Adenoma,0
1786,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endometrioid adenocarcinoma recurrent,0
1787,Recurrent disease,Light chain disease,0
1788,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage I Nasal Cavity Cancer AJCC v6 and v7,0
1789,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,0
1790,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IA Lung Adenosquamous Carcinoma AJCC v7,0
1791,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0
1792,Intersecting Sharply Marginated Clusters of Spindle Cells Present,signet ring cell carcinoma of pancreas,0
1793,Increased megakaryocytes (bone marrow),Stage III Acral Lentiginous Melanoma AJCC v7,0
1794,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Sertoli cell tumor of testis,0
1795,Increased megakaryocytes (bone marrow),Mediastinal Lymphangioma,0
1796,Increased megakaryocytes (bone marrow),Stage II Rectal Cancer AJCC v8,0
1797,Spindle Cell Metaplasia of Malignant Cells Present,Chordoma of clivus,0
1798,Solitary Skin Tumor,Intestinal Neuroendocrine Tumor G2,0
1799,Increased megakaryocytes (bone marrow),Parathyroid Gland Lipoadenoma,0
1800,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant mesothelioma,0
1801,Spindle Cell Metaplasia of Malignant Cells Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
1802,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Childhood Lymphoblastic Lymphoma,0
1803,Cervical lymphadenopathy,Cervical Verrucous Carcinoma,0
1804,Aberrant Thyroid Tissue Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,0
1805,Increased megakaryocytes (bone marrow),Stage IIIB Hilar Cholangiocarcinoma AJCC v7,0
1806,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Gliosarcoma,0
1807,Solar Radiation Toxicity,Central Neurocytoma,0
1808,Increased megakaryocytes (bone marrow),Benign cystic nephroma,0
1809,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Parasite-Related Carcinoma,0
1810,Increased megakaryocytes (bone marrow),Vaginal Mucinous Adenocarcinoma,0
1811,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Deep seated dermatophytosis,0
1812,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Dermatophytosis of scalp and beard,0
1813,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Vulvar Carcinoma,0
1814,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Borderline cystadenoma,0
1815,Lesion with Diameter of 2cm or Less,Ovarian Dermoid Cyst with Secondary Melanocytic Lesion,0
1816,Fenestrated Pattern,Stage IIIA Fallopian Tube Cancer AJCC v8,0
1817,Increased megakaryocytes (bone marrow),Pigmented hairy epidermal nevus,0
1818,Fenestrated Pattern,FIGO Stage III Ovarian Cancer,0
1819,Solar Radiation Toxicity,Pelvic Cancer,0
1820,Fenestrated Pattern,Renal Pelvis Urothelial Papilloma,0
1821,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of lower third of esophagus,0
1822,Fenestrated Pattern,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent,0
1823,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0
1824,Well Differentiated Lesion,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,0
1825,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,tubulopapillary adenoma of extrahepatic bile duct,0
1826,Melanoma Cells Present,Stage IIB Uveal Melanoma AJCC v7,0
1827,Spindle Cell Metaplasia of Malignant Cells Present,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract,0
1828,Blasts Expressing CD56 and Immature T-Cell Markers Present,Immature Granulocytic Sarcoma,0
1829,Aberrant Thyroid Tissue Present,Thyroid Gland Mucinous Follicular Adenoma,0
1830,Nodular and Diffuse Pattern,Stage III Paranasal Sinus Cancer AJCC v6 and v7,0
1831,Solar Radiation Toxicity,Adult Lymphoblastic Lymphoma,0
1832,Increased megakaryocytes (bone marrow),Stage IIB Uterine Sarcoma AJCC v7,0
1833,Solitary Skin Tumor,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
1834,Recurrent Malignant Neoplasm,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
1835,Glandular Differentiation,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,0
1836,Fenestrated Pattern,Stage I Hilar Cholangiocarcinoma AJCC v7,0
1837,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Melanocytic nevus of skin,0
1838,Plasma cell inflammation,Clear cell cystadenofibroma,0
1839,Low Grade Neuroendocrine Lesion,Grade I Lymphomatoid Granulomatosis,0
1840,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
1841,Mixture of Germ Cell Neoplastic Components Present,Childhood Subependymal Giant Cell Astrocytoma,0
1842,Spindle Cell Metaplasia of Malignant Cells Present,Metastatic Unresectable Basal Cell Carcinoma,0
1843,Villous Projections of the Neoplastic Epithelium Present,Adenocarcinoma of the prostate stage II,0
1844,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Cancer by AJCC v6 Stage,0
1845,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hodgkin's lymphoma of mediastinum,0
1846,Basal Cells with Pale Cytoplasm Present,Skin Basal Cell Carcinoma with Adnexal Differentiation,0
1847,Nodular and Diffuse Pattern,Stage IB Testicular Cancer AJCC v6 and v7,0
1848,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Refractory Malignant Mesothelioma,0
1849,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of thyroid,0
1850,Solar Radiation Toxicity,Scrotal Hemangioma,0
1851,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Neoplasm by Grade,0
1852,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Extrahepatic Bile Duct Neuroendocrine Carcinoma,0
1853,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse malignant mesothelioma,0
1854,Spindle Cell Osteo-Fibrous Component Present,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
1855,Solar Radiation Toxicity,oligodendroglioma,0
1856,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0 Testicular Cancer AJCC v6 and v7,0
1857,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult T-cell lymphoma/leukemia stage III,0
1858,Gastric dysplasia,Clinical Stage IVB Gastric Cancer AJCC v8,0
1859,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,0
1860,Mixture of Germ Cell Neoplastic Components Present,Refractory Malignant Testicular Germ Cell Tumor,0
1861,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hereditary retinal dystrophy,0
1862,Well Differentiated Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
1863,Confluent Sheets of Anaplastic T-Lymphocytes Present,Childhood Anaplastic Ependymoma,0
1864,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Lung Carcinoma,0
1865,Increased megakaryocytes (bone marrow),Pharyngeal cancer recurrent,0
1866,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,0
1867,Fenestrated Pattern,Senile nevus,0
1868,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Primary chondrosarcoma of bone,0
1869,Nodular and Diffuse Pattern,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,0
1870,Intraepithelial Neoplasia,Low Grade Penile Intraepithelial Neoplasia,0
1871,Multihormonal Immunoreactivity Present in a Single Cell Type,Ovarian Clear Cell Cystadenocarcinoma,0
1872,Cystic Lesion,Childhood Multilocular Cystic Renal Neoplasm,0
1873,Multihormonal Immunoreactivity Present in a Single Cell Type,Acidophil Stem Cell Pituitary Gland Adenoma,0
1874,Mature Neutrophils Present,Sellar Mature Teratoma,0
1875,Absence of Malignant Features,carcinosarcoma of gallbladder,0
1876,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1877,Fenestrated Pattern,Mastocytosis,0
1878,Increased megakaryocytes (bone marrow),Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,0
1879,Solitary Skin Tumor,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,0
1880,Spindle Cell Metaplasia of Malignant Cells Present,Paget disease of anal canal,0
1881,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Sarcoma,0
1882,Peau d'orange surface of breast,Benign neoplasm of breast,0
1883,Low Grade Neuroendocrine Lesion,Classical Low Grade Fibromyxoid Sarcoma,0
1884,Increased megakaryocytes (bone marrow),Intracranial lipoma,0
1885,Schwannian Stroma More than 50 Percent of the Tumor Volume,Sarcoma of the Extremity,0
1886,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of large intestine,0
1887,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Laryngeal Carcinoma,0
1888,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Acute Myeloid Leukemia with t(5;17)(q35;q21),0
1889,Absence of Malignant Features,Stage IA Pleural Malignant Mesothelioma AJCC v8,0
1890,Intraepithelial Neoplasia,Anal Canal Squamous Intraepithelial Neoplasia,0
1891,Spindle Cell Metaplasia of Malignant Cells Present,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,0
1892,High Grade Non Cartilaginous Sarcomatous Stroma Present,Low Grade Esophageal Squamous Intraepithelial Neoplasia,0
1893,Increased megakaryocytes (bone marrow),"Lymphoma, AIDS-Related",0
1894,Low Grade Neuroendocrine Lesion,High Grade Corneal Intraepithelial Neoplasia,0
1895,Intermediate Grade Neuroendocrine Lesion,Intermediate Osteogenic Neoplasm,0
1896,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of sphenoidal sinus,0
1897,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Bladder Papillary Urothelial Carcinoma,0
1898,Absence of Malignant Features,Malignant neoplasm of subglottis,0
1899,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Monoclonal Gammopathy of Renal Significance,0
1900,Increased megakaryocytes (bone marrow),Stage IV Bladder Cancer AJCC v8,0
1901,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Liver Cavernous Hemangioma,0
1902,Recurrent Malignant Neoplasm,Recurrent T-Cell Prolymphocytic Leukemia,0
1903,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Oligodendroglioma of spinal cord,0
1904,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,0
1905,Increased megakaryocytes (bone marrow),Stage II Oropharyngeal Carcinoma,0
1906,High Grade Lesion,Grade 2 Endometrial Endometrioid Adenocarcinoma,0
1907,Absence of Malignant Features,hepatoid adenocarcinoma of bladder,0
1908,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Pericytic Neoplasm,0
1909,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Salivary Duct Carcinoma,0
1910,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Papilloma of eyelid,0
1911,Large Spaces Filled with Blood Present,Testicular Spermatocytic Seminoma with Sarcoma,0
1912,Non-Encapsulated Neoplasm,Refractory Digestive System Neuroendocrine Neoplasm,0
1913,Increased megakaryocytes (bone marrow),Bronchial adenoma,0
1914,Follicular Cell Differentiation,Thyroid Gland Spindle Cell Follicular Adenoma,0
1915,Exophytic Papillary Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0
1916,Spindle Cell Osteo-Fibrous Component Present,Recurrent Chromophobe Renal Cell Carcinoma,0
1917,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Ovarian Germ Cell Tumor,0
1918,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Deep histiocytoma,0
1919,Local disease,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,0
1920,Follicular Differentiation,Ann Arbor Stage I Grade 3 Follicular Lymphoma,0
1921,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage III Pancreatic Cancer AJCC v6 and v7,0
1922,Low Grade Neuroendocrine Lesion,Digestive System Neuroendocrine Neoplasm,0
1923,Cystic Lesion,Metastatic Adenoid Cystic Carcinoma,0
1924,Increased megakaryocytes (bone marrow),Cardiac Synovial Sarcoma,0
1925,Increased megakaryocytes (bone marrow),Neoplasm malignant aggravated,0
1926,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,0
1927,Increased megakaryocytes (bone marrow),Liver Lipoma,0
1928,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Major Salivary Gland Adenoid Cystic Carcinoma,0
1929,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Masaoka-Koga Stage IVb,0
1930,Solar Radiation Toxicity,Double-Hit Lymphoma,0
1931,Cervical lymphadenopathy,Stage 0 Cervical Cancer AJCC v6,0
1932,Plasma cell inflammation,"Intraocular melanoma, spindle cell",0
1933,NRBC - Nucleated red blood cell present result,Adenosquamous cell lung cancer recurrent,0
1934,Tissue Differentiation Uncertain,Stage IA Adult Soft Tissue Sarcoma AJCC v7,0
1935,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Solid Neoplasm,0
1936,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral Intrahepatic Cholangiocarcinoma,0
1937,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
1938,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of gastrointestinal tract,0
1939,Spindle Cell Metaplasia of Malignant Cells Present,leiomyosarcoma of vagina,0
1940,Mixture of Embryonal and Alveolar Features Present,Fusion-Negative Alveolar Rhabdomyosarcoma,0
1941,NRBC - Nucleated red blood cell present result,Anal margin basal cell carcinoma,0
1942,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,non-Hodgkin's lymphoma of small intestine,0
1943,Increased megakaryocytes (bone marrow),Stage IV Uterine Corpus Cancer AJCC v8,0
1944,Mammary Gland Type Features Present,Low Grade Salivary Gland Mucoepidermoid Carcinoma,0
1945,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Lung Cancer AJCC v7,0
1946,Fenestrated Pattern,Stage IIB Lung Cancer AJCC v7,0
1947,Stable Disease,Scheuermann's Disease,0
1948,Fenestrated Pattern,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1",0
1949,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Spindle Cell Type A Uveal Melanoma,0
1950,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,0
1951,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Juvenile fibroadenoma of breast,0
1952,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Primary Carcinoma,0
1953,Increased megakaryocytes (bone marrow),Intraosseous well differentiated osteosarcoma,0
1954,Mixture of Germ Cell Neoplastic Components Present,Stage III Merkel Cell Carcinoma AJCC v7,0
1955,Spindle Cell Metaplasia of Malignant Cells Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,0
1956,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System T-Cell Non-Hodgkin Lymphoma,0
1957,Mixture of Embryonal and Alveolar Features Present,Adult Alveolar Soft Part Sarcoma,0
1958,Spindle Cell Metaplasia of Malignant Cells Present,Stage II Pleural Malignant Mesothelioma AJCC v8,0
1959,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage IV Adult Lymphoma AJCC v8,0
1960,Endometrial Type Glands and Stroma Present,Benign Outer Hair Sheath and Infundibulum Neoplasm,0
1961,Small Aggregates of Tumor Cells Present,Refractory Extensive Stage Lung Small Cell Carcinoma,0
1962,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Thyroid Gland Follicular Carcinoma,0
1963,Gastric dysplasia,Benign Gastric Soft Tissue Neoplasm,0
1964,Increased megakaryocytes (bone marrow),Stage II Rectal Cancer,0
1965,Schwannian Stroma More than 50 Percent of the Tumor Volume,Juvenile Polyp of the Small Intestine,0
1966,Chronic Clinical Course,Chronic Neutrophilic Leukemia,0
1967,Absence of Malignant Features,Benign neoplasm of pituitary gland,0
1968,Lesion with Diameter of 2cm or Less,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction,0
1969,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,intraductal micropapillary carcinoma of breast,0
1970,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0
1971,Fenestrated Pattern,Ganglioneuromatosis,0
1972,Fenestrated Pattern,Refractory Ependymoma,0
1973,Follicular Differentiation,Follicular Lymph Node Hyperplasia,0
1974,NRBC - Nucleated red blood cell present result,Atypical fibroxanthoma - spindle cell type,0
1975,Schwannian Stroma More than 50 Percent of the Tumor Volume,Squamous cell carcinoma of the hypopharynx stage I,0
1976,Increased megakaryocytes (bone marrow),Aldosterone-Producing Adrenal Cortex Adenoma,0
1977,Neoplastic Plasma Cells Present in Bone Marrow,Adenocarcinoma in tubulovillous adenoma,0
1978,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Lip Carcinoma,0
1979,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,0
1980,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Central Nervous System Germ Cell Tumor,0
1981,Increased megakaryocytes (bone marrow),Necrotic intraocular melanoma,0
1982,Fenestrated Pattern,Early T Acute Lymphoblastic Leukemia,0
1983,Solar Radiation Toxicity,Neuronevus,0
1984,Absence of Stromal Invasion,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
1985,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Urachal Squamous Cell Carcinoma,0
1986,Fenestrated Pattern,Gastro-enteropancreatic neuroendocrine tumor,0
1987,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Borderline Resectable Carcinoma,0
1988,Marked Thickening of the Bladder Urothelium Present,Bladder adenocarcinoma stage III,0
1989,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Kidney Mixed Epithelial and Stromal Tumor,0
1990,Acute inflammation,DDIT4L Acute Lymphoblastic Leukemia,0
1991,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of ampulla of Vater,0
1992,Solar Radiation Toxicity,Vulvar Angiomyofibroblastoma,0
1993,High Grade Non Cartilaginous Sarcomatous Stroma Present,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,0
1994,Villous Projections of the Neoplastic Epithelium Present,Squamous cell carcinoma of the oral cavity stage II,0
1995,Absence of Malignant Features,Malignant Outer Hair Sheath and Infundibulum Neoplasm,0
1996,Moderately Differentiated Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma,0
1997,Solar Radiation Toxicity,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8,0
1998,Skin Red Dot,"Skin Diseases, Infectious",0
1999,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Renal Pelvis and Ureter Carcinoma,0
2000,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma,0
2001,Lesion Less than 5mm in Diameter,Adenocarcinoma in tubular adenoma,0
2002,Fenestrated Pattern,Borderline Ovarian Endometrioid Cystadenofibroma,0
2003,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Appendix Carcinoma AJCC v7,0
2004,Solar Radiation Toxicity,Radiation-Induced Cancer,0
2005,Intravascular Spread,Intravascular Angioleiomyoma,0
2006,Solar Radiation Toxicity,Neuroblastoma recurrent,0
2007,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Immature Teratoma,0
2008,Increased megakaryocytes (bone marrow),Conventional Cardiac Rhabdomyoma,0
2009,High Grade Non Cartilaginous Sarcomatous Stroma Present,AJCC Grade 1 Sarcoma,0
2010,Solitary Skin Tumor,"Skin Diseases, Bacterial",0
2011,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Thyroid Gland Mucoepidermoid Carcinoma,0
2012,Absence of Malignant Features,Benign neoplasm of oral cavity,0
2013,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Ampulla of Vater Neuroendocrine Carcinoma,0
2014,Schwannian Stroma More than 50 Percent of the Tumor Volume,Mucoepidermoid carcinoma of the oral cavity stage III,0
2015,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Osteogenic Neoplasm,0
2016,Gastric dysplasia,Pathologic Stage IIA Gastric Cancer AJCC v8,0
2017,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Distal Bile Duct Cancer AJCC v8,0
2018,Fenestrated Pattern,Rhabdomyosarcoma,0
2019,Multihormonal Immunoreactivity Present in a Single Cell Type,Childhood Ovarian Germ Cell Tumor,0
2020,Cervical lymphadenopathy,Cervical Adenocarcinoma In Situ,0
2021,Solar Radiation Toxicity,FIGO Stage IC3 Ovarian Cancer,0
2022,Absence of Malignant Features,Crohn's disease of small intestine,0
2023,High Grade Non Cartilaginous Sarcomatous Stroma Present,Invasive Breast Carcinoma by Histologic Grade,0
2024,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,0
2025,Fenestrated Pattern,Adenocarcinoma Of Esophagus,0
2026,Solar Radiation Toxicity,Rhabdoid meningioma,0
2027,Spindle Cell Metaplasia of Malignant Cells Present,Giant Cell Fibroblastoma,0
2028,Increased megakaryocytes (bone marrow),Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,0
2029,Nodular and Diffuse Pattern,Stage IA Cervical Cancer AJCC v6 and v7,0
2030,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Congenital spondylolysis of lumbosacral region,0
2031,Small Aggregates of Tumor Cells Present,Splenic Small Lymphocytic Lymphoma,0
2032,Increased megakaryocytes (bone marrow),Colorectal Medullary Carcinoma,0
2033,Spindle Cell Osteo-Fibrous Component Present,Subglottic Squamous Cell Carcinoma,0
2034,Increased megakaryocytes (bone marrow),Sellar Chondroid Chordoma,0
2035,Solar Radiation Toxicity,Radiation-Induced Cerebritis,0
2036,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Skull Base Chordoma,0
2037,Schwannian Stroma More than 50 Percent of the Tumor Volume,Squamous Papilloma of the Nasopharynx,0
2038,Vacuolated Plasma Cells in the Bone Marrow,Rectal Carcinoma Metastatic in the Liver,0
2039,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Mediastinal Solitary Fibrous Tumor,0
2040,Increased megakaryocytes (bone marrow),Cutaneous leiomyoma,0
2041,Absence of Malignant Features,Disorder of vein,0
2042,Absence of Malignant Features,Invasive intraductal papillary-mucinous carcinoma of pancreas,0
2043,Humoral hypercalcemia of malignancy (disorder),"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)",0
2044,Multihormonal Immunoreactivity Present in a Single Cell Type,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,0
2045,Fried-Egg Appearance of the Bone Marrow,Adenocarcinoma of the prostate metastatic,0
2046,Increased megakaryocytes (bone marrow),Prostate Cancer by AJCC v7 Stage,0
2047,Increased megakaryocytes (bone marrow),Regional Adrenal Gland Pheochromocytoma,0
2048,Solar Radiation Toxicity,Esophageal Liposarcoma,0
2049,Solar Radiation Toxicity,Stage II Pancreatic Cancer AJCC v8,0
2050,Absence of Malignant Features,Multiple hamartoma of lung,0
2051,Nodular and Diffuse Pattern,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
2052,NRBC - Nucleated red blood cell present result,Nodulo-ulcerative basal cell carcinoma,0
2053,Immunoglobulin Heavy Chain Deposition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2054,Immature Myeloid Cells Increased in Bone Marrow,Adenocarcinoma in villous adenoma,0
2055,Increased megakaryocytes (bone marrow),Classical Burkitt Lymphoma,0
2056,Spindle Cell Osteo-Fibrous Component Present,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,0
2057,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gallbladder Leiomyosarcoma,0
2058,Increased megakaryocytes (bone marrow),Pancreatic Somatostatinoma,0
2059,Fenestrated Pattern,Stage IIB Pancreatic Cancer AJCC v8,0
2060,Increased megakaryocytes (bone marrow),Chest Wall Fibromatosis,0
2061,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Tonsillar Carcinoma,0
2062,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,"Peripheral T-Cell Lymphoma, Unclassifiable",0
2063,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,0
2064,Mammary Gland Type Features Present,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,0
2065,Lesion with Diameter of 2cm or Less,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),0
2066,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Parosteal Osteosarcoma,0
2067,Solar Radiation Toxicity,Stage I Esophageal Cancer,0
2068,Mammary Gland Type Features Present,Anterior Pituitary Gland Endocrine Neoplasm,0
2069,Solar Radiation Toxicity,"Leukoplakia, Hairy",0
2070,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
2071,Fenestrated Pattern,Rectosigmoid Adenocarcinoma,0
2072,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fibrous tissue neoplasm of skin,0
2073,Fenestrated Pattern,Mycosis fungoides stage III,0
2074,Mammary Gland Type Features Present,Metastatic Thyroid Gland Papillary Carcinoma,0
2075,Fenestrated Pattern,Benign Cardiac Schwannoma,0
2076,Multihormonal Immunoreactivity Present in a Single Cell Type,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0
2077,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,FSH-Producing Gonadotroph Adenoma,0
2078,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Nasopharyngeal Carcinoma by AJCC v8 Stage,0
2079,Increased megakaryocytes (bone marrow),Prostate Cancer by AJCC v8 Stage,0
2080,Spindle Cell Osteo-Fibrous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,0
2081,Increased megakaryocytes (bone marrow),Peutz Jehgers polyp,0
2082,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign tumor of choroid plexus,0
2083,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Fallopian Tube Cancer AJCC v6 and v7,0
2084,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant germ cell neoplasm,0
2085,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Sclerosing Stromal Tumor,0
2086,Non-Encapsulated Neoplasm,Intrahepatic Bile Duct Papillary Neoplasm,0
2087,Sonic Hedgehog/Patch Pathway Activated,Recurrent Childhood Visual Pathway Astrocytoma,0
2088,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Ampulla of Vater Signet Ring Cell Carcinoma,0
2089,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Carcinoma Unspecified Site,0
2090,Mammary Gland Type Features Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0
2091,Absence of Malignant Features,HER2-positive carcinoma of breast,0
2092,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
2093,Solar Radiation Toxicity,Stage 0 Esophageal Cancer AJCC v6,0
2094,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,liposarcoma of mediastinum,0
2095,Increased megakaryocytes (bone marrow),Mediastinal Neurofibroma,0
2096,Non-Encapsulated Neoplasm,Stage II Gestational Trophoblastic Neoplasm AJCC v8,0
2097,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Endometrial Mixed Cell Adenocarcinoma,0
2098,Fenestrated Pattern,Stage IVA Prostate Cancer AJCC v8,0
2099,Argentaffin Positive Neoplastic Cells Present,"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
2100,Increased megakaryocytes (bone marrow),Prostate Angiosarcoma,0
2101,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Meyerson Nevus,0
2102,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of upper third of esophagus,0
2103,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Acute Myeloid Leukemia with t(5;17)(q35;q21),0
2104,Villous Projections of the Neoplastic Epithelium Present,Small cell carcinoma of the cervix,0
2105,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermatosis Papulosa Nigra,0
2106,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anal carcinoma,0
2107,Fenestrated Pattern,synovial sarcoma,0
2108,Fenestrated Pattern,Stage IVB Pharyngeal Carcinoma,0
2109,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,olfactory neuroblastoma of nasal cavity,0
2110,Increased megakaryocytes (bone marrow),BCLC Stage B Hepatocellular Carcinoma,0
2111,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intravenous leiomyomatosis,0
2112,Questionable Invasive Lesion,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2113,Increased megakaryocytes (bone marrow),Gastric Non-Neoplastic Polyp,0
2114,Fenestrated Pattern,Stage IV Childhood Lymphoblastic Lymphoma,0
2115,Marked Thickening of the Bladder Urothelium Present,Infiltrating Bladder Carcinoma,0
2116,Small Aggregates of Tumor Cells Present,Small intestine carcinoma stage II,0
2117,Fenestrated Pattern,Adrenal Cancer,0
2118,Cutaneous plaque,Solar Radiation-Related Cutaneous Melanoma,0
2119,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lymphocyte Rich Classical Hodgkin Lymphoma,0
2120,Solar Radiation Toxicity,Enchondromatosis,0
2121,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mixed Ductal-Endocrine Carcinoma,0
2122,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Colorectal Adenosquamous Carcinoma,0
2123,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Thymoma, type A, malignant",0
2124,Mammary Gland Type Features Present,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
2125,Increased megakaryocytes (bone marrow),Askin's tumor,0
2126,Cutaneous plaque,Cutaneous neurofibroma,0
2127,Increased megakaryocytes (bone marrow),Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
2128,Solar Radiation Toxicity,Ovarian Mucinous Adenofibroma,0
2129,Fenestrated Pattern,Endocervical polyp,0
2130,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder adenocarcinoma recurrent,0
2131,Metaplasia of Malignant Cells Present,Malignant neoplasm of salivary gland,0
2132,Distortion of the Hair Follicle,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2133,Fenestrated Pattern,Urethral Urothelial Papilloma,0
2134,Solar Radiation Toxicity,Anal polyp,0
2135,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7,0
2136,Chromogranin A Positive Neoplastic Cells Present,Luminal A Prostate Carcinoma,0
2137,Indolent Clinical Course,Recurrent Indolent Adult Non-Hodgkin Lymphoma,0
2138,Increased megakaryocytes (bone marrow),Cercarial Dermatitis,0
2139,Increased megakaryocytes (bone marrow),Adult Acute Monocytic Leukemia,0
2140,Large Spaces Filled with Blood Present,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
2141,Less than 2 Mitoses per 10HPF,Vaginal intraepithelial neoplasia grade 2,0
2142,Solitary Skin Tumor,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
2143,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Epithelioid Hemangioendothelioma,0
2144,Fenestrated Pattern,Stage III Esophageal Adenocarcinoma AJCC v7,0
2145,Increased megakaryocytes (bone marrow),Radiation-Induced Cerebritis,0
2146,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Neuroendocrine neoplasm of larynx,0
2147,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Hyperparathyroidism-Jaw Tumor Syndrome,0
2148,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,0
2149,Gastric dysplasia,Gastric Cronkhite Canada Polyposis,0
2150,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA2 Cervical Cancer AJCC v8,0
2151,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Juvenile fibroadenoma of breast,0
2152,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,0
2153,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Laryngeal Cancer AJCC v6 and v7,0
2154,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IC Fallopian Tube Cancer AJCC v8,0
2155,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cervical Adenoid Cystic Carcinoma,0
2156,Spindle Cell Metaplasia of Malignant Cells Present,Ichthyosis Bullosa of Siemens,0
2157,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Gallbladder Cancer by AJCC v7 Stage,0
2158,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Placental Choriocarcinoma,0
2159,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Retroperitoneal Sarcoma by AJCC v8 Stage,0
2160,Increased megakaryocytes (bone marrow),Cardiac Cavernous Hemangioma,0
2161,Recurrent Malignant Neoplasm,Recurrent Breast Lymphoma,0
2162,Aberrant Thyroid Tissue Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,0
2163,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Esophageal Carcinoma,0
2164,Peau d'orange surface of breast,Tubular adenoma of breast,0
2165,Solar Radiation Toxicity,Stage IB Uterine Corpus Cancer AJCC v8,0
2166,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Digestive System Carcinoma,0
2167,Progressive Clinical Course,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
2168,Increased megakaryocytes (bone marrow),Nasopharyngeal Papillary Adenocarcinoma,0
2169,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Laryngeal Adenosquamous Carcinoma,0
2170,Nodular and Diffuse Pattern,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,0
2171,Malignant Primitive Cellular Infiltrate,Childhood Malignant Kidney Neoplasm,0
2172,Blasts Expressing CD56 and Immature T-Cell Markers Present,Refractory Hepatosplenic T-Cell Lymphoma,0
2173,High Grade Lesion,Epithelioid Sarcoma NCI Grade 2,0
2174,Fenestrated Pattern,Plantar wart,0
2175,Windblown Appearance of Atypical Keratinocytes,Cervical Atypical Polypoid Adenomyoma,0
2176,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sublingual Gland Adenocarcinoma,0
2177,Primary Lesion,Primary mediastinal large B-cell lymphoma stage IV,0
2178,Glandular Differentiation,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,0
2179,Spindle Cell Metaplasia of Malignant Cells Present,Distantly Metastatic Malignant Neoplasm,0
2180,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Gallbladder Cancer AJCC v7,0
2181,Increased NFkappaB Pathway Activation,Recurrent Childhood Visual Pathway Astrocytoma,0
2182,Disease regression,Bowen's Disease,0
2183,Fenestrated Pattern,Benign Intracranial Meningioma,0
2184,Endometrial Type Glands and Stroma Present,Stage IVA Lip Cancer AJCC v6 and v7,0
2185,Increased megakaryocytes (bone marrow),Infiltrating angiolipoma,0
2186,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Thyroid Gland Anaplastic Carcinoma,0
2187,Increased megakaryocytes (bone marrow),Dedifferentiated chondrosarcoma,0
2188,Increased megakaryocytes (bone marrow),Sarcomatosis,0
2189,Metaplasia of Malignant Cells Present,Malignant melanoma of iris,0
2190,Absence of Malignant Features,Adenocarcinoma of cecum,0
2191,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Usual ductal hyperplasia of breast,0
2192,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Keratoderma,0
2193,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIA Lung Large Cell Carcinoma AJCC v7,0
2194,Florid Follicular Hyperplasia,Papillary Urothelial Hyperplasia,0
2195,Large Spaces Filled with Blood Present,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0
2196,Increased megakaryocytes (bone marrow),Esophageal squamous papilloma,0
2197,Spindle Cell Osteo-Fibrous Component Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,0
2198,Spindle Cell Metaplasia of Malignant Cells Present,Benign germ cell tumor of ovary,0
2199,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm,0
2200,Recurrent Malignant Neoplasm,Resectable Malignant Neoplasm,0
2201,Nodular and Diffuse Pattern,Skin Nodular Basal Cell Carcinoma,0
2202,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Malignant Mixed Tumor, Not Otherwise Specified",0
2203,Multihormonal Immunoreactivity Present in a Single Cell Type,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
2204,Clear Perinuclear Halo Present,Clear cell hidradenoma,0
2205,Schwannian Stroma More than 50 Percent of the Tumor Volume,Gestational Trophoblastic Tumor by AJCC v7 Stage,0
2206,Increased megakaryocytes (bone marrow),Stage IIIC Colorectal Cancer AJCC v8,0
2207,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,"Squamous Cell Carcinoma of the Penis, Usual Type",0
2208,Solitary Skin Tumor,Stage IA Gestational Trophoblastic Tumor AJCC v7,0
2209,Fenestrated Pattern,Stage IIIB Lung Cancer AJCC v8,0
2210,Breast Implant-Related Lesion,Non-Hodgkin Breast Lymphoma,0
2211,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Alcohol-Related Laryngeal Carcinoma,0
2212,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8,0
2213,Squamous metaplasia of bladder,Squamous cell carcinoma of prostate,0
2214,Fenestrated Pattern,Classical Glioblastoma,0
2215,Increased megakaryocytes (bone marrow),Childhood Brain Germinoma,0
2216,Increased megakaryocytes (bone marrow),Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8,0
2217,Increased megakaryocytes (bone marrow),Stage IIA Lung Cancer AJCC v8,0
2218,Multihormonal Immunoreactivity Present in a Single Cell Type,Thyroid Gland Langerhans Cell Histiocytosis,0
2219,Increased megakaryocytes (bone marrow),Histiocytic Necrotizing Lymphadenitis,0
2220,Increased megakaryocytes (bone marrow),Stage III Distal Bile Duct Cancer AJCC v8,0
2221,Fenestrated Pattern,Disseminated carcinoma,0
2222,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Cancer by AJCC v8 Stage,0
2223,Increased megakaryocytes (bone marrow),Embryonal Carcinoma,0
2224,Nodular and Diffuse Pattern,Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
2225,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Leiomyoma of Gallbladder,0
2226,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,TUBEROUS SCLEROSIS 2 (disorder),0
2227,Increased megakaryocytes (bone marrow),Anal Ectopic Fibroadenoma,0
2228,Spindle Cell Metaplasia of Malignant Cells Present,Unresectable Malignant Mesothelioma,0
2229,Glandular cell atypia,Adenosquamous cell lung cancer,0
2230,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ovarian Wilms Tumor,0
2231,Absence of Malignant Features,basaloid carcinoma of penis,0
2232,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of duodenum recurrent,0
2233,Gastric dysplasia,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,0
2234,Spindle Cell Metaplasia of Malignant Cells Present,Pancreatic Large Cell Neuroendocrine Carcinoma,0
2235,Primary Lesion,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma,0
2236,Intraepithelial Neoplasia,Gastrointestinal Intraepithelial Neoplasia,0
2237,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,0
2238,Proliferation of Follicular Dendritic Cells Present,Ann Arbor Stage I Grade 3 Follicular Lymphoma,0
2239,Fenestrated Pattern,Colon Leiomyoma,0
2240,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Pineal Region Yolk Sac Tumor,0
2241,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Hypopharyngeal Carcinoma AJCC v8,0
2242,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Lung PEComa,0
2243,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Recurrent Desmoplastic Small Round Cell Tumor,0
2244,Nodular and Diffuse Pattern,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
2245,Fenestrated Pattern,Borderline Ovarian Serous Cystadenofibroma,0
2246,Argentaffin Positive Neoplastic Cells Present,"Neoplastic Syndromes, Hereditary",0
2247,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,BCLC Stage B Hepatocellular Carcinoma,0
2248,Intersecting Sharply Marginated Clusters of Spindle Cells Present,rhabdomyosarcoma of liver,0
2249,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage III Appendix Neuroendocrine Tumor AJCC v7,0
2250,Monoclonal Myeloid or Lymphoid Cells Present,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,0
2251,Solar Radiation Toxicity,Stage IIIC Uterine Corpus Cancer AJCC v7,0
2252,Increased megakaryocytes (bone marrow),Superior Vena Cava Leiomyosarcoma,0
2253,Fenestrated Pattern,Breast Ductal Adenoma,0
2254,Locally Aggressive Lesion,Locally Advanced Unresectable Cervical Carcinoma,0
2255,Multihormonal Immunoreactivity Present in a Single Cell Type,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,0
2256,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Solitary Myofibromatosis,0
2257,Large Spaces Filled with Blood Present,Stage III Diffuse Large B-Cell Lymphoma,0
2258,Recurrent Genetic Abnormalities Present,Biochemically Recurrent Prostate Carcinoma,0
2259,Small Aggregates of Tumor Cells Present,Small Intestinal Neuroendocrine Tumor G2,0
2260,Fenestrated Pattern,Dermatitis,0
2261,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epidermodysplasia Verruciformis,0
2262,Increased megakaryocytes (bone marrow),Acute monocytic/monoblastic leukemia,0
2263,Endometrial Type Glands and Stroma Present,Recurrent Head and Neck Carcinoma,0
2264,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of oropharynx,0
2265,Mixed Neoplastic Glandular and Squamous Cell Population,Thoracic Esophagus Squamous Cell Carcinoma,0
2266,Tumor Mass,Hereditary Kidney Wilms Tumor,0
2267,Fenestrated Pattern,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",0
2268,Malignant Primitive Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm,0
2269,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7,0
2270,Spindle Cell Metaplasia of Malignant Cells Present,Ovarian Clear Cell Adenofibroma,0
2271,Five or Less Mitoses per 50HPF,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,0
2272,Spindle Cell Metaplasia of Malignant Cells Present,Condyloma acuminata of vulva,0
2273,Fenestrated Pattern,Duodenal Cancer,0
2274,Increased megakaryocytes (bone marrow),Disseminated adenocarcinoma,0
2275,Absence of Malignant Features,Lipoma of breast,0
2276,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mycosis fungoides stage IV,0
2277,Increased megakaryocytes (bone marrow),Subcutaneous Disorder,0
2278,Glandular cell atypia,Testicular germ cell tumor mixed stage I,0
2279,Absence of Malignant Features,Recurrent Malignant Glioma,0
2280,Solar Radiation Toxicity,Ovarian Serous Adenofibroma,0
2281,Endometrial Type Glands and Stroma Present,Invasive Ductal and Lobular Carcinoma,0
2282,Fenestrated Pattern,Bile duct cancer recurrent,0
2283,Increased megakaryocytes (bone marrow),"Medulloblastoma, WNT-Activated",0
2284,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mammary-Type Myofibroblastoma,0
2285,Plasma cell inflammation,Non-small cell lung cancer recurrent,0
2286,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Laryngeal Adenoid Cystic Carcinoma,0
2287,Increased megakaryocytes (bone marrow),Serous Tubal Intraepithelial Carcinoma,0
2288,Fenestrated Pattern,Rectal hyperplastic polyp,0
2289,Intraepithelial Neoplasia,Serous Endometrial Intraepithelial Carcinoma,0
2290,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Calcifying Odontogenic Cyst,0
2291,Fenestrated Pattern,Alveolar Soft Part Sarcoma,0
2292,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,ENSAT Stage III Adrenal Cortex Carcinoma,0
2293,Increased megakaryocytes (bone marrow),Refractory Plasmablastic Lymphoma,0
2294,Mammary Gland Type Features Present,Submandibular Gland Undifferentiated Carcinoma,0
2295,Increased megakaryocytes (bone marrow),Serous surface papillary carcinoma,0
2296,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyosarcoma,0
2297,Solar Radiation Toxicity,Childhood Craniopharyngioma,0
2298,Multihormonal Immunoreactivity Present in a Single Cell Type,Esophageal Large Cell Neuroendocrine Carcinoma,0
2299,White blood cell count increased (lab result),Ovarian germ cell choriocarcinoma stage IV,0
2300,Recurrent Genetic Abnormalities Present,Recurrent Male Reproductive System Carcinoma,0
2301,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Papillary craniopharyngioma,0
2302,Nodular and Diffuse Pattern,Stage IVA Vaginal Cancer AJCC v6 and v7,0
2303,Increased megakaryocytes (bone marrow),Renal carcinoma,0
2304,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign tumor of pancreas,0
2305,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone metastatic,0
2306,Fenestrated Pattern,Angiocentric lymphoma stage I,0
2307,Fenestrated Pattern,Stage I Adrenal Cortex Carcinoma AJCC v7,0
2308,Spindle Cell Metaplasia of Malignant Cells Present,Stage III Lip Basal Cell Carcinoma,0
2309,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Mixed Germ Cell Tumor,0
2310,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,ROSE Cluster 7,0
2311,Endodermal Sinus Pattern,Frontal Sinus Squamous Cell Carcinoma,0
2312,Recurrent Genetic Abnormalities Present,Recurrent Grade I Lymphomatoid Granulomatosis,0
2313,Increased megakaryocytes (bone marrow),Dermatitis acneiform,0
2314,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Necrobiosis Lipoidica,0
2315,Increased megakaryocytes (bone marrow),Endometrioid adenocarcinoma recurrent,0
2316,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Childhood Choroid Plexus Carcinoma,0
2317,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Breast Carcinoma with Choriocarcinomatous Features,0
2318,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Eyelid Carcinoma by AJCC v7 Stage,0
2319,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Extragonadal Germ Cell Tumor,0
2320,Solar Radiation Toxicity,Stage I Penile Cancer AJCC v8,0
2321,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Paget's disease and intraductal carcinoma of breast,0
2322,Vertical Growth Phase,"Polycythemia Vera, Polycythemic Phase",0
2323,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,papillary carcinoma of renal pelvis,0
2324,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Myelodysplastic Syndrome,0
2325,Increased megakaryocytes (bone marrow),Angiocentric lymphoma stage IV,0
2326,Fenestrated Pattern,Prolactin-producing pituitary tumor,0
2327,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
2328,Endometrial Type Glands and Stroma Present,Stage IIA Testicular Cancer AJCC v6 and v7,0
2329,Solar Radiation Toxicity,Peritoneal mesothelioma malignant recurrent,0
2330,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Desmoplastic fibroma,0
2331,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oropharyngeal Polyp,0
2332,Mammary Gland Type Features Present,Adrenal Gland Composite Pheochromocytoma,0
2333,Glandular cell atypia,Gallbladder squamous cell carcinoma,0
2334,Osseous Metaplasia of Malignant Cells Present,Recurrent Malignant Neoplasm of Multiple Primary Sites,0
2335,No Evidence of Metastatic Disease,Metastatic osteosarcoma,0
2336,Proliferation of Small Ducts Present,Small intestine carcinoma metastatic,0
2337,Nodular and Diffuse Pattern,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,0
2338,Endometrial Type Glands and Stroma Present,Stage IV Vaginal Cancer AJCC v6 and v7,0
2339,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenomatoid tumor of epididymis,0
2340,Malignant Primitive Cellular Infiltrate,Cellular Pleomorphic Adenoma,0
2341,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Polyp of gallbladder,0
2342,Solar Radiation Toxicity,Desmoplastic mesothelioma,0
2343,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Primary Peritoneal Cancer AJCC v7,0
2344,Increased megakaryocytes (bone marrow),Refractory Ovarian Carcinoma,0
2345,Increased megakaryocytes (bone marrow),Sublingual Gland Adenocarcinoma,0
2346,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extranodal marginal zone B-cell lymphoma (MALT type) stage II,0
2347,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
2348,Solar Radiation Toxicity,Stage IV Renal Pelvis Cancer AJCC v7,0
2349,Spindle Cell Metaplasia of Malignant Cells Present,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
2350,Multihormonal Immunoreactivity Present in a Single Cell Type,Intermediate Cell Type Choroid Melanoma,0
2351,Chronic Inflammatory Infiltrate,Urinary Bladder Inflammatory Myofibroblastic Tumor,0
2352,Aberrant Thyroid Tissue Present,Stage II Soft Tissue Sarcoma AJCC v7,0
2353,Spindle Cell Metaplasia of Malignant Cells Present,neurofibroma of esophagus,0
2354,NRBC - Nucleated red blood cell present result,Adenosquamous cell lung cancer stage I,0
2355,Spindle Cell Osteo-Fibrous Component Present,Spindle Cell/Pleomorphic Lipoma,0
2356,Solar Radiation Toxicity,Stage IV Colorectal Cancer,0
2357,Skin Red Dot,Stage IV Skin Cancer,0
2358,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,0
2359,Increased megakaryocytes (bone marrow),Stage IIB Lung Cancer AJCC v7,0
2360,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,0
2361,Increased megakaryocytes (bone marrow),Pacinian tumor,0
2362,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage,0
2363,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lipoma of pleura,0
2364,High Grade Non Cartilaginous Sarcomatous Stroma Present,Adult Grade I Meningioma,0
2365,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,0
2366,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bile duct carcinoma,0
2367,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Contact dermatitis due to acid,0
2368,Low Grade Neuroendocrine Lesion,WHO Grade III Glioma,0
2369,Absence of Malignant Features,squamous cell carcinoma of ureter,0
2370,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,0
2371,Increased megakaryocytes (bone marrow),Exophytic Schneiderian Papilloma,0
2372,Minimal Invasion Present,Minimal Deviation Melanoma,0
2373,Fenestrated Pattern,"lymphomatoid papulosis, type A",0
2374,Rubbery Skin Lesion,Skin Basaloid Carcinoma,0
2375,Fenestrated Pattern,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,0
2376,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Adenoma, Sweat Gland",0
2377,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Fibromatosis, Plantar",0
2378,Increased megakaryocytes (bone marrow),FIGO Stage II Ovarian Cancer,0
2379,High Grade Lesion,Grade 3a Follicular Lymphoma,0
2380,Increased megakaryocytes (bone marrow),Stage II Nasopharyngeal Carcinoma AJCC v7,0
2381,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,sarcoma of trachea,0
2382,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant myoepithelioma,0
2383,Increased megakaryocytes (bone marrow),"Pregnancy, Ovarian",0
2384,Mixed Neoplastic Glandular and Squamous Cell Population,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm,0
2385,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Paranasal Sinus Squamous Cell Carcinoma,0
2386,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Functioning Pancreatic Neuroendocrine Tumor,0
2387,Absence of Stromal Invasion,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",0
2388,Solitary Skin Tumor,Hindgut Carcinoid Tumor,0
2389,Solitary Skin Tumor,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,0
2390,Fenestrated Pattern,Childhood T Acute Lymphoblastic Leukemia,0
2391,Abundance of Small Lymphocytes,Advanced Small Intestinal Neuroendocrine Carcinoma,0
2392,Tumor Mass,Stage I Rectal Neuroendocrine Tumor AJCC v8,0
2393,Endometrial Type Glands and Stroma Present,Refractory Endometrial Carcinoma,0
2394,Moderately Differentiated Lesion,Poorly Differentiated Hepatocellular Carcinoma,0
2395,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cerebral Hemisphere Lipoma,0
2396,Malignant Primitive Cellular Infiltrate,Malignant Testicular Leydig Cell Tumor,0
2397,Malignant Primitive Cellular Infiltrate,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0
2398,Low Grade Neuroendocrine Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",0
2399,Neoplastic Plasma Cells Present in Bone Marrow,Stage IA Bone Cancer AJCC v7,0
2400,Increased megakaryocytes (bone marrow),Aleukemic Acute Lymphoblastic Leukemia Cutis,0
2401,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,0
2402,Abundance of Small Lymphocytes,Small cell carcinoma of prostate,0
2403,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of spleen,0
2404,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Liver Yolk Sac Tumor,0
2405,Intersecting Sharply Marginated Clusters of Spindle Cells Present,small cell carcinoma of ureter,0
2406,Questionable Invasive Lesion,Recurrent Invasive Ductal Breast Carcinoma,0
2407,Fenestrated Pattern,Peritoneal cystic mesothelioma,0
2408,NRBC - Nucleated red blood cell present result,Adenosquamous cell lung cancer recurrent,0
2409,Increased megakaryocytes (bone marrow),Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7,0
2410,Well Differentiated Lesion,Differentiated Granulocytic Sarcoma,0
2411,Nests of Nevus Cells Resembling Nerve Bundles Present,Nevus comedonicus,0
2412,Spindle Cell Metaplasia of Malignant Cells Present,malignant gastrinoma of pancreas,0
2413,Neoplastic Plasma Cells Present in Bone Marrow,Stage IVA Bone Sarcoma AJCC v7,0
2414,Endometrial Type Glands and Stroma Present,Stage II Hypopharyngeal Carcinoma AJCC v6 and v7,0
2415,Fenestrated Pattern,Unresectable Desmoid-Type Fibromatosis,0
2416,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Carcinoma in situ of trachea,0
2417,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Subcutaneous panniculitis-like T-cell lymphoma,0
2418,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pityriasis Rubra Pilaris,0
2419,Recurrent Malignant Neoplasm,Recurrent Rectal Cancer,0
2420,Increased megakaryocytes (bone marrow),Intracranial Germinoma,0
2421,Mammary Gland Type Features Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,0
2422,No Evidence of Metastatic Disease,Metastatic malignant neoplasm to nasopharynx,0
2423,Increased megakaryocytes (bone marrow),Adult Lymphocyte-Rich Classical Hodgkin Lymphoma,0
2424,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8,0
2425,Atypical Mitotic Figures,Atypical choroid plexus papilloma,0
2426,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Advanced Neuroendocrine Neoplasm,0
2427,Clear Perinuclear Halo Present,"Glycogen-Rich, Clear Cell Breast Carcinoma",0
2428,Progressive Clinical Course,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2429,Solar Radiation Toxicity,Kidney Synovial Sarcoma,0
2430,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hereditary Fallopian Tube Carcinoma,0
2431,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adamantinoma,0
2432,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Invasive Ductal Breast Carcinoma,0
2433,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Ovarian Cancer AJCC v8,0
2434,Radial Growth Phase,Radial scar,0
2435,Increased megakaryocytes (bone marrow),Stage IVA Gallbladder Carcinoma,0
2436,Absence of Malignant Features,sarcoma of mediastinum,0
2437,Increased megakaryocytes (bone marrow),Acne Keloid,0
2438,Mammary Gland Type Features Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,0
2439,Solar Radiation Toxicity,Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
2440,Solar Radiation Toxicity,Radiation-Related Osteosarcoma,0
2441,Multihormonal Immunoreactivity Present in a Single Cell Type,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
2442,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Luminal A Prostate Carcinoma,0
2443,Multihormonal Immunoreactivity Present in a Single Cell Type,DS Stage I Plasma Cell Myeloma,0
2444,Multihormonal Immunoreactivity Present in a Single Cell Type,Testicular Large Cell Calcifying Sertoli Cell Tumor,0
2445,Solar Radiation Toxicity,"Optic Atrophy, Hereditary, Leber",0
2446,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Hepatocellular Carcinoma,0
2447,Fenestrated Pattern,Non-Hodgkin's lymphoma refractory,0
2448,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical choroid plexus papilloma,0
2449,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIA Merkel Cell Carcinoma AJCC v7,0
2450,Increased megakaryocytes (bone marrow),Submandibular Gland Adenocarcinoma,0
2451,White blood cell count increased (lab result),Balloon cell malignant melanoma,0
2452,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Gestational Trophoblastic Neoplasm AJCC v8,0
2453,Fenestrated Pattern,Fallopian Tube Endometrioid Polyp,0
2454,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Adult Acute Erythroid Leukemia,0
2455,Fenestrated Pattern,Lichen Planus,0
2456,Fenestrated Pattern,Secondary osteosarcoma,0
2457,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Stage IIA Distal Bile Duct Cancer AJCC v7,0
2458,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Uterine Corpus Cancer,0
2459,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage,0
2460,Spindle Cell Osteo-Fibrous Component Present,MiT Family Translocation-Associated Renal Cell Carcinoma,0
2461,Fenestrated Pattern,Esophageal squamous papilloma,0
2462,Spindle Cell Metaplasia of Malignant Cells Present,Bladder Urachal Squamous Cell Carcinoma,0
2463,Increased megakaryocytes (bone marrow),Benign Mastocytoma,0
2464,Fried-Egg Appearance of the Bone Marrow,Paget's Disease of the Nipple,0
2465,Fenestrated Pattern,Infiltrating papillary adenocarcinoma,0
2466,Schwannian Stroma More than 50 Percent of the Tumor Volume,Localized tumors of the Ewing's family,0
2467,Absence of Malignant Features,Stage I Carcinoma of Penis,0
2468,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Erythroid Neoplasm,0
2469,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Hepatoblastoma,0
2470,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Bladder Cancer AJCC v8,0
2471,Increased megakaryocytes (bone marrow),Rectosigmoid cancer recurrent,0
2472,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0
2473,Endodermal Sinus Pattern,Stage IVB Paranasal Sinus Cancer AJCC v7,0
2474,Small Aggregates of Tumor Cells Present,Colorectal Small Cell Neuroendocrine Carcinoma,0
2475,Increased megakaryocytes (bone marrow),External Ear Carcinoma,0
2476,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
2477,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Castration-Sensitive Prostate Carcinoma,0
2478,Nodular and Diffuse Pattern,Adult Diffuse Large B-Cell Lymphoma,0
2479,Favorable Clinical Outcome,Early Favorable Non-Hodgkin Lymphoma,0
2480,High Grade Lesion,Grade 3 Colorectal Adenocarcinoma,0
2481,Absence of Malignant Features,mucinous adenocarcinoma of salivary gland,0
2482,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Breast Carcinoma with Osteoclastic Giant Cells,0
2483,Focal Pattern,Secondary Focal Segmental Glomerulosclerosis,0
2484,Solitary Skin Tumor,Stage I Skin Cancer,0
2485,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ileal Neuroendocrine Tumor,0
2486,Cervical Glandular Dysplasia,Metastatic Cervical Adenocarcinoma,0
2487,Increased megakaryocytes (bone marrow),Secondary Focal Segmental Glomerulosclerosis,0
2488,Nodular and Diffuse Pattern,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",0
2489,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IV Ileal Neuroendocrine Tumor AJCC v8,0
2490,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intramuscular Myxoma,0
2491,Multihormonal Immunoreactivity Present in a Single Cell Type,Acinic Cell Breast Carcinoma,0
2492,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive papillary breast carcinoma,0
2493,Tumor Mass,Solid Glomus Tumor,0
2494,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,0
2495,Nodular and Diffuse Pattern,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8",0
2496,Congenital Abnormality,Congenital hypotrichia,0
2497,Solar Radiation Toxicity,Chordoid meningioma,0
2498,Intracytoplasmic Eosinophilic Spherical Inclusion,Eosinophilic Granuloma,0
2499,Increased megakaryocytes (bone marrow),"Dermatitis, Allergic Contact",0
2500,Marked Thickening of the Bladder Urothelium Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
2501,Fenestrated Pattern,Pedunculated conjunctival papilloma,0
2502,Solar Radiation Toxicity,Lymphoepithelial malignant thymoma,0
2503,Schwannian Stroma More than 50 Percent of the Tumor Volume,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
2504,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Adult Central Nervous System Mature Teratoma,0
2505,Recurrent Malignant Neoplasm,Refractory Malignant Solid Neoplasm,0
2506,Fried-Egg Appearance of the Bone Marrow,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
2507,Spindle Cell Metaplasia of Malignant Cells Present,Secondary malignant neoplasm of vulva,0
2508,Spindle Cell Osteo-Fibrous Component Present,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
2509,Spindle Cell Metaplasia of Malignant Cells Present,Adult Type Granulosa Cell Tumor,0
2510,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Small Intestinal Neuroendocrine Carcinoma,0
2511,Increased megakaryocytes (bone marrow),Central Nervous System Leiomyoma,0
2512,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ovarian serous cystadenofibroma,0
2513,Solitary Skin Tumor,Extrahepatic Bile Duct Carcinoid Tumor,0
2514,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Childhood Central Nervous System Embryonal Carcinoma,0
2515,Solar Radiation Toxicity,Fallopian tube leiomyoma,0
2516,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of lung,0
2517,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon adenoma,0
2518,Plasma cell inflammation,Ovarian germ cell choriocarcinoma stage III,0
2519,Solar Radiation Toxicity,Keratosis pilaris,0
2520,Fenestrated Pattern,Pediatric nodal marginal zone lymphoma,0
2521,Increased megakaryocytes (bone marrow),Papillary mucinous cystadenoma,0
2522,Fenestrated Pattern,Colon Lipoma,0
2523,Schwannian Stroma More than 50 Percent of the Tumor Volume,Thyroid Gland Solitary Fibrous Tumor,0
2524,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,0
2525,Spindle Cell Osteo-Fibrous Component Present,Occult Lung Squamous Cell Carcinoma,0
2526,Spindle Cell Metaplasia of Malignant Cells Present,Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
2527,Spindle Cell Metaplasia of Malignant Cells Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,0
2528,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Gliomatosis Cerebri,0
2529,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Solid Papillary Breast Carcinoma,0
2530,Cystic Lesion,Posterior Tongue Adenoid Cystic Carcinoma,0
2531,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Neoplasm with Regional Lymph Node Involvement,0
2532,Solar Radiation Toxicity,"Phosphaturic mesenchymal tumor, benign",0
2533,Increased megakaryocytes (bone marrow),Unresectable Neuroblastoma,0
2534,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
2535,Lesion with Diameter of 2cm or Less,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
2536,Fenestrated Pattern,estrogen-producing adrenal cortical adenoma,0
2537,Blasts Expressing CD56 and Immature T-Cell Markers Present,Recurrent T-Cell Prolymphocytic Leukemia,0
2538,Small Aggregates of Tumor Cells Present,Small cell lung cancer recurrent,0
2539,Primary Site Unspecified,Stage IV Primary Peritoneal Cancer AJCC v8,0
2540,Fenestrated Pattern,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,0
2541,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Squamous Cell Carcinoma of the Larynx,0
2542,Fenestrated Pattern,Solid carcinoma,0
2543,Fenestrated Pattern,Plexiform Schwannoma,0
2544,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Ureter Cancer AJCC v7,0
2545,Large Spaces Filled with Blood Present,Acute myelomonocytic leukemia with abnormal eosinophils,0
2546,Increased megakaryocytes (bone marrow),Childhood Lymphomatoid Granulomatosis,0
2547,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Pancoast Tumor,0
2548,Fenestrated Pattern,Endometrioid tumor,0
2549,Squamous metaplasia of bladder,Squamous cell carcinoma of trachea,0
2550,Large Spaces Filled with Blood Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),0
2551,Recurrent Genetic Abnormalities Present,Recurrent BRCA-Mutated Ovarian Carcinoma,0
2552,Spindle Cell Metaplasia of Malignant Cells Present,RISS Stage II Plasma Cell Myeloma,0
2553,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Ligament Adenocarcinoma,0
2554,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
2555,Endometrial Type Glands and Stroma Present,Recurrent Neurofibromatosis Type 1,0
2556,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Paget's disease and intraductal carcinoma of breast,0
2557,Increased megakaryocytes (bone marrow),Stage III Intrahepatic Bile Duct Cancer AJCC v8,0
2558,Spindle Cell Metaplasia of Malignant Cells Present,Refractory Malignant Mesothelioma,0
2559,Fenestrated Pattern,Secondary Cerebral Hodgkin Lymphoma,0
2560,Spindle Cell Osteo-Fibrous Component Present,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma,0
2561,Fenestrated Pattern,Treatment related leukaemia,0
2562,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Vulvar Cancer AJCC v6,0
2563,Solar Radiation Toxicity,Secondary Central Nervous System Lymphoma,0
2564,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Dermatitis, Occupational",0
2565,Local disease,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,0
2566,Fenestrated Pattern,Adenomatous Polyposis Coli,0
2567,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Liver Carcinoma,0
2568,Metaplasia of Malignant Cells Present,Malignant tumor of extrahepatic bile duct,0
2569,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Poorly Differentiated Malignant Neoplasm,0
2570,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,0
2571,Florid Follicular Hyperplasia,Follicular Lymph Node Hyperplasia,0
2572,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,"Occipital Lobe, Parietal Lobe, and Ventricular Ependymal Tumor",0
2573,Solar Radiation Toxicity,"Neoplasms, Radiation-Induced",0
2574,Solar Radiation Toxicity,Stage II Uterine Corpus Cancer,0
2575,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Superficial Angiomyxoma,0
2576,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,malignant tumor of male genital organ,0
2577,Mammary Gland Type Features Present,Parotid Gland Sebaceous Lymphadenoma,0
2578,Fenestrated Pattern,Thyroid Lymphoma,0
2579,Fenestrated Pattern,Childhood B Lymphoblastic Lymphoma,0
2580,Malignant Primitive Cellular Infiltrate,Malignant Ovarian Teratoma,0
2581,Gastric dysplasia,Pathologic Stage 0 Gastric Cancer AJCC v8,0
2582,Increased megakaryocytes (bone marrow),Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8,0
2583,Increased megakaryocytes (bone marrow),Virus-Related Lymphoma,0
2584,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Locally Advanced Gastrointestinal Stromal Tumor,0
2585,Spindle Cell Metaplasia of Malignant Cells Present,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type",0
2586,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Cervical Cancer AJCC v8,0
2587,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Condyloma Acuminatum with Dysplasia,0
2588,Intravascular papillary endothelial hyperplasia,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
2589,Cystic Lesion,Bartholin Gland Adenoid Cystic Carcinoma,0
2590,Increased megakaryocytes (bone marrow),Megakaryocytic Neoplasm,0
2591,Solar Radiation Toxicity,Adrenocortical carcinoma,0
2592,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,0
2593,Malignant Primitive Cellular Infiltrate,Vulvar Cellular Angiofibroma,0
2594,Proliferation of Follicular Dendritic Cells Present,Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma,0
2595,Multihormonal Immunoreactivity Present in a Single Cell Type,Skin Signet Ring Cell Basal Cell Carcinoma,0
2596,Villous Projections of the Neoplastic Epithelium Present,Crohn's disease of the ileum,0
2597,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Unresectable Prostate Carcinoma,0
2598,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma gastric recurrent,0
2599,Cervical lymphadenopathy,Recurrent Cervical Adenocarcinoma,0
2600,Solitary Skin Tumor,Dentinogenic Ghost Cell Tumor,0
2601,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,0
2602,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Lung Cancer AJCC v8,0
2603,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Adult Hodgkin Lymphoma,0
2604,Osseous Metaplasia of Malignant Cells Present,Malignant tumor of eye,0
2605,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Laryngeal Liposarcoma,0
2606,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Primary Non-Hodgkin Lymphoma of Bone,0
2607,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Synovial Sarcoma,0
2608,Absence of Malignant Features,Malignant Uterine Corpus Neoplasm,0
2609,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,0
2610,Cervical Glandular Dysplasia,Locally Advanced Cervical Carcinoma,0
2611,Increased megakaryocytes (bone marrow),Melanotic malignant nerve sheath tumor,0
2612,Tumor Mass,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0
2613,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Primary Effusion Lymphoma,0
2614,Erythroid hyperplasia,Adrenal hyperplasia,0
2615,Fenestrated Pattern,Lung Myoepithelioma,0
2616,Epithelial hyperplasia of skin,Fibrous tissue neoplasm of skin,0
2617,Solar Radiation Toxicity,Stage IIC Prostate Cancer AJCC v8,0
2618,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Acute Myeloid Leukemia with Gene Mutations,0
2619,Solar Radiation Toxicity,Gallbladder Kaposi's Sarcoma,0
2620,Increased megakaryocytes (bone marrow),Vertebral chordoma,0
2621,Fenestrated Pattern,"Lymphoma, Non-Hodgkin",0
2622,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Parathyroid Gland Carcinoma,0
2623,Increased megakaryocytes (bone marrow),AIDS-Related Isosporiasis,0
2624,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extra-abdominal fibromatosis,0
2625,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Thymus Solitary Fibrous Tumor,0
2626,Fenestrated Pattern,Postsurgical Stage I Hepatoblastoma,0
2627,Recurrent Malignant Neoplasm,Pilar-Associated Mesenchyme Neoplasm,0
2628,Fenestrated Pattern,Colon Serrated Polyposis,0
2629,Increased megakaryocytes (bone marrow),Major Salivary Gland Carcinoma,0
2630,Less than 2 Mitoses per 10HPF,Cervical intraepithelial neoplasia grade 2,0
2631,Increased megakaryocytes (bone marrow),Tinea Favosa,0
2632,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8,0
2633,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Pharynx Carcinoma,0
2634,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Contact dermatitis due to alkali,0
2635,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Lung Cancer AJCC v8,0
2636,Aberrant Thyroid Tissue Present,Childhood Thyroid Gland Papillary Carcinoma,0
2637,Fenestrated Pattern,Childhood Central Nervous System Choriocarcinoma,0
2638,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Lip Carcinoma,0
2639,Nodular and Diffuse Pattern,Diffuse Large B-Cell Lymphoma,0
2640,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma of the Floor of the Mouth,0
2641,Lesion Less than 5mm in Diameter,Adenocarcinoma in Situ,0
2642,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hemangiosarcoma of heart,0
2643,Fenestrated Pattern,Stage III Adult Liver Cancer AJCC v7,0
2644,More Than Two Separate Tumor Masses Present in the Same Organ,Breast Carcinoma Metastatic in the Spine,0
2645,Increased megakaryocytes (bone marrow),Venous Angioleiomyoma,0
2646,Fenestrated Pattern,Osteosarcoma localised,0
2647,Increased megakaryocytes (bone marrow),Spermatocytic seminoma,0
2648,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Mixed Salivary Gland Tumor,0
2649,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Occult Lung Adenosquamous Carcinoma,0
2650,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extra-osseous Ewing's sarcoma recurrent,0
2651,Local disease,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,0
2652,Intraepithelial Neoplasia,High Grade Glandular Intraepithelial Neoplasia,0
2653,Fenestrated Pattern,Extra-osseous Ewing's sarcoma recurrent,0
2654,Moderately Differentiated Lesion,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,0
2655,Schwannian Stroma More than 50 Percent of the Tumor Volume,Gastric Neuroendocrine Tumor,0
2656,Spindle Cell Metaplasia of Malignant Cells Present,Basal Cell Neoplasm,0
2657,Glandular cell atypia,Juvenile type ovarian granulosa cell tumor,0
2658,Absence of Malignant Features,Benign epithelial tumor of ovary,0
2659,Malignant Primitive Cellular Infiltrate,Refractory Malignant Head and Neck Neoplasm,0
2660,Small Aggregates of Tumor Cells Present,Small intestine carcinoma stage II,0
2661,Increased megakaryocytes (bone marrow),Junctional nevus,0
2662,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tobacco-Related Carcinoma,0
2663,Increased megakaryocytes (bone marrow),Post-transplant lymphoproliferative disorder,0
2664,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Adult Immunoblastic Lymphoma,0
2665,Spindle Cell Osteo-Fibrous Component Present,Colorectal Mantle Cell Lymphoma,0
2666,Non-Encapsulated Neoplasm,Vulvar Squamous Neoplasm,0
2667,Nodular and Diffuse Pattern,Stage IIB Ovarian Cancer AJCC v6 and v7,0
2668,Absence of Malignant Features,Polyp of nasal sinus,0
2669,Recurrent Malignant Neoplasm,Recurrent Primary Effusion Lymphoma,0
2670,Fenestrated Pattern,Leiomyomatosis,0
2671,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Paranasal Sinus Lymphoma,0
2672,Multihormonal Immunoreactivity Present in a Single Cell Type,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,0
2673,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Kaposi's sarcoma of esophagus,0
2674,Fenestrated Pattern,furuncle,0
2675,Fenestrated Pattern,Esophageal Lymphoma,0
2676,High Grade Lesion,Refractory High Risk Myelodysplastic Syndrome,0
2677,Recurrent Genetic Abnormalities Present,Recurrent Acute Myeloid Leukemia,0
2678,Fenestrated Pattern,Cutaneous Lymphomatoid Granulomatosis,0
2679,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Gallbladder Cancer by AJCC v6 Stage,0
2680,No Evidence of Metastatic Disease,Metastatic Cervical Carcinoma,0
2681,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,0
2682,Increased megakaryocytes (bone marrow),Glycogen-rich carcinoma,0
2683,Increased megakaryocytes (bone marrow),Stage II Colorectal Cancer AJCC v7,0
2684,Hypertensive disease,Polycystic liver disease,0
2685,Multihormonal Immunoreactivity Present in a Single Cell Type,Subglottic Squamous Cell Carcinoma,0
2686,Increased megakaryocytes (bone marrow),Stage IIIC Rectal Cancer AJCC v7,0
2687,Spindle Cell Metaplasia of Malignant Cells Present,Stage III Childhood Anaplastic Large Cell Lymphoma,0
2688,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Choroidal and Ciliary Body Melanoma AJCC v8,0
2689,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma ex pleomorphic adenoma of parotid gland,0
2690,Nodular and Diffuse Pattern,Stage IB Testicular Cancer AJCC v6 and v7,0
2691,Increased megakaryocytes (bone marrow),Synovial sarcoma metastatic,0
2692,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Ovarian Clear Cell Adenocarcinoma,0
2693,Absence of Malignant Features,Malignant Vulvar Phyllodes Tumor,0
2694,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Fallopian Tube Cancer AJCC v8,0
2695,Hyperplastic Tissue Present,Refractory Soft Tissue Sarcoma,0
2696,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Fallopian Tube Cancer AJCC v8,0
2697,Increased megakaryocytes (bone marrow),Stage IIIA Rectal Cancer AJCC v7,0
2698,Loss of INI 1 Protein Expression,"Seminoma of testis, stage 1",0
2699,Solitary Skin Tumor,Lateral Ventricle Ependymal Tumor,0
2700,Increased megakaryocytes (bone marrow),Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8,0
2701,Lesion with Diameter of 2cm or Less,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,0
2702,Absence of Malignant Features,small cell carcinoma of larynx,0
2703,Abundance of Small Lymphocytes,Small Cell Undifferentiated Hepatoblastoma,0
2704,Fenestrated Pattern,Stage IVB Nasopharyngeal Carcinoma AJCC v8,0
2705,Fenestrated Pattern,Pituitary Gland Paraganglioma,0
2706,Follicular Differentiation,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,0
2707,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Mucoepidermoid carcinoma of parotid gland,0
2708,Cutaneous plaque,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,0
2709,Fenestrated Pattern,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
2710,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IV Gestational Trophoblastic Tumor AJCC v7,0
2711,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Placental polyp,0
2712,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epithelial tumor of ovary,0
2713,High Grade Lesion,Recurrent Grade III Lymphomatoid Granulomatosis,0
2714,Fenestrated Pattern,Myxosarcoma,0
2715,Spindle Cell Metaplasia of Malignant Cells Present,Leydig cell neoplasm of testis,0
2716,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Clear cell papillary renal cell carcinoma,0
2717,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Vulvar Yolk Sac Tumor,0
2718,Proliferation of Follicular Dendritic Cells Present,Ann Arbor Stage IV Grade 1 Follicular Lymphoma,0
2719,Aberrant Thyroid Tissue Present,Unresectable Thyroid Gland Carcinoma,0
2720,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Venous Angioleiomyoma,0
2721,Fenestrated Pattern,Locally Advanced Pancreatic Adenocarcinoma,0
2722,Absence of Malignant Features,Juvenile fibroadenoma of breast,0
2723,Abundance of Small Lymphocytes,Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2724,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Prostate Cancer AJCC v8,0
2725,Recurrent Genetic Abnormalities Present,Recurrent HIV-Associated Lymphoproliferative Disorder,0
2726,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sternal Intraosseous Schwannoma,0
2727,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of cerebrum,0
2728,Vacuolated Plasma Cells in the Bone Marrow,Breast Carcinoma Metastatic in the Central Nervous System,0
2729,Small Lesion,Stage III Small Intestinal Adenocarcinoma AJCC v8,0
2730,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Neoplasm,0
2731,Rubbery Skin Lesion,Non-Neoplastic Skin Disorder,0
2732,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Thymoma,0
2733,Spindle Cell Metaplasia of Malignant Cells Present,Fibrous histiocytoma of tendon sheath,0
2734,Pleural effusion disorder,Chronic myeloproliferative disorder,0
2735,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,0
2736,Solitary mass,Pleural Solitary Fibrous Tumor,0
2737,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Ciliary Body Spindle Cell Melanoma,0
2738,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive carcinoma of breast,0
2739,Fenestrated Pattern,Stage II Colorectal Cancer AJCC v7,0
2740,Unfavorable Clinical Outcome,Early Unfavorable Hodgkin Lymphoma,0
2741,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lymphoplasmacytoid lymphoma/immunocytoma stage IV,0
2742,Solar Radiation Toxicity,Cholangiocarcinoma non-resectable,0
2743,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ependymoma,0
2744,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermatitis acneiform,0
2745,Chronic Inflammatory Infiltrate,Cardiac Inflammatory Myofibroblastic Tumor,0
2746,Solar Radiation Toxicity,Adrenal Cortical Adenoma,0
2747,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Lung and Pleural Neoplasm,0
2748,Fenestrated Pattern,melanoma,0
2749,Increased megakaryocytes (bone marrow),Stage IVA Ovarian Cancer AJCC v8,0
2750,Plasma cell inflammation,Benign germ cell neoplasm,0
2751,Plasma cell inflammation,Parathyroid mixed cell type adenoma,0
2752,Recurrent Malignant Neoplasm,Precursor Lymphoid Neoplasm,0
2753,Absence of Malignant Features,Stage I Pleural Malignant Mesothelioma AJCC v8,0
2754,Fenestrated Pattern,Pharyngeal cancer stage I,0
2755,Mediastinal mass,Mediastinal Paraganglioma,0
2756,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Nevus of eyelid,0
2757,Mucocele of appendix,leiomyosarcoma of appendix,0
2758,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,0
2759,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Left atrial myxoma,0
2760,Fenestrated Pattern,Lymphomatoid Papulosis,0
2761,Low Grade Neuroendocrine Lesion,Digestive System Neuroendocrine Neoplasm,0
2762,Increased megakaryocytes (bone marrow),"Perineurioma, malignant",0
2763,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
2764,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Coronary Venous Dissection,0
2765,NRBC - Nucleated red blood cell present result,Nodulo-ulcerative basal cell carcinoma,0
2766,Glandular metaplasia,Adenocarcinoma with osseous metaplasia,0
2767,Absence of Malignant Features,Sertoli-Leydig cell tumor of ovary,0
2768,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Adrenal Cortex Carcinoma AJCC v7,0
2769,Endometrial Type Glands and Stroma Present,Stage IIB Testicular Cancer AJCC v6 and v7,0
2770,Solar Radiation Toxicity,Kidney Lipoma,0
2771,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0
2772,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sternal Lymphoma,0
2773,Finding related to pregnancy,Metastatic Neoplasm to the Gallbladder,0
2774,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Kaposi Sarcoma,0
2775,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Splenic Soft Tissue Neoplasm,0
2776,Fenestrated Pattern,ALK positive large B-cell lymphoma,0
2777,Recurrent Malignant Neoplasm,Recurrent Non-Cutaneous Melanoma,0
2778,Fenestrated Pattern,Epidermolysis Bullosa Simplex,0
2779,Cystic Change,Prostate Adenoid Cystic Carcinoma,0
2780,Fenestrated Pattern,Mediastinal Melanotic Schwannoma,0
2781,Solitary Skin Tumor,Unresectable Skin Carcinoma,0
2782,Metaplasia of Malignant Cells Present,Malignant neoplasm of oropharynx,0
2783,Fenestrated Pattern,Stage IIA Ovarian Cancer AJCC v8,0
2784,Increased megakaryocytes (bone marrow),Papillary fibroelastoma,0
2785,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,0
2786,Spindle Cell Metaplasia of Malignant Cells Present,Glomerulosa Cell Adrenal Cortical Adenoma,0
2787,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of pleura,0
2788,White blood cell count increased (lab result),Disseminated squamous cell carcinoma,0
2789,Fenestrated Pattern,Mediastinal Extraskeletal Osteosarcoma,0
2790,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mycosis fungoides stage I,0
2791,Spindle Cell Osteo-Fibrous Component Present,Vaginal Keratinizing Squamous Cell Carcinoma,0
2792,Fenestrated Pattern,Ventricular myxoma,0
2793,Mammary Gland Type Features Present,Recurrent Anterior Pituitary Gland Neoplasm,0
2794,Intravascular papillary endothelial hyperplasia,Gallbladder papillary adenocarcinoma,0
2795,Tumor Mass,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
2796,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Esophageal Neoplasm by Topographic Region,0
2797,Fenestrated Pattern,Central Nervous System Angiolipoma,0
2798,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Advanced Head and Neck Carcinoma,0
2799,Atypical Lymphocytes Present in Peripheral Blood,Atypical choroid plexus papilloma,0
2800,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Esophageal Cancer by AJCC v8 Stage,0
2801,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Benign Testicular Sertoli Cell Tumor,0
2802,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIC Colon Cancer AJCC v7,0
2803,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,small cell carcinoma of larynx,0
2804,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIA Esophagus Carcinoma,0
2805,Increased megakaryocytes (bone marrow),Stage IV Vaginal Cancer AJCC v8,0
2806,Increased megakaryocytes (bone marrow),Locally Advanced Unresectable Sarcoma,0
2807,Malignant Primitive Cellular Infiltrate,Refractory Malignant Germ Cell Tumor,0
2808,Small Lesion,Childhood Small Intestinal Leiomyosarcoma,0
2809,Nodular and Diffuse Pattern,Cervical Mesonephric Remnants and Hyperplasia,0
2810,Absence of Malignant Features,Secondary malignant neoplasm of testis,0
2811,Spindle Cell Metaplasia of Malignant Cells Present,Pigmented Basal Cell Carcinoma,0
2812,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Soft Tissue Tumor of Uncertain Differentiation,0
2813,Marked Thickening of the Bladder Urothelium Present,Bladder squamous cell carcinoma recurrent,0
2814,Fenestrated Pattern,Osteoblastoma,0
2815,Large Spaces Filled with Blood Present,Rhabdomyosarcoma with ganglionic differentiation,0
2816,Small Aggregates of Tumor Cells Present,Rectal Small Cell Neuroendocrine Carcinoma,0
2817,High Grade Lesion,Grade 1 Diffuse Follicular Lymphoma,0
2818,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,adenocarcinoma of breast with squamous metaplasia,0
2819,Solar Radiation Toxicity,AIDS-Related Enterocolitis,0
2820,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostate Cancer by AJCC v8 Stage,0
2821,Immature Myeloid Cells Increased in Bone Marrow,Stage IVB Bone Sarcoma AJCC v7,0
2822,Increased megakaryocytes (bone marrow),Plexosarcoma,0
2823,Multihormonal Immunoreactivity Present in a Single Cell Type,Combined Lung Small Cell and Squamous Cell Carcinoma,0
2824,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Histiocytic and Dendritic Cell Neoplasm,0
2825,Fenestrated Pattern,Stage IIB Colorectal Cancer AJCC v8,0
2826,Blasts Expressing CD56 and Immature T-Cell Markers Present,Cutaneous Angioimmunoblastic T-Cell Lymphoma,0
2827,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage IVA Hodgkin Lymphoma,0
2828,Increased megakaryocytes (bone marrow),"Adenoma, Monomorphic",0
2829,Solar Radiation Toxicity,"Lichen Planus, Oral",0
2830,Low Grade Cartilaginous Component Present,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
2831,Fenestrated Pattern,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,0
2832,Endometrial Type Glands and Stroma Present,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7,0
2833,Solar Radiation Toxicity,Extra-osseous Ewing's sarcoma non-metastatic,0
2834,Solar Radiation Toxicity,Verrucous carcinoma,0
2835,Fenestrated Pattern,Myxoid liposarcoma metastatic,0
2836,Recurrent Genetic Abnormalities Present,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,0
2837,Metaplasia of Malignant Cells Present,Malignant neoplasm of gallbladder,0
2838,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Acute lymphoblastic leukemia recurrent,0
2839,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Testicular Sertoli Cell Tumor,0
2840,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage III Lung Small Cell Carcinoma AJCC v7,0
2841,Absence of Malignant Features,Congenital anomaly of lens,0
2842,Melanoma Cells Present,Metastatic Non-Cutaneous Melanoma,0
2843,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Ovarian Cancer by AJCC v6 and v7 Stage,0
2844,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Chordoma,0
2845,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage I Ileal Neuroendocrine Tumor AJCC v8,0
2846,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
2847,Increased megakaryocytes (bone marrow),Rectosigmoid Cancer by AJCC v6 Stage,0
2848,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0
2849,Fenestrated Pattern,Stage II Vaginal Cancer AJCC v8,0
2850,Increased megakaryocytes (bone marrow),Double expressor lymphoma,0
2851,Fenestrated Pattern,Salivary duct carcinoma,0
2852,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Mucinous adenocarcinoma of appendix,0
2853,Spindle Cell Metaplasia of Malignant Cells Present,Adenocarcinoma of ampulla of Vater,0
2854,Spindle Cell Metaplasia of Malignant Cells Present,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,0
2855,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage I Anal Canal Cancer AJCC v6 and v7,0
2856,Squamous metaplasia of bladder,Squamous intraepithelial neoplasia grade 2,0
2857,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoid tumor of the duodenum,0
2858,Mass of body structure,Malignant neoplasm of carotid body,0
2859,Moderately Differentiated Lesion,Poorly Differentiated Angiosarcoma,0
2860,Increased megakaryocytes (bone marrow),Contralateral Breast Carcinoma,0
2861,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cavernous hemangioma of the face,0
2862,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Distal Bile Duct Cancer AJCC v8,0
2863,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Mesothelioma, biphasic, malignant",0
2864,Aberrant Thyroid Tissue Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
2865,Immature Myeloid Cells Increased in Bone Marrow,"Acute Myeloid Leukemia, M1",0
2866,Distortion of the Hair Follicle,Non-Neoplastic Hair Disorder,0
2867,Non-Encapsulated Neoplasm,Oncocytic Neoplasm,0
2868,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Placental aromatase deficiency,0
2869,Tumor Mass,Stage IIIB Gestational Trophoblastic Tumor AJCC v7,0
2870,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prognostic Stage IIB Breast Cancer AJCC v8,0
2871,Large Mass,Pancreatic Large Cell Neuroendocrine Carcinoma,0
2872,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Parapsoriasis,0
2873,Increased megakaryocytes (bone marrow),Major Salivary Gland Carcinoma,0
2874,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intracranial lipoma,0
2875,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
2876,Low Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Neoplasm,0
2877,Solar Radiation Toxicity,Sparsely Granulated Non-Functioning Corticotroph Adenoma,0
2878,Villous Projections of the Neoplastic Epithelium Present,Mucoepidermoid carcinoma of the oral cavity stage II,0
2879,Immature Myeloid Cells Increased in Bone Marrow,Stage III Immature Testicular Teratoma AJCC v6 and v7,0
2880,Solar Radiation Toxicity,Childhood Central Nervous System Germinoma,0
2881,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Melanoma in Congenital Melanocytic Nevus,0
2882,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
2883,Spindle Cell Osteo-Fibrous Component Present,Refractory Hairy Cell Leukemia,0
2884,Spindle Cell Metaplasia of Malignant Cells Present,Subependymal Giant Cell Astrocytoma,0
2885,More Than Two Separate Tumor Masses Present in the Same Organ,Rectal Carcinoma Metastatic in the Liver,0
2886,Increased megakaryocytes (bone marrow),Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8,0
2887,Diffuse Cellular Infiltrate,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0
2888,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Diencephalic Neoplasm,0
2889,Fenestrated Pattern,Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8,0
2890,No Evidence of Metastatic Disease,Metastatic Thyroid Gland Carcinoma,0
2891,Unfavorable Clinical Outcome,Clinical Stage IIB Cutaneous Melanoma AJCC v8,0
2892,Multihormonal Immunoreactivity Present in a Single Cell Type,Adenocarcinoma in adenomatous polyp,0
2893,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Lipoma of spinal cord,0
2894,Increased megakaryocytes (bone marrow),Fallopian Tube Cancer by AJCC v6 Stage,0
2895,Aberrant Thyroid Tissue Present,Sporadic Thyroid Gland Micromedullary Carcinoma,0
2896,Fenestrated Pattern,Macrofollicular adenoma,0
2897,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cervical Adenomyoma,0
2898,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2899,Peau d'orange surface of breast,Atypical hyperplasia of breast,0
2900,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Leukemia, Myeloid, Chronic-Phase",0
2901,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary cutaneous gamma-delta T-cell lymphoma,0
2902,Spindle Cell Metaplasia of Malignant Cells Present,Lung Clear Cell Tumor,0
2903,Solar Radiation Toxicity,Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8,0
2904,Slowly Progressive Clinical Course,"Leukoencephalopathy, Progressive Multifocal",0
2905,Villous Projections of the Neoplastic Epithelium Present,Carcinoma of the Appendix,0
2906,Increased megakaryocytes (bone marrow),Colorectal Cancer by AJCC v6 Stage,0
2907,Increased megakaryocytes (bone marrow),Prolactin-producing pituitary tumor,0
2908,Mammary Gland Type Features Present,Bladder Enteric Type Adenocarcinoma,0
2909,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Colorectal Mixed Adenoneuroendocrine Carcinoma,0
2910,Non-Encapsulated Neoplasm,Refractory Neoplasm,0
2911,Complex Glandular Pattern,Breast Complex Fibroadenoma,0
2912,Increased megakaryocytes (bone marrow),Radiation sickness syndrome,0
2913,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bartholin Gland Adenocarcinoma,0
2914,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of intestinal tract,0
2915,Moderately Differentiated Lesion,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",0
2916,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Deep Lipoma,0
2917,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Papillary transitional cell neoplasm of low malignant potential,0
2918,Recurrent Genetic Abnormalities Present,Recurrent Parotid Gland Undifferentiated Carcinoma,0
2919,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Lymphoproliferative disorder caused by methotrexate,0
2920,Absence of Malignant Features,Carcinoma of unknown primary,0
2921,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
2922,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Prostate Cancer by AJCC v6 Stage,0
2923,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Gastric Gastrointestinal Stromal Tumor,0
2924,Increased megakaryocytes (bone marrow),Precursor B-lymphoblastic lymphoma stage I,0
2925,Increased megakaryocytes (bone marrow),Typical Ovarian Thecoma,0
2926,Spindle Cell Metaplasia of Malignant Cells Present,epithelial-myoepithelial carcinoma of salivary gland,0
2927,Increased megakaryocytes (bone marrow),Childhood Medulloblastoma,0
2928,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Nonossifying Fibromyxoid Tumor,0
2929,Mixture of Germ Cell Neoplastic Components Present,Langerhans Cell Sarcoma,0
2930,Chromogranin A Positive Neoplastic Cells Present,"Xeroderma pigmentosum, group A",0
2931,Increased megakaryocytes (bone marrow),Adult Hodgkin Lymphoma by Ann Arbor Stage,0
2932,Solar Radiation Toxicity,Eyelid Xanthoma,0
2933,Solar Radiation Toxicity,Stage II Vaginal Cancer AJCC v8,0
2934,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ependymoma of brain stem,0
2935,Mammary Gland Type Features Present,Non-Functioning Pituitary Gland Microadenoma,0
2936,Fenestrated Pattern,Central Nervous System Germinoma,0
2937,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant fibrous histiocytoma recurrent,0
2938,Solar Radiation Toxicity,Erythroleukemia (Erythroid/Myeloid),0
2939,Solar Radiation Toxicity,Glycogen-rich carcinoma,0
2940,Increased megakaryocytes (bone marrow),Bartholin Gland Adenosquamous Carcinoma,0
2941,Fenestrated Pattern,Stage IV Vulvar Cancer AJCC v8,0
2942,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma,0
2943,Solar Radiation Toxicity,Cerebral Glioblastoma,0
2944,Solar Radiation Toxicity,Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8,0
2945,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Placenta Percreta,0
2946,Increased megakaryocytes (bone marrow),Childhood Central Nervous System Embryonal Carcinoma,0
2947,Fenestrated Pattern,Stage IIC Appendix Carcinoma AJCC v7,0
2948,Neoplastic Cells with TFH Cell Phenotype Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",0
2949,Increased megakaryocytes (bone marrow),Bizarre parosteal osteochondromatous proliferation,0
2950,Retiform Structures Comprise 90% or More of the Tumor,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,0
2951,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Densely Granulated Lactotroph Adenoma,0
2952,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2953,Solar Radiation Toxicity,Stage IIIB Lung Cancer AJCC v7,0
2954,Aberrant Thyroid Tissue Present,Stage IV Adult Soft Tissue Sarcoma AJCC v7,0
2955,Increased megakaryocytes (bone marrow),Stage 0 Penile Cancer AJCC v7,0
2956,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Childhood Central Nervous System Mature Teratoma,0
2957,Fenestrated Pattern,Splenic B Lymphoblastic Lymphoma,0
2958,Increased megakaryocytes (bone marrow),Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma,0
2959,Solar Radiation Toxicity,Pterygium Of Conjunctiva And Cornea,0
2960,Abundance of Small Lymphocytes,Small intestine carcinoma stage II,0
2961,Chronic Clinical Course,Refractory Chronic Myelomonocytic Leukemia,0
2962,Multihormonal Immunoreactivity Present in a Single Cell Type,Giant Cell Glioblastoma,0
2963,Human Papillomavirus Positive,Human Papillomavirus-Related Adenocarcinoma,0
2964,Low Grade Neuroendocrine Lesion,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,0
2965,Granuloma,Eosinophilic Granuloma,0
2966,Solar Radiation Toxicity,Stage IVB Liver Cancer,0
2967,Solar Radiation Toxicity,Ureteric cancer regional,0
2968,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of large intestine,0
2969,Recurrent disease,Hodgkin's disease mixed cellularity stage IV,0
2970,Small Aggregates of Tumor Cells Present,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
2971,Fenestrated Pattern,Breast Mucinous Cystadenocarcinoma,0
2972,Humoral hypercalcemia of malignancy (disorder),"Endometrioid adenoma, borderline malignancy",0
2973,Solar Radiation Toxicity,Stage II Osteosarcoma AJCC v7,0
2974,High Grade Non Cartilaginous Sarcomatous Stroma Present,Recurrent Grade 2 Follicular Lymphoma,0
2975,Increased megakaryocytes (bone marrow),Stage IVB Lung Cancer AJCC v8,0
2976,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hobnail Hemangioma,0
2977,Spindle Cell Metaplasia of Malignant Cells Present,Thoracic Esophagus Squamous Cell Carcinoma,0
2978,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postsurgical Stage I Hepatoblastoma,0
2979,Intersecting Sharply Marginated Clusters of Spindle Cells Present,leiomyosarcoma of appendix,0
2980,Mammary Gland Type Features Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,0
2981,Schwannian Stroma More than 50 Percent of the Tumor Volume,Adenoid cystic carcinoma of the oral cavity stage IV,0
2982,Solar Radiation Toxicity,Facial paralysis,0
2983,Diffuse Cellular Infiltrate,Recurrent Extranodal Diffuse Large B-cell Lymphoma,0
2984,Nodular and Diffuse Pattern,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
2985,Cervical Glandular Dysplasia,Cervical Angiosarcoma,0
2986,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,benign neurofibroma of gallbladder,0
2987,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mixed epithelial tumor of ovary,0
2988,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
2989,Large Spaces Filled with Blood Present,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,0
2990,Well Differentiated Hyaline Cartilage Present,Well Differentiated Malignant Neoplasm,0
2991,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Colorectal Cancer AJCC v8,0
2992,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,0
2993,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Rectal Cancer AJCC v8,0
2994,NRBC - Nucleated red blood cell present result,Parathyroid mixed cell type adenoma,0
2995,Solar Radiation Toxicity,Desmoplastic melanoma,0
2996,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Solid Angioleiomyoma,0
2997,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Burkitt Lymphoma,0
2998,Increased megakaryocytes (bone marrow),Refractory Hodgkin Lymphoma,0
2999,Large Spaces Filled with Blood Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0
3000,Solar Radiation Toxicity,Stage IIB Vaginal Cancer AJCC v8,0
3001,Multihormonal Immunoreactivity Present in a Single Cell Type,Thyroid Gland Clear Cell Follicular Adenoma,0
3002,Solitary Skin Tumor,Stage IIIA Gestational Trophoblastic Tumor AJCC v7,0
3003,Solar Radiation Toxicity,Stage IC Uterine Corpus Cancer AJCC v6,0
3004,Glandular cell atypia,Clear cell hidradenoma,0
3005,Fenestrated Pattern,Biliary Adenofibroma,0
3006,Increased megakaryocytes (bone marrow),Refractory Adrenal Gland Pheochromocytoma,0
3007,Multihormonal Immunoreactivity Present in a Single Cell Type,Mixed Cell Uveal Melanoma,0
3008,Fenestrated Pattern,Ovarian Fibromata,0
3009,Hyperplastic Tissue Present,Metastatic Soft Tissue Sarcoma,0
3010,High Grade Lesion,Recurrent Grade II Lymphomatoid Granulomatosis,0
3011,Increased megakaryocytes (bone marrow),Laryngeal Cancer by AJCC v7 Stage,0
3012,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IC Ovarian Cancer AJCC v6 and v7,0
3013,Increased megakaryocytes (bone marrow),Mixed phenotype acute leukemia,0
3014,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IB Lung Squamous Cell Carcinoma AJCC v7,0
3015,Fenestrated Pattern,Stage IA Lung Cancer AJCC v7,0
3016,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of pericardium,0
3017,Solar Radiation Toxicity,Fallopian Tube Gestational Choriocarcinoma,0
3018,Increased megakaryocytes (bone marrow),Stage IV Uterine Sarcoma AJCC v7,0
3019,Diffuse Cellular Infiltrate,Recurrent Diffuse Intrinsic Pontine Glioma,0
3020,Solar Radiation Toxicity,Childhood Neuroblastoma,0
3021,Nerve palsy,Recurrent Childhood Optic Nerve Astrocytoma,0
3022,Glandular cell atypia,Gallbladder squamous cell carcinoma,0
3023,Endometrial Type Glands and Stroma Present,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,0
3024,Spindle Cell Metaplasia of Malignant Cells Present,Myxoid/Round Cell Liposarcoma,0
3025,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Paraganglioma,0
3026,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Parotid Gland Kaposi Sarcoma,0
3027,Solar Radiation Toxicity,Familial Hemophagocytic Lymphocytosis,0
3028,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of endocervix,0
3029,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Ovarian Granulosa Cell Tumor,0
3030,Low Grade Neuroendocrine Lesion,Low grade appendiceal mucinous neoplasm,0
3031,Peau d'orange surface of breast,Lipoma of breast,0
3032,Malignant Primitive Cellular Infiltrate,Refractory Malignant Pharyngeal Neoplasm,0
3033,Increased megakaryocytes (bone marrow),Second Primary Cancers,0
3034,Increased megakaryocytes (bone marrow),Uterine Corpus Cancer by AJCC v8 Stage,0
3035,Absence of Malignant Features,Malignant tumor of gum,0
3036,Fenestrated Pattern,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0
3037,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Meningothelial meningioma,0
3038,Increased megakaryocytes (bone marrow),Lung Myolipoma,0
3039,Endometrial Type Glands and Stroma Present,Stage IV Lip Cancer AJCC v6 and v7,0
3040,Absence of Malignant Features,benign mature teratoma of pancreas,0
3041,Spindle Cell Osteo-Fibrous Component Present,Laryngeal Acantholytic Squamous Cell Carcinoma,0
3042,Villous Projections of the Neoplastic Epithelium Present,Sarcoma of the Extremity,0
3043,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
3044,Schwannian Stroma More than 50 Percent of the Tumor Volume,Pericardial Adenomatoid Tumor,0
3045,Absence of Malignant Features,Benign neoplasm of testis,0
3046,Multihormonal Immunoreactivity Present in a Single Cell Type,Platinum-Resistant Lung Small Cell Carcinoma,0
3047,Absence of Malignant Features,Malignant neoplasm of chest wall,0
3048,Spindle Cell Osteo-Fibrous Component Present,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,0
3049,Increased megakaryocytes (bone marrow),Childhood Ovarian Dysgerminoma,0
3050,Solar Radiation Toxicity,Childhood Testicular Choriocarcinoma,0
3051,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Complex Fibroadenoma,0
3052,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenoma of the nipple,0
3053,Fenestrated Pattern,Stage IVC Pharyngeal Carcinoma,0
3054,Spindle Cell Metaplasia of Malignant Cells Present,Clear cell adenocarcinoma of ovary,0
3055,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,0
3056,Fenestrated Pattern,AIDS-Related Toxoplasmosis,0
3057,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIIB Testicular Cancer AJCC v6 and v7,0
3058,Mammary Gland Type Features Present,Adrenal Gland Lymphoma,0
3059,Recurrent Genetic Abnormalities Present,Recurrent Pancreatic Neuroendocrine Carcinoma,0
3060,Clear Perinuclear Halo Present,Clear cell cystadenofibroma,0
3061,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Hepatocellular Carcinoma AJCC v6,0
3062,Nodular and Diffuse Pattern,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,0
3063,Spindle Cell Metaplasia of Malignant Cells Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,0
3064,Cervical Glandular Dysplasia,Cervical Cancer by AJCC v6 Stage,0
3065,Skin Erosion,Skin Basaloid Carcinoma,0
3066,Fenestrated Pattern,Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8,0
3067,Fenestrated Pattern,Bizarre parosteal osteochondromatous proliferation,0
3068,Plasma cell inflammation,Basaloid squamous cell carcinoma,0
3069,Fenestrated Pattern,Chondroma,0
3070,Plasma cell inflammation,Acinar cell cystadenocarcinoma,0
3071,Solitary Skin Tumor,Thyroid Gland Solitary Fibrous Tumor,0
3072,Systemic disease,Hodgkin's disease mixed cellularity stage III,0
3073,Solar Radiation Toxicity,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,0
3074,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign phyllodes neoplasm of breast,0
3075,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Leiomyosarcoma,0
3076,Spindle Cell Metaplasia of Malignant Cells Present,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,0
3077,Increased megakaryocytes (bone marrow),Stage IIB Testicular Cancer AJCC v8,0
3078,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Vulvar Cancer AJCC v8,0
3079,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Infective Phlebitis,0
3080,Increased megakaryocytes (bone marrow),Anatomic Stage IIB Breast Cancer AJCC v8,0
3081,Gastric dysplasia,Gastric Intestinal-Type Adenocarcinoma,0
3082,Nodular and Diffuse Pattern,Glucagon Cell Hyperplasia and Neoplasia,0
3083,Fenestrated Pattern,Refractory Synovial Sarcoma,0
3084,Cutaneous plaque,Stage III Cutaneous Melanoma AJCC v6,0
3085,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma,0
3086,Plasma cell inflammation,granulosa cell tumor,0
3087,Solar Radiation Toxicity,Thecoma,0
3088,Increased megakaryocytes (bone marrow),AIDS-Related Isosporiasis,0
3089,Spindle Cell Metaplasia of Malignant Cells Present,Adenoid cystic carcinoma of parotid gland,0
3090,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,0
3091,Intersecting Sharply Marginated Clusters of Spindle Cells Present,clear cell adenocarcinoma of urethra,0
3092,Abundance of Small Lymphocytes,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,0
3093,Fenestrated Pattern,Stage I Colorectal Cancer AJCC v8,0
3094,Intestinal metaplasia of gastric mucosa,Squamous cell carcinoma of buccal mucosa,0
3095,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Testicular Cancer by AJCC v8 Stage,0
3096,Erythroid hyperplasia,Foveolar hyperplasia,0
3097,Tumor Mass,Childhood Ovarian Yolk Sac Tumor,0
3098,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3099,Increased megakaryocytes (bone marrow),Stage III Breast Cancer AJCC v7,0
3100,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon Liposarcoma,0
3101,Spindle Cell Osteo-Fibrous Component Present,Thoracic Esophagus Squamous Cell Carcinoma,0
3102,Mixed Neoplastic Glandular and Squamous Cell Population,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0
3103,New bone formation (morphologic abnormality),Primary bone lymphoma,0
3104,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,fibroma of testis,0
3105,Spindle Cell Osteo-Fibrous Component Present,Stage III Renal Cell Cancer AJCC v8,0
3106,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lipoma of pleura,0
3107,Spindle Cell Metaplasia of Malignant Cells Present,Bartholin Gland Squamous Cell Carcinoma,0
3108,Spindle Cell Osteo-Fibrous Component Present,Cervical Keratinizing Squamous Cell Carcinoma,0
3109,Fenestrated Pattern,Impetigo,0
3110,Malignant Primitive Cellular Infiltrate,Malignant Testicular Sertoli Cell Tumor,0
3111,Non-Encapsulated Neoplasm,Metastatic Well Differentiated Neuroendocrine Neoplasm,0
3112,Fenestrated Pattern,Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma,0
3113,Nodular and Diffuse Pattern,Gastric Fundus Carcinoma In Situ AJCC v6 and v7,0
3114,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
3115,Increased megakaryocytes (bone marrow),Adult Brain Stem Neoplasm,0
3116,Large Spaces Filled with Blood Present,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0
3117,Fenestrated Pattern,Stage IIA Prostate Cancer AJCC v7,0
3118,Canalicular Pattern,"Testicular Yolk Sac Tumor, Papillary Pattern",0
3119,Spindle Cell Metaplasia of Malignant Cells Present,Borderline Ovarian Clear Cell Adenofibroma,0
3120,Large Spaces Filled with Blood Present,Cataract associated with radiation,0
3121,Solar Radiation Toxicity,Hamartomatous polyp,0
3122,Increased megakaryocytes (bone marrow),Ectopic Pregnancy,0
3123,Fenestrated Pattern,Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8,0
3124,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage II Hodgkin Lymphoma AJCC v8,0
3125,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant fibrous histiocytoma metastatic,0
3126,Fenestrated Pattern,Sweat Gland Neoplasms,0
3127,Multihormonal Immunoreactivity Present in a Single Cell Type,Minor Salivary Gland Small Cell Carcinoma,0
3128,Acral Lesion,Acral Fibromyxoma,0
3129,Solar Radiation Toxicity,"Adenocarcinoma, Scirrhous",0
3130,Solar Radiation Toxicity,Nasopharyngeal Paraganglioma,0
3131,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Myeloid/Lymphoid Neoplasms with PCM1-JAK2,0
3132,Fenestrated Pattern,Stage IV Gallbladder Cancer AJCC v6,0
3133,Spindle Cell Osteo-Fibrous Component Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0
3134,Glandular metaplasia,Esophageal Glandular Intraepithelial Neoplasia,0
3135,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of colon,0
3136,Tumor Mass,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0
3137,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent HIV-Associated Lymphoproliferative Disorder,0
3138,Mixture of Germ Cell Neoplastic Components Present,Refractory Lung Non-Small Cell Carcinoma,0
3139,Prominent In Situ Component Present,High Grade Ductal Breast Carcinoma In Situ,0
3140,Fenestrated Pattern,Pulmonary Artery Leiomyosarcoma,0
3141,Spindle Cell Metaplasia of Malignant Cells Present,Renal Cell Cancer by AJCC v8 Stage,0
3142,Increased megakaryocytes (bone marrow),Ewings sarcoma,0
3143,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Urethral Cancer AJCC v7,0
3144,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,BCLC Stage A Adult Hepatocellular Carcinoma,0
3145,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Soft Tissue Tumor of Uncertain Differentiation,0
3146,Increased megakaryocytes (bone marrow),Sebaceous Gland Neoplasms,0
3147,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,0
3148,High Grade Lesion,Low Grade Fallopian Tube Serous Adenocarcinoma,0
3149,Lymphocyte count increased,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage,0
3150,Cervical lymphadenopathy,Stage IIA1 Cervical Cancer AJCC v8,0
3151,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0 Anal Canal Cancer AJCC v6 and v7,0
3152,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Childhood Giant Cell Glioblastoma,0
3153,Glandular cell atypia,Undifferentiated round cell sarcoma,0
3154,High Grade Non Cartilaginous Sarcomatous Stroma Present,Unresectable Low Grade Glioma,0
3155,Multiple Tumor Masses,Multiple adenomatous polyps,0
3156,Endodermal Sinus Pattern,Keratinizing Paranasal Sinus Squamous Cell Carcinoma,0
3157,Erythroid hyperplasia,Drug-induced gingival hyperplasia,0
3158,Absence of Malignant Features,"Benign neoplasm of brain, unspecified",0
3159,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,High Grade Salivary Gland Carcinoma,0
3160,Solar Radiation Toxicity,Stage II Colorectal Cancer AJCC v8,0
3161,Fenestrated Pattern,Stage IIIC Esophageal Adenocarcinoma AJCC v7,0
3162,Invasive Lesion,Early Invasive Cervical Adenocarcinoma,0
3163,Fenestrated Pattern,Hepatic Angiomyolipoma,0
3164,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Eyelid Carcinoma AJCC v8,0
3165,Solitary Skin Tumor,Glomus Tumor,0
3166,Increased megakaryocytes (bone marrow),Trichilemmocarcinoma,0
3167,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Stage IB Pleural Malignant Mesothelioma AJCC v8,0
3168,Spindle Cell Metaplasia of Malignant Cells Present,mucinous adenocarcinoma of lung,0
3169,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pancreatic neuroendocrine tumor metastatic,0
3170,Acute inflammation,Refractory Childhood Acute Lymphoblastic Leukemia,0
3171,Exophytic Papillary Lesion,Papillary Thyroid Microcarcinoma,0
3172,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,follicular lymphoma of thyroid gland,0
3173,Solar Radiation Toxicity,Stage IVB Colorectal Cancer AJCC v7,0
3174,Malignant Primitive Cellular Infiltrate,Childhood Malignant Ovarian Germ Cell Tumor,0
3175,Mammary Gland Type Features Present,Metastatic Thyroid Gland Papillary Carcinoma,0
3176,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ovarian Thecoma,0
3177,Increased megakaryocytes (bone marrow),Pleural Monophasic Synovial Sarcoma,0
3178,Spindle Cell Metaplasia of Malignant Cells Present,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
3179,Mammary Gland Type Features Present,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0
3180,Solar Radiation Toxicity,Hidroacanthoma simplex,0
3181,Recurrent Malignant Neoplasm,Malignant Lung Hilum Neoplasm,0
3182,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thymic Mucoepidermoid Carcinoma,0
3183,Epithelioid Differentiation,Epithelioid and spindle cell nevus,0
3184,Recurrent Genetic Abnormalities Present,Recurrent Breast Angiosarcoma,0
3185,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage,0
3186,Increased megakaryocytes (bone marrow),Thymus Lipofibroadenoma,0
3187,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Vaginal Glandular Neoplasm,0
3188,Mixture of Embryonal and Alveolar Features Present,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3189,Multihormonal Immunoreactivity Present in a Single Cell Type,Intraepithelial Neoplasia in Barrett Esophagus,0
3190,Non-Encapsulated Neoplasm,Benign Genitourinary System Neoplasm,0
3191,Fenestrated Pattern,Stage IVB Hepatocellular Carcinoma AJCC v7,0
3192,Increased megakaryocytes (bone marrow),Juvenile rheumatoid arthritis,0
3193,Spindle Cell Metaplasia of Malignant Cells Present,RISS Stage III Plasma Cell Myeloma,0
3194,Increased megakaryocytes (bone marrow),Papillary neoplasm,0
3195,Diffuse Cellular Infiltrate,"Mastocytosis, Diffuse Cutaneous",0
3196,Intersecting Sharply Marginated Clusters of Spindle Cells Present,polyembryoma of ovary,0
3197,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Serous cystadenocarcinoma ovary,0
3198,Increased megakaryocytes (bone marrow),Fallopian Tube Papillary Adenocarcinoma,0
3199,Fenestrated Pattern,Stage IA Mycosis Fungoides AJCC v7,0
3200,Fenestrated Pattern,Stage IB Vulvar Cancer AJCC v7,0
3201,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of adrenal cortex,0
3202,Low Grade Neuroendocrine Lesion,Grade 2 Colorectal Adenocarcinoma,0
3203,Increased megakaryocytes (bone marrow),"Vaginal Deep ""Aggressive"" Angiomyxoma",0
3204,Increased megakaryocytes (bone marrow),Stage IB2 Cervical Cancer AJCC v8,0
3205,Solar Radiation Toxicity,Lugano Classification Stage IE Adult Lymphoma AJCC v8,0
3206,Fenestrated Pattern,Benign digestive system neoplasms,0
3207,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of vulva,0
3208,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage I Adult Lymphoma AJCC v8,0
3209,Solar Radiation Toxicity,Ossifying Fibroma,0
3210,Fenestrated Pattern,Refractory B-Cell Prolymphocytic Leukemia,0
3211,Fenestrated Pattern,Childhood Fibrillary Astrocytoma,0
3212,Multihormonal Immunoreactivity Present in a Single Cell Type,Prostate Basal Cell Carcinoma,0
3213,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Paraganglioma of head and neck,0
3214,Solar Radiation Toxicity,Kidney Synovial Sarcoma,0
3215,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cyst of Skene's duct,0
3216,Recurrent Malignant Neoplasm,Recurrent Adult Lymphoblastic Lymphoma,0
3217,Spindle Cell Metaplasia of Malignant Cells Present,Carcinomatosis of peritoneal cavity,0
3218,Increased megakaryocytes (bone marrow),Corneal Melanoma,0
3219,Increased megakaryocytes (bone marrow),Ossifying Fibroma,0
3220,Increased megakaryocytes (bone marrow),Lung Micropapillary Adenocarcinoma,0
3221,Mixture of Embryonal and Alveolar Features Present,Adult Alveolar Soft Part Sarcoma,0
3222,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Phyllodes Tumor of Prostate,0
3223,Spindle Cell Metaplasia of Malignant Cells Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0
3224,Diffuse Immunoblastic Proliferation,Immunoblastic Large-Cell Lymphoma,0
3225,Increased megakaryocytes (bone marrow),Papillary ependymoma,0
3226,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma Metastatic to the Skin,0
3227,Fried-Egg Appearance of the Bone Marrow,Stage I Bone Sarcoma AJCC v7,0
3228,Fenestrated Pattern,Stage IIIA Retroperitoneal Sarcoma AJCC v8,0
3229,Solitary Skin Tumor,Extrahepatic Bile Duct Benign Granular Cell Tumor,0
3230,Epithelial hyperplasia of skin,Adenomatous hyperplasia,0
3231,Gastric dysplasia,Sporadic Diffuse Gastric Adenocarcinoma,0
3232,High Grade Lesion,Low Grade Broad Ligament Serous Adenocarcinoma,0
3233,Skin Erosion,Skin Abnormalities,0
3234,Fenestrated Pattern,"Ichthyosis, X-Linked",0
3235,Diffuse Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
3236,Solar Radiation Toxicity,Extragonadal Seminoma,0
3237,Solar Radiation Toxicity,Masaoka-Koga Stage II,0
3238,Cutaneous plaque,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0
3239,Fenestrated Pattern,Childhood Leiomyosarcoma,0
3240,Intersecting Sharply Marginated Clusters of Spindle Cells Present,large cell neuroendocrine carcinoma of breast,0
3241,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Non-Functioning Pituitary Gland Macroadenoma,0
3242,Increased megakaryocytes (bone marrow),Liver Lymphangioma,0
3243,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ampulla of Vater Adenosquamous Carcinoma,0
3244,Mediastinal mass,Mature Mediastinal Teratoma,0
3245,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIA Pancreatic Cancer AJCC v6 and v7,0
3246,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hemangioma of subcutaneous tissue,0
3247,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Esophageal Adenocarcinoma by AJCC v7 Stage,0
3248,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Familial medullary thyroid carcinoma,0
3249,Spindle Cell Metaplasia of Malignant Cells Present,Refractory Hairy Cell Leukemia,0
3250,Solid Growth Pattern,Unresectable Solid Neoplasm,0
3251,Mammary Gland Type Features Present,Recurrent Submandibular Gland Acinic Cell Carcinoma,0
3252,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucinous neoplasm,0
3253,Increased megakaryocytes (bone marrow),Gastric Cardia Adenocarcinoma,0
3254,Absence of Malignant Features,Benign phyllodes neoplasm of breast,0
3255,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8,0
3256,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pyriform Fossa Carcinoma,0
3257,Endometrial Type Glands and Stroma Present,Cerebellar and Fourth Ventricle Ependymal Tumor,0
3258,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Human Papillomavirus-Related Endocervical Adenocarcinoma,0
3259,Spindle Cell Osteo-Fibrous Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7,0
3260,Well Differentiated Lesion,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,0
3261,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,0
3262,Fenestrated Pattern,Advanced Sarcoma,0
3263,Increased megakaryocytes (bone marrow),Upper Gingival Verrucous Carcinoma,0
3264,Increased megakaryocytes (bone marrow),Acute Placental Infarction,0
3265,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma in situ of trachea,0
3266,Nodular lesions,Nodular Sclerosis Classical Hodgkin Lymphoma,0
3267,Fenestrated Pattern,Childhood Anaplastic Ependymoma,0
3268,Absence of Malignant Features,Benign neoplasm of ear,0
3269,Fenestrated Pattern,Juvenile Xanthogranuloma,0
3270,Fenestrated Pattern,Splenic diffuse red pulp small B-cell lymphoma,0
3271,No Evidence of Metastatic Disease,Metastatic Thyroid Gland Follicular Carcinoma,0
3272,Fenestrated Pattern,Stage IIIB Colorectal Cancer AJCC v8,0
3273,Increased megakaryocytes (bone marrow),Angioimmunoblastic T-cell lymphoma stage I,0
3274,NRBC - Nucleated red blood cell present result,Bladder transitional cell carcinoma stage III,0
3275,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Neoplasm of Uncertain Histogenesis,0
3276,Fenestrated Pattern,Gonadotroph adenoma,0
3277,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",0
3278,Spindle Cell Metaplasia of Malignant Cells Present,Infantile hemangioma of liver,0
3279,Exophytic Papillary Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0
3280,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Cowden-Associated Polyp,0
3281,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,EBV-Related Post-Transplant Lymphoproliferative Disorder,0
3282,Malignant Primitive Cellular Infiltrate,Refractory Malignant Solid Neoplasm,0
3283,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tracheal Lymphoma,0
3284,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 1 Cutaneous Follicular Lymphoma,0
3285,Increased megakaryocytes (bone marrow),Stage IIIB Primary Peritoneal Cancer AJCC v8,0
3286,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage II Hodgkin Lymphoma AJCC v8,0
3287,Fenestrated Pattern,"Pemphigoid, Benign Mucous Membrane",0
3288,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Clear cell adenoma,0
3289,Neutral Epithelial Mucin Present,Bronchial Epithelial Hyperplasia,0
3290,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Pharyngeal Neoplasm,0
3291,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lung Adenosquamous Carcinoma by AJCC v7 Stage,0
3292,Solar Radiation Toxicity,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,0
3293,Increased megakaryocytes (bone marrow),Pityriasis Lichenoides,0
3294,Fenestrated Pattern,Eccrine Poroma,0
3295,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus PEComa,0
3296,Monomorphic Cellular Infiltrate,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,0
3297,Recurrent Malignant Neoplasm,Malignant Aortic Neoplasm,0
3298,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA Ovarian Cancer,0
3299,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cholangiolocellular Carcinoma,0
3300,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of anus,0
3301,Spindle Cell Metaplasia of Malignant Cells Present,Bladder Urachal Squamous Cell Carcinoma,0
3302,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Primary Non-Hodgkin Lymphoma of Bone,0
3303,Spindle Cell Metaplasia of Malignant Cells Present,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7,0
3304,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IV Breast Cancer AJCC v6 and v7,0
3305,Increased megakaryocytes (bone marrow),Ann Arbor Stage IA Hodgkin Lymphoma,0
3306,Fenestrated Pattern,Flat Urothelial Hyperplasia,0
3307,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 1 Rectal Adenocarcinoma,0
3308,Solitary Skin Tumor,Ovarian Stromal-Leydig Cell Tumor,0
3309,Fenestrated Pattern,FIGO Stage IIIA1(ii) Ovarian Cancer,0
3310,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Undifferentiated Sarcoma, Not Otherwise Specified",0
3311,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hypocellular Myelodysplastic Syndrome,0
3312,Non-Encapsulated Neoplasm,Benign Ovarian Neoplasm,0
3313,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Primary Peritoneal Cancer AJCC v8,0
3314,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Esophageal Adenocarcinoma,0
3315,Solar Radiation Toxicity,Female Reproductive System Adenofibroma,0
3316,Absence of Malignant Features,large cell neuroendocrine carcinoma of gallbladder,0
3317,Clear Perinuclear Halo Present,Clear cell hidradenoma,0
3318,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Vascular neoplasm of skin,0
3319,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Virus-Related Sarcoma,0
3320,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cervical intraepithelial neoplasia grade 2,0
3321,Absence of Malignant Features,Malignant Childhood Neoplasm,0
3322,Diffuse Immunoblastic Proliferation,Stage III Adult Immunoblastic Lymphoma,0
3323,Florid Follicular Hyperplasia,Simple Endometrial Hyperplasia without Atypia,0
3324,Increased megakaryocytes (bone marrow),"Extra-adrenal paraganglioma, malignant",0
3325,Increased megakaryocytes (bone marrow),Childhood Lymphoma,0
3326,Increased megakaryocytes (bone marrow),Stage II Uterine Corpus Leiomyosarcoma AJCC v8,0
3327,Increased megakaryocytes (bone marrow),Primary peritoneal carcinoma,0
3328,Intermediate Grade Neuroendocrine Lesion,Sarcoma NCI Grade 1,0
3329,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Vulvar Cancer AJCC v8,0
3330,Endometrial Type Glands and Stroma Present,Stage IIB Fallopian Tube Cancer AJCC v6 and v7,0
3331,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
3332,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rectal Juvenile Polyp,0
3333,Immature Myeloid Cells Increased in Bone Marrow,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0
3334,Spindle Cell Metaplasia of Malignant Cells Present,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,0
3335,Fenestrated Pattern,Adult Leiomyosarcoma,0
3336,Fenestrated Pattern,Telangiectatic Glomangioma,0
3337,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Cerebellar Neoplasm,0
3338,Tumor Mass,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
3339,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7,0
3340,Fenestrated Pattern,Peritoneal mesothelioma malignant advanced,0
3341,Entrapped Respiratory Epithelium Present,Germinative Follicular Epithelium Neoplasm,0
3342,Absence of Malignant Features,keratinizing squamous cell carcinoma of nasal cavity,0
3343,Fenestrated Pattern,Stage III Childhood Burkitt Lymphoma,0
3344,Chronic Inflammatory Infiltrate,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0
3345,Increased megakaryocytes (bone marrow),Gallbladder adenoma,0
3346,Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach stage I,0
3347,Fenestrated Pattern,Stage 1 Neuroblastoma,0
3348,Plasma cell inflammation,"Basal cell carcinoma, micronodular",0
3349,Spindle Cell Metaplasia of Malignant Cells Present,Mixed Squamous Cell Carcinoma of the Penis,0
3350,Cystic Change,Ethmoid Sinus Adenoid Cystic Carcinoma,0
3351,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage,0
3352,Erythroid hyperplasia,Lymphoid hyperplasia,0
3353,Mixture of Embryonal and Alveolar Features Present,Childhood Ovarian Embryonal Carcinoma,0
3354,Recurrent Genetic Abnormalities Present,Recurrent Fallopian Tube Serous Adenocarcinoma,0
3355,Nodular and Diffuse Pattern,Stage III Bladder Cancer AJCC v6 and v7,0
3356,Exophytic Papillary Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0
3357,Spindle Cell Metaplasia of Malignant Cells Present,Stage IA Ampulla of Vater Cancer AJCC v8,0
3358,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Keratinizing Squamous Cell Carcinoma,0
3359,Solar Radiation Toxicity,Stage IIIB Anal Cancer AJCC v8,0
3360,Fenestrated Pattern,Medulloblastoma,0
3361,Fenestrated Pattern,Class 1a Uveal Melanoma,0
3362,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenosarcoma,0
3363,Absence of Malignant Features,intestinal type adenocarcinoma of gallbladder,0
3364,Moderately Differentiated Lesion,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,0
3365,Increased megakaryocytes (bone marrow),Adult Pineocytoma,0
3366,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVA Lip Cancer AJCC v6 and v7,0
3367,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage II Merkel Cell Carcinoma AJCC v7,0
3368,Spindle Cell Metaplasia of Malignant Cells Present,"Ovarian Small Cell Carcinoma, Pulmonary Type",0
3369,Osseous Metaplasia of Malignant Cells Present,Malignant Mesothelioma of Peritoneum,0
3370,Recurrent Malignant Neoplasm,Metastatic Malignant Solid Neoplasm,0
3371,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IB Ovarian Cancer AJCC v6 and v7,0
3372,Pleural effusion disorder,Pleural Monophasic Synovial Sarcoma,0
3373,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vestibular Papilloma,0
3374,Increased megakaryocytes (bone marrow),Stage IV Intrahepatic Bile Duct Cancer AJCC v8,0
3375,Follicular Differentiation,Ann Arbor Stage IV Grade 2 Follicular Lymphoma,0
3376,Melanoma Cells Present,Cutaneous Melanoma by AJCC v8 Stage,0
3377,Fenestrated Pattern,Stage IIIB Fallopian Tube Cancer AJCC v7,0
3378,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Central Nervous System Neoplasm,0
3379,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of gallbladder localized,0
3380,Nodular and Diffuse Pattern,Stage IIA Ovarian Cancer AJCC V6 and v7,0
3381,Endometrial Type Glands and Stroma Present,Ann Arbor Stage III Mature T- and NK-Cell Lymphoma,0
3382,Increased megakaryocytes (bone marrow),Stage 0is Penile Cancer AJCC v8,0
3383,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Penile Cancer AJCC v6,0
3384,Solar Radiation Toxicity,Solar lentigo,0
3385,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Apocrine Breast Carcinoma,0
3386,Nodular and Diffuse Pattern,BN2 Diffuse Large B-Cell Lymphoma,0
3387,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV adult soft tissue sarcoma,0
3388,Tumor Mass,Phyllodes Tumor,0
3389,Marked Thickening of the Bladder Urothelium Present,Bladder transitional cell carcinoma stage III,0
3390,Recurrent Genetic Abnormalities Present,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0
3391,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,0
3392,Increased megakaryocytes (bone marrow),Stage IV Burkitt Lymphoma,0
3393,Multihormonal Immunoreactivity Present in a Single Cell Type,Benign Childhood Germ Cell Tumor,0
3394,Absence of Malignant Features,Sarcoma of liver,0
3395,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Nonencapsulated sclerosing tumor,0
3396,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of esophagus,0
3397,Solitary Skin Tumor,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,0
3398,Fenestrated Pattern,Melanotic Schwannoma,0
3399,Solitary Skin Tumor,Keratocystic Odontogenic Tumor,0
3400,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung adenocarcinoma recurrent,0
3401,Fenestrated Pattern,Stage IV Rectal Cancer AJCC v7,0
3402,Multiple Tumor Masses,Hereditary Multiple Exostoses,0
3403,Increased megakaryocytes (bone marrow),Stage II Gallbladder Cancer AJCC v7,0
3404,Increased megakaryocytes (bone marrow),Benign Intraocular Teratoid Medulloepithelioma,0
3405,Intersecting Sharply Marginated Clusters of Spindle Cells Present,leiomyosarcoma of anus,0
3406,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Distal Urethral Carcinoma,0
3407,High Grade Non Cartilaginous Sarcomatous Stroma Present,Recurrent Grade II Lymphomatoid Granulomatosis,0
3408,Solitary Skin Tumor,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,0
3409,Absence of Malignant Features,Malignant Fibrous Histiocytoma,0
3410,Increased megakaryocytes (bone marrow),Ethmoid Sinus Adenocarcinoma,0
3411,Absence of Malignant Features,Secondary malignant neoplasm of anus,0
3412,Fenestrated Pattern,Stage IIB Osteosarcoma AJCC v7,0
3413,Solar Radiation Toxicity,Thymus Lipofibroadenoma,0
3414,Large Spaces Filled with Blood Present,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),0
3415,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
3416,Recurrent Malignant Neoplasm,Immunodeficiency-Related Malignant Neoplasm,0
3417,Non-Encapsulated Neoplasm,Childhood Pineal Parenchymal Cell Neoplasm,0
3418,Solar Radiation Toxicity,Nodal marginal zone B-cell lymphoma recurrent,0
3419,Follicular Differentiation,Follicular Bronchitis/Bronchiolitis,0
3420,Solar Radiation Toxicity,Somatostatinoma,0
3421,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pineal germinoma,0
3422,Immature Granulocytes in Peripheral Blood Increased,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",0
3423,Absence of Stromal Invasion,Gastrointestinal Stromal Tumor by AJCC v8 Stage,0
3424,Lesion with Diameter of 2cm or Less,Ovarian Dermoid Cyst with Angiosarcoma,0
3425,Solar Radiation Toxicity,Diencephalic Astrocytoma,0
3426,Large Spaces Filled with Blood Present,"Embryonal Tumor with Multilayered Rosettes, Not Otherwise Specified",0
3427,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Classic Hodgkin Lymphoma,0
3428,Fenestrated Pattern,Salivary gland carcinoma,0
3429,Increased megakaryocytes (bone marrow),Stage IVC Nasopharyngeal Carcinoma AJCC v7,0
3430,Nodular and Diffuse Pattern,Stage I Renal Pelvis and Ureter Cancer AJCC v8,0
3431,Questionable Invasive Lesion,Invasive Prostate Carcinoma,0
3432,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
3433,Aggressive Clinical Course,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
3434,Increased megakaryocytes (bone marrow),Resectable Digestive System Carcinoma,0
3435,Increased megakaryocytes (bone marrow),Childhood Meningeal Melanoma,0
3436,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tenosynovial giant cell tumor,0
3437,Solar Radiation Toxicity,AIDS-Related Enterocolitis,0
3438,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Colorectal Adenocarcinoma Metastatic in the Liver,0
3439,Fenestrated Pattern,Intra-Abdominal Paraganglioma,0
3440,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Lung Carcinoma,0
3441,Multihormonal Immunoreactivity Present in a Single Cell Type,Pyriform Fossa Squamous Cell Carcinoma,0
3442,Adnexal Differentiation,Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3443,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraductal Non-Comedo Breast Adenocarcinoma,0
3444,Fenestrated Pattern,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified",0
3445,Fenestrated Pattern,Stage I Uterine Corpus Cancer,0
3446,Solar Radiation Toxicity,Adult Ganglioglioma,0
3447,Immature Myeloid Cells Increased in Bone Marrow,Stage IVB Bone Cancer AJCC v8,0
3448,Mammary Gland Type Features Present,Intermediate Cell Type Iris Melanoma,0
3449,Solar Radiation Toxicity,Melanoacanthoma,0
3450,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,sialadenoma papilliferum of salivary gland,0
3451,Fenestrated Pattern,Vertebral chordoma,0
3452,High Grade Non Cartilaginous Sarcomatous Stroma Present,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",0
3453,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Soft Tissue Tumor of Uncertain Differentiation,0
3454,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chronic rejection of renal transplant,0
3455,Prominent Elastic Tissue Cores Present,Refractory Soft Tissue Sarcoma,0
3456,Solitary Skin Tumor,Hyperparathyroidism-Jaw Tumor Syndrome,0
3457,Increased megakaryocytes (bone marrow),Ependymoblastoma,0
3458,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Papillomatosis,0
3459,Fenestrated Pattern,Stage IIB Eyelid Carcinoma AJCC v8,0
3460,Proliferation of Small Ducts Present,Stage III Small Intestinal Adenocarcinoma AJCC v8,0
3461,Increased megakaryocytes (bone marrow),Periampullary Adenocarcinoma,0
3462,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,sarcoma of tongue,0
3463,Solar Radiation Toxicity,Hemangioendothelioma,0
3464,Metastatic/Recurrent Disease,Multi-centric Castleman's Disease,0
3465,Large Spaces Filled with Blood Present,MCD Diffuse Large B-Cell Lymphoma,0
3466,Immature Myeloid Cells Increased in Bone Marrow,Carcinoma in situ in a polyp,0
3467,Fenestrated Pattern,Angioimmunoblastic Lymphadenopathy,0
3468,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus Sarcoma,0
3469,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Urothelial Carcinoma,0
3470,Fenestrated Pattern,Stage IIIA Appendix Carcinoma AJCC v7,0
3471,Increased megakaryocytes (bone marrow),Broad Ligament Serous Adenocarcinoma,0
3472,Multihormonal Immunoreactivity Present in a Single Cell Type,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant",0
3473,Increased megakaryocytes (bone marrow),Thymic Lymphoma,0
3474,Increased megakaryocytes (bone marrow),Stage II Distal Bile Duct Cancer AJCC v8,0
3475,Intraepithelial Neoplasia,Colorectal Low Grade Intraepithelial Neoplasia,0
3476,Increased megakaryocytes (bone marrow),Central Nervous System Chondroma,0
3477,Recurrent Malignant Neoplasm,Childhood Malignant Liver Neoplasm,0
3478,Increased megakaryocytes (bone marrow),Pilosebaceous Hamartoma,0
3479,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Parotid Gland Sarcoma,0
3480,Metaplasia of Malignant Cells Present,Malignant neoplasm of acoustic nerve,0
3481,Solar Radiation Toxicity,Desmoplastic trichilemmoma,0
3482,Fenestrated Pattern,Appendix Sessile Serrated Adenoma/Polyp,0
3483,Absence of Malignant Features,Cystadenofibroma of fallopian tube,0
3484,Nodular lesions,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3485,Neoplastic Plasma Cells Present in Bone Marrow,"Urinary bladder carcinoma stage I, with cancer in situ",0
3486,Carcinomatous Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
3487,Multinodular Mass,Uterine Angiosarcoma,1
3488,Thyroglobulin Positive Neoplastic Cells Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
3489,Vascular Channel Formation,Hemangioma of skin,1
3490,Pseudoencapsulated Mass,"Perineurioma, malignant",1
3491,Malignant Cellular Infiltrate,Exocervical Carcinoma,1
3492,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
3493,Malignant Cellular Infiltrate,Stage 0a Ureter Cancer AJCC v8,1
3494,No Evidence of Metastatic Disease,Benign pheochromocytoma of adrenal gland,1
3495,Intestinal metaplasia,Gastric Intestinal-Type Adenocarcinoma,1
3496,Carcinomatous Component Present,Adenocarcinoma with neuroendocrine differentiation,1
3497,Malignant Cellular Infiltrate,"Lymphoma, Follicular, Grade 1",1
3498,Indolent Clinical Course,Lipoma of axilla,1
3499,Malignant Cellular Infiltrate,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
3500,Malignant Cellular Infiltrate,Periampullary Adenocarcinoma,1
3501,Carcinomatous Component Present,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
3502,Malignant Cellular Infiltrate,Solid carcinoma,1
3503,Well-Circumscribed Lesion,Appendix Villous Adenoma,1
3504,Malignant Cellular Infiltrate,Stage I Carcinoma of Bladder,1
3505,Metastatic Lesion,Metastatic Bone Ewing Sarcoma,1
3506,Immunosuppression-Related Post-Transplant Toxicity,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
3507,Epithelial Component Present,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
3508,Glandular Pattern,Nipple Syringomatous Adenoma,1
3509,Pushing Tumor Margin,Verrucous carcinoma of the oral cavity recurrent,1
3510,Carcinomatous Component Present,Posterior Tongue Mucoepidermoid Carcinoma,1
3511,Childhood Lesion,Childhood Ovarian Teratoma,1
3512,Benign Cellular Infiltrate,Thyroid Gland Lipoadenoma,1
3513,Epithelial Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
3514,Malignant Cellular Infiltrate,"Gallbladder Adenocarcinoma, Biliary Type",1
3515,Malignant Cellular Infiltrate,Recurrent Hepatosplenic T-Cell Lymphoma,1
3516,Anaplasia,Childhood Giant Cell Glioblastoma,1
3517,Regional Disease,Locally Advanced Small Intestinal Carcinoma,1
3518,Tubular Pattern,Ampulla of Vater Tubulovillous Adenoma,1
3519,Malignant Cellular Infiltrate,Adult Favorable Prognosis Hodgkin Lymphoma,1
3520,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v8,1
3521,Cartilaginous Differentiation,Bizarre parosteal osteochondromatous proliferation,1
3522,Indolent Clinical Course,Pyogenic granuloma of skin and subcutaneous tissue,1
3523,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage III,1
3524,Cystic Change,Bile duct cystadenocarcinoma,1
3525,Malignant Cellular Infiltrate,Stage IB Lung Adenosquamous Carcinoma AJCC v7,1
3526,Metastatic Lesion,Metastatic Salivary Gland Carcinoma,1
3527,Stromal Invasion,serous surface papillary carcinoma of ovary,1
3528,Malignant Cellular Infiltrate,Locally Advanced Prostate Carcinoma,1
3529,Cystic Change,Brenner Tumor,1
3530,Mesenchymal Component Present,Phyllodes Tumor,1
3531,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
3532,Favorable Clinical Outcome,Cutaneous Mastocytosis,1
3533,Intermediate Filaments Present,Recurrent Atypical Teratoid/Rhabdoid Tumor,1
3534,Recurrent disease,Recurrent Salivary Duct Carcinoma,1
3535,Carcinomatous Component Present,Localized Gallbladder Carcinoma,1
3536,Carcinomatous Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
3537,Malignant Cellular Infiltrate,Squamous Cell Carcinoma In Situ of the Nipple,1
3538,Alternative Fascicle (Bundle) Pattern,Bladder Leiomyoma,1
3539,Carcinomatous Component Present,Stage I Prostate Cancer AJCC v7,1
3540,Polymorphic Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
3541,Benign Cellular Infiltrate,Benign neoplasm of esophagus,1
3542,Cystic Change,Hidrocystoma,1
3543,Malignant Cellular Infiltrate,Metastatic Unresectable Basal Cell Carcinoma,1
3544,Biphasic Pattern,Uterine Corpus Adenofibroma,1
3545,Invasive Lesion,Metastatic Signet Ring Cell Breast Carcinoma,1
3546,Diffuse Pattern,Stage III Diffuse Large B-Cell Lymphoma,1
3547,Poorly Differentiated Neuroendocrine Lesion,Anal Canal Small Cell Neuroendocrine Carcinoma,1
3548,Sebaceous Differentiation,Extraocular Cutaneous Sebaceous Carcinoma,1
3549,Malignant Cellular Infiltrate,Glycogen-rich carcinoma,1
3550,Primary Lesion,Childhood Alveolar Rhabdomyosarcoma,1
3551,Low Mitotic Activity,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
3552,Epithelial Component Present,Grade 2 Rectal Adenocarcinoma,1
3553,Malignant Cellular Infiltrate,Malignant Breast Adenomyoepithelioma,1
3554,Malignant Cellular Infiltrate,Hereditary Kidney Wilms Tumor,1
3555,Malignant Cellular Infiltrate,Colon Mantle Cell Lymphoma,1
3556,Local disease,Localized Lymphoma,1
3557,Cutaneous plaque,Infiltrating basal cell carcinoma,1
3558,Carcinomatous Component Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,1
3559,Metastatic Lesion,Metastatic Bladder Small Cell Carcinoma,1
3560,Aggressive Clinical Course,"Leukemia, Mast-Cell",1
3561,Epithelial Component Present,Invasive papillary breast carcinoma,1
3562,Cavernous Vascular Space Formation,Intracranial cavernous hemangioma,1
3563,Carcinomatous Component Present,Bladder transitional cell carcinoma stage IV,1
3564,Geographic Necrosis,Extragonadal primary embryonal carcinoma,1
3565,Epithelial Component Present,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,1
3566,Low Mitotic Activity,Small Intestinal Neuroendocrine Tumor G2,1
3567,Malignant Cellular Infiltrate,Refractory Childhood Hodgkin Lymphoma,1
3568,Malignant Cellular Infiltrate,Recurrent Ovarian Clear Cell Adenocarcinoma,1
3569,Carcinomatous Component Present,Hepatitis B Virus-Related Hepatocellular Carcinoma,1
3570,High Grade Lesion,rhabdomyosarcoma of liver,1
3571,Malignant Cellular Infiltrate,Recurrent tumors of the Ewing's family,1
3572,Indolent Clinical Course,Cranial Nodular Fasciitis,1
3573,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1,1
3574,Glial Differentiation,Adult Brain Stem Gliosarcoma,1
3575,Epithelial Component Present,Anatomic Stage II Breast Cancer AJCC v8,1
3576,CD1a-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
3577,Epithelial Component Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
3578,Locally Aggressive Lesion,Kaposiform Hemangioendothelioma,1
3579,Epithelial Component Present,Esophageal High Grade Intraepithelial Neoplasia,1
3580,Epithelial Component Present,Stage IVB Laryngeal Cancer AJCC v7,1
3581,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
3582,Indolent Clinical Course,Lung Myolipoma,1
3583,Malignant Cellular Infiltrate,Stage IIIC Breast Cancer AJCC v7,1
3584,Epithelial Component Present,tubular adenoma of gallbladder,1
3585,Recurrent disease,Recurrent Paranasal Sinus Squamous Cell Carcinoma,1
3586,Epithelial Component Present,Breast Carcinoma with Osseous Metaplasia,1
3587,Malignant Cellular Infiltrate,Stage I Urethral Cancer AJCC v8,1
3588,Carcinomatous Component Present,Vulvar Cancer by AJCC v7 Stage,1
3589,Epithelial Component Present,Extra-Adrenal Retroperitoneal Paraganglioma,1
3590,Malignant Cellular Infiltrate,mucinous adenocarcinoma of lung,1
3591,Malignant Cellular Infiltrate,Stage IIIB Esophageal Adenocarcinoma AJCC v7,1
3592,Malignant Cellular Infiltrate,Malignant neoplasm of larynx,1
3593,Childhood Lesion,Mixed epithelial-mesenchymal hepatoblastoma,1
3594,Mitotic Activity,Testicular yolk sac tumor stage I,1
3595,Mixed Cellular Population,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
3596,Malignant Cellular Infiltrate,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
3597,Malignant Cellular Infiltrate,Uveal Melanoma Metastatic in the Liver,1
3598,Malignant Cellular Infiltrate,Rectal Micropapillary Adenocarcinoma,1
3599,Increased Cellularity Present,Stage 2A Neuroblastoma,1
3600,Epithelial Component Present,Ampulla of Vater Tubular Adenoma,1
3601,Epithelial Component Present,Papillary Lung Adenocarcinoma,1
3602,Benign Cellular Infiltrate,Benign Cervical Soft Tissue Neoplasm,1
3603,Necrotic changes (finding),Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
3604,Malignant Cellular Infiltrate,Diffuse Intrinsic Pontine Glioma,1
3605,Indolent Clinical Course,Benign vascular neoplasm,1
3606,Epithelial Component Present,Hidrocystoma,1
3607,Malignant Cellular Infiltrate,Locally Advanced Digestive System Carcinoma,1
3608,Epithelial Component Present,Type 1 Papillary Renal Cell Carcinoma,1
3609,Anaplasia,"Transitional cell carcinoma, spindle cell",1
3610,Carcinomatous Component Present,Metastatic Oral Cavity Squamous Cell Carcinoma,1
3611,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
3612,Superficial Lesion,Peyronie Disease,1
3613,Recurrent disease,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
3614,Malignant Cellular Infiltrate,Stage IV Breast Cancer AJCC v6 and v7,1
3615,Epithelial Component Present,Stage IIC Fallopian Tube Cancer AJCC v6 and v7,1
3616,Histiocytosis haematophagic,Secondary haemophagocytic lymphohistiocytosis,1
3617,Cutaneous Involvement,Benign Eccrine Neoplasm,1
3618,Carcinomatous Component Present,Periampullary Adenocarcinoma,1
3619,Cartilaginous Differentiation,Secondary Central Chondrosarcoma,1
3620,Malignant Cellular Infiltrate,Prostate Carcinoma Metastatic in the Soft Tissue,1
3621,Anaplasia,Anaplastic Brain Stem Glioma,1
3622,Epithelial Component Present,Vaginal Carcinosarcoma,1
3623,Carcinomatous Component Present,Alcohol-Related Hepatocellular Carcinoma,1
3624,Malignant Cellular Infiltrate,Primary Pulmonary Diffuse Large B-Cell Lymphoma,1
3625,Epithelial Component Present,Stage IV Esophagus Carcinoma,1
3626,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
3627,Exophytic Papillary Lesion,verrucous carcinoma of vagina,1
3628,Neuroectodermal Differentiation,Regional Neuroblastoma,1
3629,Absence of Stromal Invasion,Serous Endometrial Intraepithelial Carcinoma,1
3630,Malignant Cellular Infiltrate,Metastatic Malignant Genitourinary System Neoplasm,1
3631,Metastatic Lesion,Locally Advanced Squamous Cell Carcinoma,1
3632,Biphasic Pattern,Malignant phyllodes tumor of breast,1
3633,Polyvesicular Vitelline Pattern,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
3634,Epithelial Component Present,"Carcinoma, Ovarian Epithelial",1
3635,Unifocal Disease at Presentation,Extracutaneous Mastocytoma,1
3636,Epithelial Component Present,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
3637,Chromogranin A Positive Neoplastic Cells Present,Jejunal Neuroendocrine Tumor G1,1
3638,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia,1
3639,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v6,1
3640,Secondary Lesion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
3641,Carcinomatous Component Present,Solid Lung Adenocarcinoma,1
3642,Malignant Cellular Infiltrate,Dedifferentiated Solitary Fibrous Tumor,1
3643,Birbeck Granules Present,Thyroid Gland Langerhans Cell Histiocytosis,1
3644,Epithelial Component Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
3645,Local disease,Lipoma of spinal cord,1
3646,Malignant Cellular Infiltrate,"Anaplastic Astrocytoma, IDH-Mutant",1
3647,Epithelial Component Present,Stage I Carcinoma of Bladder,1
3648,Carcinomatous Component Present,Cystic basal cell carcinoma,1
3649,Cutaneous Involvement,Ichthyosis Vulgaris,1
3650,Childhood Lesion,Childhood Lymphoma,1
3651,Mesenchymal Component Present,Malignant Cystosarcoma Phyllodes,1
3652,Infantile Lesion,Infant Leukemia,1
3653,Exophytic Polypoid Lesion,Ampulla of Vater Tubulovillous Adenoma,1
3654,Encapsulated Mass,Thyroid Gland Black Follicular Adenoma,1
3655,Epithelial Component Present,Mixed Somatotroph and Lactotroph Adenoma,1
3656,Polymorphic Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
3657,Carcinomatous Component Present,Stage III Liver Cancer,1
3658,Indolent Clinical Course,Lipomatosis of Nerve,1
3659,Intraductal Lesion,Biliary papillomatosis,1
3660,Secondary Lesion,Chondrosarcoma metastatic,1
3661,Carcinomatous Component Present,Endometrioid adenocarcinoma recurrent,1
3662,Dysplasia,Appendix High Grade Intraepithelial Neoplasia,1
3663,Epithelial Component Present,Metastatic Fibrolamellar Carcinoma,1
3664,Adulthood Lesion,Adult Solid Neoplasm,1
3665,Cystic Change,"Cystadenoma, Serous",1
3666,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage III,1
3667,Tubular Pattern,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
3668,Carcinomatous Component Present,Recurrent Hepatocellular Carcinoma,1
3669,Nodular Pattern,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,1
3670,Follicular Cell Differentiation,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
3671,Malignant Cellular Infiltrate,Stage IVA Hepatocellular Carcinoma AJCC v7,1
3672,Adulthood Lesion,Lugano Classification Limited Stage Adult Lymphoma AJCC v8,1
3673,Childhood Lesion,Childhood Acute Basophilic Leukemia,1
3674,Malignant Cellular Infiltrate,squamous cell carcinoma of renal pelvis,1
3675,Low Mitotic Activity,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
3676,High Grade Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma,1
3677,Carcinomatous Component Present,Synchronous Bilateral Breast Carcinoma,1
3678,Splenomegaly,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
3679,Metastatic Lesion,Metastatic Prostate Small Cell Carcinoma,1
3680,Malignant Cellular Infiltrate,Angiosarcoma of spleen,1
3681,CD30-Positive Neoplastic Cells Present,Adult Systemic Anaplastic Large Cell Lymphoma,1
3682,Well-Circumscribed Lesion,Clear Cell Adrenal Cortical Adenoma,1
3683,Metastatic Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
3684,Dermal Involvement,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
3685,Epithelial Component Present,Clear Cell Hepatocellular Carcinoma,1
3686,Extensive Stage Lesion,Advanced Digestive System Carcinoma,1
3687,Carcinomatous Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
3688,Malignant Cellular Infiltrate,Subglottic Squamous Cell Carcinoma,1
3689,Exophytic Polypoid Lesion,tubular adenoma of gallbladder,1
3690,Carcinomatous Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage,1
3691,Childhood Lesion,Childhood Ovarian Teratoma,1
3692,Monomorphic Cellular Infiltrate,Pineal parenchymal tumor of intermediate differentiation,1
3693,Secondary Lesion,Skin squamous cell carcinoma metastatic,1
3694,Carcinomatous Component Present,Squamous cell carcinoma of conjunctiva,1
3695,Indolent Clinical Course,Cavernous Angioleiomyoma,1
3696,Immunologic Deficiency Syndromes,AIDS-Related Lymphoblastic Lymphoma,1
3697,Benign Cellular Infiltrate,Infantile hemangioma,1
3698,Regional Disease,Locally Advanced Salivary Gland Carcinoma,1
3699,Epithelial Component Present,Adenoma of Minor Vestibular Glands,1
3700,Bilateral Mass,Contralateral Breast Carcinoma,1
3701,Malignant Cellular Infiltrate,Iris Spindle Cell Melanoma,1
3702,Well-Circumscribed Lesion,Epididymal Papillary Cystadenoma,1
3703,Vascular Channel Formation,Endovascular papillary angioendothelioma,1
3704,Malignant Cellular Infiltrate,Stage IIIB Anal Cancer AJCC v8,1
3705,Carcinomatous Component Present,Adenocarcinoma in multiple adenomatous polyps,1
3706,Epithelial Component Present,Alcohol-Related Carcinoma,1
3707,Bone marrow reticulin fibrosis,Progressive Hairy Cell Leukemia Initial Treatment,1
3708,High Mitotic Activity,small cell carcinoma of breast,1
3709,Carcinomatous Component Present,Solid Lung Adenocarcinoma,1
3710,Malignant Cellular Infiltrate,Stage IV Merkel Cell Carcinoma AJCC v7,1
3711,Recurrent disease,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,1
3712,Increased Cellularity Present,Stage 1 Neuroblastoma,1
3713,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Bone,1
3714,Peripheral Nuclear Palisading,Basaloid squamous cell carcinoma,1
3715,Carcinomatous Component Present,Pathologic Stage IB Gastric Cancer AJCC v8,1
3716,Malignant Cellular Infiltrate,Pericardial mesothelioma malignant advanced,1
3717,Non-Hereditary Lesion,Signet-ring cell adenocarcinoma gastric,1
3718,Carcinomatous Component Present,Renal Pelvis and Ureter Cancer by AJCC v8 Stage,1
3719,Neuroendocrine Differentiation,"Carcinoma, Neuroendocrine",1
3720,Neuroectodermal Differentiation,"Neuroectodermal Tumor, Melanotic",1
3721,Malignant Cellular Infiltrate,Undifferentiated spindle cell sarcoma,1
3722,Mixed Cellular Population,carcinosarcoma of liver,1
3723,Neuroectodermal Differentiation,malignant ganglioneuroblastoma of adrenal gland,1
3724,Neuropil Present,Differentiating Neuroblastoma,1
3725,Firm mass,Glandular malignant peripheral nerve sheath tumor,1
3726,Malignant Cellular Infiltrate,Breast Lymphoma,1
3727,Epithelial Component Present,insulinoma,1
3728,Malignant Cellular Infiltrate,Malignant neoplasm of hypopharynx recurrent,1
3729,Recurrent Lymphoma,EBV-Related Hodgkin Lymphoma,1
3730,Follicular Structures Present,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,1
3731,Clinical TNM Finding,Gastric Cancer by AJCC v8 Clinical Stage,1
3732,Benign Cellular Infiltrate,Benign neoplasm of chest wall,1
3733,Malignant Cellular Infiltrate,Cutaneous Mature B-Cell Neoplasm,1
3734,Primary Lesion,Recurrent Cutaneous Melanoma of the Extremity,1
3735,Secondary Lesion,Colorectal Carcinoma Metastatic in the Liver,1
3736,Primary Lesion,Metastatic Fibrolamellar Carcinoma,1
3737,Carcinomatous Component Present,Urethral Carcinoma,1
3738,Neuroendocrine Differentiation,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
3739,Adulthood Lesion,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage,1
3740,Childhood Lesion,Childhood Central Nervous System Germ Cell Tumor,1
3741,Childhood Lesion,Childhood Acute Basophilic Leukemia,1
3742,Diffuse Pattern,Glioblastoma,1
3743,Epithelial Component Present,Well Differentiated Hepatocellular Carcinoma,1
3744,Hemorrhagic,Gallbladder Angiosarcoma,1
3745,Malignant Cellular Infiltrate,Burkitt-like lymphoma with 11q aberration,1
3746,Carcinomatous Component Present,"Endocervical Adenocarcinoma, Usual Type",1
3747,Adulthood Lesion,Adult Classical Hodgkin Lymphoma,1
3748,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Aleukemic Monocytic Leukemia Cutis,1
3749,Childhood Lesion,Childhood Leukemia,1
3750,Serrated Glandular Architecture,Rectal Serrated Adenocarcinoma,1
3751,Carcinomatous Component Present,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
3752,Stromal Invasion,Stage IIA Ovarian Cancer AJCC V6 and v7,1
3753,Slow Growing Mass,Adult Subependymoma,1
3754,Epithelial Component Present,Early Hepatocellular Carcinoma,1
3755,Neuroendocrine Differentiation,Unresectable Carcinoid Tumor,1
3756,Childhood Lesion,Childhood Thyroid Gland Follicular Carcinoma,1
3757,Erythema,Inflammatory carcinoma of breast stage III,1
3758,Endophytic Tumor Growth,Plantar Verrucous Skin Carcinoma,1
3759,Malignant Cellular Infiltrate,Duodenal Extraskeletal Osteosarcoma,1
3760,Malignant Cellular Infiltrate,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
3761,Benign Cellular Infiltrate,Benign bone neoplasm,1
3762,Primary Lesion,Multinodular and Vacuolated Tumor of the Cerebrum,1
3763,Epithelial Component Present,Stage IIB Esophageal Carcinoma,1
3764,Nerve palsy,Facial Nerve Palsy Related to Trauma,1
3765,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Neuroendocrine Carcinoma,1
3766,Secondary Lesion,Colon Carcinoma Metastatic in the Lung,1
3767,Malignant Cellular Infiltrate,Recurrent Parotid Gland Adenoid Cystic Carcinoma,1
3768,Absence of Invasion,Carcinoma in situ of trachea,1
3769,Progressive Disease,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas",1
3770,atypia morphology,Borderline Ovarian Serous Adenofibroma,1
3771,Carcinomatous Component Present,Nodulo-ulcerative basal cell carcinoma,1
3772,Epithelial Component Present,High-Grade Prostatic Intraepithelial Neoplasia,1
3773,Secondary Lesion,Lung Carcinoma Metastatic in the Liver,1
3774,Severe cytologic atypia,Esophageal Neuroendocrine Carcinoma,1
3775,Malignant Cellular Infiltrate,Metastatic Cervical Carcinoma,1
3776,Absence of Stromal Invasion,Borderline Ovarian Mucinous Adenofibroma,1
3777,Secondary Lesion,Metastatic Lung Neuroendocrine Neoplasm,1
3778,Epithelial Component Present,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
3779,Sarcomatous Component Present,Recurrent Uterine Corpus Carcinosarcoma,1
3780,Malignant Cellular Infiltrate,Pancreatic Cancer by AJCC v6 and v7 Stage,1
3781,Carcinomatous Component Present,Stage IIIA Rectal Cancer AJCC v7,1
3782,Benign Cellular Infiltrate,Digestive System Hemangioma,1
3783,Malignant Cellular Infiltrate,Squamous cell carcinoma of the nasal cavity,1
3784,Carcinomatous Component Present,Serous cystadenocarcinoma ovary,1
3785,Dysplasia,adenoma of intrahepatic bile duct,1
3786,Epithelial Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
3787,Primary Lesion,Primary Carcinoma,1
3788,Well-Circumscribed Lesion,Epididymal Papillary Cystadenoma,1
3789,Benign Cellular Infiltrate,Rectal Lipoma,1
3790,Exophytic Polypoid Lesion,Adenomatous Polyps,1
3791,Malignant Cellular Infiltrate,Sacral Chordoma,1
3792,Diffuse Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,1
3793,Monomorphic Cellular Infiltrate,Ependymoma of brain stem,1
3794,Malignant Cellular Infiltrate,Cytogenetically normal acute myeloid leukemia,1
3795,Epithelial Component Present,Parathyroid Gland Lipoadenoma,1
3796,Malignant Cellular Infiltrate,Resectable Malignant Neoplasm,1
3797,Epithelial Component Present,Cholangiocarcinoma metastatic,1
3798,Benign Cellular Infiltrate,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",1
3799,Follicular Structures Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
3800,Syncytial Pattern,Oropharyngeal lymphoepithelioma stage III,1
3801,Mucinous degeneration,Protoplasmic astrocytoma,1
3802,Epithelial Component Present,Endocervical polyp,1
3803,Malignant Cellular Infiltrate,Recurrent Salivary Gland Cancer,1
3804,Multihormonal Immunoreactivity Present in Two or More Cell Types,Plurimorphous Plurihormonal Pituitary Gland Adenoma,1
3805,Recurrent disease,Recurrent Adult Brain Neoplasm,1
3806,Malignant Cellular Infiltrate,Stage IIA Lung Cancer AJCC v8,1
3807,Recurrent disease,Larynx carcinoma recurrent,1
3808,Adulthood Lesion,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
3809,Malignant Cellular Infiltrate,Kaposi's sarcoma of lung,1
3810,Secondary Lesion,Squamous Cell Carcinoma of Unknown Primary,1
3811,Papillary Pattern,serous surface papillary carcinoma of ovary,1
3812,Local disease,Fallopian Tube Adenomatoid Tumor,1
3813,Malignant Cellular Infiltrate,DS Stage II Plasma Cell Myeloma,1
3814,Benign Cellular Infiltrate,Breast Myofibroblastoma,1
3815,Benign Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
3816,Refractory Disease,Refractory Mediastinal Lymphoma,1
3817,Carcinomatous Component Present,Vaginal Non-Keratinizing Squamous Cell Carcinoma,1
3818,Epithelial Component Present,Basal Cell Neoplasm,1
3819,Carcinomatous Component Present,Trichilemmocarcinoma,1
3820,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage III,1
3821,Malignant Cellular Infiltrate,Medulloblastoma with Leptomeningeal Spread,1
3822,Recurrent disease,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
3823,Epithelial Component Present,Esophageal Cancer by AJCC v8 Stage,1
3824,Childhood Lesion,Hydroa vacciniforme-like lymphoma,1
3825,Tubular Structures Present,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",1
3826,Malignant Cellular Infiltrate,Malignant neoplasm of lung,1
3827,Epithelial Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
3828,Epithelial Component Present,Stage III Oropharyngeal Carcinoma AJCC v6,1
3829,Epithelial Component Present,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
3830,Epithelial Component Present,Penis carcinoma,1
3831,Epithelial Component Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
3832,Carcinomatous Component Present,Sarcomatoid Hepatocellular Carcinoma,1
3833,Malignant Cellular Infiltrate,Stage IIA Ovarian Cancer AJCC V6 and v7,1
3834,Carcinomatous Component Present,Stage IVA Major Salivary Gland Cancer AJCC v8,1
3835,Malignant Cellular Infiltrate,Invasive carcinoma of breast,1
3836,Mild cytologic atypia,Pancreatic Intraepithelial Neoplasia-1A,1
3837,Carcinomatous Component Present,papillary squamous cell carcinoma of larynx,1
3838,Infiltrative Growth Pattern,Fibromatosis,1
3839,Fever,Sinus histiocytosis,1
3840,Malignant Cellular Infiltrate,Hereditary Kidney Wilms Tumor,1
3841,Stromal Invasion,Hereditary Ovarian Carcinoma,1
3842,Mitotic Activity,Anaplastic Diencephalic Astrocytoma,1
3843,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v7,1
3844,Epithelial Component Present,Stage IVA Oropharyngeal Carcinoma AJCC v7,1
3845,Malignant Cellular Infiltrate,Refractory Malignant Female Reproductive System Neoplasm,1
3846,Epithelial Component Present,Metastatic Adenoid Cystic Carcinoma,1
3847,Invasive Lesion,"Dermatofibrosarcoma Protuberans, Myxoid",1
3848,Epithelial Component Present,"Gallbladder Adenocarcinoma, Biliary Type",1
3849,Carcinomatous Component Present,carcinoma of gingiva,1
3850,Diffuse Pattern,Pleural Desmoplastic Mesothelioma,1
3851,Neoplastic Promonocytes in Bone Marrow Markedly Increased,M5b Acute differentiated monocytic leukemia,1
3852,Carcinomatous Component Present,Non-Small Cell Lung Carcinoma,1
3853,Local disease,Cardiac Lipoma,1
3854,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v8,1
3855,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v8,1
3856,Epithelial Component Present,Renal Cell Cancer by AJCC v6 Stage,1
3857,Polymorphic Cellular Infiltrate,Letterer-Siwe Disease,1
3858,Epithelial Component Present,Recurrent Carcinoma of Unknown Primary,1
3859,Carcinomatous Component Present,Metastatic Colorectal Carcinoma,1
3860,Pregnancy Complications,Placental Non-Neoplastic Disorder,1
3861,Secondary Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,1
3862,Epithelial Component Present,Hard Palate Adenoid Cystic Carcinoma,1
3863,Indolent Clinical Course,Uterine Corpus Epithelioid Leiomyoma,1
3864,Malignant Cellular Infiltrate,Sezary Syndrome,1
3865,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
3866,Mucoid Stroma Formation,Thyroid Gland Mucinous Follicular Adenoma,1
3867,Epithelial Component Present,Small intestine adenocarcinoma metastatic NOS,1
3868,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v8 Stage,1
3869,Refractory Disease,Refractory Neuroblastoma,1
3870,Increased Cellularity Present,Cellular Schwannoma,1
3871,Carcinomatous Component Present,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
3872,Epithelial Component Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
3873,Poorly Differentiated Lesion,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
3874,Indolent Clinical Course,Ossifying Fibroma,1
3875,Refractory Disease,Acute myeloid leukemia refractory,1
3876,Carcinomatous Component Present,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
3877,Malignant Cellular Infiltrate,Metastatic Bladder Small Cell Carcinoma,1
3878,Microvascular Proliferation,Recurrent Gliosarcoma,1
3879,Villous Pattern,Colorectal Villous Adenoma,1
3880,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
3881,Benign Cellular Infiltrate,Benign neoplasm of extrahepatic bile ducts,1
3882,Secondary Lesion,stage IV pancreatic cancer,1
3883,Bone marrow reticulin fibrosis,Hairy Cell Leukemia,1
3884,Papillary Pattern,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
3885,Cutaneous Involvement,Carcinoma of apocrine gland,1
3886,Epithelial Component Present,Stage IIIA Gastric Carcinoma,1
3887,Epithelial Component Present,"Mucinous adenocarcinoma, endocervical type",1
3888,Malignant Cellular Infiltrate,Thyroid Immunoblastic Lymphoma,1
3889,Adnexal Differentiation,Hair Follicle Neoplasm,1
3890,Absence of Invasion,Stage 0 Lip Carcinoma,1
3891,Malignant Cellular Infiltrate,Stage III Pancreatic Cancer AJCC v6 and v7,1
3892,Pseudopapillary Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
3893,Epithelial Component Present,malignant myoepithelioma of breast,1
3894,Immunologic Deficiency Syndromes,Burkitt lymphoma associated with AIDS,1
3895,Malignant Cellular Infiltrate,Childhood Extragonadal Malignant Germ Cell Tumor,1
3896,Exophytic Papillary Lesion,Cervical Squamotransitional Carcinoma,1
3897,Malignant Cellular Infiltrate,Cutaneous Follicular Lymphoma,1
3898,Locally Aggressive Lesion,"Gastrointestinal stromal tumor, uncertain malignant potential",1
3899,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
3900,Well-Circumscribed Lesion,Multiple adenomatous polyps,1
3901,Epithelial Component Present,Malignant Pancreatic Insulinoma,1
3902,Hypercellular bone marrow,"Myeloid Leukemia, Chronic",1
3903,Malignant Cellular Infiltrate,Ureter Lymphoma,1
3904,Carcinomatous Component Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,1
3905,Epithelial Component Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma,1
3906,Malignant Cellular Infiltrate,Sublingual Gland Adenocarcinoma,1
3907,Malignant Cellular Infiltrate,adenosquamous carcinoma of pancreas,1
3908,Carcinomatous Component Present,Cervical Squamous Cell Carcinoma,1
3909,Stromal Invasion,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
3910,Tissue Differentiation Uncertain,Alveolar soft part sarcoma metastatic,1
3911,Adulthood Lesion,Stage III Adult Burkitt Lymphoma,1
3912,Malignant Cellular Infiltrate,Childhood T Acute Lymphoblastic Leukemia,1
3913,Fibrotic Stroma Formation,mucoepidermoid carcinoma of lung,1
3914,Hereditary Lesion,Familial Nonmedullary Thyroid Gland Carcinoma,1
3915,Malignant Cellular Infiltrate,Malignant Testicular Sex Cord-Stromal Tumor,1
3916,Carcinomatous Component Present,Resectable Digestive System Carcinoma,1
3917,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage I,1
3918,Epithelial Component Present,Carcinoma ex pleomorphic adenoma of lacrimal gland,1
3919,Malignant Cellular Infiltrate,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7,1
3920,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Minimal Differentiation,1
3921,Anaplasia,Stage I Childhood Anaplastic Large Cell Lymphoma,1
3922,Malignant Cellular Infiltrate,Paranasal Sinus Cancer,1
3923,Nuclear pleomorphism,Large Cell Dysplasia,1
3924,Infiltrating Tumor Margins Present,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
3925,Severe dysplasia,Pathologic Stage 0 Gastric Cancer AJCC v8,1
3926,Firm mass,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
3927,Benign Cellular Infiltrate,Breast Ductal Adenoma,1
3928,Cartilaginous Differentiation,Subungual exostoses,1
3929,Malignant Cellular Infiltrate,Childhood Desmoplastic Small Round Cell Tumor,1
3930,Edematous Stroma Formation,Angiomyofibroblastoma,1
3931,Carcinomatous Component Present,Stage IA Vaginal Cancer AJCC v8,1
3932,Diffuse Pattern,large B-cell diffuse lymphoma of spleen,1
3933,Epithelial Component Present,Intestinal Intraepithelial Neoplasia,1
3934,Malignant Cellular Infiltrate,Stage III Laryngeal Cancer AJCC v8,1
3935,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
3936,Recurrent disease,Pharyngeal cancer recurrent,1
3937,Secondary Lesion,Secondary malignant neoplasm of brain stem,1
3938,Edematous Stroma Formation,Cervical Rhabdomyoma,1
3939,Vascular Channel Formation,Post-Radiotherapy Breast Angiosarcoma,1
3940,Cystic Change,Ovarian Papillary Cystadenoma,1
3941,Nodular lesions,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
3942,Myxoid Stroma Formation,Adult Extraskeletal Myxoid Chondrosarcoma,1
3943,Low Grade Neuroendocrine Lesion,Ascending Colon Neuroendocrine Tumor G1,1
3944,Local disease,Vulvar Fibrolipoma,1
3945,Epithelial Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
3946,Borderline Lesion,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
3947,Epithelial Component Present,Squamous cell carcinoma of the nasal cavity,1
3948,Myxoid Stroma Formation,Aggressive angiomyxoma,1
3949,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,1
3950,Secondary Lesion,Locally Advanced Urothelial Carcinoma,1
3951,Absence of Invasion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
3952,Papillary Pattern,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
3953,Cutaneous Involvement,adenosquamous carcinoma of skin,1
3954,Malignant Cellular Infiltrate,Stage IIB Bone Cancer AJCC v7,1
3955,Carcinomatous Component Present,Stage I Renal Pelvis Cancer AJCC v7,1
3956,Epithelial Component Present,Minimally Invasive Mucinous Lung Adenocarcinoma,1
3957,Malignant Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v7,1
3958,Epithelial Component Present,Signet-ring cell adenocarcinoma gastric,1
3959,Carcinomatous Component Present,Oropharyngeal lymphoepithelioma stage III,1
3960,Carcinomatous Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
3961,Glandular Pattern,Intestinal-Type Sinonasal Adenocarcinoma,1
3962,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity stage III,1
3963,Non-Invasive Lesion,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,1
3964,Vascular Channel Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
3965,Oligodendroglial Component Present,Anaplastic Oligoastrocytoma,1
3966,Malignant Cellular Infiltrate,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
3967,Epithelial Component Present,Neuroendocrine neoplasm of appendix,1
3968,Epithelial Component Present,Ameloblastic Carcinoma,1
3969,Thick-Walled Hyalinized Vessels Present,Degenerated Schwannoma,1
3970,Carcinomatous Component Present,Cervical Squamotransitional Carcinoma,1
3971,Cutaneous Involvement,Cutaneous Mantle Cell Lymphoma,1
3972,Epithelial Component Present,Stage IA Ovarian Cancer AJCC v8,1
3973,Malignant Cellular Infiltrate,Stage 0 Pharynx Carcinoma,1
3974,Malignant Cellular Infiltrate,Stage IIB Penile Cancer AJCC v8,1
3975,Benign Cellular Infiltrate,Papilloma of eyelid,1
3976,Epithelial Component Present,Stage IV Ovarian Carcinoma,1
3977,Vascular Channel Formation,Superior Vena Cava Angiosarcoma,1
3978,Carcinomatous Component Present,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
3979,Childhood Lesion,Childhood Carcinoid Tumor,1
3980,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Neoplasm,1
3981,Mucoid Stroma Formation,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
3982,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Mixed Mesodermal (Mullerian) Tumor,1
3983,Epithelial Component Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
3984,Cytoplasmic Accumulation of Black Pigment,Thyroid Gland Black Follicular Adenoma,1
3985,Monoclonal Cellular Population Present,"Leukemia, Mast-Cell",1
3986,Pregnancy Complications,Complete hydatidiform mole,1
3987,More than 5 Mitoses per 50HPF,Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
3988,Mixed Cellular Population,Borderline Ovarian Serous Adenofibroma,1
3989,Chromogranin A Positive Neoplastic Cells Present,Gallbladder Goblet Cell Carcinoid,1
3990,Primary Lesion,Alcohol-Related Hepatocellular Carcinoma,1
3991,Carcinomatous Component Present,Stage IV Liver Cancer,1
3992,Tissue of Mullerian Origin Present,Uterine Corpus Adenofibroma,1
3993,Carcinomatous Component Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
3994,Subcutaneous nodule,Subcutaneous panniculitis-like T-cell lymphoma,1
3995,Malignant Cellular Infiltrate,Acute myeloid leukemia with recurrent genetic abnormality,1
3996,Neuroendocrine Differentiation,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,1
3997,Malignant Cellular Infiltrate,Hypopharyngeal Cancer,1
3998,Epithelial Component Present,Adenocarcinoma of colon,1
3999,Neuroendocrine Differentiation,Carcinoid tumor of appendix,1
4000,Well Differentiated Neuroendocrine Lesion,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
4001,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Superficial basal cell carcinoma,1
4002,Benign Cellular Infiltrate,Parotid monomorphic adenoma,1
4003,Carcinomatous Component Present,Carcinoma of extrahepatic bile duct,1
4004,Malignant Cellular Infiltrate,Locally Advanced Basal Cell Carcinoma,1
4005,Diffuse Pattern,Sarcomatoid Mesothelioma,1
4006,Biphasic Pattern,Perineal Ectopic Fibroadenoma,1
4007,Malignant Cellular Infiltrate,"Carcinoma, Signet Ring Cell",1
4008,Exophytic Polypoid Lesion,villous adenoma of stomach,1
4009,Malignant Cellular Infiltrate,Chest Wall Lymphoma,1
4010,Mitotic Activity,Sellar Yolk Sac Tumor,1
4011,Malignant Cellular Infiltrate,Adenocarcinoma of anal canal,1
4012,Extensive Stage Lesion,Advanced Digestive System Neuroendocrine Neoplasm,1
4013,Malignant Cellular Infiltrate,Burkitt's lymphoma of small intestine,1
4014,Numerous Stromal Mast Cells Present,Angiomyofibroblastoma,1
4015,Carcinomatous Component Present,Stage IIC Colorectal Cancer AJCC v8,1
4016,Malignant Cellular Infiltrate,Refractory T-Cell Prolymphocytic Leukemia,1
4017,Ground Glass Nuclear Inclusion,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
4018,Benign Cellular Infiltrate,Benign neoplasm of ethmoidal sinus,1
4019,Nested Pattern,Ovarian gonadoblastoma,1
4020,Regional Disease,Locally Advanced Prostate Adenocarcinoma,1
4021,Poorly Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Carcinoma,1
4022,Invasive Lesion,Invasive Lobular Breast Carcinoma,1
4023,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Epithelioid Leiomyoma,1
4024,Tubular Pattern,Ampulla of Vater Tubulovillous Adenoma,1
4025,Epithelial Component Present,Craniopharyngioma,1
4026,Cutaneous Involvement,Sebaceous Gland Neoplasms,1
4027,Adulthood Lesion,Adult T-Cell Lymphoma/Leukemia,1
4028,Osteoid formation,Aggressive osteoblastoma,1
4029,High Mitotic Activity,Stage III Lung Small Cell Carcinoma AJCC v7,1
4030,Ineffective hematopoiesis,Treatment related acute myeloid leukaemia,1
4031,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
4032,Carcinomatous Component Present,Alcohol-Related Laryngeal Carcinoma,1
4033,Absence of Invasion,Prognostic Stage 0 Breast Cancer AJCC v8,1
4034,Indolent Clinical Course,Uterine Corpus Atypical Polypoid Adenomyoma,1
4035,High Grade Lesion,Recurrent Gliosarcoma,1
4036,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma,1
4037,Malignant Cellular Infiltrate,Recurrent Hematologic Malignancy,1
4038,Benign Cellular Infiltrate,Cardiac Intramuscular Hemangioma,1
4039,Metastatic Lesion,Locally Advanced Carcinoma,1
4040,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
4041,Epithelial Component Present,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
4042,Malignant Germinomatous Cellular Infiltrate,Stage III Testicular Seminoma AJCC v6 and v7,1
4043,Indolent Clinical Course,Benign Ameloblastoma,1
4044,Malignant Cellular Infiltrate,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
4045,Mixture of Morphologic Patterns,Mixed Squamous Cell Carcinoma of the Penis,1
4046,Malignant Cellular Infiltrate,Parotid Gland Undifferentiated Carcinoma,1
4047,Osseous Differentiation,Stage IA Osteosarcoma AJCC v7,1
4048,Bone Marrow Involvement,Hepatosplenic T-cell lymphoma,1
4049,Benign Cellular Infiltrate,Fundic gland polyp,1
4050,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Tumor G2,1
4051,Malignant Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v8 Stage,1
4052,Radial Growth Phase,Stage I Superficial Spreading Melanoma AJCC v7,1
4053,Intravascular Fibrin Thrombus Formation,Epidural Spinal Canal Angiolipoma,1
4054,Secondary Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
4055,Malignant Cellular Infiltrate,M5b Acute differentiated monocytic leukemia,1
4056,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
4057,Cutaneous Involvement,"Xeroderma pigmentosum, group A",1
4058,Epithelial Component Present,Palate carcinoma,1
4059,Epithelial Component Present,Refractory Extensive Stage Lung Small Cell Carcinoma,1
4060,Adulthood Lesion,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8,1
4061,Adnexal Differentiation,Eccrine hidrocystoma,1
4062,Absence of Stromal Invasion,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,1
4063,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v7,1
4064,Acantholysis,Acantholytic squamous cell carcinoma of skin,1
4065,Carcinomatous Component Present,Stage IIIA Rectal Cancer AJCC v8,1
4066,Splenomegaly,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
4067,Epithelial Component Present,Densely Granulated Non-Functioning Corticotroph Adenoma,1
4068,Peripheral Nuclear Palisading,Occult Lung Small Cell Carcinoma,1
4069,Clusters and Cords of GFAP Positive Epithelioid Tumor Cells Present,Chordoid Glioma of the Third Ventricle,1
4070,High Mitotic Activity,large cell neuroendocrine carcinoma of thymus,1
4071,Single Cell Necrosis,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
4072,Carcinomatous Component Present,Nasopharyngeal squamous cell carcinoma stage II,1
4073,Non-Hereditary Lesion,Parietal cell carcinoma,1
4074,Recurrent disease,Recurrent Biliary Tract Carcinoma,1
4075,Childhood Lesion,Childhood Testicular Neoplasm,1
4076,Increased Cellularity Present,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
4077,Exophytic Polypoid Lesion,Intrahepatic Bile Duct Microcystic Adenoma,1
4078,Cutaneous Involvement,Skin Nodular Basal Cell Carcinoma,1
4079,Carcinomatous Component Present,Cervix carcinoma recurrent,1
4080,Malignant Cellular Infiltrate,Transplant-Related Hematologic Malignancy,1
4081,Well-Circumscribed Lesion,Colorectal Adenoma with Severe Dysplasia,1
4082,Carcinomatous Component Present,"Paget's Disease, Mammary",1
4083,Benign Cellular Infiltrate,Benign tumor of penis,1
4084,Tubular Pattern,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
4085,Refractory Disease,Refractory Extranodal Diffuse Large B-cell Lymphoma,1
4086,Vascular Channel Formation,Cardiac Epithelioid Hemangioendothelioma,1
4087,Rimming of Adipose Tissue Cells Present,Subcutaneous panniculitis-like T-cell lymphoma,1
4088,Recurrent disease,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
4089,Recurrent disease,Recurrent Female Reproductive System Carcinoma,1
4090,Cutaneous Involvement,Grade 1 Cutaneous Follicular Lymphoma,1
4091,Carcinomatous Component Present,Breast Cancer by AJCC v8 Prognostic Stage,1
4092,Carcinomatous Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v8,1
4093,Epithelial Component Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
4094,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Columnar Cell Hyperplasia of the Breast,1
4095,Follicular Structures Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
4096,Malignant Cellular Infiltrate,Vaginal Keratinizing Squamous Cell Carcinoma,1
4097,Erythroid hyperplasia,Refractory anemia with ringed sideroblasts,1
4098,Mixed Cellular Population,Malignant Phyllodes Tumor of Prostate,1
4099,Epithelial Component Present,Stage IV Primary Peritoneal Cancer AJCC v8,1
4100,Secondary Lesion,Metastatic Bone Ewing Sarcoma,1
4101,Increased Cellularity Present,Undifferentiated Neuroblastoma,1
4102,Well-Circumscribed Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,1
4103,Epithelial Component Present,Unresectable Pancreatic Neuroendocrine Carcinoma,1
4104,Benign Cellular Infiltrate,Colon Lipoma,1
4105,Epithelial Component Present,Gastric Intestinal-Type Adenocarcinoma,1
4106,Dysplasia,High Grade Esophageal Squamous Intraepithelial Neoplasia,1
4107,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
4108,Epithelial Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
4109,Malignant Cellular Infiltrate,Breast Cancer by AJCC v8 Stage,1
4110,Epithelial Component Present,Stage II Anal Cancer AJCC v8,1
4111,Carcinomatous Component Present,Stage II Renal Pelvis Cancer AJCC v7,1
4112,Mixed Cellular Population,Malignant Mixed Mesodermal (Mullerian) Tumor,1
4113,Recurrent disease,Recurrent Childhood Spinal Cord Neoplasm,1
4114,Carcinomatous Component Present,Unresectable Basal Cell Carcinoma,1
4115,Congenital Lesion,Vulvar Congenital Melanocytic Nevus,1
4116,Adulthood Lesion,Stage III Adult Soft Tissue Sarcoma AJCC v7,1
4117,Cutaneous Involvement,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
4118,Papillary Pattern,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
4119,Collagenous Stroma Formation,Angiomyofibroblastoma,1
4120,Ulcer,Esophageal Neuroendocrine Tumor G2,1
4121,Multifocal Lesion,Multifocal breast carcinoma,1
4122,Epithelial Component Present,Non-Small Cell Adenocarcinoma,1
4123,Neuroendocrine Differentiation,Platinum-Resistant Lung Small Cell Carcinoma,1
4124,Immunologic Deficiency Syndromes,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
4125,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
4126,Epithelial Component Present,Epithelioma,1
4127,Cutaneous Involvement,Large cell acanthoma,1
4128,Heterologous Elements Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
4129,Malignant Cellular Infiltrate,Stage 0is Bladder Cancer AJCC v8,1
4130,Epithelial Component Present,Appendix adenoma,1
4131,Benign Cellular Infiltrate,Benign neoplasm vagina,1
4132,Resectable Mass,Resectable Renal Cell Carcinoma,1
4133,Neuroendocrine Differentiation,Malignant Bladder Paraganglioma,1
4134,Infiltrating Tumor Margins Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
4135,Childhood Lesion,Childhood Meningioma,1
4136,Carcinomatous Component Present,Papillary squamous cell carcinoma,1
4137,Epithelial Component Present,Borderline Ovarian Clear Cell Cystadenofibroma,1
4138,Benign Cellular Infiltrate,Ganglioneuromatosis,1
4139,Capillary Sized Vascular Channel Formation,Central Nervous System Hemangioblastoma,1
4140,Rimming of Adipose Tissue Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
4141,Well-Circumscribed Lesion,Eccrine acrospiroma,1
4142,Secondary Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
4143,High Mitotic Activity,Central Nervous System Embryonal Carcinoma,1
4144,Malignant Cellular Infiltrate,Metastatic Kidney Carcinoma,1
4145,Carcinomatous Component Present,Cervical Cancer by AJCC v8 Stage,1
4146,Nuclear Molding,Stage I Lung Small Cell Carcinoma AJCC v7,1
4147,Dysplasia,Colorectal Adenoma with Moderate Dysplasia,1
4148,Epithelial Component Present,Stage 0a Penile Cancer AJCC v8,1
4149,Slow Growing Mass,Cavernous Angioleiomyoma,1
4150,Vascular Channel Formation,Small Intestinal Angiosarcoma,1
4151,High Mitotic Activity,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
4152,Squamous metaplasia of bladder,Bladder squamous cell carcinoma recurrent,1
4153,Cystic Change,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
4154,Deep Lesion,Central Nervous System Desmoid-Type Fibromatosis,1
4155,Epithelial Component Present,Stage IV Ureter Cancer AJCC v7,1
4156,Hyperkeratosis,Melanoacanthoma,1
4157,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,1
4158,Carcinomatous Component Present,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
4159,Malignant Cellular Infiltrate,Stage III Major Salivary Gland Cancer AJCC v8,1
4160,Benign Cellular Infiltrate,Cervical Squamous Papilloma,1
4161,Benign Cellular Infiltrate,Benign Glomus Tumor,1
4162,Malignant Cellular Infiltrate,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
4163,Anastomosing Strands of Tumor Cells Present,Odontoameloblastoma,1
4164,Local disease,Localized Gastroesophageal Junction Adenocarcinoma,1
4165,Malignant Cellular Infiltrate,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8,1
4166,Anaplasia,Recurrent Anaplastic Oligoastrocytoma,1
4167,Carcinomatous Component Present,Metastatic Fibrolamellar Carcinoma,1
4168,Local disease,Adenomatoid tumor of epididymis,1
4169,Secondary Lesion,Lung Carcinoma Metastatic in the Central Nervous System,1
4170,Mixed Cellular Population,Mixed germ cell-sex cord-stromal tumor,1
4171,Malignant Cellular Infiltrate,Cardiac Lymphoma,1
4172,Primary Lesion,Meningeal Lymphoma,1
4173,Benign Cellular Infiltrate,Atrial myxoma,1
4174,Intraosseous Lesion,Ossifying Fibroma,1
4175,High Grade Lesion,High Grade Liver Dysplastic Nodule,1
4176,Epithelial Component Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
4177,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,1
4178,Epithelial Component Present,Advanced Well Differentiated Neuroendocrine Neoplasm,1
4179,Epithelial Component Present,intraepithelial glandular neoplasia of cervix,1
4180,Refractory Disease,Refractory Mixed Phenotype Acute Leukemia,1
4181,Pregnancy Complications,Placenta Previa,1
4182,Malignant Germinomatous Cellular Infiltrate,Dysgerminoma of ovary,1
4183,Fibromuscular Stroma Formation,Bartholin Gland Adenomyoma,1
4184,Refractory Disease,B-cell lymphoma refractory,1
4185,Therapy-Related Toxicity,Chemotherapy-Related Leukemia,1
4186,Epithelial Component Present,Intestinal Neuroendocrine Tumor G2,1
4187,Carcinomatous Component Present,Pancreatic adenocarcinoma recurrent,1
4188,Benign Cellular Infiltrate,Ancell-Spiegler cylindromas,1
4189,Cutaneous Involvement,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
4190,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated CEBPA,1
4191,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma,1
4192,HMB-45-Positive Neoplastic Cells Present,Childhood Kidney Angiomyolipoma,1
4193,Malignant Cellular Infiltrate,Recurrent Malignant Thyroid Gland Neoplasm,1
4194,Carcinomatous Component Present,Lung Acinar Adenocarcinoma,1
4195,Benign Cellular Infiltrate,Hidroacanthoma simplex,1
4196,Recurrent disease,Recurrent Adult Spinal Cord Neoplasm,1
4197,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
4198,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,1
4199,Poorly Differentiated Lesion,Sarcomatoid Carcinoma of the Penis,1
4200,Malignant Cellular Infiltrate,Advanced Microsatellite Stable Colorectal Carcinoma,1
4201,Malignant Cellular Infiltrate,"Chondrosarcoma, Clear Cell",1
4202,Carcinomatous Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8,1
4203,Diffuse Pattern,Childhood Anaplastic Oligodendroglioma,1
4204,Absence of Invasion,Adenocarcinoma in situ in tubular adenoma,1
4205,Malignant Cellular Infiltrate,Stage I Renal Cell Carcinoma,1
4206,Epithelial Component Present,Stage IB Fallopian Tube Cancer AJCC v6 and v7,1
4207,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
4208,Malignant Cellular Infiltrate,Adult Systemic Anaplastic Large Cell Lymphoma,1
4209,Malignant Cellular Infiltrate,Recurrent Invasive Ductal Breast Carcinoma,1
4210,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8,1
4211,Recurrent disease,recurrent childhood acute myeloid leukemia,1
4212,Pregnancy Complications,Cesarean Scar Pregnancy,1
4213,Malignant Cellular Infiltrate,Stage I Vulvar Carcinoma,1
4214,Encapsulated Mass,Benign cystic nephroma,1
4215,Borderline Lesion,Monoclonal Gammopathy of Undetermined Significance,1
4216,Adnexal Differentiation,Benign Germinative Follicular Epithelium Neoplasm,1
4217,Carcinomatous Component Present,"Uterine Carcinosarcoma, Homologous Type",1
4218,Benign Cellular Infiltrate,Vaginal Angiomyofibroblastoma,1
4219,Exophytic Polypoid Lesion,tubular adenoma of extrahepatic bile duct,1
4220,Comedo Necrosis,Comedocarcinoma,1
4221,Congenital Lesion,Ectopia Lentis,1
4222,Epithelial Component Present,combined small cell carcinoma of lung,1
4223,Epithelial Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
4224,Benign Cellular Infiltrate,Acoustic Neuroma,1
4225,Epithelial Component Present,Stage IB Eyelid Carcinoma AJCC v8,1
4226,Malignant Cellular Infiltrate,Ann Arbor Stage IVA Hodgkin Lymphoma,1
4227,Vascular Channel Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
4228,Malignant Cellular Infiltrate,Anaplastic Kidney Wilms Tumor,1
4229,Epithelial Component Present,Stage II Nasal Cavity Cancer AJCC v6 and v7,1
4230,Malignant Cellular Infiltrate,Angiosarcoma NCI Grade 2,1
4231,Carcinomatous Component Present,Pathologic Stage IV Gastric Cancer AJCC v8,1
4232,Malignant Cellular Infiltrate,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
4233,Malignant Cellular Infiltrate,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
4234,Malignant Cellular Infiltrate,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
4235,Refractory Disease,Refractory Endometrial Clear Cell Adenocarcinoma,1
4236,Malignant Cellular Infiltrate,Stage I Lung Cancer AJCC v8,1
4237,Childhood Lesion,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8,1
4238,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v6 and v7,1
4239,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v8,1
4240,Malignant Cellular Infiltrate,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
4241,Malignant Cellular Infiltrate,Meningothelial sarcoma,1
4242,Dysplasia,Dysplasia of anus,1
4243,High Mitotic Activity,Testicular embryonal carcinoma stage I,1
4244,Absence of Invasion,High Grade Ductal Breast Carcinoma In Situ,1
4245,High Mitotic Activity,Testicular embryonal carcinoma stage III,1
4246,Endocervical Type Epithelium Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
4247,Recurrent disease,Recurrent Anaplastic Oligodendroglioma,1
4248,Benign Cellular Infiltrate,Neurilemmoma,1
4249,Recurrent disease,Recurrent Malignant Ovarian Transitional Cell Tumor,1
4250,Adulthood Lesion,Localized Resectable Adult Hepatocellular Carcinoma,1
4251,Pushing Tumor Margin,Verrucous carcinoma,1
4252,Carcinomatous Component Present,Uterine Ligament Clear Cell Adenocarcinoma,1
4253,Malignant Cellular Infiltrate,Stage IB Retroperitoneal Sarcoma AJCC v8,1
4254,Villous Pattern,Cecum Villous Adenoma,1
4255,Infiltrative Growth Pattern,Giant Cell Glioblastoma,1
4256,Necrotic changes (finding),small cell carcinoma of extrahepatic bile duct,1
4257,Carcinomatous Component Present,Carcinoma of apocrine gland,1
4258,Mesenchymal Differentiation,Childhood Brain Stem Gliosarcoma,1
4259,Malignant Cellular Infiltrate,Stage 0 Lip Carcinoma,1
4260,Malignant Cellular Infiltrate,Burkitt's lymphoma of breast,1
4261,Malignant Cellular Infiltrate,Malignant neoplasm of endocrine gland,1
4262,Refractory Disease,Refractory Bile Duct Carcinoma,1
4263,Slow Growing Mass,Elastofibroma,1
4264,Epithelial Component Present,undifferentiated carcinoma of salivary gland,1
4265,Low Mitotic Activity,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,1
4266,Malignant Cellular Infiltrate,Refractory Bile Duct Carcinoma,1
4267,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Cancer AJCC v8,1
4268,Biphasic Pattern,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
4269,Primary Lesion,Clear Cell Hepatocellular Carcinoma,1
4270,Well Differentiated Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
4271,Extraosseous Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,1
4272,Primary Lesion,Peripheral neuroepithelioma of bone recurrent,1
4273,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage I,1
4274,Epithelial Component Present,Superior Sulcus Lung Carcinoma,1
4275,Mixed Cellular Population,Childhood Anaplastic Oligoastrocytoma,1
4276,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
4277,Anaplasia,Anaplastic Kidney Wilms Tumor,1
4278,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I,1
4279,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
4280,Malignant Cellular Infiltrate,Metastatic Nasopharyngeal Undifferentiated Carcinoma,1
4281,Epithelial Component Present,Adult Type Testicular Granulosa Cell Tumor,1
4282,Abundance of Small Lymphocytes,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma,1
4283,Secondary Lesion,Advanced Sarcoma of the Extremity,1
4284,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v8,1
4285,Malignant Cellular Infiltrate,Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma,1
4286,Carcinomatous Component Present,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
4287,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,1
4288,Hyperplastic Tissue Present,Breast hyperplasia,1
4289,Primary Lesion,Childhood Hepatocellular Carcinoma,1
4290,Epithelial Component Present,Recurrent Male Reproductive System Carcinoma,1
4291,Epithelial Component Present,Thyrotroph adenoma,1
4292,Vascular Channel Formation,"Hemangioma, Intramuscular",1
4293,Malignant Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma,1
4294,Malignant Cellular Infiltrate,Gallbladder Angiosarcoma,1
4295,Junctional Proliferation,Compound nevus of skin,1
4296,Local disease,Vulvar Lipoma,1
4297,Epithelial Component Present,Pancreatic Somatostatinoma,1
4298,Epithelial Component Present,Metastatic Sarcomatoid Renal Cell Carcinoma,1
4299,Carcinomatous Component Present,Stage IV Hepatocellular Carcinoma AJCC v6,1
4300,Malignant Cellular Infiltrate,Extramedullary Plasmacytoma,1
4301,Cutaneous Involvement,External Ear Basal Cell Carcinoma,1
4302,Epithelial Component Present,Stomach Carcinoma,1
4303,Carcinomatous Component Present,undifferentiated carcinoma of anal canal,1
4304,Malignant Cellular Infiltrate,Plasma Cell Post-Transplant Lymphoproliferative Disorder,1
4305,Epithelial Component Present,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
4306,Carcinomatous Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
4307,Epithelial Component Present,Locally Advanced Cervical Carcinoma,1
4308,Malignant Cellular Infiltrate,Recurrent Childhood Gliomatosis Cerebri,1
4309,Malignant Cellular Infiltrate,Stage IIA Bone Cancer AJCC v7,1
4310,Malignant Cellular Infiltrate,FIGO Stage IIIA1(ii) Ovarian Cancer,1
4311,Primary Lesion,Adult Primary Melanocytic Lesion of Meninges,1
4312,Malignant Cellular Infiltrate,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
4313,Malignant Cellular Infiltrate,Prognostic Stage I Breast Cancer AJCC v8,1
4314,Nuclear pleomorphism,Anaplastic Medulloblastoma,1
4315,Dysplasia,Anal Canal Squamous Intraepithelial Neoplasia,1
4316,Fibrosis,"Breast Fibrocystic Change, Non-Proliferative Type",1
4317,Unresectable Mass,Advanced Unresectable Gastric Adenocarcinoma,1
4318,Exophytic Polypoid Lesion,Cervix adenomatous polyp,1
4319,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",1
4320,Epithelial Component Present,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
4321,Peripheral Nuclear Palisading,Stage I Lung Small Cell Carcinoma AJCC v7,1
4322,Epithelial Component Present,Endometrial Large Cell Neuroendocrine Carcinoma,1
4323,Severe dysplasia,Stage 0 Appendix Carcinoma AJCC v7,1
4324,Non-Invasive Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
4325,Malignant Cellular Infiltrate,Recurrent Childhood Acute Lymphoblastic Leukemia,1
4326,Epithelial Component Present,Carotid Body Paraganglioma,1
4327,Solitary mass,Metastatic Chordoma,1
4328,Five or Less Mitoses per 50HPF,Benign Gastric Gastrointestinal Stromal Tumor,1
4329,Pathologic TNM Finding,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
4330,Malignant Cellular Infiltrate,Recurrent Extragonadal Seminoma,1
4331,Recurrent disease,Recurrent Endometrial Clear Cell Adenocarcinoma,1
4332,Epithelial Component Present,Pancreatic Hepatoid Adenocarcinoma,1
4333,Malignant Cellular Infiltrate,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,1
4334,Carcinomatous Component Present,Squamous cell carcinoma of the head and neck,1
4335,Malignant Cellular Infiltrate,Unresectable Basal Cell Carcinoma,1
4336,Childhood Lesion,Childhood Kidney Neoplasm,1
4337,Invasive Lesion,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
4338,Malignant Cellular Infiltrate,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,1
4339,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
4340,Benign Cellular Infiltrate,Benign Prostate Phyllodes Tumor,1
4341,Malignant Cellular Infiltrate,Splenic Marginal Zone B-Cell Lymphoma,1
4342,Epithelial Component Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
4343,Secondary Lesion,Locally Advanced Digestive System Carcinoma,1
4344,Cutaneous Involvement,Desmoplastic Neurotropic Melanoma,1
4345,Malignant Cellular Infiltrate,undifferentiated carcinoma of salivary gland,1
4346,Malignant Cellular Infiltrate,External Ear Carcinoma,1
4347,Local disease,Lipoma of axilla,1
4348,Epithelial Component Present,Breast Carcinoma Metastatic in the Spine,1
4349,Epithelial Component Present,Sphenoid Sinus Inverted Papilloma,1
4350,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal tumor of soft tissue,1
4351,Collagenous Stroma Formation,Vulvar Superficial Myofibroblastoma,1
4352,Pathologic TNM Finding,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
4353,Well-Circumscribed Lesion,Polyp of gallbladder,1
4354,Malignant Cellular Infiltrate,Malignant melanoma in junctional nevus,1
4355,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v7,1
4356,Malignant Cellular Infiltrate,Hepatitis C Virus-Related Hepatocellular Carcinoma,1
4357,Severe cytologic atypia,Pancreatic Small Cell Neuroendocrine Carcinoma,1
4358,Malignant Cellular Infiltrate,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
4359,CD56-Positive Neoplastic Cells Present,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
4360,Calcitonin Positive Neoplastic Cells Present,Familial medullary thyroid carcinoma,1
4361,Oligodendroglial Component Present,Adult Oligodendroglial Tumor,1
4362,Carcinomatous Component Present,Stage IIIC Anal Cancer AJCC v8,1
4363,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Gangliocytic Paraganglioma,1
4364,Carcinomatous Component Present,Refractory Digestive System Carcinoma,1
4365,Carcinomatous Component Present,Digestive System Large Cell Neuroendocrine Carcinoma,1
4366,Carcinomatous Component Present,Bronchioloalveolar Adenocarcinoma,1
4367,Epithelial Component Present,Bladder Neuroendocrine Neoplasm,1
4368,Junctional Proliferation,Junctional nevus,1
4369,Benign Cellular Infiltrate,Ovarian Mucinous Cystadenofibroma,1
4370,Increased Cellularity Present,Refractory Neuroblastoma,1
4371,Mesenchymal Metaplasia of Malignant Cells Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
4372,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Tumor,1
4373,Carcinomatous Component Present,Stage II Breast Cancer AJCC v6 and v7,1
4374,Vascular Channel Formation,Breast Capillary Hemangioma,1
4375,Epithelial Component Present,Grade 1 Endometrial Mucinous Adenocarcinoma,1
4376,Epithelial Component Present,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
4377,Malignant Cellular Infiltrate,Recurrent Follicular Lymphoma,1
4378,Clinical TNM Finding,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
4379,Single Cell Necrosis,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
4380,Childhood Lesion,Childhood Testicular Yolk Sac Tumor,1
4381,Malignant Cellular Infiltrate,Stage III Skin Cancer,1
4382,Epithelial Component Present,Anal cancer recurrent,1
4383,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
4384,Malignant Cellular Infiltrate,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
4385,Mixed Cellular Population,Recurrent Ovarian Carcinosarcoma,1
4386,Malignant Cellular Infiltrate,Stage IIB Testicular Cancer AJCC v8,1
4387,Epithelial Component Present,Pathologic Stage IIB Gastric Cancer AJCC v8,1
4388,Cutaneous Involvement,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma,1
4389,Malignant Cellular Infiltrate,"Thymoma, type B2, malignant",1
4390,Refractory Disease,Refractory Head and Neck Squamous Cell Carcinoma,1
4391,Adulthood Lesion,Stage I Adult Soft Tissue Sarcoma AJCC v7,1
4392,Epithelial Component Present,Stage IVB Rectal Cancer AJCC v7,1
4393,Nuclear pleomorphism,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
4394,Cystic Change,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
4395,Dysplasia,Biliary Intraepithelial Neoplasia-2,1
4396,Epithelial Component Present,Renal Pelvis Cancer by AJCC v8 Stage,1
4397,Neoplastic Promonocytes in Bone Marrow Markedly Increased,M5b Acute differentiated monocytic leukemia,1
4398,Malignant Cellular Infiltrate,Stage II Colon Cancer AJCC v7,1
4399,Extensive Stage Lesion,Advanced Unresectable Gastric Adenocarcinoma,1
4400,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
4401,Trabecular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
4402,Carcinomatous Component Present,minimally invasive follicular carcinoma of the thyroid gland,1
4403,Epithelial Component Present,small cell carcinoma of extrahepatic bile duct,1
4404,Malignant Cellular Infiltrate,Primary cerebral lymphoma,1
4405,Childhood Lesion,Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage,1
4406,Malignant Cellular Infiltrate,Stage 0 Colorectal Cancer AJCC v8,1
4407,Immunologic Deficiency Syndromes,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
4408,Therapy-Related Toxicity,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
4409,Tumor Vascular Invasion,Malignant Testicular Leydig Cell Tumor,1
4410,Cutaneous Involvement,Primary cutaneous lymphoma,1
4411,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
4412,Malignant Cellular Infiltrate,Advanced Lung Carcinoma,1
4413,High Mitotic Activity,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
4414,Increased Cellularity Present,Poorly Differentiated Neuroblastoma,1
4415,Macrocystic Change,"Lymphangioma, Cystic",1
4416,Benign Cellular Infiltrate,Adrenal Cortex Adenomatoid Tumor,1
4417,Chromogranin A Positive Neoplastic Cells Present,Uterine Corpus Carcinoid Tumor,1
4418,Dysplasia,Flat Ductal Epithelial Atypia of the Breast,1
4419,Biphasic Pattern,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
4420,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Cancer AJCC v8,1
4421,Malignant Cellular Infiltrate,Pleuropulmonary blastoma,1
4422,Malignant Cellular Infiltrate,Carcinoma in situ of trachea,1
4423,Carcinomatous Component Present,Pharyngeal Carcinoma,1
4424,Sarcomatous Component Present,carcinosarcoma of salivary gland,1
4425,Benign Cellular Infiltrate,Erosive Adenomatosis of the Nipple,1
4426,Neuroendocrine Differentiation,Stage II Appendix Neuroendocrine Tumor AJCC v8,1
4427,Epithelial Component Present,adenosquamous carcinoma of breast,1
4428,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",1
4429,Carcinomatous Component Present,Recurrent Cervical Adenocarcinoma,1
4430,Plasma cell inflammation,Syringocystadenoma Papilliferum,1
4431,Epithelial Component Present,Glucagonoma,1
4432,Mixed Cellular Population,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,1
4433,Epithelial Component Present,Maxillary Sinus Adenoid Cystic Carcinoma,1
4434,High Mitotic Activity,large cell neuroendocrine carcinoma of gallbladder,1
4435,Adnexal Differentiation,Pilar tumor,1
4436,Epithelial Component Present,Metastatic Prostate Small Cell Carcinoma,1
4437,Primary Lesion,Stage IB Hepatocellular Carcinoma AJCC v8,1
4438,Bilateral Mass,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,1
4439,Mild dysplasia,Appendix Low Grade Intraepithelial Neoplasia,1
4440,Diffuse Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
4441,Carcinomatous Component Present,Metastatic Urethral Urothelial Carcinoma,1
4442,Carcinomatous Component Present,AIDS-Related Cervical Carcinoma,1
4443,Carcinomatous Component Present,signet ring cell carcinoma of pancreas,1
4444,Malignant Cellular Infiltrate,Stage II Lung Small Cell Carcinoma AJCC v7,1
4445,Malignant Cellular Infiltrate,Stage IIA Testicular Cancer AJCC v6 and v7,1
4446,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
4447,Well Differentiated Neuroendocrine Lesion,Stage IIB Colon Neuroendocrine Tumor AJCC v8,1
4448,Rapidly Enlarging Mass,Fusion-Positive Alveolar Rhabdomyosarcoma,1
4449,Papillary Pattern,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia,1
4450,Non-Invasive Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
4451,Papillary Pattern,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
4452,Mitotic Activity,Adult Gliosarcoma,1
4453,Well Differentiated Neuroendocrine Lesion,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
4454,CD30-Positive Neoplastic Cells Present,Stage II Childhood Anaplastic Large Cell Lymphoma,1
4455,Dysplasia,Intrahepatic Bile Duct Microcystic Adenoma,1
4456,Epithelial Component Present,Bartholin's gland carcinoma,1
4457,Epithelial Component Present,Prostate Adenoid Cystic Carcinoma,1
4458,Carcinomatous Component Present,Endometrial Squamous Cell Carcinoma,1
4459,Dysplasia,Vaginal Tubular Adenoma,1
4460,Argentaffin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
4461,Extensive Stage Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
4462,Congenital Lesion,GIANT PIGMENTED HAIRY NEVUS,1
4463,Epithelial Component Present,Colorectal Adenoma with Severe Dysplasia,1
4464,Epithelial Component Present,adenomatous polyp of stomach,1
4465,Malignant Cellular Infiltrate,Stage IIB Testicular Cancer AJCC v8,1
4466,Antoni A Pattern,Mediastinal Schwannoma,1
4467,Benign Cellular Infiltrate,Jugular Foramen Schwannoma,1
4468,Adulthood Lesion,Refractory Adult Acute Lymphoblastic Leukemia,1
4469,Benign Cellular Infiltrate,Maxillary Sinus Schneiderian Papilloma,1
4470,Cutaneous Involvement,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
4471,Poorly Differentiated Lesion,Pancreatic Medullary Carcinoma,1
4472,Benign Cellular Infiltrate,Benign Pilar-Associated Mesenchyme Neoplasm,1
4473,Multinodular Pattern,Chest Wall Plexiform Fibrohistiocytic Neoplasm,1
4474,Epithelial Component Present,Hereditary Male Breast Carcinoma,1
4475,Tissue of Mullerian Origin Present,Mucinous adenofibroma,1
4476,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage I,1
4477,Tissue of Mullerian Origin Present,Borderline Ovarian Serous Cystadenofibroma,1
4478,Malignant Cellular Infiltrate,Refractory Gastric Carcinoma,1
4479,Malignant Cellular Infiltrate,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
4480,In Situ Lesion,Lung Adenocarcinoma In Situ,1
4481,Cutaneous Involvement,Squamous Cell Carcinoma of Anal Margin,1
4482,Unresectable Mass,Unresectable Lung Carcinoma,1
4483,Malignant Cellular Infiltrate,Recurrent Subsequent Malignant Neoplasm,1
4484,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
4485,Villous Pattern,Urethral Villous Adenoma,1
4486,Benign Cellular Infiltrate,Classic Type Trichilemmoma,1
4487,Infiltrative Growth Pattern,Frontal Lobe Anaplastic Astrocytoma,1
4488,Poorly Differentiated Lesion,Stage IIIA Lung Large Cell Carcinoma AJCC v7,1
4489,Carcinomatous Component Present,Stage IIIA Gallbladder Cancer AJCC v8,1
4490,Tissue Differentiation Uncertain,Extraskeletal Myxoid Chondrosarcoma,1
4491,Exophytic Polypoid Lesion,Appendix Tubular Adenoma,1
4492,Malignant Cellular Infiltrate,Grade I Chondrosarcoma,1
4493,Ineffective hematopoiesis,Treatment related acute myeloid leukaemia,1
4494,White blood cell count increased (lab result),"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
4495,Malignant Cellular Infiltrate,Nasopharyngeal Differentiated Carcinoma,1
4496,Epithelial Component Present,Gallbladder adenoma,1
4497,Childhood Lesion,Childhood Neuroblastoma,1
4498,Carcinomatous Component Present,Stage II Laryngeal Cancer AJCC v6 and v7,1
4499,Carcinomatous Component Present,Stage II Bladder Cancer AJCC v8,1
4500,Epithelial Component Present,Type 1 Papillary Renal Cell Carcinoma,1
4501,Chromogranin A Positive Neoplastic Cells Present,Anal Canal Neuroendocrine Tumor G1,1
4502,Invasive Lesion,Invasive Cribriform Breast Carcinoma,1
4503,Tissue Differentiation Uncertain,Atrial myxoma,1
4504,Carcinomatous Component Present,Stage IIIB Ovarian Cancer AJCC v8,1
4505,Secondary Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,1
4506,Malignant Cellular Infiltrate,Locally Advanced Melanoma,1
4507,Malignant Cellular Infiltrate,Pharyngeal cancer recurrent,1
4508,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage II,1
4509,Necrotic changes (finding),Endometrial Large Cell Neuroendocrine Carcinoma,1
4510,Epithelial Component Present,"Neuroendocrine carcinoma, metastatic",1
4511,Papillary Pattern,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
4512,Epithelial Component Present,Stage IVB Basal Cell Lip Carcinoma,1
4513,Well Differentiated Lesion,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
4514,Malignant Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
4515,atypia morphology,Recurrent Grade II Lymphomatoid Granulomatosis,1
4516,Benign Cellular Infiltrate,Benign neoplasm of adrenal gland,1
4517,Papillary Pattern,Choroid Plexus Papilloma,1
4518,Malignant Cellular Infiltrate,Unresectable Synovial Sarcoma,1
4519,Epithelial Component Present,Stage III Colorectal Cancer AJCC v7,1
4520,Recurrent disease,Recurrent Metastatic Malignant Neoplasm,1
4521,Cutaneous Involvement,Large cell acanthoma,1
4522,Benign Cellular Infiltrate,Classic Rhabdomyoma,1
4523,Serrated Glandular Architecture,Colon Sessile Serrated Adenoma/Polyp,1
4524,Malignant Cellular Infiltrate,Hepatoma resectable,1
4525,Malignant Cellular Infiltrate,"Adenocarcinoma, Scirrhous",1
4526,Lytic lesion,Giant Cell Lesion of Small Bones,1
4527,Melanin Pigment Present,Common blue nevus of skin,1
4528,Necrotic changes (finding),Endometrial Small Cell Carcinoma,1
4529,Epithelial Component Present,Borderline Ovarian Endometrioid Cystadenofibroma,1
4530,Hyperplastic Tissue Present,Utricle-Associated Mucosal Gland Hyperplasia,1
4531,Epithelial Component Present,Undifferentiated carcinoma of esophagus,1
4532,Hyperplastic Tissue Present,Islet Glucagon Cell Hyperplasia,1
4533,Recurrent disease,Recurrent Primary Effusion Lymphoma,1
4534,Peripheral Nuclear Palisading,Cervical Basaloid Carcinoma,1
4535,Malignant Cellular Infiltrate,rhabdomyosarcoma of liver,1
4536,Epithelial Component Present,Anatomic Stage IIIA Breast Cancer AJCC v8,1
4537,Recurrent disease,Recurrent Lip Basal Cell Carcinoma,1
4538,Neuroectodermal Differentiation,ganglioneuroblastoma of mediastinum,1
4539,Adulthood Lesion,Stage II Adult Immunoblastic Lymphoma,1
4540,Carcinomatous Component Present,Stage IIIA Ampulla of Vater Cancer AJCC v8,1
4541,Vascular Channel Formation,Lymphangiomatosis,1
4542,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of trachea,1
4543,Cutaneous Involvement,Giant Cell Fibroblastoma,1
4544,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,1
4545,Cutaneous Involvement,Stage III Lip Basal Cell Carcinoma,1
4546,Epithelial Component Present,Esophageal Cancer by AJCC v6 Stage,1
4547,Increased Cellularity Present,Stage 2B Neuroblastoma,1
4548,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
4549,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone metastatic,1
4550,Malignant Cellular Infiltrate,Sebaceous Adenocarcinoma,1
4551,Malignant Cellular Infiltrate,Parietal cell carcinoma,1
4552,Childhood Lesion,Childhood Gliomatosis Cerebri,1
4553,Malignant Cellular Infiltrate,Well Differentiated Leiomyosarcoma,1
4554,Cutaneous Involvement,Indeterminate dendritic cell tumor,1
4555,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
4556,Microvascular Proliferation,Recurrent Childhood Glioblastoma,1
4557,Papillary Pattern,Papillary tumor of renal pelvis,1
4558,Stromal Invasion,Ovarian Cancer by AJCC v6 and v7 Stage,1
4559,Pseudoalveolar Pattern,Vulvar Alveolar Soft Part Sarcoma,1
4560,Malignant Cellular Infiltrate,Stage I Lentigo Maligna Melanoma AJCC v7,1
4561,Decreased platelet count,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,1
4562,Malignant Cellular Infiltrate,Grade 2 Invasive Breast Carcinoma,1
4563,Follicular Cell Differentiation,Papillary thyroid carcinoma,1
4564,Childhood Lesion,Childhood Adrenal Gland Pheochromocytoma,1
4565,Cutaneous Involvement,Mycosis fungoides stage I,1
4566,Malignant Germinomatous Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
4567,Low Mitotic Activity,Stage I Appendix Neuroendocrine Tumor AJCC v7,1
4568,Well-Circumscribed Lesion,Vulvar Angiomyofibroblastoma,1
4569,Blasts Expressing B-Lymphoid and Myeloid Markers Present,Mixed phenotype acute leukemia B/myeloid,1
4570,Carcinomatous Component Present,Stage IIIB Penile Cancer AJCC v8,1
4571,Adulthood Lesion,Adult Craniopharyngioma,1
4572,Malignant Cellular Infiltrate,Mucin-producing adenocarcinoma,1
4573,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,1
4574,Secondary Lesion,Metastatic Neuroblastoma,1
4575,Cellular Pleomorphism,Atypical neurofibroma,1
4576,No Evidence of Metastatic Disease,Benign Adrenal Gland Composite Pheochromocytoma,1
4577,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7,1
4578,Metastatic Lesion,Locally Advanced Basal Cell Carcinoma,1
4579,Multinodular Mass,Radiation-Related Angiosarcoma,1
4580,Carcinomatous Component Present,Unresectable Thyroid Gland Carcinoma,1
4581,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell",1
4582,Malignant Cellular Infiltrate,Stage IIIA Esophageal Adenocarcinoma AJCC v7,1
4583,Glial Differentiation,Desmoplastic infantile astrocytoma,1
4584,Monoclonal Langerhans Cells Present,Letterer-Siwe Disease,1
4585,High Mitotic Activity,Salivary duct carcinoma,1
4586,Benign Cellular Infiltrate,Giant Cell Lesion of Small Bones,1
4587,Epithelial Component Present,Vaginal Neuroendocrine Carcinoma,1
4588,Calcitonin serum level increased,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,1
4589,Malignant Cellular Infiltrate,Malignant Phyllodes Tumor of Prostate,1
4590,Neuroendocrine Differentiation,small cell carcinoma of kidney,1
4591,Refractory Disease,Marginal zone lymphoma refractory,1
4592,Anastomosing Strands of Tumor Cells Present,Odontoameloblastoma,1
4593,Carcinomatous Component Present,Stage IIA Small Intestinal Cancer AJCC v7,1
4594,Malignant Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage,1
4595,Carcinomatous Component Present,Pancreatic Medullary Carcinoma,1
4596,Malignant Cellular Infiltrate,Verrucous carcinoma of the oral cavity recurrent,1
4597,Dilated Terminal Duct Lobular Units Present,Columnar Cell Hyperplasia of the Breast with Atypia,1
4598,Neuroectodermal Differentiation,High-Risk Neuroblastoma,1
4599,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
4600,Epithelial Component Present,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
4601,Malignant Cellular Infiltrate,Adult Lymphoma,1
4602,Benign Cellular Infiltrate,"Adenoma, Sweat Gland",1
4603,Malignant Cellular Infiltrate,Peritoneal mesothelioma malignant advanced,1
4604,Recurrent Genetic Abnormalities Present,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",1
4605,Malignant Cellular Infiltrate,lymphoma of spinal cord,1
4606,Absence of Stromal Invasion,Borderline Ovarian Serous Adenofibroma,1
4607,Carcinomatous Component Present,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,1
4608,Thyroglobulin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Papillary Carcinoma,1
4609,Malignant Cellular Infiltrate,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome,1
4610,Severe dysplasia,Stage 0 Pancreatic Cancer AJCC v8,1
4611,Recurrent disease,Intrahepatic cholangiocarcinoma recurrent,1
4612,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
4613,Secondary Lesion,Carcinoma ex pleomorphic adenoma of parotid gland,1
4614,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
4615,Benign Cellular Infiltrate,Cervical Leiomyoma,1
4616,Malignant Cellular Infiltrate,Choroid Necrotic Melanoma,1
4617,Metastatic/Recurrent Disease,"Phosphaturic mesenchymal tumor, malignant",1
4618,Absence of Invasion,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
4619,Cervical lymphadenopathy,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
4620,Malignant Cellular Infiltrate,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
4621,Carcinomatous Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,1
4622,Cystic Change,Hidradenoma Papilliferum,1
4623,Benign Cellular Infiltrate,Mature Pericardial Teratoma,1
4624,Anaplasia,Anaplastic Oligoastrocytoma,1
4625,Extensive Stage Lesion,Advanced Cervical Adenocarcinoma,1
4626,Epithelial Component Present,Stage IB Vulvar Carcinoma AJCC v6,1
4627,Primary Lesion,Hepatoblastoma recurrent,1
4628,Immunoglobulin Deposition,Primary Systemic Amyloidosis,1
4629,Organoid Pattern,Alveolar Soft Part Sarcoma,1
4630,Thin-Branching Papillae Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
4631,Malignant Cellular Infiltrate,Intestinal T-Cell Lymphoma,1
4632,Malignant Cellular Infiltrate,malignant neoplasm of bone marrow,1
4633,Fibrotic Stroma Formation,mucoepidermoid carcinoma of floor of mouth,1
4634,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
4635,Myxoid Stroma Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
4636,Childhood Lesion,Childhood Salivary Gland Carcinoma,1
4637,Exophytic Papillary Lesion,verrucous carcinoma of esophagus,1
4638,Epithelial Component Present,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
4639,Malignant Cellular Infiltrate,"Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8",1
4640,Perineural spread,Cervical Adenoid Cystic Carcinoma,1
4641,Epithelial Component Present,Colon Carcinoma,1
4642,Malignant Cellular Infiltrate,Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8,1
4643,Dermal Involvement,Neuronevus,1
4644,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx recurrent,1
4645,Malignant Cellular Infiltrate,Stage I Choroidal and Ciliary Body Melanoma AJCC v8,1
4646,Epithelial Component Present,Bladder adenocarcinoma stage II,1
4647,Mitotic Activity,Malignant Ovarian Thecoma,1
4648,Malignant Cellular Infiltrate,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,1
4649,Malignant Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v7,1
4650,Childhood Lesion,Childhood Brain Glioblastoma,1
4651,Regional Disease,Locally Advanced Adrenal Gland Pheochromocytoma,1
4652,Adulthood Lesion,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
4653,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma,1
4654,Mesenchymal Component Present,Benign phyllodes neoplasm of breast,1
4655,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
4656,Eosinophilic inflammation,Cardiac Inflammatory Myofibroblastic Tumor,1
4657,Carcinomatous Component Present,Pancreatic Cancer by AJCC v6 and v7 Stage,1
4658,Epithelial Component Present,Combined Lung Carcinoma,1
4659,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
4660,Adulthood Lesion,Adult Synovial Sarcoma,1
4661,Secondary Lesion,Secondary Myelodysplastic Syndrome,1
4662,Malignant Cellular Infiltrate,Suprasellar Germinoma,1
4663,Metastatic Lesion,Advanced cancer,1
4664,Slow Growing Mass,Central Nervous System Hemangioblastoma,1
4665,Carcinomatous Component Present,Paget's disease of penis,1
4666,Malignant Cellular Infiltrate,Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
4667,Malignant Cellular Infiltrate,Oral Cavity Mucosal Melanoma,1
4668,Primary Lesion,Childhood Brain Stem Astrocytoma,1
4669,Childhood Lesion,Recurrent Childhood Kidney Neoplasm,1
4670,Epithelial Component Present,Unresectable Lung Non-Small Cell Carcinoma,1
4671,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia,1
4672,Solitary mass,Mediastinal Epithelioid Hemangioendothelioma,1
4673,Refractory Disease,Refractory Endometrial Clear Cell Adenocarcinoma,1
4674,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
4675,Platinum Resistance,Platinum-Resistant Urothelial Carcinoma,1
4676,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage,1
4677,Recurrent disease,Recurrent Acute Megakaryoblastic Leukemia,1
4678,Papillary Pattern,Vulvar Papillary Hidradenoma,1
4679,Epithelial Component Present,Vaginal clear cell adenocarcinoma,1
4680,Monomorphic Cellular Infiltrate,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
4681,Epithelial Component Present,Metastatic Breast Carcinoid Tumor,1
4682,Dual Population of Bone Marrow Blasts Present,Acute bilineal leukemia,1
4683,Mesenchymal Component Present,Malignant Vulvar Phyllodes Tumor,1
4684,Epithelial Component Present,Stage IVB Fallopian Tube Cancer AJCC v8,1
4685,Resectable Mass,Resectable Pancreatic Acinar Cell Carcinoma,1
4686,atypia morphology,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral",1
4687,Endobronchial Lesion,Respiratory papilloma,1
4688,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma recurrent,1
4689,Tissue Differentiation Uncertain,Refractory Synovial Sarcoma,1
4690,Carcinomatous Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7,1
4691,Biphasic Pattern,Stage IV Uterine Corpus Adenosarcoma AJCC v8,1
4692,Lipomatous Component Present,Angiomyolipoma,1
4693,Malignant Cellular Infiltrate,Colorectal Mixed Adenoneuroendocrine Carcinoma,1
4694,Cutaneous Involvement,Proliferative dermal lesion in congenital nevus,1
4695,Carcinomatous Component Present,Recurrent Lip and Oral Cavity Carcinoma,1
4696,Carcinomatous Component Present,Urothelial carcinoma ureter recurrent,1
4697,Neuroendocrine Differentiation,Superior and Inferior Paraaortic Paraganglioma,1
4698,Malignant Cellular Infiltrate,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
4699,Malignant Cellular Infiltrate,apocrine adenocarcinoma of vulva,1
4700,Malignant Cellular Infiltrate,Stage I Lung Cancer AJCC v6,1
4701,Cutaneous Involvement,Dermatophytosis of scalp and beard,1
4702,Mesenchymal Component Present,Giant fibroadenoma of breast,1
4703,Mixed Cellular Population,Benign mixed epithelial and stromal tumor of kidney,1
4704,Papillary Pattern,Papilloma of nasal vestibule,1
4705,Epithelial Component Present,Pancreatic Ductal Adenocarcinoma,1
4706,Thin Bands of Collagen Present,Thyroid Gland Solitary Fibrous Tumor,1
4707,Carcinomatous Component Present,Renal Cell Carcinoma Associated with Neuroblastoma,1
4708,Exophytic Polypoid Lesion,Colorectal Adenomatous Polyp,1
4709,Carcinomatous Component Present,Stage II Vaginal Cancer AJCC v6 and v7,1
4710,Nodular lesions,Thyroid Gland Oncocytic Adenoma,1
4711,Nuclear Pseudoinclusion,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
4712,Neuroendocrine Differentiation,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
4713,High Grade Lesion,Recurrent Childhood Giant Cell Glioblastoma,1
4714,Hyperplastic Tissue Present,Breast hyperplasia,1
4715,Carcinomatous Component Present,Metastatic gastric adenocarcinoma,1
4716,Epithelial Component Present,Ocular Sebaceous Carcinoma,1
4717,Schwannian Stroma More than 50 Percent of the Tumor Volume,Childhood Ganglioneuroblastoma,1
4718,Epithelial Component Present,Basal cell carcinoma,1
4719,Epithelial Component Present,Ovarian Sertoli-Stromal Cell Tumor,1
4720,Lobulated Growth Pattern,Right atrial myxoma,1
4721,Carcinomatous Component Present,Stage 0 Vulvar Cancer,1
4722,Fibrosis,"Breast Fibrocystic Change, Proliferative Type",1
4723,Epithelial Component Present,"Squamous cell carcinoma, clear cell type",1
4724,Hyperkeratosis,Papillary squamous cell carcinoma,1
4725,Malignant Cellular Infiltrate,Infiltrating papillary adenocarcinoma,1
4726,Mixed Cellular Population,"Malignant Mixed Tumor, Not Otherwise Specified",1
4727,Papillary Pattern,Condylomata Acuminata,1
4728,Epithelial Component Present,Hard Palate Squamous Cell Carcinoma,1
4729,Toxic effect,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
4730,Vascular Channel Formation,Central Nervous System Kaposi Sarcoma,1
4731,Malignant Cellular Infiltrate,Invasive Apocrine Breast Carcinoma,1
4732,Carcinomatous Component Present,Vaginal Large Cell Neuroendocrine Carcinoma,1
4733,In Situ Lesion,Carcinoma in situ in a polyp,1
4734,Curvilinear Thin-Walled Vascular Pattern,Cardiac Myxofibrosarcoma,1
4735,Perineural spread,Desmoplastic Neurotropic Melanoma,1
4736,Cutaneous Involvement,Congenital Nonbullous Ichthyosiform Erythroderma,1
4737,Malignant Cellular Infiltrate,Recurrent Ureter Carcinoma,1
4738,Childhood Lesion,Childhood Central Nervous System Choriocarcinoma,1
4739,Malignant Cellular Infiltrate,Grade 2 Invasive Breast Carcinoma,1
4740,Immunologic Deficiency Syndromes,HIV-Associated Lymphoproliferative Disorder,1
4741,Epithelial Component Present,Non-Functioning Endocrine Neoplasm,1
4742,Papillary Pattern,Papilloma of buccal mucosa,1
4743,Fibrotic Stroma Formation,Uterine Corpus Carcinofibroma,1
4744,Chromogranin A Positive Neoplastic Cells Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
4745,Epithelial Component Present,Small intestine carcinoma stage IV,1
4746,Castration-Naive,Castration-Naive Prostate Carcinoma,1
4747,Hereditary Lesion,Hereditary Leiomyomatosis and Renal Cell Cancer,1
4748,In Situ Lesion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
4749,Epithelial Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7,1
4750,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
4751,Biphasic Pattern,Cervical Adenomyoma,1
4752,Carcinomatous Component Present,Verrucous carcinoma of penis,1
4753,Nodular lesions,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
4754,Papillary Pattern,Papillary fibroelastoma,1
4755,Carcinomatous Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
4756,Malignant Cellular Infiltrate,Metastases to adrenals,1
4757,Carcinomatous Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
4758,Carcinomatous Component Present,Moderately Differentiated Hepatocellular Carcinoma,1
4759,Epithelial Component Present,Adenoma,1
4760,Malignant Cellular Infiltrate,Breast Lymphoma,1
4761,Malignant Cellular Infiltrate,Metastatic melanoma,1
4762,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
4763,Calcitonin serum level increased,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
4764,Adulthood Lesion,Adult Diffuse Astrocytoma,1
4765,Metastatic/Recurrent Disease,Adult Epithelioid Sarcoma,1
4766,Cystic Change,Testicular Brenner Tumor,1
4767,Metaplasia of Malignant Cells Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
4768,Malignant Cellular Infiltrate,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
4769,Dysplasia,Corneal intraepithelial neoplasia,1
4770,Malignant Cellular Infiltrate,Grade 3 Clear Cell Renal Cell Carcinoma,1
4771,Melanin Pigment Present,Pigmented Basal Cell Carcinoma,1
4772,Anaplasia,Stage II Childhood Anaplastic Large Cell Lymphoma,1
4773,Hemorrhagic,Hemangiosarcoma,1
4774,Malignant Cellular Infiltrate,Follicular thyroid carcinoma,1
4775,Malignant Cellular Infiltrate,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
4776,Absence of Stromal Invasion,Borderline epithelial tumor of ovary,1
4777,Malignant Cellular Infiltrate,Recurrent Transformed B-cell Non-Hodgkin Lymphoma,1
4778,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Germ Cell Tumor,1
4779,Desmoplastic Stroma Formation,Desmoplastic infantile astrocytoma,1
4780,Monoclonal Cellular Population Present,Microfollicular adenoma,1
4781,Extensive Stage Lesion,Advanced Uveal Melanoma,1
4782,Hyperplastic Epithelial Tissue Present,Atypical Ductal Breast Hyperplasia,1
4783,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma,1
4784,Cutaneous Involvement,Vulvar Seborrheic Keratosis,1
4785,Metastatic/Recurrent Disease,Extraskeletal Myxoid Chondrosarcoma,1
4786,Benign Cellular Infiltrate,Benign neoplasm of lymph vessels,1
4787,Malignant Cellular Infiltrate,Cloacogenic carcinoma,1
4788,Vascular Channel Formation,Breast Epithelioid Hemangioma,1
4789,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Poorly Differentiated Neuroblastoma,1
4790,Carcinomatous Component Present,Transplant-Related Skin Squamous Cell Carcinoma,1
4791,Hereditary Lesion,Rhabdoid tumor predisposition syndrome,1
4792,Benign Cellular Infiltrate,Ventricular myxoma,1
4793,Well Differentiated Hyaline Cartilage Present,"Chondrosarcoma, Clear Cell",1
4794,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",1
4795,Carcinomatous Component Present,Hereditary clear cell renal cell carcinoma,1
4796,Fried-Egg Appearance of the Bone Marrow,Refractory Hairy Cell Leukemia,1
4797,Malignant Cellular Infiltrate,Stage III Retroperitoneal Sarcoma AJCC v8,1
4798,Malignant Cellular Infiltrate,Advanced Unresectable Gastric Adenocarcinoma,1
4799,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage III,1
4800,Adulthood Lesion,Lugano Classification Adult Lymphoma by AJCC v8 Stage,1
4801,Malignant Cellular Infiltrate,Stage IIIB Distal Bile Duct Cancer AJCC v8,1
4802,Anaplasia,Malignant Meningioma,1
4803,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Cytopenia of Childhood,1
4804,Epithelial Component Present,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
4805,Local disease,Localized Primitive Neuroectodermal Tumor,1
4806,Vascular Channel Formation,Pyogenic granuloma,1
4807,Epithelial Component Present,"Carcinoma, Basal Cell",1
4808,Pseudolobular Pattern,Ovarian Sclerosing Stromal Tumor,1
4809,Acanthosis,Verrucous carcinoma of penis,1
4810,Nuclear pleomorphism,Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma,1
4811,Malignant Cellular Infiltrate,Stage II Colorectal Cancer AJCC v7,1
4812,Collagenous Stroma Formation,Recurrent Desmoid-Type Fibromatosis,1
4813,Cartilaginous Differentiation,Grade I Chondrosarcoma,1
4814,Malignant Cellular Infiltrate,Localized Resectable Neuroblastoma,1
4815,Eosinophil count raised (finding),Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,1
4816,Koilocytotic atypia,Cervical Warty Carcinoma,1
4817,Mild dysplasia,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,1
4818,Epithelial Component Present,Stage IVA Vulvar Cancer AJCC v7,1
4819,Diffuse Pattern,Adult Mixed Glioma,1
4820,Malignant Cellular Infiltrate,Osteosarcoma recurrent,1
4821,Malignant Cellular Infiltrate,Colon Cancer by AJCC v8 Stage,1
4822,Malignant Cellular Infiltrate,Unresectable Soft Tissue Sarcoma,1
4823,Malignant Cellular Infiltrate,Primary Peritoneal High Grade Serous Adenocarcinoma,1
4824,Epithelial Component Present,Colon Serrated Adenocarcinoma,1
4825,Epithelial Component Present,Metastatic Gastroesophageal Junction Adenocarcinoma,1
4826,Entrapped Respiratory Epithelium Present,Hamartoma of lung,1
4827,Malignant Cellular Infiltrate,Retinoblastoma by AJCC v8 Stage,1
4828,Carcinomatous Component Present,Tubular breast carcinoma,1
4829,Malignant Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
4830,Epithelial Component Present,adenoid cystic carcinoma of accessory sinus,1
4831,Exophytic Polypoid Lesion,Rectal Sessile Serrated Adenoma/Polyp,1
4832,High Grade Lesion,Dedifferentiated Solitary Fibrous Tumor,1
4833,Malignant Cellular Infiltrate,Mediastinal seminoma,1
4834,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma,1
4835,Necrotic changes (finding),Small cell lung cancer recurrent,1
4836,Carcinomatous Component Present,High Grade Mucoepidermoid Breast Carcinoma,1
4837,Cystic Change,"Cystadenocarcinoma, Mucinous",1
4838,Therapy-Related Toxicity,Methotrexate-Associated Burkitt Lymphoma,1
4839,Cellular Pleomorphism,High grade surface osteosarcoma,1
4840,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
4841,Primary Lesion,Refractory Central Nervous System Non-Hodgkin Lymphoma,1
4842,Carcinomatous Component Present,Stage IV Appendix Carcinoma AJCC v8,1
4843,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
4844,Malignant Cellular Infiltrate,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
4845,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
4846,Indolent Clinical Course,Encephalocraniocutaneous lipomatosis,1
4847,Benign Cellular Infiltrate,Hibernoma,1
4848,Necrotic changes (finding),Endometrial Small Cell Carcinoma,1
4849,Childhood Lesion,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
4850,Malignant Cellular Infiltrate,Metastatic Malignant Solid Neoplasm,1
4851,Carcinomatous Component Present,Human Papillomavirus-Related Squamous Cell Carcinoma,1
4852,Poorly Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
4853,Benign Cellular Infiltrate,Adult Pineocytoma,1
4854,Epithelial Component Present,Unresectable Thyroid Gland Carcinoma,1
4855,Benign Cellular Infiltrate,neurofibroma of esophagus,1
4856,Neuroendocrine Differentiation,Malignant carcinoid tumor of lung,1
4857,Neuroectodermal Differentiation,Undifferentiated Neuroblastoma,1
4858,Carcinomatous Component Present,Human Papillomavirus-Related Adenocarcinoma,1
4859,More than 5 Mitoses per 50HPF,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
4860,Radiation Sickness,Radiation Pneumonitis,1
4861,Carcinomatous Component Present,BCLC Stage B Hepatocellular Carcinoma,1
4862,Ground Glass Nuclear Inclusion,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
4863,Carcinomatous Component Present,Small Intestinal Neuroendocrine Carcinoma,1
4864,Malignant Cellular Infiltrate,small cell carcinoma of larynx,1
4865,Dysplasia,Low Grade Penile Intraepithelial Neoplasia,1
4866,Carcinomatous Component Present,Adrenal Cortex Carcinoma by AJCC v8 Stage,1
4867,S-100-Positive Neoplastic Cells Present,Langerhans Cell Sarcoma,1
4868,Tissue Differentiation Uncertain,Epithelioid Sarcoma NCI Grade 3,1
4869,Adulthood Lesion,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
4870,Childhood Lesion,Childhood Extragonadal Malignant Germ Cell Tumor,1
4871,Epithelial Component Present,Distal Bile Duct Carcinoma,1
4872,Secondary Lesion,Metastatic Hypopharyngeal Carcinoma,1
4873,Epithelial Component Present,Adenoma of small intestine,1
4874,Eosinophil count raised (finding),Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,1
4875,Metastatic/Recurrent Disease,Childhood Desmoplastic Small Round Cell Tumor,1
4876,Malignant Cellular Infiltrate,Malignant neoplasm of ureter,1
4877,Epithelial Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
4878,Recurrent disease,Neuroblastoma recurrent,1
4879,Diffuse Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
4880,Malignant Cellular Infiltrate,Stage I Burkitt Lymphoma,1
4881,Malignant Cellular Infiltrate,Mixed Cell Uveal Melanoma,1
4882,Absence of Stromal Invasion,Borderline epithelial tumor of ovary,1
4883,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v7,1
4884,Secondary Lesion,Metastatic Urethral Urothelial Carcinoma,1
4885,Benign Cellular Infiltrate,Mucinous adenofibroma,1
4886,Malignant Cellular Infiltrate,"Adenocarcinoma, Tubular",1
4887,Carcinomatous Component Present,Renal Cell Cancer by AJCC v8 Stage,1
4888,Benign Cellular Infiltrate,Benign neoplasm of Bartholin's gland,1
4889,Cystic Change,Malignant ovarian cyst,1
4890,Insular Pattern,Pancreatic Somatostatinoma,1
4891,Necrotic changes (finding),Necrotic intraocular melanoma,1
4892,Carcinomatous Component Present,Grade 1 Invasive Breast Carcinoma,1
4893,Metastatic Lesion,Adenocarcinoma of the prostate metastatic,1
4894,Papillary Pattern,Cervical Squamotransitional Carcinoma,1
4895,Slow Growing Mass,Brain Ependymoma,1
4896,Dysplasia,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
4897,Severe dysplasia,Anatomic Stage 0 Breast Cancer AJCC v8,1
4898,Cartilage-Like Elements Present,Clivus Chondroid Chordoma,1
4899,Indolent Clinical Course,fibroma of testis,1
4900,Indolent Clinical Course,Tufted angioma of skin,1
4901,Multinodular Pattern,Ancell-Spiegler cylindromas,1
4902,Carcinomatous Component Present,Stage II Fallopian Tube Cancer AJCC v8,1
4903,Malignant Cellular Infiltrate,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
4904,Congenital Lesion,Congenital anomaly of eyelid,1
4905,Malignant Cellular Infiltrate,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
4906,More than 5 Mitoses per 50HPF,Unresectable Gastrointestinal Stromal Tumor,1
4907,Epithelial Component Present,Stage III Renal Cell Cancer AJCC v7,1
4908,Carcinomatous Component Present,Skin Metatypical Carcinoma,1
4909,Mitotic Activity,MGMT-Methylated Glioblastoma,1
4910,Carcinomatous Component Present,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7,1
4911,Secondary Lesion,Metastatic Kidney Carcinoma,1
4912,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Sellar Choriocarcinoma,1
4913,Carcinomatous Component Present,Superficial basal cell carcinoma,1
4914,Extensive Stage Lesion,Advanced Renal Cell Carcinoma,1
4915,Well Differentiated Neuroendocrine Lesion,Advanced Pancreatic Neuroendocrine Tumor,1
4916,Lobulated Growth Pattern,Solid pseudopapillary tumor of the pancreas,1
4917,Malignant Cellular Infiltrate,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
4918,Malignant Cellular Infiltrate,Adenocarcinoma in situ in villous adenoma,1
4919,Benign Cellular Infiltrate,Benign tumor of external ear,1
4920,Carcinomatous Component Present,Stage III Lung Cancer AJCC v8,1
4921,Skin nodule,Fibroepithelioma of Pinkus,1
4922,Multinodular Mass,Pericardial Angiosarcoma,1
4923,Carcinomatous Component Present,Stage IIC Merkel Cell Carcinoma AJCC v7,1
4924,Malignant Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",1
4925,Unresectable Mass,Pancreatic carcinoma non-resectable,1
4926,Malignant Cellular Infiltrate,Colon Leiomyosarcoma,1
4927,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma,1
4928,Malignant Cellular Infiltrate,Acute lymphoblastic leukemia recurrent,1
4929,"Undifferentiated ""Fetal-Type"" Tissues Present","Teratoma, Malignant",1
4930,Malignant Cellular Infiltrate,Stage IV Breast Cancer AJCC v6 and v7,1
4931,Encapsulated Mass,Childhood Thyroid Gland Follicular Carcinoma,1
4932,Sonic Hedgehog/Patch Pathway Activated,"Refractory Medulloblastoma, SHH-Activated",1
4933,Carcinomatous Component Present,Stage IIA Breast Carcinoma,1
4934,Malignant Cellular Infiltrate,Lentigo maligna melanoma,1
4935,Peau d'orange surface of breast,Inflammatory carcinoma of breast recurrent,1
4936,Papillary Pattern,Ovarian Papillary Cystadenoma,1
4937,Cutaneous Involvement,Stage IV Skin Cancer,1
4938,Angiodestructive Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
4939,Malignant Cellular Infiltrate,Pancreatic carcinoma resectable,1
4940,Epithelial Component Present,stage IV pancreatic cancer,1
4941,Malignant Cellular Infiltrate,Renal carcinoma,1
4942,Dysplasia,High Grade Glandular Intraepithelial Neoplasia,1
4943,Fried-Egg Appearance of the Bone Marrow,Hairy Cell Leukemia,1
4944,Malignant Cellular Infiltrate,Stage IIA Vaginal Cancer AJCC v8,1
4945,Malignant Cellular Infiltrate,High Grade Salivary Gland Carcinoma,1
4946,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v8,1
4947,Epithelial Component Present,Stage IV Colorectal Cancer AJCC v7,1
4948,Epithelial Component Present,Carcinoma in situ of skin,1
4949,Benign Cellular Infiltrate,Anal Canal Squamous Papilloma,1
4950,Intestinal metaplasia of gastric mucosa,tubular adenoma of stomach,1
4951,Well Developed Rough Endoplasmic Reticulum Present,Densely Granulated Somatotroph Adenoma,1
4952,Acanthosis,Buccal Mucosa Verrucous Carcinoma,1
4953,Benign Cellular Infiltrate,Benign oncocytoma of salivary gland,1
4954,Well-Circumscribed Lesion,Pulmonary Sclerosing Hemangioma,1
4955,Neuroendocrine Differentiation,Small cell carcinoma of lung,1
4956,High Grade Lesion,Recurrent Glioblastoma,1
4957,Malignant Cellular Infiltrate,Recurrent Gastroesophageal Junction Adenocarcinoma,1
4958,Secondary Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,1
4959,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage III,1
4960,Malignant Cellular Infiltrate,Stage IIB Pancreatic Cancer AJCC v8,1
4961,Benign Cellular Infiltrate,Hemolymphangioma,1
4962,Benign Cellular Infiltrate,Benign neoplasm of scrotum,1
4963,Recurrent disease,Recurrent Thyroid Gland Papillary Carcinoma,1
4964,Benign Cellular Infiltrate,Epithelioid cell nevus,1
4965,Melanin Pigment Present,Melanocytic nevus of skin,1
4966,Well-Circumscribed Lesion,Neoplastic Polyp,1
4967,Malignant Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v8,1
4968,Metastatic Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,1
4969,Epithelial Component Present,Stage IIIB Small Intestinal Cancer AJCC v7,1
4970,Epithelial Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8,1
4971,High Grade Lesion,Unresectable Dedifferentiated Liposarcoma,1
4972,Benign Cellular Infiltrate,Mixed Cell Adrenal Cortical Adenoma,1
4973,Above the Diaphragm Disease,Hodgkin's disease mixed cellularity stage I supradiaphragmatic,1
4974,Metastatic Lesion,Disseminated Malignant Neoplasm,1
4975,Primary Lesion,Recurrent Glioblastoma,1
4976,Carcinomatous Component Present,Mucinous adenocarcinoma gastric,1
4977,Local disease,Localized Resectable Adult Liver Carcinoma,1
4978,Metastatic Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,1
4979,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage,1
4980,Pathologic TNM Finding,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
4981,Epithelial Component Present,Stage IVB Vulvar Cancer AJCC v6 and v7,1
4982,Melanin Pigment Present,Common blue nevus of skin,1
4983,Benign Cellular Infiltrate,Solitary Osteochondroma,1
4984,Nested Pattern,Gonadoblastoma,1
4985,Mixed Cellular Population,Recurrent Childhood Oligoastrocytoma,1
4986,Malignant Cellular Infiltrate,Childhood Testicular Embryonal Carcinoma,1
4987,Secondary Lesion,Stage IV Esophageal Squamous Cell Carcinoma,1
4988,Myxoid Stroma Formation,Neurothekeoma,1
4989,Dysplasia,Grade II Glandular Intraepithelial Neoplasia,1
4990,Recurrent Lymphoma,Recurrent EBV-Related Lymphoma,1
4991,Malignant Cellular Infiltrate,Malignant Abdominal Neoplasm,1
4992,Malignant Cellular Infiltrate,malignant lymphoma of mediastinum,1
4993,Absence of Invasion,Stage 0is Urethral Cancer AJCC v7,1
4994,Malignant Cellular Infiltrate,Stage IVC Pharyngeal Carcinoma,1
4995,Malignant Cellular Infiltrate,Pediatric Extraocular Retinoblastoma,1
4996,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
4997,Epithelial Component Present,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
4998,Infiltrating Tumor Margins Present,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
4999,Fibrotic Stroma Formation,Benign Brenner Tumor,1
5000,Carcinomatous Component Present,"Carcinoma bladder stage I, without cancer in situ",1
5001,Vascular Channel Formation,Kaposi's sarcoma of extrahepatic bile duct,1
5002,Presence of a Hormonal Syndrome,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
5003,Carcinomatous Component Present,Adrenal Cortex Carcinoma by AJCC v8 Stage,1
5004,Carcinomatous Component Present,Ampulla of Vater Neuroendocrine Carcinoma,1
5005,Mixed Cellular Population,Pleomorphic adenoma of parotid gland,1
5006,Epithelial Component Present,Non-Invasive Urothelial Neoplasm,1
5007,Recurrent disease,Recurrent T Acute Lymphoblastic Leukemia,1
5008,Cystic Change,Malignant Brenner Tumor,1
5009,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation,1
5010,Carcinomatous Component Present,Gallbladder Goblet Cell Carcinoid,1
5011,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
5012,Metastatic Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
5013,Refractory Disease,Refractory Pancreatic Carcinoma,1
5014,Malignant Cellular Infiltrate,Osteosarcoma Arising in Paget Disease of Bone,1
5015,Malignant Cellular Infiltrate,Stage IVC Nasopharyngeal Carcinoma AJCC v7,1
5016,Epithelial Component Present,Breast Complex Fibroadenoma,1
5017,Neuroendocrine Differentiation,Carotid Body Paraganglioma,1
5018,Locally Aggressive Lesion,Intermediate Soft Tissue Tumor,1
5019,Epithelial Component Present,Anatomic Stage IV Breast Cancer AJCC v8,1
5020,Neuroendocrine Differentiation,Stage IIB Merkel Cell Carcinoma AJCC v7,1
5021,Malignant Cellular Infiltrate,Stage II Cutaneous Melanoma AJCC v6 and v7,1
5022,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, inv(16)(p13q22)",1
5023,Malignant Cellular Infiltrate,Supraglottic Squamous Cell Carcinoma,1
5024,Metastatic Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,1
5025,Stromal Invasion,Recurrent Ovarian Mucinous Adenocarcinoma,1
5026,Malignant Cellular Infiltrate,Vulvar Adenocarcinoma of Mammary Gland Type,1
5027,Indolent Clinical Course,"Mixed Tumor, Not Otherwise Specified",1
5028,Carcinomatous Component Present,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
5029,Neuroectodermal Differentiation,Stage 4S neuroblastoma,1
5030,Adnexal Differentiation,Adenoid cystic eccrine carcinoma,1
5031,Invasive Lesion,Breast Carcinoma with Osseous Metaplasia,1
5032,Carcinomatous Component Present,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5033,Adulthood Lesion,Adult Diffuse Astrocytoma,1
5034,High Grade Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
5035,Secondary Lesion,Metastatic Triple-Negative Breast Carcinoma,1
5036,Malignant Cellular Infiltrate,Anal Cancer by AJCC v8 Stage,1
5037,Rapidly Enlarging Mass,Adult Rhabdomyosarcoma,1
5038,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,1
5039,Microvascular Proliferation,Classical Glioblastoma,1
5040,Borderline Lesion,Non-IgM Monoclonal Gammopathy of Undetermined Significance,1
5041,Capillary Sized Vascular Channel Formation,Hemangioblastoma,1
5042,Benign Cellular Infiltrate,Benign Adult Brain Neoplasm,1
5043,Epithelial Component Present,Rectal Carcinoma Metastatic in the Liver,1
5044,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
5045,Papillary Pattern,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
5046,Malignant Cellular Infiltrate,Recurrent Glioblastoma,1
5047,Cutaneous Involvement,Exacerbation of acne,1
5048,Malignant Cellular Infiltrate,Advanced Melanoma,1
5049,Epithelial Component Present,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
5050,Childhood Lesion,Childhood Astrocytoma,1
5051,Lesion with Diameter of 5cm or Less,"Gastrointestinal stromal tumor, benign",1
5052,Epithelial Component Present,Dermal Duct Tumor,1
5053,Malignant Cellular Infiltrate,Cardiac Rhabdomyosarcoma,1
5054,Benign Cellular Infiltrate,Myxoma,1
5055,Plasma cell inflammation,Inflammatory pseudotumor of liver,1
5056,Epithelial Component Present,Stage II Vaginal Cancer AJCC v8,1
5057,More than 10 Mitoses per 10HPF,Refractory Extensive Stage Lung Small Cell Carcinoma,1
5058,Epithelial Component Present,Fallopian Tube Cancer by AJCC v7 Stage,1
5059,Absence of Invasion,Lobular Neoplasia,1
5060,Composite Lesion,Recurrent Combined Thymic Epithelial Neoplasm,1
5061,Malignant Cellular Infiltrate,"Childhood Ganglioneuroblastoma, Nodular",1
5062,Diffuse Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
5063,Epithelial Component Present,Ampulla of Vater Gangliocytic Paraganglioma,1
5064,Hypercellular bone marrow,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
5065,Carcinomatous Component Present,Adenocarcinoma of large intestine,1
5066,Benign Cellular Infiltrate,Benign Outer Hair Sheath and Infundibulum Neoplasm,1
5067,Negative Peripheral Blood,Aleukemic Acute Lymphoblastic Leukemia,1
5068,Borderline Lesion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
5069,Benign Cellular Infiltrate,Vulvar Leiomyoma,1
5070,Hereditary Lesion,Werner Syndrome,1
5071,Epithelial Component Present,Stage IV Colorectal Cancer AJCC v7,1
5072,Osteoid formation,Mediastinal Extraskeletal Osteosarcoma,1
5073,Epithelial Component Present,Stage III Oral Cavity Cancer AJCC v6 and v7,1
5074,Slow Growing Mass,Plexiform fibrohistiocytic tumor,1
5075,Malignant Cellular Infiltrate,Extraskeletal Myxoid Chondrosarcoma,1
5076,Benign Cellular Infiltrate,Leiomyomatosis,1
5077,Indolent Clinical Course,hemangioma of mediastinum,1
5078,Malignant Cellular Infiltrate,Stage IVB Fallopian Tube Cancer AJCC v8,1
5079,Epithelial Component Present,"Pancreatic carcinoma, familial",1
5080,Malignant Cellular Infiltrate,DDIT4L Acute Lymphoblastic Leukemia,1
5081,Mixed Cellular Population,Nonanaplastic Kidney Wilms Tumor,1
5082,Benign Cellular Infiltrate,Clear cell cystadenofibroma,1
5083,Epithelial Component Present,Stage IA Ovarian Cancer,1
5084,Metastatic Lesion,Prostate Carcinoma Metastatic in the Lung,1
5085,Malignant Cellular Infiltrate,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
5086,Ineffective hematopoiesis,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
5087,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Adenocarcinoma,1
5088,Well-Circumscribed Lesion,Adult Type Testicular Granulosa Cell Tumor,1
5089,Diffuse Lesion,Recurrent Diffuse Intrinsic Pontine Glioma,1
5090,Refractory Disease,Refractory Human Papillomavirus-Related Malignant Neoplasm,1
5091,'Starry-sky' pattern,Burkitt's lymphoma of small intestine,1
5092,Benign Cellular Infiltrate,Cardiac Lipoma,1
5093,Diffuse Pattern,Childhood Gliomatosis Cerebri,1
5094,Epithelial Component Present,Distal Esophagus Squamous Cell Carcinoma,1
5095,Cellular Changes Resembling Foveolar Epithelium Cells,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
5096,Indolent Clinical Course,Cerebral hemangioma,1
5097,Thin Bands of Collagen Present,Dedifferentiated Solitary Fibrous Tumor,1
5098,Malignant Cellular Infiltrate,"Spindle cell melanoma, type B",1
5099,Hemorrhagic,Angiosarcoma of spleen,1
5100,Childhood Lesion,Childhood Neuroblastoma,1
5101,Carcinomatous Component Present,Refractory Female Reproductive System Carcinoma,1
5102,Malignant Cellular Infiltrate,Fallopian Tube Adenocarcinoma,1
5103,Malignant Cellular Infiltrate,solid type ductal carcinoma in situ of breast,1
5104,Refractory Disease,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
5105,Fibrosis,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
5106,Malignant Cellular Infiltrate,Ampulla of Vater Hepatoid Adenocarcinoma,1
5107,Fibromyxoid Stroma Formation,Acral Fibromyxoma,1
5108,Malignant Cellular Infiltrate,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
5109,Carcinomatous Component Present,Anatomic Stage II Breast Cancer AJCC v8,1
5110,Malignant Cellular Infiltrate,Renal Pelvis Cancer by AJCC v8 Stage,1
5111,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pleura,1
5112,Carcinomatous Component Present,Major Salivary Gland Carcinoma,1
5113,Chromogranin A Positive Neoplastic Cells Present,Advanced Carcinoid Tumor,1
5114,Epithelial Component Present,Fallopian Tube Squamous Cell Carcinoma,1
5115,Benign Cellular Infiltrate,Benign neoplasm of glottis,1
5116,Epithelial Component Present,Colorectal Adenosquamous Carcinoma,1
5117,Extraosseous Lesion,Peripheral primitive neuroectodermal tumor of soft tissue,1
5118,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anaemia with excess blasts,1
5119,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage,1
5120,Cutaneous Involvement,Erythema toxicum neonatorum,1
5121,Epithelial Component Present,Advanced Lung Non-Small Cell Squamous Carcinoma,1
5122,Epithelial Component Present,Small Intestinal Adenocarcinoma by AJCC v8 Stage,1
5123,Metastatic Lesion,Locally Advanced Head and Neck Carcinoma,1
5124,Epithelial Component Present,Renal Cell Carcinoma Associated with Neuroblastoma,1
5125,Benign Cellular Infiltrate,Cellular Schwannoma,1
5126,Biphasic Pattern,serous adenocarcinofibroma of ovary,1
5127,Hyperplastic Tissue Present,Squamous Hyperplasia,1
5128,Carcinomatous Component Present,Squamous cell carcinoma of tonsil,1
5129,Parakeratinized Stratified Squamous Epithelium Present,Keratocystic Odontogenic Tumor,1
5130,Papillary Pattern,Laryngeal papillomatosis,1
5131,Therapy-Related Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
5132,Malignant Cellular Infiltrate,Adult Angiosarcoma,1
5133,Epithelial Component Present,Choroid Plexus Papilloma,1
5134,Malignant Cellular Infiltrate,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma,1
5135,Malignant Cellular Infiltrate,Acute monoblastic leukemia,1
5136,Malignant Cellular Infiltrate,Laryngeal verrucous carcinoma stage IV,1
5137,Malignant Cellular Infiltrate,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8,1
5138,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
5139,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP E",1
5140,Carcinomatous Component Present,Stage II Fallopian Tube Cancer AJCC v8,1
5141,Necrotic changes (finding),Prostate Stromal Sarcoma,1
5142,Immunologic Deficiency Syndromes,Renal Allograft Thrombosis,1
5143,Malignant Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
5144,Well-Circumscribed Lesion,Pineocytoma,1
5145,Fibrotic Stroma Formation,Ovarian Clear Cell Adenofibroma,1
5146,Epithelial Component Present,Familial Nonmedullary Thyroid Gland Carcinoma,1
5147,Carcinomatous Component Present,Stage IIB Gastric Cancer AJCC v7,1
5148,Epithelial Component Present,Locally Advanced Salivary Gland Carcinoma,1
5149,Cutaneous Involvement,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,1
5150,Well Differentiated Neuroendocrine Lesion,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
5151,Well Differentiated Neuroendocrine Lesion,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,1
5152,Malignant Cellular Infiltrate,Ann Arbor Stage IIIB Hodgkin Lymphoma,1
5153,Malignant Cellular Infiltrate,Refractory Chronic Leukemia,1
5154,Papillary Pattern,Intraductal papillary adenocarcinoma with invasion,1
5155,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of gallbladder,1
5156,Metastatic Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
5157,Cutaneous Involvement,Solar lentigo,1
5158,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
5159,Malignant Cellular Infiltrate,Parotid Gland Carcinoma,1
5160,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v8,1
5161,Indolent Clinical Course,Uterine Corpus Dissecting Leiomyoma,1
5162,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",1
5163,Geographic Necrosis,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
5164,Firm mass,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
5165,Malignant Cellular Infiltrate,Stage IVB Rectal Cancer AJCC v8,1
5166,Non-Invasive Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
5167,Epithelial Component Present,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,1
5168,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8,1
5169,Hereditary Lesion,"Colorectal cancer, hereditary nonpolyposis, type 1",1
5170,Cutaneous Involvement,Folliculitis,1
5171,Dysplasia,Endometrial intraepithelial neoplasia,1
5172,Recurrent disease,Recurrent Childhood Rhabdomyosarcoma,1
5173,Multinodular Mass,Angiosarcoma of liver,1
5174,Childhood Lesion,Childhood Extraskeletal Osteosarcoma,1
5175,Insular Pattern,"Somatostatinoma, malignant",1
5176,Osseous Differentiation,Extraskeletal osteosarcoma non-metastatic,1
5177,Infiltrative Growth Pattern,Secondary Supratentorial Anaplastic Astrocytoma,1
5178,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx,1
5179,CD1a-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis,1
5180,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myelomonocytic, Chronic",1
5181,Epithelial Component Present,Metastatic Carcinoma in the Lung,1
5182,Primary Lesion,Epithelioid sarcoma non-metastatic,1
5183,Hereditary Lesion,"Elliptocytosis, Hereditary",1
5184,Papillary Pattern,Plantar Verrucous Skin Carcinoma,1
5185,Cutaneous Involvement,Carcinoma ex Eccrine Spiradenoma,1
5186,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Acute Erythroblastic Leukemia,1
5187,Malignant Cellular Infiltrate,EZB Diffuse Large B-Cell Lymphoma,1
5188,Epithelial Component Present,Stage IV Oropharyngeal Carcinoma,1
5189,Carcinomatous Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,1
5190,Exophytic Papillary Lesion,Verrucous carcinoma of oral cavity,1
5191,Epithelial Component Present,Cholangiolocellular Carcinoma,1
5192,Syncytial Pattern,Laryngeal Lymphoepithelial Carcinoma,1
5193,Clinical TNM Finding,Clinical Stage IV Cutaneous Melanoma AJCC v8,1
5194,Antoni A Pattern,Neurilemmoma,1
5195,Mixed Cellular Population,Juvenile fibroadenoma of breast,1
5196,Malignant Cellular Infiltrate,Ovarian Cancer by AJCC v6 and v7 Stage,1
5197,Benign Cellular Infiltrate,Vulvar Trichoepithelioma,1
5198,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v7,1
5199,Necrotic changes (finding),Esophageal Malignant Peripheral Nerve Sheath Tumor,1
5200,Malignant Cellular Infiltrate,Metastatic Thyroid Gland Carcinoma,1
5201,Malignant Cellular Infiltrate,Chronic myeloproliferative disorder,1
5202,Secondary Lesion,Advanced Cervical Carcinoma,1
5203,Secondary Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,1
5204,Carcinomatous Component Present,Advanced Prostate Carcinoma,1
5205,High Mitotic Activity,Malignant Granulosa Cell Tumor,1
5206,Low Mitotic Activity,Stage I Duodenal Neuroendocrine Tumor AJCC v8,1
5207,Borderline Lesion,Borderline cystadenoma,1
5208,Vascular Channel Formation,Bone Epithelioid Hemangioma,1
5209,Biphasic Pattern,gliosarcoma,1
5210,Malignant Cellular Infiltrate,Adult Hodgkin Lymphoma,1
5211,Carcinomatous Component Present,Anatomic Stage IIA Breast Cancer AJCC v8,1
5212,Malignant Cellular Infiltrate,Recurrent Acute Megakaryoblastic Leukemia,1
5213,Malignant Cellular Infiltrate,Metastatic Epithelioid Hemangioendothelioma,1
5214,More than 5 Mitoses per 50HPF,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage",1
5215,Epithelial Component Present,Low Grade Gastric Intraepithelial Neoplasia,1
5216,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v8,1
5217,Severe cytologic atypia,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
5218,Carcinomatous Component Present,Stage 0is Renal Pelvis Cancer AJCC v8,1
5219,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Ovarian Endometrioid Tumor,1
5220,Necrotic changes (finding),Endometrial Small Cell Carcinoma,1
5221,Malignant Cellular Infiltrate,Acute Lymphoblastic Leukemia by ROSE Cluster,1
5222,Carcinomatous Component Present,Metastatic Kidney Medullary Carcinoma,1
5223,Epithelial Component Present,Common wart,1
5224,Absence of Invasion,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,1
5225,Well-Circumscribed Lesion,Malignant Vulvar Phyllodes Tumor,1
5226,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Endometrial Endometrioid Adenocarcinoma,1
5227,Epithelial Component Present,Metastatic Lung Small Cell Carcinoma,1
5228,Epithelial Component Present,Recurrent Oral Cavity Carcinoma,1
5229,Secondary Lesion,Advanced Melanoma,1
5230,Recurrent disease,Recurrent Rhabdomyosarcoma,1
5231,Childhood Lesion,"Optic Nerve Glioma, Childhood",1
5232,IDH Gene Family Mutation Status Unknown,Diffuse Astrocytoma,1
5233,Secondary Lesion,Secondary malignant neoplasm of liver,1
5234,Non-Invasive Lesion,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
5235,Unresectable Mass,Locally Advanced Unresectable Gastric Adenocarcinoma,1
5236,Low Grade Lesion,Extracutaneous Mastocytoma,1
5237,Epithelial Component Present,Histiocytoid Breast Carcinoma,1
5238,Diffuse Pattern,Diffuse malignant mesothelioma,1
5239,Diffuse Pattern,Double expressor lymphoma,1
5240,Low Mitotic Activity,Colorectal Neuroendocrine Tumor G2,1
5241,Epithelial Component Present,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
5242,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
5243,Follicular Cell Differentiation,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
5244,Fibrotic Stroma Formation,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8,1
5245,Secondary Lesion,Breast Carcinoma Metastatic in the Spine,1
5246,Biphasic Pattern,Ovarian Serous Adenofibroma,1
5247,High Grade Lesion,Refractory Dedifferentiated Liposarcoma,1
5248,Lymphadenopathy,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
5249,Malignant Cellular Infiltrate,Paget Disease Extramammary,1
5250,Glial Differentiation,Recurrent Childhood Gliosarcoma,1
5251,Cutaneous Involvement,Dermatophytosis of groin and perianal area,1
5252,Exophytic Polypoid Lesion,Adenoma of rectum,1
5253,Poorly Differentiated Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma,1
5254,Malignant Cellular Infiltrate,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
5255,Neuroendocrine Differentiation,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
5256,Calcinosis,Calcifying Odontogenic Cyst,1
5257,Epithelial Component Present,Grade 1 Colorectal Adenocarcinoma,1
5258,Diffuse Pattern,Anaplastic Brain Stem Astrocytoma,1
5259,Malignant Cellular Infiltrate,Malignant neoplasm of urinary bladder,1
5260,Epithelial Component Present,Malignant Sertoli Cell Tumor,1
5261,Endophytic Tumor Growth,Verrucous carcinoma of oral cavity,1
5262,Carcinomatous Component Present,mucinous adenocarcinoma of ovary,1
5263,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
5264,atypia morphology,Atypical Breast Myoepitheliosis,1
5265,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Acute Myelomonocytic Leukemia,1
5266,Recurrent disease,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",1
5267,Adulthood Lesion,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
5268,Borderline Resectable Mass,Borderline Resectable Pancreatic Carcinoma,1
5269,Monoclonal Langerhans Cells Present,Recurrent Langerhans Cell Histiocytosis,1
5270,Malignant Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
5271,Malignant Cellular Infiltrate,Ann Arbor Stage IV AIDS-Related Lymphoma,1
5272,Rapidly Enlarging Mass,Recurrent Alveolar Rhabdomyosarcoma,1
5273,Epithelial Component Present,Clear cell papillary renal cell carcinoma,1
5274,Malignant Cellular Infiltrate,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
5275,Malignant Cellular Infiltrate,Nonencapsulated sclerosing tumor,1
5276,Malignant Cellular Infiltrate,Cervical Papillary Squamous Cell Carcinoma,1
5277,Low Mitotic Activity,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
5278,Cutaneous Involvement,Pathologic Stage IV Cutaneous Melanoma AJCC v8,1
5279,Primary Lesion,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
5280,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
5281,Varicosity,Coronary Venous Dissection,1
5282,Papillary Pattern,"Transitional cell papilloma, inverted",1
5283,Epithelial Component Present,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
5284,Malignant Cellular Infiltrate,Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7,1
5285,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
5286,Recurrent disease,Recurrent Ovarian Cystadenocarcinoma,1
5287,Carcinomatous Component Present,Stage II Anal Canal Cancer AJCC v6 and v7,1
5288,Endophytic Tumor Growth,Verrucous carcinoma of oral cavity,1
5289,Cutaneous Involvement,Congenital hypotrichia,1
5290,Benign Cellular Infiltrate,Ovarian Adenomatoid Tumor,1
5291,Unresectable Mass,Unresectable Solid Neoplasm,1
5292,Recurrent disease,Recurrent Salivary Duct Carcinoma,1
5293,Metastatic Lesion,Metastatic Vulvar Carcinoma,1
5294,Epithelial Component Present,Mucinous neoplasm,1
5295,Malignant Cellular Infiltrate,Stage IV Cutaneous Melanoma AJCC v6 and v7,1
5296,Carcinomatous Component Present,Luminal B Breast Carcinoma,1
5297,Lymphoplasmacytic Infiltrate,Angiocentric immunoproliferative lesion grade 2,1
5298,Mixed Cellular Population,"Mixed Tumor, Not Otherwise Specified",1
5299,Carcinomatous Component Present,Stage 0a Ureter Cancer AJCC v7,1
5300,Defective Heavy Chain Present,gamma-Chain Disease,1
5301,Unresectable Mass,Locally Advanced Unresectable Basal Cell Carcinoma,1
5302,Epithelial Component Present,Hard Palate Adenoid Cystic Carcinoma,1
5303,Chronic Inflammatory Infiltrate,Dysgerminoma,1
5304,Nuclear Molding,Small cell carcinoma of lung,1
5305,Epithelial Component Present,Stage IIIB Esophageal Adenocarcinoma AJCC v7,1
5306,Epithelial Component Present,Benign Testicular Sertoli Cell Tumor,1
5307,Carcinomatous Component Present,Recurrent Carcinoma,1
5308,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA,1
5309,Malignant Cellular Infiltrate,Ductal Carcinoma In Situ with Microinvasion,1
5310,Indolent Clinical Course,Lipoblastoma,1
5311,Cutaneous Involvement,Mucoepidermoid carcinoma of skin,1
5312,Indolent Clinical Course,Extrahepatic Bile Duct Fibroma,1
5313,Malignant Cellular Infiltrate,Recurrent Hairy Cell Leukemia,1
5314,Exophytic Polypoid Lesion,Hamartomatous polyposis,1
5315,Carcinomatous Component Present,Maxillary Sinus Carcinoma,1
5316,Benign Cellular Infiltrate,Rectal Lipoma,1
5317,Secondary Lesion,carcinoma ex pleomorphic adenoma of salivary gland,1
5318,Primary Lesion,Adult Pineal Gland Astrocytoma,1
5319,Intraductal Lesion,High Grade Ductal Breast Carcinoma In Situ,1
5320,Granulocytes Increased in Bone Marrow,Overt Primary Myelofibrosis,1
5321,Primary Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7,1
5322,Malignant Cellular Infiltrate,"Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2",1
5323,Childhood Lesion,Recurrent Childhood Brain Stem Glioma,1
5324,Schwannian Stroma Predominant Component of the Tumor Volume,Ganglioneuromatosis,1
5325,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,"Acute Myeloid Leukemia, M1",1
5326,Metaplasia,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1
5327,Chronic lymphocytic inflammation,"Thymoma, type AB, malignant",1
5328,Mixed Cellular Population,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
5329,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v8,1
5330,Benign Cellular Infiltrate,Epidural Spinal Canal Angiolipoma,1
5331,Epithelial Component Present,"Breast Cancer, Familial",1
5332,atypia morphology,Simple Endometrial Hyperplasia with Atypia,1
5333,Malignant Cellular Infiltrate,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,1
5334,Epithelial Component Present,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
5335,Diffuse Pattern,ALK positive large B-cell lymphoma,1
5336,Epithelial Component Present,Stage II Primary Peritoneal Cancer AJCC v8,1
5337,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v7 Stage,1
5338,Carcinomatous Component Present,Nipple Carcinoma,1
5339,Carcinomatous Component Present,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
5340,Malignant Cellular Infiltrate,mucinous adenocarcinoma of anus,1
5341,Papillary Pattern,"Papillomatosis, glandular",1
5342,Desmoplastic Stroma Formation,Desmoplastic Neurotropic Melanoma,1
5343,Mixed Cellular Population,Benign phyllodes neoplasm of breast,1
5344,Malignant Cellular Infiltrate,Pathologic Stage I Gastric Cancer AJCC v8,1
5345,Hyperkeratosis,papillary carcinoma of penis,1
5346,Carcinomatous Component Present,Vaginal Adenoid Cystic Carcinoma,1
5347,Non-Contiguous Disease,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
5348,Malignant Cellular Infiltrate,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8,1
5349,Carcinomatous Component Present,Anal canal squamous cell carcinoma,1
5350,Malignant Cellular Infiltrate,Cholangiolocellular Carcinoma,1
5351,Benign Cellular Infiltrate,Benign Adult Brain Stem Neoplasm,1
5352,Necrotic changes (finding),Combined Lung Large Cell Neuroendocrine Carcinoma,1
5353,Refractory Disease,Chronic lymphocytic leukemia refractory,1
5354,Intermediate Grade Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2,1
5355,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
5356,Epithelial Component Present,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",1
5357,Carcinomatous Component Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
5358,Secondary Lesion,Secondary malignant neoplasm of small intestine,1
5359,Carcinomatous Component Present,Anal Intraepithelial Neoplasia 3,1
5360,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
5361,Metastatic Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma,1
5362,CD1a-Positive Neoplastic Cells Present,Eosinophilic Granuloma,1
5363,Carcinomatous Component Present,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
5364,Recurrent disease,Recurrent Childhood Glioblastoma,1
5365,Carcinomatous Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
5366,Secondary Lesion,Melanoma Metastatic in the Central Nervous System,1
5367,Carcinomatous Component Present,Non-small cell lung cancer stage II,1
5368,Mixed Cellular Population,Malignant Vulvar Phyllodes Tumor,1
5369,Carcinomatous Component Present,Stage IIC Appendix Carcinoma AJCC v8,1
5370,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v8,1
5371,Heterologous Elements Present,Intraocular Teratoid Medulloepithelioma,1
5372,Epithelial Component Present,Renal Pelvis and Ureter Cancer by AJCC v7 Stage,1
5373,Malignant Cellular Infiltrate,Colon Micropapillary Adenocarcinoma,1
5374,Invasive Lesion,Intraductal papillary adenocarcinoma with invasion,1
5375,Carcinomatous Component Present,Stage IVA Gallbladder Cancer AJCC v8,1
5376,Carcinomatous Component Present,Endometrioid adenocarcinoma recurrent,1
5377,Benign Cellular Infiltrate,Cystadenofibroma,1
5378,Malignant Cellular Infiltrate,Stage 4S neuroblastoma,1
5379,High Mitotic Activity,Small Intestinal Neuroendocrine Carcinoma,1
5380,Nidus Formation,Aggressive osteoblastoma,1
5381,Carcinomatous Component Present,Stage IV Intrahepatic Bile Duct Cancer AJCC v8,1
5382,Nuclear Atypia,Childhood Glioblastoma,1
5383,Absence of Invasion,Adenocarcinoma in Situ,1
5384,Childhood Lesion,Refractory Diffuse Intrinsic Pontine Glioma,1
5385,Carcinomatous Component Present,Gingival Squamous Cell Carcinoma,1
5386,Pagetoid Proliferation,Stage II Superficial Spreading Melanoma AJCC v6 and v7,1
5387,Lymphoplasmacytic Infiltrate,Adult Central Nervous System Germinoma,1
5388,Epithelial Component Present,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
5389,Exophytic Polypoid Lesion,Malignant lymphomatous polyposis,1
5390,Epithelial Component Present,Squamous cell carcinoma of pharynx,1
5391,Epithelial Component Present,Ovarian Signet Ring Stromal Tumor,1
5392,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,1
5393,Cutaneous Involvement,Glomus tumor of skin,1
5394,Malignant Cellular Infiltrate,Stage III Hodgkin Lymphoma,1
5395,Metastatic Lesion,Secondary malignant neoplasm of peritoneum,1
5396,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor,1
5397,Malignant Cellular Infiltrate,Localized Carcinoma,1
5398,Intraductal Lesion,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,1
5399,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5400,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myelomonocytic Leukemia,1
5401,Angiodestructive Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
5402,Perivascular Arrangement of Tumor Cells,Childhood Kidney Angiomyolipoma,1
5403,Childhood Lesion,Extrarenal rhabdoid tumor,1
5404,Osteosclerotic Lesion,Osteosclerotic Plasma Cell Myeloma,1
5405,Intracellular Accumulation of Lipids,Pleomorphic Xanthoastrocytoma,1
5406,Adnexal Differentiation,Malignant Germinative Follicular Epithelium Neoplasm,1
5407,Cutaneous Involvement,Lymphomatoid Papulosis,1
5408,Primary Lesion,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
5409,Eosinophilic inflammation,Bone Epithelioid Hemangioma,1
5410,Necrotic changes (finding),Recurrent Glioblastoma,1
5411,Splenomegaly,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant",1
5412,Primary Lesion,Frontal Lobe Anaplastic Astrocytoma,1
5413,Indolent Clinical Course,Vulvar Leiomyoma,1
5414,Mixed Cellular Population,Fallopian Tube Adenosarcoma,1
5415,Pseudoglandular Pattern,Childhood Testicular Embryonal Carcinoma,1
5416,Cytoplasmic Membrane-Bound Granules Present,Stage IIC Merkel Cell Carcinoma AJCC v7,1
5417,Tissue of Mullerian Origin Present,Adenosarcoma of cervix uteri,1
5418,Carcinomatous Component Present,"Carcinoma, Papillary",1
5419,Serrated Glandular Architecture,Rectal Sessile Serrated Adenoma/Polyp,1
5420,Recurrent disease,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
5421,Chromogranin A Positive Neoplastic Cells Present,Ovarian Trabecular Carcinoid Tumor,1
5422,Malignant Cellular Infiltrate,Combined Lung Small Cell and Squamous Cell Carcinoma,1
5423,Fibrotic Stroma Formation,Vulvar Fibrolipoma,1
5424,Carcinomatous Component Present,Grade 3 Rectal Adenocarcinoma,1
5425,Pregnancy Complications,Stage IV Gestational Trophoblastic Tumor AJCC v7,1
5426,High Grade Lesion,Vulvar Alveolar Rhabdomyosarcoma,1
5427,Benign Cellular Infiltrate,Cellular Schwannoma,1
5428,Hereditary Lesion,Cutaneous Malignant Melanoma 2,1
5429,Recurrent Genetic Abnormalities Present,Acute Promyelocytic Leukemia,1
5430,Epithelial Component Present,Posterior Pharyngeal Wall Carcinoma,1
5431,Adulthood Lesion,Adult Immunoblastic Lymphoma,1
5432,Epithelial Component Present,Adenosquamous cell lung cancer stage I,1
5433,Carcinomatous Component Present,BCLC Stage A Hepatocellular Carcinoma,1
5434,Malignant Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v7,1
5435,Malignant Cellular Infiltrate,Malignant Mixed Tumor,1
5436,"Fully Differentiated ""Adult-Type"" Tissues Present",Central Nervous System Mature Teratoma,1
5437,Acanthosis,Human Papillomavirus-Related Verrucous Carcinoma,1
5438,Cystic Change,mucoepidermoid carcinoma of lung,1
5439,Primary Lesion,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
5440,Dysplasia,Squamous Lung Dysplasia,1
5441,Benign Cellular Infiltrate,Central Nervous System Chondroma,1
5442,S-100-Positive Neoplastic Cells Present,Malignant Lung PEComa,1
5443,Benign Cellular Infiltrate,Strawberry nevus of skin,1
5444,Tissues Derived from Two or Three Embryonic Layers Present,Childhood Ovarian Mature Teratoma,1
5445,Cutaneous Involvement,Congenital Nonbullous Ichthyosiform Erythroderma,1
5446,Slow Growing Mass,Metastatic Chordoma,1
5447,Sebaceous Differentiation,sebaceous adenoma of salivary gland,1
5448,Metaplasia of Malignant Cells Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
5449,Epithelial Component Present,Stage IIB Ovarian Cancer AJCC v6 and v7,1
5450,Indolent Clinical Course,Lumbosacral Lipoma,1
5451,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity recurrent,1
5452,Peripheral Nuclear Palisading,Refractory Extensive Stage Lung Small Cell Carcinoma,1
5453,Epithelial Component Present,Stage IIIB Colorectal Cancer AJCC v7,1
5454,Lymphadenopathy,Pediatric nodal marginal zone lymphoma,1
5455,Ventricular Involvement Only,Fourth Ventricle Ependymal Tumor,1
5456,Epithelial Component Present,Disseminated squamous cell carcinoma,1
5457,Carcinomatous Component Present,Pancreatic carcinoma recurrent,1
5458,Epithelial Component Present,Stage IVA Lung Cancer AJCC v8,1
5459,Carcinomatous Component Present,atypical medullary carcinoma of breast,1
5460,Firm mass,Refractory Malignant Peripheral Nerve Sheath Tumor,1
5461,Chronic Inflammatory Infiltrate,Intracranial Benign Fibrous Histiocytoma,1
5462,Carcinomatous Component Present,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
5463,Carcinomatous Component Present,Skin Clear Cell Basal Cell Carcinoma,1
5464,Absence of Stromal Invasion,Borderline Ovarian Clear Cell Cystadenofibroma,1
5465,Malignant Cellular Infiltrate,fibrosarcoma of kidney,1
5466,Severe dysplasia,Stage 0 Appendix Carcinoma AJCC v7,1
5467,Epithelial Component Present,Ampulla of Vater Neuroendocrine Neoplasm,1
5468,Mild dysplasia,Colorectal Low Grade Intraepithelial Neoplasia,1
5469,Malignant Cellular Infiltrate,Moderately Differentiated Hepatocellular Carcinoma,1
5470,Hemorrhagic,Mediastinal Angiosarcoma,1
5471,Malignant Cellular Infiltrate,Stage I Adult Burkitt Lymphoma,1
5472,Malignant Cellular Infiltrate,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
5473,Cutaneous Involvement,Malignant melanoma in junctional nevus,1
5474,Malignant Cellular Infiltrate,ROSE Cluster 3,1
5475,Rapidly Enlarging Mass,Pleomorphic Rhabdomyosarcoma,1
5476,Trabecular Pattern,"Adenoma, Trabecular",1
5477,Refractory Disease,Mycosis fungoides refractory,1
5478,High Mitotic Activity,Stage IA Lung Small Cell Carcinoma AJCC v7,1
5479,Carcinomatous Component Present,High Grade Mucoepidermoid Breast Carcinoma,1
5480,Tissue Differentiation Uncertain,Pulmonary lymphangioleiomyomatosis,1
5481,Epithelial Component Present,Colorectal Sarcomatoid Carcinoma,1
5482,Single Cell Necrosis,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
5483,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction,1
5484,Necrotic changes (finding),MGMT-Unmethylated Glioblastoma,1
5485,Presence of a Hormonal Syndrome,Secretory adenoma of pituitary,1
5486,Neuroendocrine Differentiation,Metastatic Jugulotympanic Paraganglioma,1
5487,Childhood Lesion,Childhood Nasal Cavity Carcinoma,1
5488,Pathologic TNM Finding,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8,1
5489,Organoid Pattern,Bladder Alveolar Soft Part Sarcoma,1
5490,Malignant Cellular Infiltrate,Advanced Lymphoma,1
5491,Malignant Cellular Infiltrate,Metastatic Malignant Germ Cell Tumor,1
5492,Vascular Channel Formation,Venous Angioleiomyoma,1
5493,Malignant Cellular Infiltrate,Recurrent Malignant Male Reproductive System Neoplasm,1
5494,Epithelial Component Present,Invasive Mucinous Lung Adenocarcinoma,1
5495,Glial Differentiation,Dysembryoplastic neuroepithelial tumor,1
5496,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
5497,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Soft Tissues,1
5498,High Mitotic Activity,Stage I Lung Small Cell Carcinoma AJCC v7,1
5499,Primary Lesion,Stage IVA Hepatocellular Carcinoma AJCC v7,1
5500,Perineural spread,Anterior Tongue Adenoid Cystic Carcinoma,1
5501,Malignant Cellular Infiltrate,Undifferentiated Fallopian Tube Carcinoma,1
5502,Aggressive Clinical Course,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,1
5503,High Mitotic Activity,Recurrent Childhood Anaplastic Oligodendroglioma,1
5504,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,1
5505,Lobulated Growth Pattern,malignant myoepithelioma of breast,1
5506,Malignant Cellular Infiltrate,Stage IVB Rectal Cancer AJCC v7,1
5507,Benign Cellular Infiltrate,Pigmented villonodular synovitis,1
5508,Recurrent disease,Recurrent Childhood Liver Cancer,1
5509,Epithelial Component Present,Maxillary Sinus Carcinoma,1
5510,Malignant Cellular Infiltrate,"Leiomyosarcoma, Epithelioid",1
5511,Malignant Cellular Infiltrate,Secondary malignant neoplasm of thymus,1
5512,Epithelial Component Present,Cholangiocarcinoma,1
5513,Carcinomatous Component Present,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
5514,Indolent Clinical Course,Fibromyxolipoma,1
5515,Low Mitotic Activity,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,1
5516,Adnexal Differentiation,Neoplasm of skin with adnexal differentiation,1
5517,Malignant Cellular Infiltrate,Cardiac Myeloid Sarcoma,1
5518,Recurrent disease,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
5519,Misplaced Exocytosis Present,Sparsely Granulated Lactotroph Adenoma,1
5520,Benign Cellular Infiltrate,Vulvar Seborrheic Keratosis,1
5521,Malignant Cellular Infiltrate,Recurrent Kaposi Sarcoma,1
5522,Spindle Cell Metaplasia of Malignant Cells Present,adenocarcinoma of breast with spindle cell metaplasia,1
5523,Carcinomatous Component Present,High Grade Ovarian Serous Adenocarcinoma,1
5524,Malignant Cellular Infiltrate,Malignant Phyllodes Tumor of Prostate,1
5525,Benign Cellular Infiltrate,Benign Intraocular Medulloepithelioma,1
5526,Anaplasia,Adult Systemic Anaplastic Large Cell Lymphoma,1
5527,Recurrent disease,Recurrent Burkitt Leukemia,1
5528,Secondary Lesion,Hormone refractory prostate cancer,1
5529,Malignant Cellular Infiltrate,Stage II Oropharyngeal Carcinoma,1
5530,Epithelial Component Present,Stage 0a Renal Pelvis Cancer AJCC v7,1
5531,Nuclear Pseudoinclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
5532,CD1a-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
5533,Diffuse Pattern,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,1
5534,Locally Aggressive Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,1
5535,Benign Cellular Infiltrate,Endobronchial Hamartoma,1
5536,Benign Cellular Infiltrate,Ethmoid Sinus Schneiderian Papilloma,1
5537,Recurrent disease,Recurrent Thymic Carcinoma,1
5538,Malignant Cellular Infiltrate,Stage III Ureter Cancer AJCC v7,1
5539,Carcinomatous Component Present,Prognostic Stage IV Breast Cancer AJCC v8,1
5540,Benign Cellular Infiltrate,Cervical Atypical Polypoid Adenomyoma,1
5541,Adulthood Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
5542,Papillary Pattern,Papillary serous cystadenocarcinoma,1
5543,Malignant Cellular Infiltrate,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5544,Malignant Cellular Infiltrate,Cecum Lymphoma,1
5545,Severe dysplasia,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
5546,Malignant Cellular Infiltrate,Refractory Malignant Male Reproductive System Neoplasm,1
5547,Necrotic changes (finding),Recurrent Gliosarcoma,1
5548,Hyalinized Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
5549,Recurrent disease,Recurrent B Acute Lymphoblastic Leukemia,1
5550,Epithelial Component Present,malignant gastrinoma of pancreas,1
5551,Malignant Cellular Infiltrate,Stage I Anal Cancer AJCC v8,1
5552,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
5553,Carcinomatous Component Present,Penis carcinoma recurrent,1
5554,Diffuse Pattern,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,1
5555,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Apoplectic Leiomyoma,1
5556,Neuroendocrine Differentiation,Vaginal Neuroendocrine Carcinoma,1
5557,High Grade Lesion,Occult Lung Small Cell Carcinoma,1
5558,Absence of Invasion of the Muscularis Externa,Gastric Intramucosal Adenocarcinoma,1
5559,Indolent Clinical Course,Paratesticular Lipoma,1
5560,Carcinomatous Component Present,Stage IIB Ampulla of Vater Cancer AJCC v7,1
5561,Pseudoglandular Pattern,Embryonal Carcinoma,1
5562,Locally Aggressive Lesion,Aggressive osteoblastoma,1
5563,Metastatic Lesion,Metastatic thymic carcinoma,1
5564,Capillary Sized Vascular Channel Formation,Infantile hemangioma,1
5565,Epithelial Component Present,Stage IB Pancreatic Cancer AJCC v6 and v7,1
5566,Cutaneous Involvement,Hutchinson's Melanotic Freckle,1
5567,Immunosuppression-Related Post-Transplant Toxicity,"Post-transplant lymphoproliferative disorder, polymorphic",1
5568,Geographic Necrosis,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
5569,Tissue Differentiation Uncertain,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
5570,Epithelial Component Present,Compact Cell Adrenal Cortical Adenoma,1
5571,Metastatic Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
5572,Carcinomatous Component Present,Stage IIIA Eyelid Carcinoma AJCC v7,1
5573,Carcinomatous Component Present,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
5574,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Non-Gestational Ovarian Choriocarcinoma,1
5575,Cutaneous Involvement,Bullous Dermatitis,1
5576,Epithelial Component Present,Recurrent Prostate Acinar Adenocarcinoma,1
5577,Encapsulated Mass,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
5578,Carcinomatous Component Present,Pancreatic Small Cell Neuroendocrine Carcinoma,1
5579,Pathologic TNM Finding,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5580,Epithelial Component Present,Stage I Appendix Neuroendocrine Tumor AJCC v7,1
5581,Apocrine Differentiation,Benign Apocrine Neoplasm,1
5582,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(17;17)(q21;q21),1
5583,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute myeloid leukemia with multilineage dysplasia,1
5584,Carcinomatous Component Present,Small intestine carcinoma recurrent,1
5585,Benign Cellular Infiltrate,Lymphangioma,1
5586,Hyalinized Stroma Formation,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
5587,Adulthood Lesion,Adult Acute Monoblastic and Monocytic Leukemia,1
5588,Necrotic changes (finding),Mesenchymal Glioblastoma,1
5589,Pregnancy Complications,Placental infarct,1
5590,Malignant Cellular Infiltrate,Stage IV Childhood Burkitt Lymphoma,1
5591,Epithelial Component Present,Adenoma of rectum,1
5592,Intraductal Lesion,Central Breast Papilloma,1
5593,Epithelial Component Present,Advanced Lung Non-Small Cell Squamous Carcinoma,1
5594,Indolent Clinical Course,Venous Angioleiomyoma,1
5595,Epithelial Component Present,Ovarian Cellular Fibroma,1
5596,Epithelial Component Present,Low Grade Conjunctival Intraepithelial Neoplasia,1
5597,Lymphadenopathy,Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
5598,Mitotic Activity,Recurrent Gliosarcoma,1
5599,Secondary Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
5600,Low Mitotic Activity,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
5601,Epithelial Component Present,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
5602,Adulthood Lesion,Adult Teratoma,1
5603,Carcinomatous Component Present,Nasopharyngeal carcinoma,1
5604,Carcinomatous Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
5605,Malignant Cellular Infiltrate,Stage IA1 Cervical Cancer,1
5606,Junctional Proliferation,Dysplastic Nevus,1
5607,Diffuse Pattern,Stage II Adult Immunoblastic Lymphoma,1
5608,Non-Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
5609,Epithelial Component Present,Unresectable Digestive System Neuroendocrine Carcinoma,1
5610,Nerve palsy,Oculomotor Nerve Paralysis,1
5611,Adulthood Lesion,Adult Immunoblastic Lymphoma,1
5612,More than 10 Mitoses per 10HPF,Metastatic Prostate Small Cell Carcinoma,1
5613,Malignant Cellular Infiltrate,Stage II Hepatocellular Carcinoma AJCC v8,1
5614,Epithelial Component Present,Stage IVA Gallbladder Cancer AJCC v8,1
5615,Myxoid Stroma Formation,Dedifferentiated chordoma,1
5616,Epithelial Component Present,Stage IIA Vaginal Cancer AJCC v8,1
5617,Malignant Cellular Infiltrate,Carcinoma of soft palate,1
5618,Geographic Necrosis,Testicular embryonal carcinoma stage I,1
5619,Adnexal Differentiation,Vulvar Clear Cell Hidradenocarcinoma,1
5620,Epithelial Component Present,Stage IIB Distal Bile Duct Cancer AJCC v7,1
5621,Recurrent disease,Recurrent Childhood Gemistocytic Astrocytoma,1
5622,Malignant Cellular Infiltrate,Pathologic Stage IV Gastric Cancer AJCC v8,1
5623,Epithelial Component Present,Stage I Jejunal Neuroendocrine Tumor AJCC v8,1
5624,Epithelial Component Present,Stage III Adult Liver Cancer AJCC v7,1
5625,Monomorphic Cellular Infiltrate,Angiocentric glioma,1
5626,Acinar Cell Differentiation,Acinar Cell Carcinoma,1
5627,Slow Growing Mass,Adult Ependymoma,1
5628,Malignant Cellular Infiltrate,Inflammatory carcinoma of breast recurrent,1
5629,Adulthood Lesion,Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8,1
5630,Tissue of Mullerian Origin Present,Adenosarcoma,1
5631,Pericanalicular Growth Pattern,Breast Complex Fibroadenoma,1
5632,Nodular lesions,Lung Typical Carcinoid Tumor,1
5633,Malignant Cellular Infiltrate,Pancreatic Mixed Adenoneuroendocrine Carcinoma,1
5634,Epithelial Component Present,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
5635,Epithelial Component Present,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",1
5636,Malignant Cellular Infiltrate,Childhood Diffuse Large B-Cell Lymphoma,1
5637,Epithelial Component Present,Stage 0 Vulvar Carcinoma,1
5638,Fenestrated Pattern,Desmoplastic trichoepithelioma,1
5639,Malignant Cellular Infiltrate,Peripheral neuroepithelioma of bone recurrent,1
5640,Malignant Cellular Infiltrate,choriocarcinoma of mediastinum,1
5641,Syncytial Pattern,Tonsillar Undifferentiated Carcinoma,1
5642,Diffuse Pattern,Recurrent Childhood Fibrillary Astrocytoma,1
5643,Low Mitotic Activity,Stage I Appendix Neuroendocrine Tumor AJCC v8,1
5644,Mild cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
5645,Epithelial Component Present,Laryngeal Cancer by AJCC v7 Stage,1
5646,Lytic lesion,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,1
5647,Cutaneous Involvement,Malignant Cutaneous Granular Cell Tumor,1
5648,Lobulated Growth Pattern,Atrial myxoma,1
5649,Benign Cellular Infiltrate,Benign neoplasm of pericardium,1
5650,Childhood Lesion,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
5651,Dilated Vascular Space Formation,Hobnail Hemangioma,1
5652,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
5653,Malignant Cellular Infiltrate,Laryngeal Lymphoepithelial Carcinoma,1
5654,Carcinomatous Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7,1
5655,Epithelial Component Present,Stage IVA Appendix Carcinoma AJCC v7,1
5656,Epithelial Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
5657,Malignant Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v8,1
5658,Blasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Chronic Myelomonocytic Leukemia,1
5659,Smooth Muscle Component Present,Multiple hamartoma of lung,1
5660,Diffuse Lesion,Liver Lymphangiomatosis,1
5661,Mitotic Activity,Secondary Supratentorial Anaplastic Astrocytoma,1
5662,Malignant Cellular Infiltrate,Head and Neck Carcinoma,1
5663,Epithelial Component Present,Ureter Cancer by AJCC v7 Stage,1
5664,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma,1
5665,Papillary Pattern,Ethmoid Sinus Inverted Papilloma,1
5666,Neuroendocrine Differentiation,Lung Small Cell Carcinoma by AJCC v7 Stage,1
5667,Local disease,Mast-Cell Sarcoma,1
5668,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
5669,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 2 Endometrial Endometrioid Adenocarcinoma,1
5670,Unresectable Mass,Metastatic Unresectable Malignant Neoplasm,1
5671,Metastatic Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,1
5672,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
5673,Carcinomatous Component Present,Prostate cancer stage B,1
5674,Benign Cellular Infiltrate,Ovarian Cystadenoma,1
5675,Malignant Cellular Infiltrate,Childhood Anaplastic Oligoastrocytoma,1
5676,Neuroectodermal Differentiation,Sellar Neuroblastoma,1
5677,Malignant Cellular Infiltrate,Malignant Extragonadal Germ Cell Tumor,1
5678,Malignant Cellular Infiltrate,Recurrent Gliosarcoma,1
5679,Carcinomatous Component Present,Grade 1 Endometrial Endometrioid Adenocarcinoma,1
5680,Multifocal Lesion,Multiple Endocrine Neoplasia Type 1,1
5681,Low Grade Lesion,Pilocytic Astrocytoma,1
5682,Thyroglobulin Positive Neoplastic Cells Present,minimally invasive follicular carcinoma of the thyroid gland,1
5683,Recurrent disease,Recurrent Chordoma,1
5684,Swelling,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,1
5685,Papillary Pattern,Papillary mucinous cystadenocarcinoma,1
5686,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile astrocytoma,1
5687,Malignant Cellular Infiltrate,AIDS-Related Diffuse Large B-cell Lymphoma,1
5688,Plasma cell inflammation,Retroperitoneal Inflammatory Myofibroblastic Tumor,1
5689,Epithelial Component Present,Stage I Nasal Cavity Cancer AJCC v6 and v7,1
5690,Epithelial Component Present,Uterine Ligament Mucinous Adenocarcinoma,1
5691,Deep Lesion,Perineural Hemangioma,1
5692,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma,1
5693,Human Papillomavirus Positive,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
5694,Carcinomatous Component Present,Thyroid Gland Adenocarcinoma,1
5695,Deep Lesion,Unresectable Desmoid-Type Fibromatosis,1
5696,Benign Cellular Infiltrate,Gingival Angiofibroma,1
5697,Adnexal Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
5698,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer recurrent,1
5699,Epithelial Component Present,Pancreatic adenocarcinoma recurrent,1
5700,Cutaneous Involvement,Lentigo maligna melanoma,1
5701,Invasive Lesion,Ductal Carcinoma In Situ with Microinvasion,1
5702,Firm mass,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
5703,Carcinomatous Component Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
5704,Multifocal Lesion,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor",1
5705,Epithelial Component Present,Stage 0 Eyelid Carcinoma AJCC v8,1
5706,Malignant Cellular Infiltrate,undifferentiated carcinoma of salivary gland,1
5707,Indolent Clinical Course,Benign Cutaneous Fibroblastic Neoplasm,1
5708,Epithelial Component Present,Anal Papillary Hidradenoma,1
5709,Malignant Cellular Infiltrate,Colon Leiomyosarcoma,1
5710,Carcinomatous Component Present,Recurrent Prostate Acinar Adenocarcinoma,1
5711,Honeycomb Pattern,Childhood Brain Oligodendroglioma,1
5712,Carcinomatous Component Present,Cervical Esophagus Squamous Cell Carcinoma,1
5713,Malignant Cellular Infiltrate,Recurrent Thymic Carcinoma,1
5714,Edematous Stroma Formation,Vulvar Superficial Angiomyxoma,1
5715,Malignant Cellular Infiltrate,Intestinal Cancer,1
5716,Secondary Lesion,Metastatic Carcinoma to the Uterine Cervix,1
5717,Epithelial Component Present,Lymphoepithelial malignant thymoma,1
5718,Malignant Cellular Infiltrate,Stage III Ureter Cancer AJCC v7,1
5719,High Grade Lesion,rhabdomyosarcoma of extrahepatic bile duct,1
5720,Carcinomatous Component Present,"Carcinoma, diffuse type",1
5721,Solitary mass,Pleural Epithelioid Hemangioendothelioma,1
5722,Well Differentiated Lesion,Supraglottic Verrucous Carcinoma,1
5723,Epithelial Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v8,1
5724,Alcohol Toxicity,Alcohol-Related Hepatocellular Carcinoma,1
5725,Epithelial Component Present,Cervical Warty Carcinoma,1
5726,Malignant Cellular Infiltrate,Pediatric Intraocular Retinoblastoma,1
5727,Diffuse Pattern,Childhood Immunoblastic Lymphoma,1
5728,Epithelial Component Present,Stage IVB Paranasal Sinus Cancer AJCC v7,1
5729,Refractory Disease,Refractory Malignant Oral Neoplasm,1
5730,Epithelial Component Present,Stage IV Esophageal Cancer AJCC v7,1
5731,Cavernous Vascular Space Formation,Colon Cavernous Hemangioma,1
5732,Hereditary Lesion,Refractory Neurofibromatosis Type 1,1
5733,Pain,Mesenchymal Chondrosarcoma,1
5734,Malignant Cellular Infiltrate,Childhood Epithelioid Hemangioendothelioma,1
5735,Malignant Cellular Infiltrate,Malignant neoplasm of skin,1
5736,Recurrent disease,Recurrent Primary Amyloidosis,1
5737,Malignant Cellular Infiltrate,Post-Radiotherapy Breast Angiosarcoma,1
5738,Absence of Invasion,Stage 0 Cervical Cancer AJCC v6,1
5739,Locally Aggressive Lesion,Classic Type Atypical Fibroxanthoma,1
5740,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma,1
5741,Malignant Cellular Infiltrate,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
5742,Carcinomatous Component Present,Stage I Major Salivary Gland Cancer AJCC v8,1
5743,Low Grade Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1,1
5744,Cold Nodule,Thyroid Angiosarcoma,1
5745,Malignant Cellular Infiltrate,Alkylating Agent-Related Myelodysplastic Syndrome,1
5746,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Sellar Region,1
5747,Carcinomatous Component Present,Thyroid Hurthle Cell Carcinoma,1
5748,Fibrotic Stroma Formation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
5749,Primary Lesion,Childhood Meningeal Melanoma,1
5750,Pseudopapillary Pattern,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
5751,Hemorrhagic,"Histiocytoma, Angiomatoid Fibrous",1
5752,Carcinomatous Component Present,Serous surface papillary carcinoma,1
5753,Mitotic Activity,Multifocal Glioblastomas,1
5754,Carcinomatous Component Present,Laryngeal Adenoid Cystic Carcinoma,1
5755,Malignant Cellular Infiltrate,Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
5756,Well-Circumscribed Lesion,Stromal Predominant Kidney Wilms Tumor,1
5757,Malignant Cellular Infiltrate,Bladder Sarcoma,1
5758,Epithelial Component Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
5759,Carcinomatous Component Present,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
5760,Malignant Cellular Infiltrate,Bladder Urothelial Carcinoma in Situ,1
5761,Malignant Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v7,1
5762,Carcinomatous Component Present,Plantar Verrucous Skin Carcinoma,1
5763,Local disease,Localized Parathyroid Gland Carcinoma,1
5764,Malignant Cellular Infiltrate,Laryngeal Mucoepidermoid Carcinoma,1
5765,Epithelial Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
5766,Local disease,Solitary Adult Fibroma,1
5767,Malignant Cellular Infiltrate,Paget's disease of penis,1
5768,High Grade Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma,1
5769,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia,1
5770,Carcinomatous Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,1
5771,Carcinomatous Component Present,Stage II Vulvar Cancer AJCC v8,1
5772,Epithelial Component Present,Intermediate Grade Lung Neuroendocrine Neoplasm,1
5773,Borderline Lesion,Pancreatic intraepithelial neoplasia,1
5774,Epithelial Component Present,Metastatic Paraganglioma,1
5775,Malignant Cellular Infiltrate,Stage I Penile Cancer AJCC v6,1
5776,Cutaneous Involvement,Cutaneous T Lymphoblastic Leukemia/Lymphoma,1
5777,Encapsulated Mass,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
5778,Malignant Cellular Infiltrate,Stage II Diffuse Large B-Cell Lymphoma,1
5779,Carcinomatous Component Present,Stage IB Ampulla of Vater Cancer AJCC v8,1
5780,Primary Lesion,"Leukemia, Mast-Cell",1
5781,Mild cytologic atypia,Supraglottic Verrucous Carcinoma,1
5782,Malignant Cellular Infiltrate,Intracortical osteosarcoma,1
5783,Benign Cellular Infiltrate,Mediastinal Rhabdomyoma,1
5784,Local disease,Pericardial Adenomatoid Tumor,1
5785,Tissue of Mullerian Origin Present,Uterine Corpus Adenosarcoma by AJCC v8 Stage,1
5786,Chronic lymphocytic inflammation,"Thymoma, type AB, malignant",1
5787,Mixed Cellular Population,Pleomorphic adenoma of parotid gland,1
5788,Carcinomatous Component Present,Metastatic Urethral Carcinoma,1
5789,Increased Cellularity Present,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System,1
5790,Severe dysplasia,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
5791,Malignant Cellular Infiltrate,Pericardial mesothelioma malignant advanced,1
5792,Epithelial Component Present,"Thymoma, type A",1
5793,Benign Cellular Infiltrate,Giant cell angiofibroma,1
5794,Benign Cellular Infiltrate,Eccrine dermal cylindroma,1
5795,Poorly Differentiated Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
5796,Malignant Cellular Infiltrate,Stage IIIA Esophageal Adenocarcinoma AJCC v7,1
5797,Malignant Cellular Infiltrate,Peripheral Primitive Neuroectodermal Tumor of the Kidney,1
5798,Cutaneous Involvement,Aleukemic Acute Lymphoblastic Leukemia Cutis,1
5799,Epithelial Component Present,Pancreatic Medullary Carcinoma,1
5800,Epithelial Component Present,Low Grade Prostatic Intraepithelial Neoplasia,1
5801,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v7,1
5802,Epithelial Component Present,Stage IIIC Breast Cancer AJCC v7,1
5803,Epithelial Component Present,Growth Hormone-Secreting Pituitary Adenoma,1
5804,Carcinomatous Component Present,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8,1
5805,Dysplasia,Colon Adenoma with Severe Dysplasia,1
5806,Malignant Cellular Infiltrate,Childhood Kidney Wilms Tumor,1
5807,Malignant Cellular Infiltrate,Anatomic Stage IIIB Breast Cancer AJCC v8,1
5808,Moderate dysplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
5809,Capillary Sized Vascular Channel Formation,Cerebral Hemangioblastoma,1
5810,Carcinomatous Component Present,Recurrent Prostate Acinar Adenocarcinoma,1
5811,Malignant Cellular Infiltrate,Stage IV Urethral Cancer AJCC v7,1
5812,Malignant Cellular Infiltrate,Stage 0 Major Salivary Gland Cancer AJCC v8,1
5813,Bone Marrow Dysplasia Present,"Myelodysplastic syndrome, no ICD-O subtype",1
5814,Malignant Cellular Infiltrate,Refractory Digestive System Carcinoma,1
5815,Indolent Clinical Course,lipoma of extrahepatic bile duct,1
5816,Malignant Cellular Infiltrate,T-cell/histiocyte rich large B-cell lymphoma,1
5817,Benign Cellular Infiltrate,Kasabach-Merritt syndrome,1
5818,Plexiform Growth Pattern,Gastric Plexiform Fibromyxoma,1
5819,Malignant Cellular Infiltrate,Stage IIA Lung Squamous Cell Carcinoma AJCC v7,1
5820,Epithelial Component Present,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8,1
5821,Alternative Fascicle (Bundle) Pattern,Gastric Leiomyoma,1
5822,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v7 Stage,1
5823,Epithelial Component Present,Stage IVA Appendix Carcinoma AJCC v7,1
5824,Primary Lesion,"Hepatocellular carcinoma, scirrhous",1
5825,Epithelial Component Present,Cervical intraepithelial neoplasia grade 2,1
5826,Low Mitotic Activity,Anal Canal Neuroendocrine Tumor G1,1
5827,Epithelial Component Present,Tonsillar Undifferentiated Carcinoma,1
5828,Severe cytologic atypia,Advanced Small Intestinal Neuroendocrine Carcinoma,1
5829,Follicular Structures Present,Thyroid Gland Follicular Adenoma,1
5830,Malignant Cellular Infiltrate,Primary leiomyosarcoma,1
5831,Epithelial Component Present,Carcinoma in situ of penis,1
5832,Microvascular Proliferation,Juvenile Pilocytic Astrocytoma,1
5833,Epithelial Component Present,Pre-Malignant Skin Epithelial Lesion,1
5834,Secondary Lesion,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
5835,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,1
5836,Malignant Cellular Infiltrate,Digestive System Non-Hodgkin Lymphoma,1
5837,Neuroendocrine Differentiation,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,1
5838,Extensive Stage Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
5839,Malignant Cellular Infiltrate,Epithelial Predominant Kidney Wilms Tumor,1
5840,Pregnancy Complications,Stage IIIA Gestational Trophoblastic Tumor AJCC v7,1
5841,Mixed Cellular Population,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
5842,Carcinomatous Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6,1
5843,Exophytic Polypoid Lesion,Anal Canal Squamous Papilloma,1
5844,Benign Cellular Infiltrate,Infantile hemangioma of liver,1
5845,Malignant Cellular Infiltrate,Stage IIIA Ovarian Carcinoma,1
5846,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pituitary gland,1
5847,Diffuse Pattern,Adult Malignant Peripheral Nerve Sheath Tumor,1
5848,Thick-Walled Hyalinized Vessels Present,Adrenal Gland Schwannoma,1
5849,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma recurrent,1
5850,Intravascular Fibrin Thrombus Formation,Central Nervous System Angiolipoma,1
5851,Epithelial Component Present,Posterior Tongue Adenoid Cystic Carcinoma,1
5852,Malignant Cellular Infiltrate,Metastatic Lung Adenosquamous Carcinoma,1
5853,Epithelial Component Present,Seminal Vesicle Adenocarcinoma,1
5854,Epithelial Component Present,Colorectal Adenocarcinoma Metastatic in the Liver,1
5855,Low Mitotic Activity,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
5856,Intracytoplasmic Eosinophilic Spherical Inclusion,Infantile digital fibromatosis,1
5857,Benign Cellular Infiltrate,Syringofibroadenoma,1
5858,Biphasic Pattern,Cystadenofibroma,1
5859,Exophytic Polypoid Lesion,Foveolar-Type Adenoma,1
5860,Trabecular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
5861,Encapsulated Mass,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
5862,High Grade Lesion,MGMT-Methylated Glioblastoma,1
5863,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
5864,Adnexal Differentiation,Benign Eccrine Neoplasm,1
5865,'Starry-sky' pattern,Recurrent Childhood Burkitt Lymphoma,1
5866,Malignant Cellular Infiltrate,Thyroid Gland Mucinous Carcinoma,1
5867,Malignant Cellular Infiltrate,Adult Anaplastic Oligodendroglioma,1
5868,Recurrent Lymphoma,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
5869,Proliferation of High Endothelial Venules Present,Angioimmunoblastic Lymphadenopathy,1
5870,Malignant Cellular Infiltrate,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage,1
5871,Primary Lesion,Adult Brain Stem Gliosarcoma,1
5872,Malignant Cellular Infiltrate,ganglioneuroblastoma of mediastinum,1
5873,Carcinomatous Component Present,Locally Advanced Unresectable Pancreatic Adenocarcinoma,1
5874,Malignant Cellular Infiltrate,Spindle Cell Melanoma,1
5875,Granulocytes Increased in Bone Marrow,Primary Myelofibrosis,1
5876,Malignant Cellular Infiltrate,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",1
5877,Epithelial Component Present,Stage IIIB Prostate Cancer AJCC v8,1
5878,Malignant Cellular Infiltrate,Thymic Carcinoid Tumor,1
5879,Benign Cellular Infiltrate,Senile hemangioma of lip,1
5880,Carcinomatous Component Present,Stage 0a Renal Pelvis Cancer AJCC v7,1
5881,High Mitotic Activity,Recurrent Anaplastic Oligoastrocytoma,1
5882,Carcinomatous Component Present,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
5883,Malignant Cellular Infiltrate,carcinoma ex pleomorphic adenoma of salivary gland,1
5884,Malignant Cellular Infiltrate,small cell carcinoma of kidney,1
5885,Cellular Stratification,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
5886,Antoni A Pattern,Trigeminal schwannoma,1
5887,Aggressive Clinical Course,Adult Burkitt Leukemia,1
5888,Acinar Cell Differentiation,Acinar cell cystadenocarcinoma,1
5889,Epithelial Component Present,Pancreatic Intraductal Neoplasms,1
5890,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v7,1
5891,Tissue of Mullerian Origin Present,Cystadenofibroma of fallopian tube,1
5892,Lytic lesion,Chondroblastoma,1
5893,Malignant Cellular Infiltrate,Stage I Esophageal Cancer,1
5894,Epithelial Component Present,Vaginal Squamous Papilloma,1
5895,Malignant Cellular Infiltrate,Cutaneous T Lymphoblastic Leukemia/Lymphoma,1
5896,Carcinomatous Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
5897,Follicular Structures Present,Thyroid Gland Black Follicular Adenoma,1
5898,Recurrent disease,Recurrent Uterine Corpus Carcinoma,1
5899,Malignant Cellular Infiltrate,Malignant Uterine Corpus PEComa,1
5900,Papillary Pattern,Primary serous papillary carcinoma of peritoneum,1
5901,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
5902,Malignant Cellular Infiltrate,Refractory Lung Non-Small Cell Carcinoma,1
5903,Tissue Differentiation Uncertain,Ovarian Myxoma,1
5904,Childhood Lesion,Recurrent Childhood Acute Lymphoblastic Leukemia,1
5905,Benign Cellular Infiltrate,Cardiac Capillary Hemangioma,1
5906,Neuroendocrine Differentiation,Recurrent Thyroid Gland Medullary Carcinoma,1
5907,Invasive Lesion,Invasive Malignant Neoplasm,1
5908,Epithelial Component Present,Anal margin Paget's disease,1
5909,Malignant Cellular Infiltrate,Pancreatic carcinoma recurrent,1
5910,Epithelial Component Present,Submandibular Gland Undifferentiated Carcinoma,1
5911,Epithelial Component Present,mucoepidermoid carcinoma of accessory sinus,1
5912,Metastatic Lesion,Metastatic Malignant Neoplasm in the Adult Brain,1
5913,Adulthood Lesion,Adult Infiltrating Astrocytoma,1
5914,Tubular Pattern,"Testicular Seminoma, Tubular Variant",1
5915,Carcinomatous Component Present,Adenocarcinoma in situ in adenomatous polyp,1
5916,Malignant Cellular Infiltrate,TSH-Producing Pituitary Gland Carcinoma,1
5917,Poorly Differentiated Lesion,Large cell lung cancer stage IV,1
5918,Malignant Cellular Infiltrate,testicular leukemia,1
5919,Carcinomatous Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v8,1
5920,Malignant Germinomatous Cellular Infiltrate,germinoma of brain,1
5921,Serotonin Positive Neoplastic Cells Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
5922,Defective Heavy Chain Present,gamma-Chain Disease,1
5923,Recurrent disease,Recurrent Pancreatic Cystadenocarcinoma,1
5924,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,1
5925,Epithelial Component Present,Transitional cell carcinoma urethra,1
5926,Clinical TNM Finding,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
5927,Epithelial Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
5928,Malignant Cellular Infiltrate,Stage IV Pleural Malignant Mesothelioma AJCC v7,1
5929,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
5930,Malignant Cellular Infiltrate,Childhood Mesenchymal Chondrosarcoma,1
5931,Indolent Clinical Course,Colon Lipoma,1
5932,Severe dysplasia,Lung Adenocarcinoma In Situ,1
5933,Severe cytologic atypia,Vaginal Undifferentiated Sarcoma,1
5934,Epithelial Component Present,Adenosquamous cell lung cancer stage I,1
5935,Carcinomatous Component Present,Tobacco Chewing-Related Carcinoma,1
5936,Malignant Cellular Infiltrate,"Acute myeloid leukemia, inv(16)(p13q22)",1
5937,Benign Cellular Infiltrate,Benign Peritoneal and Retroperitoneal Neoplasm,1
5938,Nuclear Grooves,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
5939,Epithelial Component Present,Lung Small Cell Carcinoma by AJCC v7 Stage,1
5940,Cysts Containing Proteinaceous Fluid Present,Serous cystadenocarcinoma of pancreas,1
5941,Hypercellular bone marrow,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
5942,Tissue of Mullerian Origin Present,serous adenocarcinofibroma of ovary,1
5943,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
5944,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,1
5945,Epithelial Component Present,Ovarian Cancer by AJCC v8 Stage,1
5946,Carcinomatous Component Present,Bladder Urachal Adenocarcinoma,1
5947,Borderline Lesion,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,1
5948,Malignant Cellular Infiltrate,Refractory Central Nervous System Lymphoma,1
5949,Well Differentiated Neuroendocrine Lesion,Stage I Gastric Neuroendocrine Tumor AJCC v8,1
5950,Malignant Cellular Infiltrate,Stage III Colon Cancer,1
5951,Polymorphic Cellular Infiltrate,Thyroid Gland Langerhans Cell Histiocytosis,1
5952,Minimal Invasion Present,Bronchioloalveolar Adenocarcinoma,1
5953,Tissues Derived from Two or Three Embryonic Layers Present,Malignant Ovarian Teratoma,1
5954,Malignant Cellular Infiltrate,Lymphoma of retina,1
5955,Malignant Cellular Infiltrate,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma,1
5956,Epithelial Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
5957,Carcinomatous Component Present,Colorectal Carcinoma,1
5958,Follicular Cell Differentiation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
5959,Biphasic Pattern,Cystadenofibroma,1
5960,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,1
5961,Low Grade Lesion,Microcystic adnexal carcinoma,1
5962,Epithelial Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7,1
5963,Secondary Lesion,Metastatic Parathyroid Gland Carcinoma,1
5964,Malignant Cellular Infiltrate,Small intestine carcinoma stage III,1
5965,Borderline Resectable Mass,Borderline Resectable Pancreatic Adenocarcinoma,1
5966,Epithelial Component Present,Unresectable Carcinoma,1
5967,Recurrent disease,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,1
5968,Hyperplastic Tissue Present,Neuroendocrine cell hyperplasia of infancy,1
5969,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v7,1
5970,Epithelial Component Present,Early-Stage Breast Carcinoma,1
5971,Tubular Pattern,Appendix Tubular Carcinoid,1
5972,Malignant Cellular Infiltrate,Adenocarcinoma of lung stage IIIB,1
5973,Epithelial Component Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
5974,Recurrent disease,Pericardial mesothelioma malignant recurrent,1
5975,Malignant Cellular Infiltrate,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7,1
5976,Malignant Cellular Infiltrate,Refractory anemia with excess blasts I,1
5977,Endophytic Tumor Growth,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
5978,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,1
5979,Indolent Clinical Course,Cavernous hemangioma of retina,1
5980,Mixed Cellular Population,"Cervical Adenomyoma, Endocervical Type",1
5981,Local disease,Localized Bone Ewing Sarcoma,1
5982,Epithelial Component Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
5983,Primary Lesion,Adult Pleomorphic Hepatocellular Carcinoma,1
5984,Myxoid Stroma Formation,Conventional Extraskeletal Myxoid Chondrosarcoma,1
5985,Clinical TNM Finding,Clinical Stage II Gastric Cancer AJCC v8,1
5986,Benign Cellular Infiltrate,Epicardial Lipoma,1
5987,Secondary Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
5988,Malignant Cellular Infiltrate,Posterior Tongue Mucoepidermoid Carcinoma,1
5989,Malignant Cellular Infiltrate,Refractory Burkitt Leukemia,1
5990,Epithelial Component Present,Choroid Plexus Papilloma,1
5991,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
5992,Carcinomatous Component Present,Stage IIB Lung Large Cell Carcinoma AJCC v7,1
5993,Epithelial Component Present,Thyroid Hurthle Cell Carcinoma,1
5994,Secondary Lesion,Secondary malignant neoplasm of sternum,1
5995,Perivascular Arrangement of Tumor Cells,Malignant Pericytic Neoplasm,1
5996,Malignant Cellular Infiltrate,Stage IVA Colorectal Cancer AJCC v7,1
5997,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma,1
5998,Epithelial Component Present,Stage III Ampulla of Vater Cancer AJCC v7,1
5999,Perivascular Arrangement of Tumor Cells,Glomangiomatosis,1
6000,Metastatic Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,1
6001,Carcinomatous Component Present,verrucous carcinoma of vulva,1
6002,Carcinomatous Component Present,"Carcinoma, Neuroendocrine",1
6003,Malignant Cellular Infiltrate,Vulvar Cancer by AJCC v7 Stage,1
6004,Immature Granulocytes in Peripheral Blood Increased,Juvenile Myelomonocytic Leukemia,1
6005,Primary Lesion,Brain Ependymoma,1
6006,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage IV,1
6007,Carcinomatous Component Present,Small cell carcinoma of esophagus,1
6008,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage I,1
6009,Resectable Mass,Resectable Pancreatic Acinar Cell Carcinoma,1
6010,CD30-Positive Neoplastic Cells Present,Adult Anaplastic Large Cell Lymphoma,1
6011,Exophytic Papillary Lesion,Buschke-Lowenstein Tumor,1
6012,Necrotic changes (finding),Recurrent Childhood Glioblastoma,1
6013,Carcinomatous Component Present,Gallbladder Cancer by AJCC v6 Stage,1
6014,Refractory Disease,Refractory Primary Cutaneous Lymphoma,1
6015,Malignant Cellular Infiltrate,Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
6016,Severe dysplasia,Lung Non-Mucinous Adenocarcinoma In Situ,1
6017,Malignant Cellular Infiltrate,Metastatic Renal Pelvis Urothelial Carcinoma,1
6018,Antoni B Pattern,Acoustic Neuroma,1
6019,Carcinomatous Component Present,Stage I Vulvar Cancer AJCC v8,1
6020,Malignant Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v8,1
6021,Exophytic Polypoid Lesion,Adenoma of rectum,1
6022,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
6023,Perivascular Arrangement of Tumor Cells,Glomangioma of skin,1
6024,Epithelial Component Present,Stage I Adult Liver Cancer AJCC v7,1
6025,Carcinomatous Component Present,Stage IIIA Vulvar Cancer AJCC v8,1
6026,Malignant Cellular Infiltrate,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8,1
6027,Infiltrative Growth Pattern,Collecting Duct Carcinoma of the Kidney,1
6028,Favorable Clinical Outcome,Beta-Catenin-Activated Hepatocellular Adenoma,1
6029,Carcinomatous Component Present,Carcinosarcoma of ovary,1
6030,Recurrent disease,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,1
6031,Malignant Cellular Infiltrate,sarcoma of penis,1
6032,Carcinomatous Component Present,Breast Cancer by AJCC v7 Stage,1
6033,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage I,1
6034,Well-Circumscribed Lesion,"Leydig cell tumor, benign",1
6035,Carcinomatous Component Present,Stage IV Major Salivary Gland Carcinoma with Metastasis,1
6036,Glandular Pattern,Gastric Intestinal-Type Adenocarcinoma,1
6037,Metastatic Lesion,Metastatic Lung Small Cell Carcinoma,1
6038,Rapidly Enlarging Mass,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type",1
6039,Infiltrating Tumor Margins Present,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
6040,Carcinomatous Component Present,Recurrent Endometrial Cancer,1
6041,Malignant Cellular Infiltrate,Synovial sarcoma metastatic,1
6042,Carcinomatous Component Present,Stage 0 Gallbladder Cancer AJCC v8,1
6043,Dilated Thin-Walled Vascular Space Formation,Angiomyofibroblastoma,1
6044,White blood cell count increased (lab result),Juvenile Myelomonocytic Leukemia,1
6045,Malignant Cellular Infiltrate,Head and Neck Basaloid Carcinoma,1
6046,Benign Cellular Infiltrate,Oral Cavity Benign Granular Cell Tumor,1
6047,Neuroendocrine Differentiation,Islet Cell Tumor,1
6048,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Acute Myeloid Leukemia (AML-M2),1
6049,Nuclear Pseudoinclusion,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
6050,Adnexal Differentiation,"Acanthoma, Pilar Sheath",1
6051,Invasive Lesion,Grade 2 Invasive Breast Carcinoma,1
6052,Hyperplastic Tissue Present,Hyperplasia,1
6053,Indolent Clinical Course,"Chondromatosis, Synovial",1
6054,Malignant Cellular Infiltrate,Pineal Region Choriocarcinoma,1
6055,Severe cytologic atypia,Esophageal Large Cell Neuroendocrine Carcinoma,1
6056,Hyperkeratosis,verrucous carcinoma of vulva,1
6057,Nuclear Atypia,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,1
6058,Benign Cellular Infiltrate,Benign Reproductive System Neoplasm,1
6059,Nodular lesions,Microfollicular adenoma,1
6060,Carcinomatous Component Present,Metastatic Pharyngeal Carcinoma,1
6061,Acanthosis,Vulvar Inverted Follicular Keratosis,1
6062,High Grade Lesion,Rectal Rhabdomyosarcoma,1
6063,Recurrent disease,Recurrent Neurofibromatosis Type 1,1
6064,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent Chronic Myelomonocytic Leukemia,1
6065,Malignant Cellular Infiltrate,Central Nervous System Embryonal Tumor with Rhabdoid Features,1
6066,Benign Cellular Infiltrate,Benign neoplasm of uterus,1
6067,Malignant Cellular Infiltrate,Stage IIIB Vulvar Cancer AJCC v8,1
6068,Epithelial Component Present,Stage IA Lung Small Cell Carcinoma AJCC v7,1
6069,Follicular Structures Present,Thyroid Gland Black Follicular Adenoma,1
6070,Epithelial Component Present,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
6071,Malignant Cellular Infiltrate,Locally Advanced Digestive System Carcinoma,1
6072,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
6073,Epithelial Component Present,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8,1
6074,Locally Aggressive Lesion,Hemosiderotic Fibrolipomatous Tumor,1
6075,Angiocentric Pattern,Grade III Lymphomatoid Granulomatosis,1
6076,Cutaneous Involvement,Aleukemic Leukemia Cutis,1
6077,Malignant Cellular Infiltrate,follicular lymphoma of thyroid gland,1
6078,Metastatic Lesion,Advanced Digestive System Neuroendocrine Neoplasm,1
6079,Malignant Cellular Infiltrate,Central Nervous System Leiomyosarcoma,1
6080,Epithelial Component Present,Lung squamous cell carcinoma stage IV,1
6081,Epithelial Component Present,Malignant basal cell tumor,1
6082,Epithelial Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
6083,Epithelial Component Present,Refractory Bladder Carcinoma,1
6084,Neuroendocrine Differentiation,Colon Small Cell Neuroendocrine Carcinoma,1
6085,Fibrotic Stroma Formation,Borderline Ovarian Endometrioid Adenofibroma,1
6086,Carcinomatous Component Present,cystadenocarcinoma of intrahepatic bile duct,1
6087,Malignant Cellular Infiltrate,Mixed Congenital Mesoblastic Nephroma,1
6088,Epithelial Component Present,Adenoma of large intestine,1
6089,Indolent Clinical Course,Dartoic myoma,1
6090,Clinical TNM Finding,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
6091,Benign Cellular Infiltrate,Pericardial Adenomatoid Tumor,1
6092,Seizures,Dysembryoplastic neuroepithelial tumor,1
6093,Lymphoplasmacytic Infiltrate,Lymphoepithelial malignant thymoma,1
6094,Moderate dysplasia,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
6095,Severe dysplasia,Stage 0 Colorectal Cancer AJCC v6 and v7,1
6096,Unfavorable Clinical Outcome,Intermediate Atypical Prostate Carcinoma,1
6097,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
6098,Intraductal Lesion,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
6099,Malignant Cellular Infiltrate,Hilar Cholangiocarcinoma by AJCC v7 Stage,1
6100,Dysplasia,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
6101,Mesenchymal Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
6102,Malignant Cellular Infiltrate,Stage IIIA Vulvar Cancer AJCC v8,1
6103,Low Mitotic Activity,Malignant Pancreatic Vipoma,1
6104,Non-Specific Glandular Pattern,Bladder Adenocarcinoma,1
6105,Cystic Change,Serous papillary cystic tumor of borderline malignancy,1
6106,Cutaneous Involvement,Vulvar Lichen Sclerosus,1
6107,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
6108,Epithelial Component Present,Stage II Rectal Cancer,1
6109,Sarcomatous Component Present,carcinosarcoma of liver,1
6110,Indolent Clinical Course,Disseminated Juvenile Xanthogranuloma,1
6111,Well-Circumscribed Lesion,Adenomatoid Tumor,1
6112,Poorly Cohesive Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric,1
6113,Lipomatous Component Present,Thymolipoma,1
6114,Metastatic Lesion,CNS metastases,1
6115,Malignant Cellular Infiltrate,Adenocarcinoma with cartilaginous metaplasia,1
6116,Carcinomatous Component Present,Stage III Ovarian Cancer AJCC v8,1
6117,Benign Cellular Infiltrate,Childhood Central Nervous System Mature Teratoma,1
6118,Unresectable Mass,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
6119,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma stage II,1
6120,Epithelial Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
6121,Schwannian Stroma Predominant Component of the Tumor Volume,Ganglioneuroma of mediastinum,1
6122,Nuclear Grooves,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
6123,Monoclonal Langerhans Cells Present,Eosinophilic Granuloma,1
6124,Malignant Cellular Infiltrate,Lung Non-Small Cell Cancer by AJCC v7 Stage,1
6125,Malignant Cellular Infiltrate,Malignant melanoma of conjunctiva,1
6126,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8,1
6127,Carcinomatous Component Present,Early Hepatocellular Carcinoma,1
6128,Carcinomatous Component Present,Moderately Differentiated Prostate Adenocarcinoma,1
6129,Childhood Lesion,Childhood Hematopoietic Neoplasm,1
6130,Benign Cellular Infiltrate,Paranasal Sinus Schneiderian Papilloma,1
6131,Vascular Channel Formation,Cardiac Capillary Hemangioma,1
6132,Chronic Inflammatory Infiltrate,"Histiocytoma, Benign Fibrous",1
6133,Epithelial Component Present,Oropharyngeal Carcinoma by AJCC v7 Stage,1
6134,Fibrous Septa Present,Dysgerminoma,1
6135,Adnexal Differentiation,Basal cell carcinoma - follicular,1
6136,Carcinomatous Component Present,small cell carcinoma of appendix,1
6137,Primary Lesion,Asynchronous Multifocal Osteosarcoma,1
6138,Malignant Cellular Infiltrate,Lung Basaloid Large Cell Carcinoma,1
6139,Malignant Cellular Infiltrate,Stage IV Childhood Hodgkin Lymphoma,1
6140,Epithelial Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
6141,Cystic Change,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
6142,Juvenile Lesion,Juvenile osteochondrosis of tibial tubercle,1
6143,Epithelial Component Present,Stage IVA Hepatocellular Carcinoma AJCC v8,1
6144,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,1
6145,Childhood Lesion,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
6146,Carcinomatous Component Present,Ear carcinoma,1
6147,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v7 Stage,1
6148,Histiocytosis,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
6149,Benign Cellular Infiltrate,Liver Lymphangioma,1
6150,Invasive Lesion,Invasive Prostate Carcinoma,1
6151,Unresectable Mass,Unresectable Solid Neoplasm,1
6152,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Neoplasm,1
6153,Recurrent Genetic Abnormalities Present,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,1
6154,Malignant Cellular Infiltrate,Primary Cutaneous Follicle Center Lymphoma,1
6155,Epithelial Component Present,Stage IIIA Small Intestinal Cancer AJCC v7,1
6156,Malignant Cellular Infiltrate,Nonestrogen-Dependent Malignant Neoplasm,1
6157,Epithelial Component Present,Lip and Oral Cavity Carcinoma,1
6158,Epithelial Component Present,Adenocarcinoma of pancreas,1
6159,Hyperkeratosis,Glottis Verrucous Carcinoma,1
6160,Secondary Lesion,Prostate Carcinoma Metastatic in the Bone,1
6161,Cystic Change,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
6162,Carcinomatous Component Present,Stage IIC Colon Cancer AJCC v8,1
6163,Epithelial Component Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
6164,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v7,1
6165,High Mitotic Activity,Malignant Testicular Leydig Cell Tumor,1
6166,Carcinomatous Component Present,Stage 0 Pancreatic Cancer AJCC v8,1
6167,Hyperchromatism,Hepatocellular Small Cell Change,1
6168,Epithelial Component Present,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
6169,Fibrovascular Septa Present,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
6170,Epithelial Component Present,Larynx carcinoma recurrent,1
6171,Carcinomatous Component Present,Clear cell squamous cell carcinoma of skin,1
6172,Neuroendocrine Differentiation,Thymic Small Cell Carcinoma,1
6173,Epithelial Component Present,Stage II Renal Cell Cancer,1
6174,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity recurrent,1
6175,Monocytosis,Chronic Myelomonocytic Leukemia-0,1
6176,Duct-Like Structures Present,epithelial-myoepithelial carcinoma of lung,1
6177,Carcinomatous Component Present,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
6178,Biphasic Pattern,carcinosarcoma of liver,1
6179,Carcinomatous Component Present,Stage IVA Bladder Cancer AJCC v8,1
6180,Malignant Cellular Infiltrate,Paranasal Sinus Cancer,1
6181,Slow Growing Mass,Ependymoma of spinal cord,1
6182,Cribriform Pattern,Rectal Cribriform Comedo-Type Adenocarcinoma,1
6183,More than 5 Mitoses per 50HPF,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
6184,Malignant Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v8,1
6185,Bone Marrow Dysplasia Present,Refractory anaemia with excess blasts,1
6186,Hyalinized Stroma Formation,Chondroid lipoma,1
6187,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8,1
6188,Perineural spread,Maxillary Sinus Adenoid Cystic Carcinoma,1
6189,Thyroglobulin Positive Neoplastic Cells Present,Poorly Differentiated Thyroid Carcinoma,1
6190,Malignant Cellular Infiltrate,Rectal Carcinoma Metastatic in the Liver,1
6191,Malignant Cellular Infiltrate,Combined Lung Carcinoma,1
6192,Carcinomatous Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
6193,Slow Growing Mass,Subependymal Giant Cell Astrocytoma,1
6194,Lymphoplasmacytic Infiltrate,Multi-centric Castleman's Disease,1
6195,Indolent Clinical Course,Pigmented villonodular synovitis,1
6196,Epithelial Component Present,Malignant Phyllodes Tumor of Prostate,1
6197,Nuclear Molding,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
6198,Monoclonal Cellular Population Present,Thyroid Gland Follicular Adenoma,1
6199,Epithelial Component Present,Transplant-Related Bladder Urothelial Carcinoma,1
6200,Carcinomatous Component Present,Gastric Squamous Cell Carcinoma,1
6201,Hydropic Villous Change,Hydatidiform Mole,1
6202,Malignant Cellular Infiltrate,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,1
6203,Epithelial Component Present,Renal Cell Cancer by AJCC v7 Stage,1
6204,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage I,1
6205,Epithelial Component Present,Extrapulmonary Small Cell Carcinoma,1
6206,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma,1
6207,Epithelial Component Present,Nodulo-ulcerative basal cell carcinoma,1
6208,Necrotic changes (finding),Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
6209,Neuroendocrine Differentiation,Functioning Pancreatic Neuroendocrine Tumor,1
6210,Epithelial Component Present,"Carcinoma, Neuroendocrine",1
6211,Vascular Channel Formation,Benign neoplasm of blood vessel,1
6212,Malignant Cellular Infiltrate,Ann Arbor Stage IIIA Hodgkin Lymphoma,1
6213,Epithelial Component Present,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
6214,Malignant Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v7 Stage,1
6215,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q),1
6216,Malignant Cellular Infiltrate,Stage IVA Colon Cancer AJCC v8,1
6217,Epithelial Component Present,Stage IIIB Rectal Cancer AJCC v7,1
6218,Neuroendocrine Differentiation,Digestive System Neuroendocrine Neoplasm,1
6219,Benign Cellular Infiltrate,Hemangioma of spleen,1
6220,Malignant Cellular Infiltrate,"Refractory Medulloblastoma, SHH-Activated",1
6221,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v8,1
6222,High Grade Lesion,Epithelioid Sarcoma NCI Grade 3,1
6223,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma recurrent,1
6224,EBV-Positive Neoplastic Cells Present,Hydroa vacciniforme-like lymphoma,1
6225,Childhood Lesion,Childhood Small Intestinal Carcinoma,1
6226,Broad Fibrous Bands Formation,Parathyroid Gland Atypical Adenoma,1
6227,Bone Marrow Dysplasia Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
6228,Carcinomatous Component Present,Basal cell carcinoma of vulva,1
6229,Invasive Lesion,Inflammatory carcinoma of breast stage III,1
6230,Epithelial Component Present,Mucinous adenocarcinoma gastric,1
6231,Peripheral Nuclear Palisading,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
6232,Epithelial Component Present,Minor Salivary Gland Carcinoma,1
6233,Benign Cellular Infiltrate,Benign neoplasm of cecum,1
6234,Malignant Cellular Infiltrate,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
6235,Unclassifiable Lesion,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",1
6236,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia,1
6237,Carcinomatous Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
6238,Immunologic Deficiency Syndromes,AIDS-Related Idiopathic Thrombocytopenic Purpura,1
6239,Metastatic Lesion,Metastatic Breast Carcinoma,1
6240,Carcinomatous Component Present,Refractory Digestive System Neuroendocrine Carcinoma,1
6241,Extraosseous Lesion,Central Nervous System Extraskeletal Osteosarcoma,1
6242,Malignant Cellular Infiltrate,Gastric Pylorus Carcinoma,1
6243,Malignant Cellular Infiltrate,Endometrial Mixed Cell Adenocarcinoma,1
6244,Carcinomatous Component Present,Stage IIA Merkel Cell Carcinoma AJCC v7,1
6245,Fibrosis,Breast Sclerosing Adenosis,1
6246,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma of parotid gland,1
6247,Malignant Cellular Infiltrate,Stage 2 Neuroblastoma,1
6248,Epithelial Component Present,Colorectal Cancer by AJCC v6 Stage,1
6249,Tissue of Mullerian Origin Present,Ovarian Serous Adenofibroma,1
6250,Indolent Clinical Course,Intramuscular lipoma,1
6251,Malignant Germinomatous Cellular Infiltrate,Sellar Germinoma,1
6252,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v8,1
6253,Carcinomatous Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8,1
6254,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v7,1
6255,Carcinomatous Component Present,Small cell carcinoma of lung,1
6256,Epithelial Component Present,Benign neoplasm of sweat gland,1
6257,Exposure to asbestos,Asbestos-Related Lung Disorder,1
6258,Mixed Cellular Population,Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
6259,Benign Cellular Infiltrate,Atypical Breast Papilloma,1
6260,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v8,1
6261,High Grade Lesion,"Anaplastic Astrocytoma, IDH-Mutant",1
6262,Childhood Lesion,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
6263,Necrotic changes (finding),Refractory Dedifferentiated Liposarcoma,1
6264,More than 10 Mitoses per 10HPF,Metastatic Lung Small Cell Carcinoma,1
6265,White blood cell count increased (lab result),"Leukemia, Myeloid, Chronic-Phase",1
6266,Malignant Cellular Infiltrate,Clinical Stage IV Cutaneous Melanoma AJCC v8,1
6267,Extensive Stage Lesion,Pleural mesothelioma malignant advanced,1
6268,Epithelial Component Present,Intraductal papillary breast neoplasm,1
6269,Neuroendocrine Differentiation,Neuroendocrine carcinoma of the bladder,1
6270,Malignant Cellular Infiltrate,small cell carcinoma of larynx,1
6271,Benign Cellular Infiltrate,Dermal Fibroma,1
6272,Malignant Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,1
6273,Benign Cellular Infiltrate,Ethmoid Sinus Schneiderian Papilloma,1
6274,Carcinomatous Component Present,Stage IVA Fallopian Tube Cancer AJCC v8,1
6275,Stromal Invasion,BRCA-Mutated Ovarian Carcinoma,1
6276,Malignant Cellular Infiltrate,Stage IB Cutaneous Melanoma AJCC v7,1
6277,Composite Lesion,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
6278,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8,1
6279,Cutaneous Involvement,Eccrine carcinoma of skin,1
6280,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma recurrent,1
6281,Well-Circumscribed Lesion,tubulovillous adenoma of stomach,1
6282,Malignant Cellular Infiltrate,Fallopian Tube Transitional Cell Carcinoma,1
6283,Low Mitotic Activity,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,1
6284,Malignant Cellular Infiltrate,Uterine Ligament Clear Cell Adenocarcinoma,1
6285,Malignant Cellular Infiltrate,Invasive Ductal and Lobular Carcinoma,1
6286,Well Differentiated Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,1
6287,Adulthood Lesion,Stage IIIA Adult Liver Cancer AJCC v7,1
6288,Cutaneous Involvement,Mycosis fungoides refractory,1
6289,High Mitotic Activity,Recurrent Childhood Anaplastic Oligoastrocytoma,1
6290,Breast Microcalcification,Well Differentiated Oligodendroglioma,1
6291,Diffuse Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
6292,Mass of body structure,Differentiated Granulocytic Sarcoma,1
6293,Epithelial Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,1
6294,Capillary Sized Vascular Channel Formation,Pyogenic granuloma of oral mucosa,1
6295,Malignant Cellular Infiltrate,Ovarian Embryonal Carcinoma,1
6296,Benign Cellular Infiltrate,Trichoadenoma,1
6297,Malignant Cellular Infiltrate,Sclerosing rhabdomyosarcoma,1
6298,Epithelial Component Present,Parasympathetic paraganglioma,1
6299,Carcinomatous Component Present,Stage IVB Pharyngeal Carcinoma,1
6300,Biphasic Pattern,Borderline Ovarian Mucinous Adenofibroma,1
6301,Malignant Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v6 and v7,1
6302,Bilateral Disease,bilateral breast cancer,1
6303,Carcinomatous Component Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
6304,Low Mitotic Activity,Low Grade Endometrial Stromal Sarcoma,1
6305,Epithelial Component Present,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,1
6306,Endobronchial Lesion,Lung Squamous Cell Papilloma,1
6307,Cavernous Vascular Space Formation,Thyroid Gland Cavernous Hemangioma,1
6308,Papillary Pattern,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
6309,Benign Cellular Infiltrate,Renal Pelvis Urothelial Papilloma,1
6310,Epithelial Component Present,Metaplastic thymoma,1
6311,Malignant Cellular Infiltrate,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
6312,Recurrent Genetic Abnormalities Present,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,1
6313,Hyalinized Stroma Formation,Central Nervous System Epithelioid Hemangioendothelioma,1
6314,Benign Cellular Infiltrate,Oral Cavity Benign Granular Cell Tumor,1
6315,Malignant Cellular Infiltrate,Gastric Papillary Adenocarcinoma,1
6316,Secondary Lesion,Advanced Favorable Non-Hodgkin Lymphoma,1
6317,Poorly Differentiated Lesion,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
6318,Malignant Cellular Infiltrate,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,1
6319,Benign Cellular Infiltrate,Vulvar Acquired Melanocytic Nevus,1
6320,Metastatic Lesion,Metastatic Squamous Cell Carcinoma of the Larynx,1
6321,Epithelial Component Present,Ethmoid Sinus Inverted Papilloma,1
6322,Carcinomatous Component Present,Tubular breast carcinoma,1
6323,atypia morphology,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,1
6324,Osseous Differentiation,Extraskeletal osteosarcoma recurrent,1
6325,Macrofollicular Structures Present,Juvenile Type Testicular Granulosa Cell Tumor,1
6326,Dermal Involvement,Classical Poroma,1
6327,Cutaneous Involvement,Primary Cutaneous Follicle Center Lymphoma,1
6328,Malignant Cellular Infiltrate,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
6329,atypia morphology,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
6330,Extensive Stage Lesion,Advanced Favorable Non-Hodgkin Lymphoma,1
6331,Epithelial Component Present,Adenocarcinoma of the prostate stage II,1
6332,Malignant Cellular Infiltrate,Primary cutaneous lymphoma,1
6333,Childhood Lesion,Stage III Childhood Burkitt Lymphoma,1
6334,Metastatic Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
6335,Epithelial Component Present,Stage IIIC Colorectal Cancer AJCC v8,1
6336,Cutaneous Involvement,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
6337,Benign Cellular Infiltrate,Intravascular Angioleiomyoma,1
6338,Carcinomatous Component Present,Metaplastic carcinoma of breast,1
6339,Adulthood Lesion,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
6340,Malignant Cellular Infiltrate,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
6341,Secondary Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,1
6342,Malignant Cellular Infiltrate,adenosquamous carcinoma of ovary,1
6343,Malignant Cellular Infiltrate,Recurrent Parotid Gland Adenoid Cystic Carcinoma,1
6344,Organoid Pattern,Bladder Alveolar Soft Part Sarcoma,1
6345,Congenital Lesion,Proliferative dermal lesion in congenital nevus,1
6346,Recurrent disease,Recurrent Plasmablastic Lymphoma,1
6347,Carcinomatous Component Present,Grade 3 Colon Adenocarcinoma,1
6348,Malignant Cellular Infiltrate,Fibrosarcoma,1
6349,Carcinomatous Component Present,mucoepidermoid carcinoma of lacrimal gland,1
6350,Severe dysplasia,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
6351,Monomorphic Cellular Infiltrate,Tanycytic ependymoma,1
6352,Epithelial Component Present,Solid Papillary Breast Carcinoma,1
6353,Vascular Channel Formation,Solid Angioleiomyoma,1
6354,Indolent Clinical Course,Vulvar Angiomyxoma,1
6355,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
6356,Mesenchymal Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
6357,Malignant Cellular Infiltrate,Advanced Kaposi Sarcoma,1
6358,Well-Circumscribed Lesion,Stromal Predominant Kidney Wilms Tumor,1
6359,Malignant Cellular Infiltrate,Acinic cell carcinoma of salivary gland,1
6360,Tissue Differentiation Uncertain,Perivascular Epithelioid Cell Neoplasms,1
6361,Osseous Differentiation,Osteosarcoma by AJCC v7 Stage,1
6362,Carcinomatous Component Present,Adenocarcinoma of Accessory Sinus,1
6363,Metastatic/Recurrent Disease,Proximal-Type Epithelioid Sarcoma,1
6364,Epithelial Component Present,Stage III Bladder Cancer AJCC v6 and v7,1
6365,Epithelial Component Present,Urinary System Paraganglioma,1
6366,Adulthood Lesion,Adult Lymphoma,1
6367,Epithelial Component Present,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
6368,Rarely Metastasizing Lesion,Endovascular papillary angioendothelioma,1
6369,Cutaneous Involvement,Acrokeratosis Verruciformis of Hopf,1
6370,Unresectable Mass,Unresectable Intrahepatic Cholangiocarcinoma,1
6371,Neuroendocrine Differentiation,insulinoma,1
6372,Benign Cellular Infiltrate,Mature Ovarian Teratoma,1
6373,Severe dysplasia,Adenocarcinoma in situ in adenomatous polyp,1
6374,Resectable Mass,Resectable Carcinoma,1
6375,Adulthood Lesion,Aggressive Adult Non-Hodgkin Lymphoma,1
6376,Generalized Dysplasia,Colorectal Filiform Serrated Adenoma,1
6377,Locally Aggressive Lesion,Retroperitoneal Inflammatory Myofibroblastic Tumor,1
6378,"Fully Differentiated ""Adult-Type"" Tissues Present",Grade 1 Ovarian Teratoma,1
6379,Epithelial Component Present,Metastatic Carcinoma to the Uterine Cervix,1
6380,Hereditary Lesion,Hereditary Ovarian Carcinoma,1
6381,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v8 Stage,1
6382,Increased NFkappaB Pathway Activation,Mediastinal (Thymic) Large B-Cell Lymphoma,1
6383,Indolent Clinical Course,Juvenile Xanthogranuloma,1
6384,Epithelial Component Present,Gallbladder Biliary Intraepithelial Neoplasia,1
6385,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Conventional Leiomyosarcoma,1
6386,Malignant Cellular Infiltrate,Stage IVB Colon Cancer AJCC v8,1
6387,Epithelial Component Present,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8,1
6388,Epithelial Component Present,Stage 0 Penile Cancer AJCC v6,1
6389,Mesenchymal Differentiation,"Transitional cell carcinoma, spindle cell",1
6390,Indolent Clinical Course,Calcifying Fibrous Pseudotumor,1
6391,Regional Disease,Locally Advanced Head and Neck Carcinoma,1
6392,Adnexal Differentiation,Benign Germinative Follicular Epithelium Neoplasm,1
6393,Epithelial Component Present,Benign pheochromocytoma of adrenal gland,1
6394,Borderline Lesion,Pancreatic Intraductal Papillary-Mucinous Adenoma,1
6395,Epithelial Component Present,undifferentiated carcinoma of cervix,1
6396,Epithelial Component Present,Ectopic Thyroid Gland Thymoma,1
6397,Resectable Mass,Resectable Pancreatic Ductal Adenocarcinoma,1
6398,Neuroendocrine Differentiation,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
6399,Recurrent Genetic Abnormalities Present,Hypodiploid B Acute Lymphoblastic Leukemia,1
6400,High Grade Lesion,Synovial sarcoma non-metastatic,1
6401,Epithelial Component Present,Borderline Ovarian Clear Cell Tumor,1
6402,Ineffective hematopoiesis,Acute myeloid leukemia with multilineage dysplasia,1
6403,Epithelial Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
6404,Epithelial Component Present,Squamous intraepithelial neoplasia grade 2,1
6405,Malignant Cellular Infiltrate,Secondary osteosarcoma,1
6406,Epithelial Component Present,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage,1
6407,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
6408,Severe dysplasia,Clinical Stage 0 Gastric Cancer AJCC v8,1
6409,Recurrent disease,Laryngeal papillomatosis,1
6410,Cambium Layer,Botryoid-Type Embryonal Rhabdomyosarcoma,1
6411,Diffuse Pattern,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
6412,Intraductal Lesion,Intraductal Hyperplasia,1
6413,Blasts Under 20 Percent of Peripheral Blood White Cells,Refractory Chronic Myelomonocytic Leukemia,1
6414,Malignant Germinomatous Cellular Infiltrate,Suprasellar Germinoma,1
6415,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage II,1
6416,Nuclear Grooves,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
6417,Indolent Clinical Course,Intra-Abdominal Lymphangioma,1
6418,Epithelial Component Present,Squamous cell carcinoma of prostate,1
6419,Tubular Pattern,Tubulovillous adenoma,1
6420,Malignant Cellular Infiltrate,Conventional Leiomyosarcoma,1
6421,Blasts Under 20 Percent of Peripheral Blood White Cells,"Leukemia, Myelomonocytic, Chronic",1
6422,Malignant Cellular Infiltrate,Vulvar Merkel Cell Carcinoma,1
6423,Malignant Cellular Infiltrate,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin,1
6424,Cutaneous Involvement,Herpes simplex dermatitis,1
6425,Unresectable Mass,Unresectable Solid Neoplasm,1
6426,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7,1
6427,Malignant Cellular Infiltrate,mucinous adenocarcinoma of ovary,1
6428,Malignant Cellular Infiltrate,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,1
6429,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage II,1
6430,Mild dysplasia,Mild epithelial dysplasia,1
6431,Well-Circumscribed Lesion,Urethra Fibroepithelial Polyp,1
6432,Epithelial Component Present,Mucoepidermoid carcinoma of parotid gland,1
6433,Malignant Cellular Infiltrate,Calcifying Nested Epithelial Stromal Tumor of the Liver,1
6434,Epithelial Component Present,Intra-Abdominal Paraganglioma,1
6435,Necrotic changes (finding),Adult Giant Cell Glioblastoma,1
6436,More than 5 Mitoses per 50HPF,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
6437,Carcinomatous Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma,1
6438,Vascular Channel Formation,Aortic Angiosarcoma,1
6439,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor G2,1
6440,Malignant Cellular Infiltrate,Rectal Signet Ring Cell Adenocarcinoma,1
6441,Ground Glass Nuclear Inclusion,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
6442,Carcinomatous Component Present,Stage III Nasal Cavity Cancer AJCC v6 and v7,1
6443,Carcinomatous Component Present,Lip Carcinoma,1
6444,Epithelial Component Present,Stage IVA Vulvar Cancer AJCC v8,1
6445,Epithelial Component Present,Unresectable Basal Cell Carcinoma,1
6446,Secondary Lesion,Fibrosarcoma metastatic,1
6447,Malignant Cellular Infiltrate,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
6448,Therapy-Related Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
6449,Follicular Cell Differentiation,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
6450,Neuroendocrine Differentiation,Recurrent Pancreatic Neuroendocrine Carcinoma,1
6451,Malignant Cellular Infiltrate,Aleukemic Lymphoid Leukemia,1
6452,Carcinomatous Component Present,Adrenal Cortex Carcinoma by AJCC v8 Stage,1
6453,No Evidence of Metastatic Disease,Benign pheochromocytoma of adrenal gland,1
6454,Dysplasia,High Grade Esophageal Glandular Intraepithelial Neoplasia,1
6455,Malignant Cellular Infiltrate,Mucoepidermoid Carcinoma,1
6456,Malignant Cellular Infiltrate,Ovarian Serous Adenocarcinoma,1
6457,Cystic Change,Malignant Brenner Tumor,1
6458,Epithelial Component Present,keratinizing squamous cell carcinoma of lung,1
6459,Histiocytosis haematophagic,Familial Hemophagocytic Lymphocytosis,1
6460,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,1
6461,Epithelial Component Present,Sarcomatoid Intrahepatic Cholangiocarcinoma,1
6462,Epithelial Component Present,Salivary duct carcinoma,1
6463,Malignant Cellular Infiltrate,Ann Arbor Stage IIIB Hodgkin Lymphoma,1
6464,Intestinal metaplasia,Vaginal Adenoma,1
6465,Neuroendocrine Differentiation,Gallbladder Tubular Carcinoid,1
6466,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Carcinoma AJCC v7,1
6467,Hypoglycemia,Malignant Pancreatic Insulinoma,1
6468,Muscle Invasion,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,1
6469,Malignant Cellular Infiltrate,EZB Diffuse Large B-Cell Lymphoma,1
6470,Malignant Cellular Infiltrate,Recurrent Malignant Soft Tissue Neoplasm,1
6471,Polymorphic Cellular Infiltrate,"Post-transplant lymphoproliferative disorder, polymorphic",1
6472,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v8,1
6473,Epithelial Component Present,Colloid Carcinoma of the Pancreas,1
6474,Mitotic Activity,Temporal Lobe Anaplastic Astrocytoma,1
6475,Melanosomes Present,Mediastinal Melanotic Schwannoma,1
6476,Benign Cellular Infiltrate,Gastric Leiomyoma,1
6477,Epithelial Component Present,Clinical Stage III Gastric Cancer AJCC v8,1
6478,Malignant Cellular Infiltrate,Small intestine adenocarcinoma metastatic NOS,1
6479,Benign Cellular Infiltrate,Benign neoplasm of oral cavity,1
6480,Epithelial Component Present,Small Intestinal Neuroendocrine Tumor,1
6481,High Grade Lesion,Recurrent Dedifferentiated Liposarcoma,1
6482,Carcinomatous Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
6483,Adnexal Differentiation,Pilar tumor,1
6484,Nuclear Molding,Combined Lung Small Cell and Squamous Cell Carcinoma,1
6485,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
6486,Metastatic Lesion,Stage IV Ovarian Carcinoma,1
6487,Systemic disease,Multi-centric Castleman's Disease,1
6488,Well-Circumscribed Lesion,Adenoma of small intestine,1
6489,Carcinomatous Component Present,Stage IV Pharynx Carcinoma,1
6490,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage II,1
6491,Slow Growing Painless Mass,calcifying aponeurotic fibroma,1
6492,Malignant Cellular Infiltrate,Recurrent Testicular Lymphoma,1
6493,Well-Circumscribed Lesion,Polyp of esophagus,1
6494,Papillary Pattern,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",1
6495,Carcinomatous Component Present,Ovarian Dermoid Cyst with Secondary Carcinoma,1
6496,Malignant Cellular Infiltrate,Ovarian Adenosarcoma,1
6497,Local disease,Localized Unresectable Adult Hepatocellular Carcinoma,1
6498,Carcinomatous Component Present,Hypopharyngeal Carcinoma,1
6499,Epithelial Component Present,Non-Functioning Adrenal Cortex Adenoma,1
6500,Malignant Cellular Infiltrate,Aleukemic Acute Lymphoblastic Leukemia Cutis,1
6501,Carcinomatous Component Present,Stage IIIB Anal Canal Cancer AJCC v6 and v7,1
6502,Refractory Disease,Refractory Oropharyngeal Squamous Cell Carcinoma,1
6503,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v7,1
6504,Benign Cellular Infiltrate,Unresectable Craniopharyngioma,1
6505,Carcinomatous Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
6506,Infiltrative Growth Pattern,Childhood Gliosarcoma,1
6507,Carcinomatous Component Present,Stage IVA Gallbladder Cancer AJCC v8,1
6508,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v8,1
6509,Secondary Lesion,Secondary malignant neoplasm of anus,1
6510,Malignant Cellular Infiltrate,Angiosarcoma of liver,1
6511,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Myxoid Leiomyoma,1
6512,Childhood Lesion,Childhood Thyroid Gland Carcinoma,1
6513,Malignant Cellular Infiltrate,"Peripheral Nerve Neoplasms, Malignant",1
6514,Gastric dysplasia,tubulovillous adenoma of stomach,1
6515,Malignant Cellular Infiltrate,"Papillary transitional cell carcinoma, non-invasive",1
6516,Fibrotic Stroma Formation,Ossifying Fibroma,1
6517,Follicular Cell Differentiation,Childhood Thyroid Gland Follicular Carcinoma,1
6518,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
6519,Epithelial Component Present,Ampulla of Vater Clear Cell Adenocarcinoma,1
6520,Lipomatous Component Present,Childhood Kidney Angiomyolipoma,1
6521,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
6522,Nuclear Pseudoinclusion,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
6523,Hyalinized Stroma Formation,Solitary fibrous tumor,1
6524,Myxoid Stroma Formation,Bone Epithelioid Hemangioendothelioma,1
6525,Malignant Cellular Infiltrate,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
6526,Epithelial Component Present,Metastatic Ductal Breast Carcinoma,1
6527,Fibrosis,Breast Apocrine Adenosis,1
6528,Carcinomatous Component Present,Endometrial Squamous Cell Carcinoma,1
6529,Malignant Cellular Infiltrate,Low-grade fibromyxoid sarcoma,1
6530,Papillary Pattern,Endolymphatic sac tumor,1
6531,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome refractory,1
6532,Increased megakaryocytes (bone marrow),Prefibrotic/Early Primary Myelofibrosis,1
6533,Follicular Cell Differentiation,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8,1
6534,Vascular Channel Formation,Brain Hemangioma,1
6535,Benign Cellular Infiltrate,Jugular Foramen Schwannoma,1
6536,Necrotic changes (finding),Glioblastoma multiforme of spinal cord,1
6537,Intracanalicular Growth Pattern,Phyllodes Tumor,1
6538,Malignant Cellular Infiltrate,Cervical Serous Adenocarcinoma,1
6539,Malignant Cellular Infiltrate,Stage II Ovarian Germ Cell Tumor AJCC v6 and v7,1
6540,Malignant Cellular Infiltrate,Type I Endometrial Adenocarcinoma,1
6541,Well Differentiated Neuroendocrine Lesion,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
6542,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
6543,Malignant Cellular Infiltrate,High Grade Fallopian Tube Serous Adenocarcinoma,1
6544,Epithelial Component Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,1
6545,Primary Lesion,Benign Adult Brain Stem Neoplasm,1
6546,Recurrent disease,Acute lymphoblastic leukemia recurrent,1
6547,Malignant Cellular Infiltrate,Advanced Malignant Solid Neoplasm,1
6548,Well-Circumscribed Lesion,Medullary carcinoma of thyroid,1
6549,Epithelial Component Present,Recurrent Thyroid Gland Anaplastic Carcinoma,1
6550,Epithelial Component Present,Clear Cell Adrenal Cortical Adenoma,1
6551,Indolent Clinical Course,Benign Cutaneous Vascular Neoplasm,1
6552,Monoclonal Cellular Population Present,Thyroid Gland Lipoadenoma,1
6553,Well Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Tumor G2,1
6554,Monoclonal Cellular Population Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
6555,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Recurrent High Risk Myelodysplastic Syndrome,1
6556,Metastatic Lesion,Advanced Melanoma,1
6557,Heterologous Elements Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
6558,Epithelial Component Present,verrucous carcinoma of vulva,1
6559,Childhood Lesion,Malignant Childhood Germ Cell Tumor,1
6560,Neuroendocrine Differentiation,Carcinoid tumor of ileum,1
6561,Malignant Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,1
6562,Malignant Cellular Infiltrate,Locally Recurrent Malignant Neoplasm,1
6563,Epithelial Component Present,Stage IV Distal Bile Duct Cancer AJCC v7,1
6564,Epithelial Component Present,Hormone secreting pituitary neoplasms,1
6565,Slow Growing Mass,Sellar Ependymoma,1
6566,'Starry-sky' pattern,Stage I Burkitt Lymphoma,1
6567,Slow Growing Mass,Kadish Stage B Olfactory Neuroblastoma,1
6568,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Alkylating Agent-Related Myelodysplastic Syndrome,1
6569,Local disease,Pericardial Adenomatoid Tumor,1
6570,Malignant Cellular Infiltrate,Second Primary Cancers,1
6571,Epithelial Component Present,Laryngeal verrucous carcinoma recurrent,1
6572,Birbeck Granules Present,Tumors Derived from Langerhans Cells,1
6573,Benign Cellular Infiltrate,Metanephric adenoma,1
6574,Epithelial Component Present,Stage IVB Appendix Carcinoma AJCC v8,1
6575,Local disease,Colon Lipoma,1
6576,Calcitonin serum level increased,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
6577,Cutaneous Involvement,Unresectable Skin Squamous Cell Carcinoma,1
6578,Mitotic Activity,Childhood Pilomyxoid Astrocytoma,1
6579,Recurrent disease,Adenoid cystic carcinoma of the oral cavity recurrent,1
6580,Malignant Cellular Infiltrate,Refractory Transformed Chronic Lymphocytic Leukemia,1
6581,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia,1
6582,Metastatic Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
6583,Fibrotic Stroma Formation,Ovarian Microcystic Stromal Tumor,1
6584,Encapsulated Mass,Macrofollicular adenoma,1
6585,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G2,1
6586,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,1
6587,Neoplastic Promonocytes in Bone Marrow Markedly Increased,Adult Acute Monocytic Leukemia,1
6588,Dysplasia,Stage 0 Cervical Cancer AJCC v6,1
6589,Malignant Cellular Infiltrate,"Glomus tumor, malignant",1
6590,Vascular Channel Formation,hemangioma of mediastinum,1
6591,More than 5 Mitoses per 50HPF,Metastatic Gastrointestinal Stromal Tumor,1
6592,Carcinomatous Component Present,Undifferentiated carcinoma of stomach,1
6593,Perivascular Arrangement of Tumor Cells,Lung PEComa,1
6594,atypia morphology,Atypical fibroxanthoma of skin,1
6595,Monomorphic Cellular Infiltrate,Cervical Basaloid Carcinoma,1
6596,Hyaline Cartilage Differentiation,Central Nervous System Chondroma,1
6597,Diffuse Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,1
6598,Neuronal Differentiation,Extraventricular neurocytoma,1
6599,Extensive Stage Lesion,Advanced Neuroendocrine Neoplasm,1
6600,Primary Lesion,Recurrent Primary Malignant Neoplasm,1
6601,Malignant Cellular Infiltrate,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
6602,Cellular Pleomorphism,Intracortical osteosarcoma,1
6603,Benign Cellular Infiltrate,Clear Cell Adrenal Cortical Adenoma,1
6604,Vascular Channel Formation,Hemolymphangioma,1
6605,Epithelial Component Present,Plurihormonal Pituitary Gland Adenoma,1
6606,Local disease,Localized Malignant Neoplasm,1
6607,Malignant Cellular Infiltrate,Malignant neoplasm of bronchus,1
6608,Epithelial Component Present,Micronodular thymoma with lymphoid stroma,1
6609,Malignant Cellular Infiltrate,Stage IA Lung Squamous Cell Carcinoma AJCC v7,1
6610,Carcinomatous Component Present,Stage IB Vulvar Carcinoma AJCC v6,1
6611,Papillary Pattern,Serous surface papilloma,1
6612,Malignant Cellular Infiltrate,Duodenal Extraskeletal Osteosarcoma,1
6613,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage III,1
6614,Primary Lesion,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
6615,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
6616,Childhood Lesion,Childhood Lymphoma,1
6617,Malignant Cellular Infiltrate,adenosquamous carcinoma of esophagus,1
6618,Bone marrow reticulin fibrosis,Splenic Manifestation of Hairy Cell Leukemia,1
6619,Malignant Cellular Infiltrate,Locally Advanced Head and Neck Carcinoma,1
6620,Carcinomatous Component Present,Thymic Adenocarcinoma,1
6621,Recurrent Genetic Abnormalities Present,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
6622,Epithelial Component Present,Gastric Cancer by AJCC v8 Clinical Stage,1
6623,Biphasic Pattern,Metaplastic thymoma,1
6624,Carcinomatous Component Present,Stage IV Prostate Cancer AJCC v8,1
6625,Invasive Lesion,Mucoepidermoid Breast Carcinoma,1
6626,Invasive Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
6627,Sebaceous Differentiation,Sebaceous Gland Neoplasms,1
6628,Carcinomatous Component Present,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
6629,Cutaneous Involvement,Scar Tissue,1
6630,Adnexal Differentiation,Eyelid Sebaceous Gland Carcinoma,1
6631,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage I,1
6632,Exophytic Polypoid Lesion,Appendix Traditional Serrated Adenoma,1
6633,Malignant Cellular Infiltrate,Malignant melanoma in junctional nevus,1
6634,Carcinomatous Component Present,Stage I Fallopian Tube Cancer AJCC v8,1
6635,Carcinomatous Component Present,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
6636,Malignant Cellular Infiltrate,Gastric Body Carcinoma,1
6637,Malignant Cellular Infiltrate,Ureter Lymphoma,1
6638,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with hyperdiploidy,1
6639,Recurrent disease,Penis carcinoma recurrent,1
6640,Carcinomatous Component Present,Stage II Rectal Cancer AJCC v8,1
6641,Anaplasia,Adult Brain Stem Gliosarcoma,1
6642,Fibrotic Stroma Formation,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
6643,Papillary Pattern,"Papillary mucinous cystadenoma, borderline malignancy",1
6644,Invasive Lesion,Adenocarcinoma of the prostate stage II,1
6645,Epithelial Component Present,Metastatic Carcinoma in the Lung,1
6646,Cutaneous Involvement,Pruritus,1
6647,Neuroendocrine Differentiation,Childhood Lung Small Cell Carcinoma,1
6648,Malignant Cellular Infiltrate,Immunoblastic lymphoma associated with AIDS,1
6649,Vascular Channel Formation,Lymphangiomatosis,1
6650,Invasive Lesion,Prostate Acinar Adenocarcinoma,1
6651,Malignant Cellular Infiltrate,Lung Cancer by AJCC v8 Stage,1
6652,Malignant Cellular Infiltrate,Adenocarcinoma of the rete testis,1
6653,Carcinomatous Component Present,Stage 0 Colorectal Cancer AJCC v8,1
6654,Epithelial Component Present,Mucinous cystadenocarcinoma of ovary,1
6655,Malignant Cellular Infiltrate,Esophageal Rhabdomyosarcoma,1
6656,Malignant Cellular Infiltrate,Childhood Pineoblastoma,1
6657,Epithelial Component Present,Densely Granulated Non-Functioning Corticotroph Adenoma,1
6658,Malignant Cellular Infiltrate,Non-Secretory Plasma Cell Myeloma,1
6659,Malignant Cellular Infiltrate,Acute myeloid leukemia with BCR-ABL1,1
6660,Diffuse Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
6661,Eosinophil count raised (finding),Adult Acute Eosinophilic Leukemia,1
6662,Malignant Cellular Infiltrate,Childhood Acute Myelomonocytic Leukemia,1
6663,Absence of Invasion,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
6664,Myxoid Stroma Formation,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
6665,Neuroendocrine Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma,1
6666,Rapidly Enlarging Mass,Childhood Alveolar Rhabdomyosarcoma,1
6667,Malignant Cellular Infiltrate,Recurrent B Acute Lymphoblastic Leukemia,1
6668,Epithelial Component Present,Colon adenoma,1
6669,Carcinomatous Component Present,Nipple Duct Carcinoma,1
6670,Benign Cellular Infiltrate,"Nevus, Intradermal",1
6671,Regional Disease,Locally Advanced Pancreatic Ductal Adenocarcinoma,1
6672,Papillary Pattern,Schneiderian papilloma,1
6673,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity stage II,1
6674,Papillary Pattern,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
6675,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adult Subependymoma,1
6676,Malignant Cellular Infiltrate,Papillary Meningioma,1
6677,Abundance of Small Lymphocytes,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
6678,Carcinomatous Component Present,Stage III Rectosigmoid Cancer AJCC v6,1
6679,Papillary Pattern,Bladder Papillary Urothelial Carcinoma,1
6680,Chromogranin A Positive Neoplastic Cells Present,Ovarian Trabecular Carcinoid Tumor,1
6681,Malignant Cellular Infiltrate,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
6682,Storiform Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
6683,"Fully Differentiated ""Adult-Type"" Tissues Present",Malignant teratoma of testis,1
6684,Multinodular Mass,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,1
6685,Malignant Cellular Infiltrate,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
6686,Malignant Cellular Infiltrate,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
6687,Vascular Channel Formation,Kaposi's sarcoma of cornea,1
6688,Pseudopapillary Pattern,Solid pseudopapillary tumor of the pancreas,1
6689,Necrotic changes (finding),Rectal Small Cell Neuroendocrine Carcinoma,1
6690,Carcinomatous Component Present,Intramucosal Adenocarcinoma,1
6691,Malignant Cellular Infiltrate,Hypopharyngeal Cancer,1
6692,Carcinomatous Component Present,Urothelial carcinoma urethra recurrent,1
6693,Recurrent disease,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
6694,Angiocentric Pattern,Childhood Grade III Lymphomatoid Granulomatosis,1
6695,Epithelial Component Present,Bladder Mixed Adenocarcinoma,1
6696,Malignant Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v8,1
6697,Well-Circumscribed Lesion,Preauricular skin tag,1
6698,Chronic Inflammatory Infiltrate,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
6699,Epithelial Component Present,Stage IIIC Colon Cancer AJCC v8,1
6700,Carcinomatous Component Present,Cholangiolocellular Carcinoma,1
6701,Widely Invasive Lesion,Widely Invasive Thymoma,1
6702,High Mitotic Activity,Testicular embryonal carcinoma,1
6703,Intraocular Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
6704,Malignant Cellular Infiltrate,sarcoma of vagina,1
6705,Benign Cellular Infiltrate,lipoma of esophagus,1
6706,Malignant Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v8,1
6707,Low Mitotic Activity,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
6708,Slow Growing Mass,Third Ventricle Pilocytic Astrocytoma,1
6709,Malignant Cellular Infiltrate,Refractory Extranodal Diffuse Large B-cell Lymphoma,1
6710,High Grade Lesion,Stage I Lung Small Cell Carcinoma AJCC v7,1
6711,High Grade Lesion,Adult Brain Glioblastoma,1
6712,Malignant Cellular Infiltrate,Adult Burkitt Leukemia,1
6713,Biphasic Pattern,Female Reproductive System Adenofibroma,1
6714,Slow Growing Mass,Childhood Supratentorial Ependymoma,1
6715,Increased Cellularity Present,Ovarian Cellular Fibroma,1
6716,Infiltrative Growth Pattern,Adult Glioblastoma,1
6717,Malignant Cellular Infiltrate,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
6718,Malignant Cellular Infiltrate,Transitional cell carcinoma urethra,1
6719,Malignant Cellular Infiltrate,Adenocarcinoma of ampulla of Vater,1
6720,Cutaneous Involvement,Trichodiscoma,1
6721,Extraocular Dissemination of Disease,Pediatric Extraocular Retinoblastoma,1
6722,Invasive Lesion,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
6723,Solitary mass,Bronchioloalveolar Adenocarcinoma,1
6724,Carcinomatous Component Present,Serous cystadenocarcinoma ovary,1
6725,Moderate dysplasia,Biliary Intraepithelial Neoplasia-2,1
6726,Primary Lesion,Brain Stem Hemangioblastoma,1
6727,Malignant Cellular Infiltrate,Vaginal Yolk Sac Tumor,1
6728,Malignant Cellular Infiltrate,Secondary malignant neoplasm of testis,1
6729,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
6730,Severe dysplasia,High Grade Ductal Breast Carcinoma In Situ,1
6731,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV,1
6732,Benign Cellular Infiltrate,Trichilemmoma,1
6733,Refractory Disease,Refractory Malignant Neoplasm of Multiple Primary Sites,1
6734,Well-Circumscribed Lesion,Small Intestinal Tubular Adenoma,1
6735,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8,1
6736,Whorling Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
6737,Carcinomatous Component Present,Major Salivary Gland Cancer by AJCC v8 Stage,1
6738,Carcinomatous Component Present,Stage II Pancreatic Cancer AJCC v6 and v7,1
6739,Epithelial Component Present,Papillary tumor of renal pelvis,1
6740,Epithelial Component Present,Anal Cancer by AJCC v8 Stage,1
6741,Malignant Cellular Infiltrate,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
6742,Steatohepatitis,Inflammatory Hepatocellular Adenoma,1
6743,Well-Circumscribed Lesion,tubulovillous adenoma of stomach,1
6744,Epithelial Component Present,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
6745,Microvascular Proliferation,"Glioblastoma, IDH-Wildtype",1
6746,Epithelial Component Present,Stage IV Ileal Neuroendocrine Tumor AJCC v8,1
6747,Local disease,Localized Primitive Neuroectodermal Tumor,1
6748,Well-Circumscribed Lesion,Epididymal Papillary Cystadenoma,1
6749,Benign Cellular Infiltrate,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
6750,Carcinomatous Component Present,"Transitional cell carcinoma, micropapillary",1
6751,Carcinomatous Component Present,Paget disease of anal canal,1
6752,Malignant Cellular Infiltrate,rhabdomyosarcoma of liver,1
6753,Papillary Pattern,Papillary mucinous cystadenocarcinoma,1
6754,Lytic lesion,Osteoclastic Giant Cell-Rich Tumor of Bone,1
6755,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
6756,Cutaneous Involvement,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
6757,Poorly Differentiated Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
6758,Delicate Arborizing Vascular Channel Formation,Refractory Myxoid Liposarcoma,1
6759,Malignant Cellular Infiltrate,Resectable Head and Neck Squamous Cell Carcinoma,1
6760,Mild cytologic atypia,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
6761,Carcinomatous Component Present,Acantholytic squamous cell carcinoma,1
6762,Malignant Cellular Infiltrate,Lung Carcinoma Metastatic in the Liver,1
6763,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
6764,Cutaneous Involvement,Sweat gland carcinoma,1
6765,Biphasic Pattern,Cervical Adenomyoma,1
6766,Trabecular Pattern,Malignant Pancreatic Somatostatinoma,1
6767,Cutaneous Involvement,Clinical Stage IIB Cutaneous Melanoma AJCC v8,1
6768,Somatostatin Positive Neoplastic Cells Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
6769,Carcinomatous Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage,1
6770,Epithelial Component Present,Adenoma of lung,1
6771,Childhood Lesion,Childhood Ovarian Choriocarcinoma,1
6772,Hyperplastic Tissue Present,Adrenal hyperplasia,1
6773,No Identifiable Line of Differentiation,Cardiac Malignant Fibrous Histiocytoma,1
6774,Breast Microcalcification,Childhood Brain Oligodendroglioma,1
6775,Benign Cellular Infiltrate,Benign neoplasm of ureter,1
6776,Metastatic Lesion,Secondary malignant neoplasm of lung,1
6777,Perineural spread,adenoid cystic carcinoma of floor of mouth,1
6778,Non-Hereditary Lesion,Gastric Tubular Adenocarcinoma,1
6779,Epithelial Component Present,Ampulla of Vater Hepatoid Adenocarcinoma,1
6780,Malignant Cellular Infiltrate,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,1
6781,Malignant Cellular Infiltrate,Stage IV Childhood Lymphoblastic Lymphoma,1
6782,Refractory Disease,Hodgkin's disease nodular sclerosis refractory,1
6783,Polymorphic Cellular Infiltrate,"Langerhans cell histiocytosis, unifocal",1
6784,Resectable Mass,Borderline Resectable Pancreatic Adenocarcinoma,1
6785,Hereditary Lesion,Congenital Bone Marrow Failure Syndromes,1
6786,Epithelial Component Present,Gallbladder Tubular Carcinoid,1
6787,Severe dysplasia,Carcinoma in situ of small intestine,1
6788,Benign Cellular Infiltrate,Chondromyxoid fibroma,1
6789,Epithelial Component Present,Breast Apocrine Adenoma,1
6790,Slowly Progressive Clinical Course,Smoldering Systemic Mastocytosis,1
6791,Unresectable Mass,Cholangiocarcinoma non-resectable,1
6792,Epithelial Component Present,Stage IIA1 Cervical Cancer AJCC v7,1
6793,Single Type of Tissue Derived from One Embryonic Layer Present,Benign Struma Ovarii,1
6794,Malignant Germinomatous Cellular Infiltrate,Testicular Seminoma with Syncytiotrophoblastic Cells,1
6795,Benign Cellular Infiltrate,Mature Gastric Teratoma,1
6796,Carcinomatous Component Present,Ampulla of Vater Cancer by AJCC v8 Stage,1
6797,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v8,1
6798,Malignant Cellular Infiltrate,Childhood Conventional Osteosarcoma,1
6799,Alternative Fascicle (Bundle) Pattern,Rectal Leiomyoma,1
6800,Peripheral Nuclear Palisading,basaloid squamous cell carcinoma of floor of mouth,1
6801,Carcinomatous Component Present,Stage II Hilar Cholangiocarcinoma AJCC v7,1
6802,Superficial Lesion,Vulvar Superficial Angiomyxoma,1
6803,Benign Cellular Infiltrate,Kasabach-Merritt syndrome,1
6804,Radial Growth Phase,Superficial spreading malignant melanoma of skin,1
6805,Childhood Lesion,Childhood Acute Myelomonocytic Leukemia,1
6806,High Grade Lesion,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
6807,Carcinomatous Component Present,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
6808,Vascular Channel Formation,AIDS with Kaposi's sarcoma,1
6809,Therapy-Related Toxicity,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
6810,Malignant Cellular Infiltrate,Lung Spindle Cell Carcinoma,1
6811,Malignant Cellular Infiltrate,Follicular Lymphoma by Ann Arbor Stage,1
6812,Recurrent disease,Chondrosarcoma recurrent,1
6813,Osseous Differentiation,Osteoblastic Osteosarcoma,1
6814,Malignant Cellular Infiltrate,"Myeloproliferative Neoplasm, Unclassifiable",1
6815,Epithelial Component Present,Metastatic Lip Carcinoma,1
6816,Epithelial Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,1
6817,Epithelial Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
6818,Malignant Cellular Infiltrate,Stage III Bone Cancer AJCC v7,1
6819,Vascular Channel Formation,Bone Epithelioid Hemangioendothelioma,1
6820,Malignant Cellular Infiltrate,Locally Advanced Unresectable Cervical Carcinoma,1
6821,Epithelial Component Present,Stage III Colorectal Cancer AJCC v8,1
6822,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v8,1
6823,Malignant Cellular Infiltrate,Acinic Cell Breast Carcinoma,1
6824,Neuroendocrine Differentiation,Benign neuroendocrine tumor,1
6825,Epithelial Component Present,Unresectable Craniopharyngioma,1
6826,Epithelial Component Present,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
6827,Ischemia,Vascular insufficiency of intestine,1
6828,Carcinomatous Component Present,Primary peritoneal carcinoma,1
6829,Osseous Differentiation,Stage I Osteosarcoma AJCC v7,1
6830,Carcinomatous Component Present,Undifferentiated carcinoma,1
6831,Carcinomatous Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v7,1
6832,Childhood Lesion,Childhood Choroid Plexus Carcinoma,1
6833,Microcystic Change,Lymphangioma circumscriptum,1
6834,Solitary Skin Tumor,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",1
6835,Papillary Pattern,Papillary carcinoma of the breast,1
6836,Epithelial Component Present,Bladder Non-Invasive Urothelial Neoplasm,1
6837,Malignant Cellular Infiltrate,Childhood Undifferentiated Pleomorphic Sarcoma,1
6838,Malignant Cellular Infiltrate,Childhood Burkitt Lymphoma,1
6839,Carcinomatous Component Present,Stage I Esophageal Squamous Cell Carcinoma AJCC v7,1
6840,Dysplasia,High grade cervical glandular intraepithelial neoplasia,1
6841,Benign Cellular Infiltrate,Venous Angioleiomyoma,1
6842,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
6843,Malignant Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v7,1
6844,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor,1
6845,Epithelial Component Present,Tracheal Carcinoma,1
6846,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,1
6847,Carcinomatous Component Present,Stage IIA Breast Carcinoma,1
6848,Indolent Clinical Course,Odontogenic myxofibroma,1
6849,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage IV,1
6850,Low Grade Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
6851,Malignant Cellular Infiltrate,Metastatic Ductal Breast Carcinoma,1
6852,Recurrent disease,Adenoid cystic carcinoma of the oral cavity recurrent,1
6853,Adulthood Lesion,Lugano Classification Stage II Adult Lymphoma AJCC v8,1
6854,Malignant Cellular Infiltrate,Ovarian Cystadenocarcinoma,1
6855,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
6856,Mixed Cellular Population,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
6857,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
6858,Anaplasia,"Anaplastic Astrocytoma, IDH-Mutant",1
6859,In Situ Lesion,Lobular carcinoma in situ of breast,1
6860,Cystic Change,Broad Ligament Papillary Cystadenoma,1
6861,Acanthosis,Cervical Verrucous Carcinoma,1
6862,Epithelial Component Present,Lower Gingival Squamous Cell Carcinoma,1
6863,Carcinomatous Component Present,Rectal Adenosquamous Carcinoma,1
6864,Benign Cellular Infiltrate,Pilocytic astrocytoma of cerebellum,1
6865,Poorly Differentiated Neuroendocrine Lesion,Unresectable Digestive System Neuroendocrine Carcinoma,1
6866,Epithelial Component Present,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
6867,Metastatic Lesion,Secondary Central Nervous System Hodgkin Lymphoma,1
6868,Borderline Lesion,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
6869,Childhood Lesion,Childhood Acute Myeloid Leukemia without Maturation,1
6870,Carcinomatous Component Present,Stage IIIB Gallbladder Cancer AJCC v7,1
6871,Malignant Cellular Infiltrate,Fascial fibrosarcoma,1
6872,Immature Myeloid Cells Increased in Bone Marrow,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
6873,Epithelial Component Present,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
6874,Benign Cellular Infiltrate,Adrenal Gland Schwannoma,1
6875,Mixed Cellular Population,Childhood Mixed Glioma,1
6876,Low Mitotic Activity,Stage IV Rectal Neuroendocrine Tumor AJCC v8,1
6877,Adulthood Lesion,Stage IV Adult Burkitt Lymphoma,1
6878,Malignant Cellular Infiltrate,Refractory High Risk Myelodysplastic Syndrome,1
6879,Neutrophilia (finding),Chronic Neutrophilic Leukemia,1
6880,Invasive Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
6881,Metastatic Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,1
6882,Intermediate Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2,1
6883,Malignant Cellular Infiltrate,hemangioendothelial sarcoma of bone,1
6884,Malignant Cellular Infiltrate,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
6885,Epithelial Component Present,Ascending Colon Neuroendocrine Tumor G1,1
6886,Malignant Cellular Infiltrate,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,1
6887,Carcinomatous Component Present,Basal cell carcinoma,1
6888,Non-Invasive Lesion,Ampulla of Vater Tubular Adenoma,1
6889,Comedo Necrosis,Colon Cribriform Comedo-Type Adenocarcinoma,1
6890,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
6891,Epithelial Component Present,Hard Palate Mucoepidermoid Carcinoma,1
6892,Papillary Pattern,Papillary Thyroid Microcarcinoma,1
6893,Malignant Cellular Infiltrate,Stage I Colon Cancer AJCC v8,1
6894,Benign Cellular Infiltrate,Dartoic myoma,1
6895,Lesion with Diameter Greater than 15mm,Medium/Large Size Posterior Uveal Melanoma,1
6896,Carcinomatous Component Present,Mucin-producing adenocarcinoma,1
6897,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia,1
6898,Malignant Cellular Infiltrate,Stage IIIA Rectal Cancer AJCC v8,1
6899,Malignant Cellular Infiltrate,basaloid carcinoma of anus,1
6900,Malignant Cellular Infiltrate,Malignant neoplasm of penis,1
6901,Secondary Lesion,Metastatic gastric adenocarcinoma,1
6902,Multifocal Lesion,Refractory Erdheim-Chester Disease,1
6903,Poorly Cohesive Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric,1
6904,Metastatic Lesion,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
6905,Malignant Cellular Infiltrate,Medullomyoblastoma,1
6906,Angioinvasion,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
6907,Mixed Cellular Population,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
6908,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage III",1
6909,Neuroendocrine Differentiation,Ovarian Neuroendocrine Neoplasm,1
6910,Benign Cellular Infiltrate,Fibrous Hamartoma of Infancy,1
6911,Papillary Pattern,Condyloma acuminata of cervix,1
6912,Hyalinized Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
6913,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage II,1
6914,Epithelial Component Present,Advanced Lung Non-Small Cell Squamous Carcinoma,1
6915,Epithelial Component Present,Moderate epithelial dysplasia,1
6916,Severe cytologic atypia,Proximal-Type Epithelioid Sarcoma,1
6917,Well Differentiated Neuroendocrine Lesion,Gastro-enteropancreatic neuroendocrine tumor,1
6918,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis,1
6919,Carcinomatous Component Present,Thymic Mucoepidermoid Carcinoma,1
6920,Well Differentiated Lesion,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
6921,Blasts Under 20 Percent of Peripheral Blood White Cells,Refractory Chronic Myelomonocytic Leukemia,1
6922,Malignant Cellular Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
6923,Hyalinized Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
6924,Malignant Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v8,1
6925,Epithelial Component Present,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
6926,Malignant Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v8,1
6927,Malignant Cellular Infiltrate,basal cell adenocarcinoma of salivary gland,1
6928,Malignant Cellular Infiltrate,Stage IIB Esophageal Carcinoma,1
6929,Tissue Differentiation Uncertain,Cellular Myxoma,1
6930,Osseous Component Present,Osteochondromyxoma,1
6931,Carcinomatous Component Present,Salivary duct carcinoma,1
6932,Low Grade Lesion,Low Grade Lung Neuroendocrine Neoplasm,1
6933,Malignant Cellular Infiltrate,Stage IIIb Penile Cancer AJCC v7,1
6934,Multifocal Epithelial Proliferations Less than 1mm in Diameter Present,Microscopic Thymoma,1
6935,Cutaneous Involvement,Paraganglioma-Like Dermal Melanocytic Tumor,1
6936,Epithelial Component Present,Condyloma anal,1
6937,Bone Marrow Eosinophilia,"Acute myeloid leukemia, inv(16)(p13q22)",1
6938,Malignant Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
6939,Low Mitotic Activity,insulinoma,1
6940,Carcinomatous Component Present,Stage IVB Ovarian Cancer AJCC v8,1
6941,Malignant Cellular Infiltrate,Stage III Small Intestinal Adenocarcinoma AJCC v8,1
6942,Malignant Cellular Infiltrate,Oncocytic Breast Carcinoma,1
6943,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Adult Acute Myeloid Leukemia with Maturation,1
6944,Malignant Cellular Infiltrate,ROSE Cluster 1,1
6945,Thick-Walled Hyalinized Vessels Present,Thyroid Gland Schwannoma,1
6946,Papillary Pattern,Esophageal squamous papilloma,1
6947,Epithelial Component Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12),1
6948,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage I,1
6949,Secondary Lesion,Breast Carcinoma Metastatic in the Lung,1
6950,Low Mitotic Activity,Colorectal Neuroendocrine Tumor,1
6951,Malignant Cellular Infiltrate,ROSE Cluster 1,1
6952,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
6953,Mild cytologic atypia,Laryngeal verrucous carcinoma stage IV,1
6954,Benign Cellular Infiltrate,Benign tumor of penis,1
6955,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
6956,Malignant Cellular Infiltrate,Recurrent Parotid Gland Squamous Cell Carcinoma,1
6957,Pseudoencapsulated Mass,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
6958,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IV,1
6959,Epithelial Component Present,Parathyroid Gland Oncocytic Adenoma,1
6960,Primary Lesion,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
6961,Carcinomatous Component Present,Stage IV Laryngeal Cancer AJCC v6,1
6962,Malignant Cellular Infiltrate,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
6963,Malignant Cellular Infiltrate,Adenocarcinoma of Skene Gland Origin,1
6964,Malignant Cellular Infiltrate,Mediastinal Synovial Sarcoma,1
6965,Carcinomatous Component Present,large cell neuroendocrine carcinoma of bladder,1
6966,Severe cytologic atypia,Extrahepatic Bile Duct Neuroendocrine Carcinoma,1
6967,Benign Cellular Infiltrate,Solitary Myofibromatosis,1
6968,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v7,1
6969,Nuclear Expression of STAT6 Protein,Peritoneal Solitary Fibrous Tumor,1
6970,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Childhood Myelodysplastic Syndrome,1
6971,Dysplasia,Carcinoma in situ of prostate,1
6972,Nerve palsy,Brown-Vialetto-Van Laere Syndrome 1,1
6973,Malignant Cellular Infiltrate,Stage IV Adult Hodgkin Lymphoma,1
6974,Metastatic Lesion,Secondary malignant neoplasm of pancreas,1
6975,Indolent Clinical Course,lipoma of esophagus,1
6976,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma recurrent,1
6977,Low Mitotic Activity,Gastric Carcinoid Tumor,1
6978,Carcinomatous Component Present,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,1
6979,Nuclear Atypia,Classical Glioblastoma,1
6980,Carcinomatous Component Present,Basophilic Adenocarcinoma,1
6981,Carcinomatous Component Present,Stage IIIC Esophageal Cancer AJCC v7,1
6982,Hyaline Cartilage Differentiation,Adult Myxoid Chondrosarcoma,1
6983,Epithelial Component Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
6984,Cystic Change,cystadenocarcinoma of salivary gland,1
6985,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Hematologic Malignancy,1
6986,Carcinomatous Component Present,Stage 0 Vaginal Cancer AJCC v7,1
6987,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Squamous Cell Carcinoma,1
6988,Vascular Channel Formation,Central Nervous System Epithelioid Hemangioendothelioma,1
6989,Malignant Cellular Infiltrate,Smoldering myeloma,1
6990,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Lipid-rich carcinoma,1
6991,Venous Type Vascular Channel Formation,Venous Angioleiomyoma,1
6992,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
6993,Benign Cellular Infiltrate,Benign Esophageal Schwannoma,1
6994,Carcinomatous Component Present,Microcystic adnexal carcinoma,1
6995,Malignant Cellular Infiltrate,Hypopharyngeal Cancer,1
6996,Recurrent disease,Recurrent Malignant Central Nervous System Neoplasm,1
6997,Malignant Cellular Infiltrate,Recurrent WHO Grade III Glioma,1
6998,Osseous Differentiation,High grade surface osteosarcoma,1
6999,Carcinomatous Component Present,Cervical Squamous Cell Carcinoma,1
7000,Infantile Lesion,Infant Leukemia,1
7001,CD56-Positive Neoplastic Cells Present,Aggressive natural killer-cell leukemia,1
7002,Monomorphic Cellular Infiltrate,Childhood Supratentorial Ependymoma,1
7003,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
7004,Childhood Lesion,Childhood Rhabdomyosarcoma,1
7005,Recurrent disease,Recurrent Olfactory Neuroblastoma,1
7006,Carcinomatous Component Present,Stage 0a Penile Cancer AJCC v8,1
7007,Fibrotic Stroma Formation,Ovarian Endometrioid Cystadenofibroma,1
7008,Malignant Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v6 and v7,1
